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QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
The Two-Step Management of Breast Cancer
A dogma has been promoted that in 
women with breast cancer “a diagnos­
tic biopsy specimen should be studied 
with permanent histologic sections be­
fore definitive therapeutic alternatives 
are discussed with the patient”.1 Only 
then is the patient able to decide on 
therapy and be returned to the oper­
ating room for the appropriate opera­
tion. While this may appeal to the 
consumer-advocate who has never 
been faced with the situation and even 
to some clinicians who usually test 
their credos with scientific trials, it 
fails to withstand analysis by common 
sense. Consider these six points:
1. The woman with a newly diag­
nosed breast cancer is seldom emo­
tionally capable of making a rational 
decision.
Recognizing this principle, physi­
cians historically have avoided per­
sonal involvement in the management 
of their own illnesses or those of their 
families. Starting with this lack of 
objectivity that accompanies personal 
involvement, threatened by the diag­
nosis of a malignant tumour about 
which she usually has an unduly pes­
simistic outlook, and often further 
frightened by the nature of the pro­
posed operation, the patient with a 
breast cancer is unlikely to be able 
to discuss her therapy rationally.
2. Patients lack the data base and 
a comprehension of the disease to dis­
cuss it intelligently.
Clinicians who have managed many 
patients with breast cancer can attest 
to its complexity and variability. The 
multiplicity of trials conducted in the 
last decade indicates the physicians’ 
uncertainties in understanding the dis­
ease. How then can a patient who 
depends on articles in the lay press 
have the factual knowledge to com­
prehend the problem?
3. What is there to discuss?
In most circumstances, the diagno­
sis of breast cancer will be obvious 
at the initial consultation with or with­
out the assistance of needle biopsy or 
mammography. When a preoperative 
diagnosis is not confidently made, the 
indication for mastectomy, total or 
segmental, is not changed by the biop­
sy, except perhaps for the grossly rec­
ognizable comedocarcinomas. There­
fore, what is there to be discussed 
that cannot be fully discussed at the 
initial visit? Even advocates of the 
two-step procedure recommend mas­
tectomy with axillary dissection as the 
standard therapy. While the role of 
segmental mastectomy is still un­
known, those who practise it seldom 
learn anything from the biopsy that 
would change an original recommend­
ation for the procedure.
4. Postponing the decision is cruel 
and causes the patient to suffer un­
necessarily.
Most of us can cope with the def­
inite but have trouble managing un­
certainty. Surely it is kinder for the 
patient to know that if the mass is 
malignant, she will awaken from the 
anesthetic to find that the surgical 
treatment has been completed rather 
than to be informed that when time 
and opportunity permit, she will be 
returned to the operating room for 
another procedure, which requires a 
second anesthetic.
5. Two anesthetics increase the 
risk, slight as it is, of an untoward 
event. Even this slight risk is un­
justifiable.
6. The two-step procedure is a 
waste of operating room time and 
hospital beds.
Physicians have the responsibility 
to use wisely these costly community 
resources. The two-step procedure 
abuses operating room time and use 
of hospital beds, denying others these 
facilities.
Some patients, having read of the
two-step procedure in the lay press, 
may propose it. But let us not be 
misled by the understandable denial 
reaction of the patient who may at­
tempt to delay the decisions that are 
usually obvious at the initial office 
consultation. Having liberated women 
from the morbidity of the traditional 
Halsted radical mastectomy, we 
should not now inflict on them un­
necessary confusion and the emotion­
al pressures of indecision associated 
with the two-step procedure.
J.E. D e v i t t . m d , f r c s [c ]
Member,
Editorial Board.
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Editor’s com m ent.—On June 5, 1979 
a consensus panel of the United States 
National Cancer Institute agreed that, 
when measured by duration of sur­
vival, mastectomy with axillary dis­
section and preservation of the pec­
toral muscles provided benefits equiv­
alent to radical mastectomy for stages 
I and II disease. The panel also rec­
ommended that a “two-step procedure 
should be used in most cases, i.e., a 
diagnostic biopsy specimen should be 
studied with permanent histologic sec­
tions before definitive therapeutic al­
ternatives are discussed with the pa­
tient”.1 In his editorial, Dr. Devitt 
gives six reasons for taking issue with 
this second recommendation; chiefly 
he states that: (a) surgeons do their 
own thing anyway; (b) delay causes 
the patient emotional suffering and 
(c) an identical surgical effort is 
hampered by an unnecessary step.
At present, the surgical literature 
contains little data to suggest that any 
procedure —  radical or simple, one- 
step or two-step — significantly alters 
patient survival. Indeed, no procedure
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on the chest wall can realistically be 
expected to alter the ultimate growth 
of micrometastases that must be pres­
ent at the time of extirpation of the 
breast. So outcome measured by dura­
tion of survival can never be used to 
assess the usefulness of a one-step 
versus a two-step procedure. The 
comfort and desires of the patient, 
compassion, concern, empathy and 
understanding of the woman's emo­
tional problems now become the de­
terminants in choosing between the 
one-step and two-step procedures. 
Rigidity of the system, of the surgeon 
or of the operative schedule all con­
spire to play against the emotional 
needs of women who face the prob­
lem of a mass in the breast and are 
expected to go to the operating room 
uncertain of the outcome (i.e., pos­
sible amputation of the breast at the 
discretion of a surgeon, without her 
psychologic preparation).
The- “first” step may be performed 
in the office or rarely through short- 
stay, day surgery. A needle biopsy,
punch biopsy or even a small open 
biopsy will generally give a positive 
diagnosis and only those women with 
proven carcinoma of the breast need 
undergo operation. They can go to 
the operating room with a definitive 
plan of treatment, with a contract 
negotiated between doctor and patient 
that permits the nature of the opera­
tive procedure to be known before 
the operation is carried out.
Adherence to a two-step procedure 
thus spares unnecessary fear and an­
guish in women who might be oper­
ated upon for benign disease, also 
saving operating room cost and effort. 
It provides the woman with cancer 
of the breast an opportunity to pre­
pare for amputation of her breast, 
not to participate in the decisions 
about which treatment may be “bet­
ter” than another, but which treat­
ment will better serve that woman’s 
particular emotional problems created 
by the imminent amputation.
Recently, a Hamilton group at­
tempted to see whether or not women
responded to their mastectomy for 
carcinoma of the breast in a fashion 
similar to the “death and dying” steps 
set forth by Kiibler-Ross. The study 
was terminated because the investiga­
tors were unable to place the variable 
attitudes of these women into a com­
prehensive sequential set of responses. 
They concluded that each woman was 
different, each has her own particular 
set of emotional and psychologic 
needs. Some, if not most, may be par­
tially satisfied by the time taken and 
knowledge imparted in the “two-step” 
procedure, needs that are not satisfied 
in the one-step, “go and when you 
wake up you will find out what has 
happened to you”, type of procedure. 
The two steps place extra demands 
on the surgeon, but are more satisfac­
tory for the patient.
C. Ba rber  M u e l l e r , m d , f r c s [c ] 
Reference
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Techniques and Results of Arterial Prosthetic 
Bypass for Aortoiliac Occlusive Disease
In order to understand where we are 
today in the treatment of aortoiliac 
disease, it is useful to remember the 
route we travelled.
In 1935, my teacher, Gordon 
Murray, was the first to give heparin 
to a patient; without this tool, vascular 
surgery would have been delayed or 
have followed a different path. Cana­
dian surgeons are proud that this 
major door to elective vascular sur­
gery was opened in our country. Pro­
gress was slow for the next decade, 
but then accelerated. Within a few 
years after World War II, the prin­
ciples of endarterectomy (dos Santos, 
1947;1 Wylie, 19522), excision of a 
blocked iliac artery with allograft ar­
terial replacement (Oudot. 1951 ;3 
Julian, 19524) and bypass grafting 
from the aorta to the iliac or femoral 
arteries (DeBakey, 19545) had been 
established. Vascular surgery was bur­
geoning.
Voorhees and colleagues introduced 
the first fabric arterial prosthesis in 
1952;6 within 5 years very acceptable 
Teflon7 and Dacron8 grafts were avail­
able. Soon the principle of bypass 
grafting, using a prosthetic arterial 
graft, had become the most common
form of surgical treatment for aorto­
iliac obstruction.
The results, with few exceptions, 
were spectacular; with these new tools, 
we entered the golden age of vascular 
surgery.
What Is the Prosthesis of Choice?
The lesson of the 1960s was that 
Dacron fabric grafts edged out Teflon 
fabric grafts. Why? There was no 
clear evidence that one performed 
better than the other. The nonwettable 
quality of Teflon was said to be bad. 
Why so? Whether it was from better 
advertising and marketing or from 
the chauvinistic but effective advocacy 
of certain prominent vascular sur­
geons, the market for fabric Teflon 
grafts had disappeared by 1970. It is 
ironic and educational to watch the 
current rising prominence of the poly- 
tetrafluoroethylene (PTFE) graft, 
which is even more “unwettable” than 
Teflon.
In the early 1970s, porosity became 
the magic selling formula. “High por­
osity” became synonymous with “good 
healing” and, by implication in many 
articles and brochures, with the pro­
duction of a normal endothelium. 
This was wishful thinking. A true 
endothelium created by transporous 
migration of granulation tissue has 
been described only once in the entire 
experience of prosthetic arterial im­
plantation in man;9 this “true endo­
thelium” was scattered and over less 
than one third of the surface of one 
axillofemoral graft. Despite the lack 
of evidence for their superiority, high 
porosity grafts, with an attendant risk 
of large blood loss during implanta­
tion and often of unproven durability, 
were highly popular for a few years.
In the mid-1970s, as porosity be­
came perceived as less important, we 
were tempted by the concept of a 
shaggy or velour surface. An “internal 
velour” had some obvious superiority 
in lining the moving chambers of an 
artificial heart. There is no evidence 
that it increased the patency rate of 
bypass grafts in the aortofemoral po­
sition.
An “external velour” allows the 
graft to become more firmly encapsu­
lated. The assumption, however, that 
such a process improves patency or 
makes infection less likely is still un­
proven.
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None the less, the prosthetic arteries 
of today are better than those avail­
able 20 years ago; they don’t fray, 
they have useful longitudinal marks 
to avoid twisting, they are soft and 
compliant and they are easy to sew.
To strive for im provem ent is com­
mendable, both for surgeons and graft 
m anufacturers. However, in the quar­
ter century since the introduction of 
crimped Dacron and Teflon grafts, 
there has been little improvement in 
the patency rates of aortofem oral by­
pass grafts.
We should continue to search for 
better prostheses, but at present I ad­
vise the prudent surgeon to choose a 
graft: (a) from a reputable m anufac­
turer, whose sales organization offers 
good service and a fair price; (b) in 
which the porosity is known and is 
compatible with personal surgical 
technique; (c) for which the lengths, 
diameters and markings on both sides 
of the bifurcation are known and, 
again, are suited to personal technique; 
and (d) which is currently the stand­
ard in his institution. Surgical repair 
of aortoiliac obstruction is usually a 
delight. An excellent result is con­
fidently expected and a planned, 
smooth, trouble-free operation is a 
pleasure to watch or to perform . Sud­
den exposure to a graft of unknown 
quality can be disastrous.
What Are the Proper Anastomotic 
Sites?
In the early 1970s, the common 
femoral artery replaced the external 
iliac as the preferred site for the dis­
tal artery anastomosis. Blood was 
delivered directly to the proper site, 
problems in the proxim al deep fe­
moral artery were sim ultaneously cor­
rected and the need for subsequent 
groin repair was diminished.
Accurate knowledge of the anatomy 
of the deep femoral artery and how 
to manage this vessel correctly became 
the hallmark of the experienced vas­
cular surgeon, who will always achieve 
adequate exposure to examine prop­
erly as long a segment of this artery 
as necessary, who will divide the la­
teral femoral circumflex veins if ne­
cessary and who will always strive to 
achieve unobstructed flow into this 
all-important vessel.
The deep femoral artery should al­
ways be approached lateral to the su­
perficial artery. It is a friable vessel 
and must be handled delicately. 
Preservation of its lateral circumflex 
branch is essential.
Although concurrent obstruction of 
the superficial fem oral artery is pres­
ent in about 40% of patients receiving 
aortofem oral bypass grafts, only a few 
will require a simultaneous down­
stream repair. Usually this is only 
done for patients suffering from in­
cipient gangrene. Since the arterial 
pressure at the ankle and flow to the 
muscles of the calf will both continue 
to rise for 1 to 2 days following an 
aortofem oral repair, a delayed down­
stream repair, if necessary, is the 
prudent course for most patients.
The proximal anastomosis should 
be just below the left renal vein. It 
mav be end-to-end or end-to-side.
In the mid-1960s, manv vascular 
surgeons began to prefer the end-to- 
end proximal anastom osis: it seemed 
to provide better protection against 
downstream em bolization and “trash 
foot”. It allowed better graft coverage 
and thus fewer late problems with 
the duodenum . It was hoped it would 
provide better long-term  patency.
I prefer to remove about l cm of 
aorta, cut the trunk of the graft short 
and thus have the bifurcation lie in 
the same anterior-posterior plane as 
the original aorta. The right limb rises 
slightlv to pass in front of the vena 
cava; the left lies behind all the veins 
and arteries of the inferior mesenteric 
axis. W ith this technique, problems 
arising from  an ischemic sigmoid co­
lon are avoided and, since the graft 
does not impinge on the duodenum, 
the tragic com plication of an aorto- 
duodenal fistula is also avoided.
I restrict the use of an end-to-end 
proxim al anastom osis to women with 
arterial hypoplasia, men with external 
iliac stenosis and a concern with 
sexual potency, patients with aber- 
rent renal arteries, and those with a 
large patent inferior mesenteric artery 
associated with bilateral iliac artery 
occlusion.
I am com fortable with this tech­
nique, but rem ind the reader that this 
is still an area of controversy. M any 
com petent vascular surgeons still p re­
fer a proximal end-to-side anasto­
mosis.
The “Extra-Anatomic” Approaches
The transobturator route was in tro­
duced by Shaw and Baue in 1963.10 
It can start from any major artery 
within the abdom en and run to the 
deep fem oral artery, the superficial 
femoral artery, or both. The long­
term results are excellent and every 
vascular surgeon should be familiar 
with this technique.
The crossfem oral route was in tro­
duced by Vetto in 1962.” When one 
iliac system is open or can be opened
by translum inal dilatation, this re la­
tively m inor operation provides very 
reasonable long-term  results. I use it 
in patients w ith the appropriate an a­
tom y who, fo r reasons of age or 
obesity, are not suited to the standard  
aortofem oral repair.
The axillofem oral graft was in tro ­
duced by Blaisdell and H all in 1963.12 
It has a tendency to nocturnal com ­
pression by the rib cage and m ay r e ­
quire repeated throm bectom y bu t it, 
too. has stood the test of tim e and 
has saved m any lives and limbs. I t is 
my im pression that P T F E  grafts and 
the “externally supported” D acron  
grafts may provide better results in 
this operation.
I  in troduced the ascending aorta-to - 
fem oral bypass in 1975.13,14 I t is an 
option for the patient in whom the 
abdom inal ao rta  cannot be used and 
may be com bined w ith a concurren t 
cardiac operation. The peritoneal ca­
vity is not entered. The graft follows 
the main ventral anastom otic route of 
the internal m am m ary and inferio r 
epigastric arteries; it lies behind the 
rectus m uscle and in fron t of the pos­
terior rectus fascia and peritoneum . A 
graft in this position is not visible o r 
palpable and cannot be com pressed 
by external pressure. The operation 
is technically easy and the long-term  
patency has been excellent.
What Results Can Be Anticipated?
T he standard  aortobifem oral bypass 
is a good operation. It carries a low 
m ortality and m orbidity and provides 
excellent long-term  patency.
In 1981, Stanley C raw ford15 pub­
lished a m onum ental review of his 
25-year experience with alm ost 1000 
patients. H e stated: “H ospital m o rta l­
ity decreased from  8%  in the 1950s 
to 3%  in the late 1960s, w here it has 
rem ained.” This is true in most cen ­
tres today.
H alf o f the 3%  o f patients w ho 
die in hospital succum b from  m yo­
cardial in farction , the others from  a 
mixture of stroke, pulm onary em bol­
ism and m ultiple system failure.
The 97%  who leave hospital co n ­
tinue to suffer the ravages of age and 
generalized atherosclerosis; 25%  die 
in 5 years and 50%  in 10 years. These 
patients have a 10-year decrease in 
expected survival over the general 
population.
T here is agreem ent from  m any 
studies tha t the expected long-term  
patency of an aortofem oral bypass is 
excellent. F rom  a consensus of recen t 
reports, we can expect patency of 
85%  at 5 years, 70%  at 10 years,
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60% at 15 years and 55% at 20 
years. This represents a patency attri­
tion rate of only 2% a year as com­
pared with 5% a year for femoropop- 
liteal saphenous vein bypass.
In more simple terms; 10 years 
after an aortofemoral graft, the pa­
tient has a 70% chance of it still 
working and a 50% chance of being 
alive. Ten years following an isolated 
femoropopliteal repair with a saphen­
ous vein, a patient has a 50% chance 
of it still working and a 30% chance 
of being alive.
To quote Felix Eastcott in this “by 
far the most fruitful field in our spe­
cialty”, we have been fortunate in 
our generation to have had the tools 
to provide a very successful answer 
to aortoiliac occlusive disease.
Ronald J. Baird, md, frcs[c], facs
Member,
Editorial Board.
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To Potential Authors
The Canadian Journal of Surgery is 
an instrument of communication 
available to Canadian surgeons of all 
disciplines. Its mission is continuing 
medical education, its orientation is 
towards its readers. Its authors come 
from a company of Canadian sur­
geons — from almost all disciplines 
— most of whom have never written 
before. Your coeditors and the editorial 
board of the Journal believe that many 
of you have something to say. You 
may make clinical observations, you 
may describe methods, give impres­
sions, provide tables or lists of pa­
tients. Some of you may be attracted 
to write. If you have a message and 
if the content is acceptable, our edi­
torial staff in Ottawa will assist in 
making your material presentable. 
Our function is to help people express 
ideas, and we want to encourage 
your expression. If you have thoughts 
on any surgical subject we will help 
put it into the format that will present 
your thoughts most favourably. The 
coeditors hope that you may be en­
couraged to write and are ready to 
assist you in making worthwhile con­
cepts and ideas acceptable to your 
peers.
C.B. Mueller, md, frcs[c]
L.D. M acL e a n , md, FRCSfc]
Coeditors
SESAP III Question
38. Hypomagnesemia is frequently associated with each of the follow­
ing diseases EXCEPT
(A) hypoparathyroidism
(B) hypothyroidism
(C) cirrhosis
(D) pancreatitis
(E) short bowel syndrome
For the incomplete statement above select the one answer that is best 
of the five given. For the critique of Item 38 see page 531 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education 
and Self-Assessment Program No. 3. For enrolment in the Surgical Edu­
cation and Self-Assessment Program No. 3, please apply to the American 
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Mechanism of Perforation Occurring 
in the Intussuscipiens
during Hydrostatic Reduction of Intussusception
Stanley  M ercer , m d , fr c s[c]* and B lair C a r p e n t e r , m d , f r c p [c] |
Perforation of bowel during attempted 
hydrostatic reduction of an 
intussusception almost always 
occurs through the distal, apparently 
uninvolved bowel. It is probably never 
seen except in a group of at-risk 
children, under 6 months of age.
It is not related to unduly high 
enema pressure, but to involvement 
of the blood supply in the intussus- 
ceptum and obstruction of the blood 
supply with resulting ischemic changes 
in the "apparently” uninvolved 
intussuscipiens. The authors provide 
support for their suggested mechanism 
by their findings at operation and 
in the resected specimens from seven 
children with an irreducible 
intussusception and one 5-month-old 
child whose bowel perforated during 
attempted hydrostatic reduction. 
Because children under 6 months 
of age are susceptible to perforation, 
hydrostatic reduction of intussuscepted 
bowel is contraindicated.
La perforation de I’intestin durant 
une tentative de reduction 
hydrostatique d’une intussusception 
survient presque toujours dans 
la partie distale, apparemment 
intacte, de I’intestin. Ceci n'est 
probablement observe que chez 
un groupe d'enfants exposes, 
ages de moins de 6 mois.
Elle n'est pas due a une pression 
exagerement elevee du liquide
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of surgery, University of Ottawa, 
Ottawa, Ont.
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Accepted for publication Apr. 26, 1982
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de lavement, mais plutot a une 
atteinte de la circulation sanguine 
dans I’intussusceptum et a 
I'obstruction de la circulation 
causant des changements ischemiques 
dans la partie “apparemment” 
intacte. Les auteurs proposent des 
arguments a I'appui du mecanisme 
suggere, arguments issus de leurs 
observations a I’operation et sur 
les echantillons reseques chez 
sept enfants presentant une 
intussusception irreductible 
et chez un enfant de 5 mois dont 
I'intestin s'est perfore durant une 
tentative de reduction hydrostatique. 
Comme les enfants de moins de 
6 mois sont sensibles a une 
perforation, la reduction hydrostatique 
est contre-indiquee dans les cas 
d’intussusception intestinale.
In the past 7 years we have noted 
a marked increase in perforation of 
the bowel during attempted hydrostatic 
reduction of acute intussusception. 
Such perforations almost always oc­
cur in an at-risk group — children 
under 6 months of age,1 through the 
apparently uninvolved intussusci­
piens2'4 rather than the intussuscep- 
tum. This is at variance with frequen­
tly stated views.5,6
We have reviewed our findings in 
children with irreducible intussuscep­
tion who underwent resection in an at­
tempt to discover the mechanism of 
perforation that occurs during barium 
enema, whether diagnostic or thera­
peutic.
Patients and Methods
Between January 1974 and Decem­
ber 1981, 106 children with acute in­
tussusception were seen at the Chil­
dren’s Hospital of Eastern Ontario, 
Ottawa. In 100, hydrostatic reduction 
was attempted; it was successful in 
69 children. The 31 in whom it failed, 
and 6 children not considered suitable
for barium enema (for such reasons 
as shock and duration of symptoms), 
were operated upon. Eight of these 
37 children underwent resection for 
irreducibility; the other 29 had sim­
ple manual reduction of the intussus­
ception. Of the children who under­
went resection, one was 15 months old 
and the other seven were less than 
10 months of age. Attempted hydro­
static reduction, carried out 72 hours 
after the first symptoms of intussus­
ception appeared, was followed by per­
foration of the right side of the trans­
verse colon in a 5-month-old child 
who underwent resection. The stand­
ard technique of hydrostatic reduction 
was used.
Findings
We believe the mechanism of per­
foration of the distal bowel in this 
and other cases is obstruction of the 
bowel’s blood supply with consequent 
ischemic changes, the vascular ob­
struction being caused by inclusion of 
the branches of the superior mesen­
teric artery to the ascending and right 
half of the transverse colon within the 
intussusceptum. The intussuscipiens 
itself is not included. The superior 
mesenteric artery ends as the ileal 
artery and this anastomoses with the 
ileocolic artery (Fig. I7). The anasto­
mosis between the ileocolic and right 
colic arteries may be incomplete. The 
evidence for this suggested mechanism
FIG. 1—Superior mesenteric artery and 
branches (after Grant7).
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of perforation, obtained from our 
operative findings and examination of 
resected specimens, is as follows.
Operative Findings
Before and during reduction, the 
arteries and veins of the distal bowel 
are involved in the intussusceptum 
and are obstructed. At the same time 
there is lymphatic obstruction of the 
distal bowel, evidenced by dilated lym­
phatics and enlarged, congested lymph 
glands, seen along the ascending and 
right transverse colon after reduction. 
(This lymph-gland enlargement has 
wrongly been considered as part of a 
local infection and as a possible cause 
of the intussusception. It is, in fact, 
the result and not the cause of the 
intussusception.)
Resected Specimens
Resected material from four pa­
tients, including the child with perfo­
ration, was examined macroscopically 
and microscopically. The microscopic 
appearances in the intussuscipiens 
showed a spectrum of changes, second­
ary to vascular and lymphatic ob­
struction. Fig. 2 represents one end of 
the spectrum. The changes consist of 
minor hemorrhage and congestion in 
the lamina propria but, apart from 
congestion, there are no changes in 
the submucosa. Fig. 3 shows hemor­
rhage into the lamina propria, edema 
and slight hemorrhage in the submu­
cosa with gross lymphatic dilatation. 
There is no ulceration of the mucosa. 
In Fig. 4 hemorrhage in the lamina 
propria and submucosa is evident. 
There is marked congestion in the 
submucosa and some loss of mucosal 
epithelium. Fig. 5 at the other end 
of the spectrum shows perforation of 
the transverse colon with barium on 
the internal and external surfaces. 
Proximal to the perforation there is 
marked hemorrhage into the lamina 
propria and submucosa, marked con­
gestion in both layers and ulceration 
of the mucosa.
D iscussion
Figs. 2 to 5 illustrate the effect of 
increasing obstruction of the blood 
and lymphatic supply to the intussus­
cipiens. This leads to necrosis of the 
bowel wall. We believe that the ob­
struction occurs at two levels.
•  The terminal arcades of the 
ileal, ileocolic, right colic and middle 
colic vessels anastomose. The ana­
stomosis between the ileocolic and 
right colic arterial arcades is often 
poor.8 The major blood supply to the 
hepatic flexure (the ascending branch 
of the right colic or the right branch
of the middle colic arteries) is quite 
variable. These arcades are sequential­
ly involved in the intussusception be­
fore involvement of their parent ves­
sels and so the blood supply of the 
distal bowel is impaired before it be­
comes involved in the intussuscep­
tum.
•  Perhaps more important, the 
origins of these branches from the 
right side of the superior mesenteric 
artery, which go to the ascending 
colon and the right transverse colon, 
become obstructed as the superior 
mesenteric artery itself is drawn into 
the intussusceptum. In this way also 
there is interference with the blood 
supply of the distal bowel before it 
is drawn into the intussusceptum. This 
vascular deprivation is related to the 
prolonged duration of the intussuscep­
tion typical of the at-risk group of 
very young children in which perfora­
tions occur. In our series, approxima­
tely 50% of patients were under 1 
year of age. Resections were required 
for seven children because of irredu- 
cibility and for one because of per­
foration; seven children were less 
than 10 months of age. The child 
whose bowel perforated at barium 
enema was 5 months old. It is pos­
sible that the intraluminal pressure 
reached in children of this age group, 
together with the usual enema pres­
sure, is greater than that produced in 
the bowel lumen of an older child. No 
clear study of this has been com­
pleted although we are presently en­
gaged in such a study. It has also 
been suggested that prolonged direct 
pressure of the intussusceptum on the
FIG. 2— Intussuscipiens. Hemorrhage 
in lamina propria (arrow). Mucosa is 
intact. Submucosal congestion without 
hemorrhage (hematoxylin-phloxine-saf- 
fron stain, reduced by 57% from x480).
FIG. 3— Mucosa is intact, but there is 
marked hemorrhage in lamina propria 
and slight hemorrhage and marked lym­
phatic dilatation in submucosa (hema- 
toxylin-phloxine-saffron stain, reduced 
by 68% from xlOO).
FIG. 4— Intussuscipiens shows marked 
hemorrhage in lamina propria and sub­
mucosa. There is congestion in submu­
cosa and some mucosal loss (hematoxylin- 
phloxine-saffron stain, reduced by 57% 
from x 375).
FIG. 5—Perforated intussuscipiens 
(middle arrow). Barium (right hand 
arrow) is on outer and upper surface 
of colon. There is marked mucosal loss 
proximal (left hand arrow) to perfora­
tion. There is gross hemorrhage in lamina 
propria and submucosa (hematoxylin- 
phloxine-saffron stain, reduced by 68% 
from x  50).
482 VOLUME 25, NO. 5, SEPTEMBER 1982 / THE CANADIAN JOURNAL OF SURGERY
inner wall of the intussuscipiens causes 
necrosis. This may be so, but such 
necrosis should be limited to the intus­
suscipiens in direct contact with the 
intussusceptum. We have not seen 
evidence of this localized necrosis and 
believe that the cause of ischemic 
changes in the intussuscipiens is se­
quential involvement of the blood 
supply of the distal bowel before it 
is intussuscepted. These ischemic 
changes allow perforation of the in­
tussuscipiens without undue hydrosta­
tic pressure and without unduly pro­
longed attempts at reduction.
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Obliteration of Processus Vaginalis 
and Inguinal Hernial Sacs in Children
J .T . M o m o h , m d , fr c s[c ]
The configuration of the sac in 
100 children presenting consecutively 
with inguinal hernia was studied in 
an attempt to understand the 
mechanism of obliteration of the 
processus vaginalis. Seven 
ciinicoanatomic varieties were found. 
From a review of these, three possible 
mechanisms of obliteration of the 
processus are postulated: (a) 
progressive fibrous obliteration of 
the funicular portion of the process 
in a cephalad direction beginning 
above the epididymis, (b) initial 
compression of the funicular portion 
of the process into a narrow tubular 
structure by surrounding tissue 
pressure followed by fibrous 
obliteration and (c) initial segmentation 
of the funicular portion followed by 
variable fibrous obliteration. The 
testicular portion of the process, in 
any of the above mechanisms, 
shrinks to form two membranes with 
potential space between them as the 
contained fluid is absorbed. The 
types of potential hernial sacs resulting 
from arrest of any of these forms 
of obliteration are also described.
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Chez 100 enfants qui ont ete 
examines consecutivement 
pour une hernie inguinale, la 
configuration du sac a ete etudiee 
dans une tentative pour comprendre 
le mecanisme d'obliteration de 
I'apophyse vaqinale. Sept varietes 
clinico-anatomiques ont ete 
retrouvees. De I'etude de celles-ci, 
trois mecanismes possibles 
d’obliteration de I'apophyse sont 
postules: a) ('obliteration fibreuse 
proqressive de la partie funiculaire 
de I’apophyse en direction cephalique 
a partir du dessus de I'epididyme, 
b) la compression initiate de la 
partie funiculaire de I'apophyse 
en une stucture tubulaire etroite, 
par la pression des tissus 
environnants, suivie d'une obliteration 
fibreuse et c) une segmentation 
initiale de la partie funiculaire 
suivie d’une obliteration fibreuse 
variable. La partie testiculaire 
de I'apophyse, dans chacun des 
mecanismes decrits precedemment, 
se resserre jusqu'a former deux 
membranes avec possibility d'un 
espace entre les deux lorsque le 
liquide qu’elle contient est absorbe.
On decrit les types possibles de sacs 
herniaires resultant de I'arret de I'une 
ou I'autre de ces formes 
d'obliteration.
The embryologic development of the 
processus vaginalis and its relation to 
the descent of the testis have been 
well established.1 It is also accepted 
that the development of inguinal her­
nias in children is related to faulty
bliteration of that structure.2,3 How­
ever, there are still some fundamental 
questions about the processus vagin­
alis that remain unanswered. For ex­
ample, why do some processes develop 
into hernias and others do not, even 
though the process remains patent; 
what are the factors that militate 
against the obliteration of the pro­
cessus and what is the actual mech­
anism of obliteration?
The review of Rowe and associates2 
gave partial answers to the first two 
questions but, except for the view 
put forward by Warwick and Wil­
liams,4 little has been written to an­
swer the third question.
In an attempt to establish the mech­
anism of obliteration of the processus 
vaginalis, the anatomic configuration 
of peritoneal sacs found in 100 chil­
dren consecutively operated on for 
inguinal hernia were studied. In ad­
dition, routine contralateral inguinal 
exploration permitted examination of 
the opposite processus. Two basic as­
sumptions were made by the study: 
(a) whatever sac was found repre­
sented a processus that either had 
completely failed to obliterate (as in 
a complete congenital hernia) or one 
in which the course of obliteration 
had been arrested for one reason or 
another (as in a funicular hernial sac) 
and (b) a study of these configura­
tions would give a reliable guide to 
the possible obliterative mechanisms 
of the processus vaginalis.
Patients and Method
The children studied ranged in age
VOLUME 25, NO. 5, SEPTEMBER 1982 / THE CANADIAN JOURNAL OF SURGERY 483
from 1 Vi months to 12 years; 94 
were boys and 6 were girls. At opera­
tion the external oblique fascia and 
external ring were opened widely to 
permit adequate study of the configu­
ration of the sac. Patients noted to 
have a unilateral hernia also under­
went contralateral inguinal explora­
tion to search for a patent processus 
vaginalis. Two boys had had unilateral 
herniotomy done at other hospitals 
before presenting to us with a second 
hernia; therefore, we explored only 
186 groins in the 94 boys.
R esu lts
In the 186 groins explored 128 sacs 
were found, 28 in the contralateral 
groin of those with unilateral hernias. 
In the six girls sacs were found in 
nine groins. These children were ex­
cluded from subsequent analysis be­
cause of the small number. From a 
study of the anatomic configuration 
of the sacs an^ l a review of the initial 
clinical presentation of the children 
we noted seven major clinicoanatomic 
groups: a complete congenital hernia 
in 35.9% (46 of 128) (Figs. 1 and 2), 
funicular hernia in 31.2% (40 of 128) 
(Fig. 2b), hernia with encysted hydro­
cele in 14.1% (18 of 128) (Fig. 3), 
communicating hernia-hydrocele in 
7% (9 of 128) (Fig. 4), hernia with 
hydrocele of the spermatic cord in 
1.6% (2 of 128) (Fig. 5), capillary 
and fibrosing hernia in 3.9% (5 of 
128) and 1.6% (2 of 128) respect­
ively (Fig. 6) and scrotal hydrocele 
in 3.2% (4 of 128) (Fig. 7).
Among those with detectable her­
FIG . 1—Complete congenital hernia.
FIG . 2—(a) Complete congenital her­
nia (46 sacs), (b) Funicular hernia (40). 
Numbers represent children who had 
these types of hernia.
nias, the clinical presentation was in­
termittent inguinal or inguinoscrotal 
swelling when the sac was in the 
position shown in Fig. 2. Children 
presented mainly with persistent scro­
tal swelling with or without a thick­
ened spermatic cord on palpation 
when the sac was as in Figs. 3, 5 and 
7. Types depicted in Fig. 4 presented 
with scrotal swelling which emptied 
slowly on firm, gentle pressure or at 
night when the patient was recum­
bent. Types in Fig. 6 presented with 
thickened spermatic cord only.
Of interest in the present context 
was the finding that the capillary and 
fibrosing sac and the variant of funi­
cular sac that were all located within 
the confines of the internal and ex­
ternal rings were found exclusively in 
the contralateral groins of children 
presenting with unilateral hernia. 
This suggests that these sacs were in 
the process of obliteration and would 
not likely have presented later in life.
D iscussion
Warwick and Williams4 suggested 
that closure of the processus vaginalis 
begins both at the deep inguinal ring 
and just above the epididymis, gradu-
FIG. 3— Hernia with encysted hydro­
cele (18). PF =  preperitoneal fat.
FIG. 4— Communicating hernia-hydro­
cele (9).
ally extending until the whole of the 
intervening portion of the process is 
converted into a fibrous cord. From 
our study this appears to be a very 
uncommon mechanism of closure. In 
only one patient could we identify a 
constriction ring just beyond the in­
ternal ring. Moreover, if this mech­
anism was frequently in operation we 
would have expected more examples 
of hydrocele of the spermatic cord in 
our study.
A close look at the anatomic con­
figurations of sacs found in our pa­
tients points to three possible mech­
anisms of obliteration of the pro­
cessus vaginalis (Fig. 8).
•  The first mechanism (Fig. 8, A) 
involves a constriction progressing to 
complete closure, which develops in 
the process proximal to the epididy­
mis. This is followed by a progressive 
obliteration of the sac in a cephalad 
direction towards the internal ring, 
until a fibrous cord of variable thick­
ness is the only remaining vestige. 
Interruption of this course leads to 
potential funicular, communicating 
hernia-hydrocele or encysted hydro­
cele varieties of hernia. The large 
proportion of patients in all age 
groups with funicular hernia indicates
FIG . 5—H ernia with hydrocele of cord 
(2 ) .
FIG . 6— (a) Capillary hernia (5). (b) 
Fibrosing sac (2).
FIG . 7— (a) True hydrocele (2). (b) 
Large internal ring with plug of peri­
toneal fat (1). (c) Sliding hernia (1). 
C f I I — cecum and terminal ileum.
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that this is the most common mode 
of obliteration irrespective of the 
child’s age.
•  The second possible mechanism 
(Fig. 8, B) involves compression of the 
entire length of the processus vaginalis 
into a narrow channel by surrounding 
tissue. This is then followed by pro­
gressive fibrous obliteration in a ce- 
phalad direction, beginning just above 
the epididymis. Interruption of this 
obliterative process leads to sacs found 
in either the communicating hernia- 
hydrocele or the capillary or fibrosing 
funicular hernia.
•  The third possible mechanism 
(Fig. 8, C) involves segmentation of 
the funicular portion by one or more 
constricting rings, some of which may 
close completely to form cysts of the 
cord. This is then followed by fibrous 
obliteration which may or may not be 
as orderly as in the mechanisms de­
scribed above. When obliteration is 
incomplete the end result is a poten­
tial hernia with encysted hydrocele, 
a hernia with hydrocele of the cord 
or a hydrocele of the cord alone.
Mechanisms B and C are less com­
mon than A; however, they are more 
likely to be operative in older chil­
FIG. 8
dren since in our series the types of 
hernia that can be associated with 
their arrest were found in children 1 
year of age and older.
Irrespective of the mechanism of 
obliteration of the funicular portion, 
the testicular portion of the process 
shrinks to form two opposed mem­
branes with a potential space be­
tween them as the contained fluid 
is taken up by the surrounding 
lymphatic vessels. When this fails, a 
hydrocele results and where there is 
failure of closure of the funicular por­
tion as well, a complete congenital 
hernia results. The rare occurrence of 
scrotal hydrocele alone in children 
suggests that fluid retention in the tes­
ticular portion is always indicative of 
patency of the funicular process.
I thank Mrs. Sue Renner of the med­
ical illustration unit for the drawings, 
and Mallam Lamidi for secretarial help.
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Operation de KasaV pour atresie des voies 
biliaires extra-hepatiques: cure ou palliation?
H erve B lanchard , m d , frc s[c ], faap , P ierre B rochu , m d , f r c p [c], A rie L. B ensoussan , md
et Ph il ip p e  M o n t u pe t , md
L’operation de Kasai, porto-enterostomie 
ou porto-cholecystostomie, represente 
actuellement I'unique forme de 
traitement chirurgical de I'atresie 
des voies biliaires extra-hepatiques 
de type non corrigeable. Sur 17 patients 
operes a I'Hopital Sainte-Justine,
11 ont eu une excretion evidente 
de bile. Une evolution de 12 a 60 mois 
apres I’intervention, montre que 
huit patients sont vivants avec une 
excretion biliaire.
Des 17 patients operes, 12 ont 
presente des complications infectieuses 
et hemorragiques. Six des huit 
patients vivants presentent des 
manifestations cliniques et biologiques 
de souffrance hepatocytaire.
(.'excretion de bile et la regression 
de I'ictere ne semblent pas mettre 
ces patients a I’abri d'une aggravation 
progressive de leur maladie.
The only surgical treatment currently 
available for patients with extrahepatic 
biliary atresia is portoenterostomy 
or portocholecystostomy, the Kasai 
operation. Seventeen such patients 
were operated upon at the Hopital 
Sainte-Justine; 11 had bile excretion. 
Eight are still alive 12 to 60 months 
after operation. They have good to fair 
bile excretion. Twelve of the 
17 patients had infectious or 
hemorrhagic complications and 
hepatic deficiency is evident in 6 of 
the 8 living patients.
The progressive deterioration of 
liver function in the majority of the 
patients still alive raises the 
question of whether the Kasai 
procedure should be considered a 
curative or only a palliative procedure.
Division de chirurgie generate 
pediatrique et de pathologie, Hopital 
Sainte-Justine, Universite de Montreal, 
Montreal, PQ
Presente au 13e congres annuel de 
l’Association canadienne de chirurgie 
pediatrique, Toronto, Ont., 
le 15 septembre, 1981
Accepte pour publication le 10 mai, 1982
Les demandes de tires-a-part doivent 
etre adressees au Dr Herve Blanchard, 
Departement de chirurgie, Hopital 
Sainte-Justine, 3175, chemin 
Ste-Catherine, Montreal, PQ H3T 1C5
Parmi les maladies hepatiques evolu- 
tives, I’atresie des voies biliaires extra- 
hepatiques est la cause la plus fre- 
quente de deces chez les enfants at- 
teints d’affection hepatique.1
Avant 1974, tous les patients ex­
plores chirurgicalement a I’Hopital 
Sainte-Justine pour une atresie des 
voies biliaires extra-hepatiques sont 
decedes en moyenne 14 mois apres 
l’exploration.
L’operation de Kasai,2 porto-ente­
rostomie, porto-cholecystostomie et ses 
variantes, introduite dans notre centre 
hospitalier en 1974, a ete pratiquee 
chez 17 enfants souffrant d’une atre­
sie des voies biliaires extra-hepatiques. 
Malgre des resultats initiaux encou- 
rageants, 1’evolution de ces patients 
apres 6 ans nous laisse perplexes 
quant a leur guerison definitive.
Patients et methode
De mars 1974 a aout 1980, 17 en­
fants (13 filles et 4 gargons) ages de 
45 a 105 jours ont eu une operation 
de Kasai' pour atresie des voies bi­
liaires extra-hepatiques. Seize patients 
avaient un poids normal a la nais- 
sance. Un gargon etait de petit poids 
pour Page de la grossesse.
La bilirubinemie totale etait en 
moyenne de 171 ^u.mol/1 et la biliru­
binemie conjuguee de 120 /zmol/1. Le 
dosage des transaminases seriques a 
ete, en moyenne, de 155 U/ml pour 
la SGPT (normale: 10 a 90 U/ml) 
et de 217 unites pour la SGOT (nor­
male; 20 a 90 unites). La concentra­
tion moyenne de la phosphatase alca- 
line a ete de 395 U /l (normale: 15 a 
175 U/l). Le coagulogramme de de- 
pistage etait normal.
L’excretion fecale de 72 heures du 
rose Bengale marque a iode-131 me- 
suree seulement chez les gargons etait 
inferieure a 10% de la dose injectee. 
Une biopsie hepatique par aspiration 
faite chez tous les patients, se revela 
compatible avec le diagnostic d’atresie 
des voies biliaires extra-hepatiques.
Resultats
L’indication operatoire est basee es- 
sentiellement sur l’existence d’une hy- 
perbilirubinemie conjuguee persistante
sans rapport avec des causes infec­
tieuses, genetiques et metaboliques.
L’exploration chirurgicale montra 
que les 17 patients presentaient une 
atresie des voies biliaires extra-hepa­
tiques du type non corrigeable (type 
III de la classification japonaise2). 
Chez 11 patients, la voie biliaire extra- 
hepatique etait transformee en cordon 
fibreux.
La cholangiographie peroperatoire 
a ete possible chez six patients. Cinq 
avaient une vesicule et un choledoque 
distal ne communiquant pas avec le 
permeables. Le sixieme, une vesicule 
permeable et un kyste du choledoque 
distal ne communiquant pas avec le 
duodenum (fig. 1).
Des malformations internes et ex- 
ternes furent notees chez six patients 
(tableau I).
Une porto-enterostomie2 a ete faite 
chez 14 patients: Kasai I: 6, Kasai II: 
2, Suruga: 5, Sawaguchi: 1. Huit de 
ces 14 patients eurent une enterosto-
FIG. 1—Cholangiographie peropera­
toire (six cas). (a) Vesicule et choledoque 
Dermeables (cinq cas). (b) Vesicule per­
meable et kyste choledoque (un cas).
486 VOLUME 25, NO. 5, SEPTEMBER 1982 / THE CANADIAN JOURNAL OF SURGERY
mie decompressive. Chez trois patients 
ayant une vesicule et un choledoque 
permeables et d’assez bon calibre, 
nous avons opte pour une porto-cho- 
lecystostomie.2
L’examen histologique du cone fi- 
breux hilaire montra des petits canaux 
biliaires dans 12 specimens. Dans un 
specimen, les canaux etaient visibles 
macroscopiquement. Quatre speci­
mens, non satisfaisants, n’ont pu etre 
interpretes histologiquement.
L’examen histologique des biopsies 
hepatiques chirurgicales montra une 
fibrose marquee a moderee dans 14 
specimens. La fibrose etait minime 
dans deux echantillons et dans un cas 
il s’agissait de cirrhose.
Evaluation des resultats fonctionnels
Les resultats fonctionnels, evalues 
sur 1'abaissement de la bilirubinemie 
totale et conjuguee, la regression to- 
tale ou partielle de Fictere et d’autres 
facteurs observables (couleur des 
selles et des urines, excretion de 
HIDA i irque au technetium-99) per- 
mettent de classer les 17 patients en 
trois groupes.
Le groupe A, bon, comprend six 
patients vivants, anicteriques ayant 
une bilirubinemie totale inferieure a 
25.6 /rmol/l.
Le groupe B, intermediaire, cornpte
cinq patients ayant excrete de la bile, 
une regression partielle de Fictere et 
une bilirubinemie totale variant de 
25.6 a 85.5 /xmol/1. De ces cinq pa­
tients, deux ont eu un arret d’excre- 
tion biliaire 45 a 90 jours apres l’in- 
tervention. Reoperes, il y eut reprise 
de Fexcretion biliaire chez un patient.
Trois patients du groupe B sont 
decedes respectivement de cholangite 
severe avec septicemie et choc, d’in- 
suffisance hepatique due a la cirrhose 
et d’arret d’excretion biliaire 3 Vi mois 
a 3 ans apres Fintervention.
Le groupe C comprend six patients 
qui n’ont jamais excrete de bile.
Sur les 17 patients operes, 11 excre- 
terent de la bile. Huit patients sont 
vivants 12 a 60 mois apres Finterven­
tion.
Correlation entre l'histologie 
du cone fibreux hilaire et du foie, 
Fexcretion biliaire et survie
Nos donnees (tableau II) ne sem- 
blent pas montrer qu’il existe de cor­
relation evidente entre l’existence de 
petits canaux biliaires, Fexcretion de 
bile et la survie. Par contre, unc fi­
brose hepatique moderee a marquee 
chez 14 patients et une cirrhose tran­
che chez 1 patient n’empecherent pas 
Fexcretion de bile chez 11 patients 
dont 8 sont encore vivants. Une fi­
brose hepatique minime chez deux 
patients ne favorisa nullement Fexcre­
tion de bile.
Complications
Des 17 patients operes, 12 presen- 
terent des complications (tableau III). 
La plus frequente et la plus redou- 
table fut l’angiocholite (54.5%). De 
frequence a peu pres egale dans les 
groupes A et B, elle fut plus severe 
et plus resistante au traitement chez 
les patients du groupe B.
Des hemorragies severes au niveau 
de l’enterostomie de decompression 
furent observees chez trois patients. 
Des huit patients vivants, quatre du 
groupe A et les deux du groupe B 
ont des manifestations cliniques et 
biologiques d’une souffrance hepa- 
tocytaire continue et progressive mais 
les preuves histologiques manquent 
(tableau IV).
Les causes de deces sont presentees 
au tableau V.
Discussion
D ’etiologie indeterminee, l’atresie 
des voies biliaires extra-hepatiques 
semble etre une maladie acquise. Son 
primum movens serait un processus 
inflammatoire qui, selon son degre 
de severite, causerait une obstruction 
ou une destruction partielle ou totale 
des voies biliaires extra-hepatiques.1,2
Du point de vue experimental, 
Okamoto et collaborateurs3 ont pro- 
duit la malformation par devasculari- 
sation complete des voies biliaires ex­
tra-hepatiques chez les chiots.
Ito et collaborateurs4 causerent des 
lesions semblables a l’atresie des voies 
biliaires extra-hepatiques de l’enfant 
en injectant par voie intra-peritoneale 
de la sporidesmin, produit de Pitho- 
myces chartarum, a des lapines ges- 
tantes et a des lapereaux.
Des malformations, en majorite 
vasculaires, sont observees chez 25% 
des patients.1,5 Aucun test ne permet 
de differencier de fagon absolue l’atre­
sie des voies biliaires extra-hepatiques 
des autres syndromes cholestatiques 
du nouveau-ne et du nourrisson.
Tableau IV-Complications resultant de
revolution de la maladie: 8 vivants
Groupe
A B
Complication (6 vivants) (2 vivants)
Alteration des
tests hepatiques 4 2
Ascite 3 2
Hemorragie digestive 1
Tableau 1-Anomalies associees -  6117
Systeme No. Anomalie
Cardio-vasculaire
Digestif
Musculo-squelettique
Communication inter-ventriculaire 
Artere hepatique preduodenale 
Veine porte preduodenale 
Malrotation
Luxation congenitale handles
Tableau II--Correlation: histologie -  excretion -  survie
Specimen No.
Excretion bile 
Present Absent
No.
survivants
Cone fibreux
Canaux presents 13 7 6 6
Examen non satisfaisant 4 4 0 2
Foie
Fibrose marquee-moderee 14 10 4 7
Fibrose minime 2 0 2 0
Cirrhose 1 1 0 1
Tableau III-Complications post derivation
Groupe
Complication No./no. total A B C
Cholangite 6111 3 2 1
Hemorragie par stomie 3/8 2 1
Prolapsus stomie 1/8 —  — 1
Arret excretion 2111 2 -
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L’indication operatoire se basera sur 
les faits cliniques suivants: nouveau-ne 
ou nourrisson de poids normal a la 
naissance avec hyperbilirubinemie 
conjuguee persistante, hepato-spleno- 
megalie, selles acholiques et bilirubi- 
nurie. Tout test ou investigation 
diagnostique susceptible de retarder 
l’intervention de plus de 72 heures 
devrait etre omis.6
L’importance de Page au moment 
de la chirurgie dicte cette celerite et 
cette attitude agressive. L’age in­
fluence aussi bien les resultats fonc- 
tionnels immediats que le prognostic 
a long terme. L’importance de l’inter- 
vention precoce est bien illustree par 
la serie de Kitamura et collabora- 
teurs.7 Cette serie de 144 patients 
montre line survie globale de 26% 
apres 5 ans. Des patients operes du- 
rant les premiers 60 jours de vie, 
35% sont vivants, de 60 a 91 jours 
39% sont vivants et de 91 a 120 jours 
17% ont survecu. Aucun patient ope- 
re apres 120 jours n'a survecu. L’en- 
quete, en cours, de la section chirur- 
gicale de l’A.A.P. (American Academy 
of Pediatrics) semble confirmer ces 
faits.8
L'histopathologie du cone fibreux 
hilaire a ete deroutante. A l’instar 
de Shandling, nous n’avons pas trou- 
ve de correlation significative entre 
la presence, le nombre et le calibre 
des canaux biliaires et l’excretion de 
bile.8
L’bistologie du foie ne semble pas 
avoir une influence determinante sur 
1’excretion eventuelle de la bile. Elle 
laisse presager, par contre, 1’evolution 
ineluctable vers la cirrhose et ses com­
plications.71' ’"
L ’angiocholite postoperatoire, dans 
sa forme severe et iterative, exerce 
une action nefaste non seulement sur 
l'excretion biliaire mais encore sur les 
lesions pre-existantes du parenchyme 
hepatique.12 Cette complication n’est 
pas l’apanage exclusif des patients 
ayant eu une operation de Kasai' de 
type I. Elle est signalee tout aussi 
bien chez les patients qui ont eu une 
operation de Kasai du type II ou une 
derivation externe type Sawaguchi. 
Nous 1’avons meme observee chez un
de nos patients du groupe A qui a 
eu une porto-cholecystostomie.
Dans notre serie, l’enterostomie de­
compressive n’a jamais prevenu, ni 
diminue la frequence ou l’intensite 
des episodes de cholangite. Par contre, 
elle fut le siege d’hemorragies severes 
chez trois des huit patients entero- 
stomises.
Dans notre experience, l’antibiothe- 
rapie prophylactique cyclique nous a 
semble plus efficace que l’enterosto- 
mie dans la prevention de la cho­
langite.
L’operation de Kasai est gratifiante 
si on accepte comme criteres de suc- 
ces l’excretion de bile et la regression 
de l’ictere. Mais ces criteres de succes 
ne sont pas synonymes de cure; car 
la cirrhose evolutive et ses complica­
tions qui surviennent a long terme 
assombrissent les espoirs et attestent 
le caractere factice de la guerison.
Conclusions
L’atresie des voies biliaires extra- 
hepatiques, maladie evolutive, laisse 
l’impression qu’elle interesse non seule­
ment les voies biliaires mais aussi 
le parenchyme hepatique. L’obstruc- 
tion du flot biliaire et ses manifesta­
tions exterieures ne representeraient 
qu’une manifestation primaire de son 
potentiel destructeur.
Nous remercions les Docteurs Claude 
Morin, Claude Roy et Andree Weber, 
service de gastro-enterologie de I’Hopital 
Sainte-Justine, de leur precieuse collabo­
ration dans les soins medicaux de ces 
patients.
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Tableau V-Causes de deces
Mois
Cause No. postoperatoire
Echec chirurgie initiale 6 3.5-16
Cholangite et sepsie (groupe B) 1 3.5
Arret excretion -  echec
reintervention (groupe B) 1 12
Insuffisance hepatique (nroupe B) 1 36
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Symposium on the Treatment of Inflammatory 
Bowel Disease in Children and Adolescents
Children and adolescents with 
inflammatory bowel disease experience 
problems that their adult counterparts 
do not share. Although there are 
some similarities, the goals of 
therapy are different. The general 
medical management of these patients 
consists of stabilization in the acute 
phase and control of the disease 
to allow the patient to grow and lead 
as normal a life as possible in the 
chronic phase. Nutritional therapy is a 
very important aspect of this 
management, but drugs such as 
steroids and sulfasalazine and, 
under special circumstances, other 
medications are useful adjuncts. 
Supportive psychotherapy is also 
important.
Les enfants et les adolescents 
souffrant de maladie inflammatoire 
abdominale font face a des problemes 
inconnus de leur contre-partie adulte. 
Bien qu'il existe des ressemblances, les 
buts du traitement sont differents.
Les grandes lignes du traitement 
medical de ces patients consistent a 
obtenir une stabilisation durant 
la phase aigue et a maitriser la 
maladie de fagon a permettre au 
patient de grandir et de mener une vie 
aussi normale que possible durant 
la phase chronique. La therapie 
nutritionnelle constitue un aspect 
tres important de ce traitement, 
mais des medicaments tels que les
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steroides et la sulfasalazine et 
dans certaines circonstances, 
d'autres medicaments sont des 
adjuvants utiles. Une psychotherapie 
de soutien est aussi importante.
Although there are similarities in the 
medical management of ulcerative 
colitis and Crohn’s disease, two factors 
influence the relative importance of 
medical therapy in the two diseases:
1. While surgical treatment can 
cure ulcerative colitis, the risk of re­
currence following surgery for Crohn's 
disease and the propensity for this 
disease to affect multiple areas of the 
intestine prevent surgery from being 
curative.
2. The incidence of Crohn’s disease 
appears to be rising.1 Since mid-1975, 
we have seen 23 new cases of inflam­
matory bowel disease in children and 
adolescents at the Children’s Hospital 
of Winnipeg. Until 1978, we were 
seeing an average of two new cases 
each of Crohn’s disease and plcerative 
colitis annually. We have had no new 
cases of ulcerative colitis since 1978, 
but in the first 8 months of 1981, we 
had five new cases of Crohn’s disease.
Medical therapy is probably more 
important in Crohn’s disease than in 
ulcerative colitis and the demand for 
it appears to be increasing.
Some of the problems children and 
adolescents with inflammatory bowel 
disease experience are similar to those 
of adults. Intestinal and extraintestinal 
symptoms are similar. Although poor 
weight gain may be a problem at all 
ages, poor linear growth and delay in 
sexual maturation are unique to chil­
dren and adolescents. The illness may 
cause a child to limit normal activity 
and may contribute to a feeling of 
being different from other children. 
A child who has lost considerable 
weight or looks Cushingoid because of 
steroid therapy or otherwise feels dif­
ferent may have a serious psychoso­
cial problem, as a complication of the 
disease.
Medical Therapy
The goals of therapy are to stabilize 
the patient in the acute phase and to 
control the disease in the chronic 
phase. By doing so, the patient may 
achieve normal growth and sexual 
maturation. Finally, it is important 
that the physician supports the pa­
tient and family and helps them accept 
the disease, get through periods of 
ill health and lead as normal a life 
as possible.
Acute Phase
Depending on the severity of the 
symptoms in the acute phase, it may 
be necessary to correct fluid and elec­
trolyte deficits and acid-base imbal­
ance. Blood and blood products may 
also he required for those who have 
substantial blood loss. Nutritional de­
ficiencies that may have arisen be­
cause of such conditions as malab­
sorption, poor intake and vomiting 
may also require correction. While an- 
tidiarrheal and antispasmodic drugs, at 
this stage, may provide symptomatic 
relief, their use may precipitate a 
deterioration in the clinical state of the 
child, particularly in those who have 
severe disease. Psychotropic drugs are 
probably not beneficial in most pa­
tients with inflammatory bowel disease 
but may help those who have some 
underlying psychiatric disorder or may 
require sedation for other reasons. 
Antibiotics are of little value for the 
management of the primary disorder, 
but should be reserved for infections 
that may occur as a result of the 
primary disease, such as sepsis or 
peritonitis. Anti-inflammatory drugs 
are the mainstay of therapy. A variety 
of other drugs and therapies have 
been tried but have not been studied 
in controlled trials or have not gained 
widespread use.
Amongst the anti-inflammatory 
drugs, steroids have proven of value 
for both ulcerative colitis and Crohn’s 
disease. The National Cooperative
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Crohn’s Disease Study that was un­
dertaken in the United States recently 
showed that 78% of patients treated 
with steroids had some form of re­
mission during the 17-week study 
period and 60% remained in remis­
sion during this time.2 Of placebo- 
treated patients, 50% had some form 
of remission but only 30% had a 
sustained remission during the study. 
This study also showed that systemi- 
cally administered steroids were more 
valuable for patients with small bowel 
involvement than for those with dis­
ease confined to the colon. Systemic 
steroids are also effective in inducing 
remissions in ulcerative colitis.3 Topi­
cal steroids in the form of enemas are 
valuable in patients with ulcerative 
colitis.4 They are of less value for 
patients with Crohn’s colitis since the 
inflammation is transmural. Adoles­
cents do not like to use enemas hut 
eventually get accustomed to them. 
While the prepackaged steroid enemas 
are convenient, they sometimes can­
not be retained long enough to be of 
value, but 100 mg of hydrocortisone 
added to 100 ml of normal saline in an 
intravenous bag can be run into the 
rectum slowly and is usually retained 
longer. While enemas are most ef­
fective in left-sided colitis, more ex­
tensive disease can be effectively 
treated as well. There is some risk 
of steroid absorption, particularly in 
patients who have a severely inflamed 
bowel,4'5 so it is advisable to discon­
tinue the enemas once remission has 
been induced.
Sulfasalazine has also been widely 
used in the management if inflam­
matory bowel disease. It is effective 
in inducing remission in ulcerative 
colitis.6 The National Cooperative 
Crohn’s Disease Study demonstrated 
that sulfasalazine was better than 
placebo in inducing a remission, parti­
cularly if the disease primarily invol­
ved the colon.7 It was not beneficial 
for small bowel disease. Its mode of 
action is unknown but 5-aminosalicy- 
lic acid (5-ASA) produced by colonic 
bacterial degradation of sulfasalazine 
appears to be the active component.8 
Recent studies have suggested that 
5-ASA acts as a prostaglandin syn­
thetase inhibitor, since prostaglandin 
E2 concentrations in colonic tissue 
from patients with ulcerative colitis 
are elevated, and in vitro studies have 
shown that these levels are reduced 
by 5-ASA.9 However, the role of pro­
staglandin E2 in the pathogenesis of 
ulcerative colitis is unknown. A more 
recent study suggested that 5-ASA 
does not act as a prostaglandin syn­
thetase inhibitor but that its mode of
action may be one of immunosup­
pression.10 Sulfasalazine enemas may 
be effective in inducing remissions in 
ulcerative colitis.8 A recent study using 
high-dose 5-ASA enemas in the treat­
ment of ulcerative colitis showed en­
couraging results.11
The value of azathioprine and its 
related drug, 6-mercaptopurine, in 
treating Crohn's disease is controver­
sial.1214 The National Cooperative 
Crohn’s Disease Study showed that 
azathioprine was no better than place­
bo in inducing a remission.14 Other 
studies of 6-mercaptopurine and aza­
thioprine have shown that the drugs 
are effective but only after at least 
3 to 4 months of therapy.13 This is 
not practical in the acute phase of 
management. However, in selected 
cases, these drugs may allow steroid 
dosage to be reduced. Higher doses 
for a longer period might be more ef­
fective but the side-effects would pre­
clude any clinical value. These drugs 
have also been advocated in ulcera­
tive colitis particularly as adjunctive 
therapy with steroids and for mainte­
nance therapy.15’16
Chronic Phase
The maintenance of good nutrition 
is one of the most important if not 
the most important component of the­
rapy in the chronic phase of inflam­
matory bowel disease.17,18 Intensive 
psychoanalysis and psychotherapy in 
these patients is unnecessary, unless 
they have some underlying psychiatric 
disorder; most simply need a lot of 
support. Clearly, the family plays a 
very important role in this. A parent 
who becomes emotionally distraught 
every time the child suffers a recur­
rence is of considerably less help than 
one who is calm. The physician’s role 
is also extremely important in this 
regard. A physician should initially be 
available to discuss the disease in an 
open and frank manner and allow the 
child to ask questions. Physicians tend 
to deal primarily with the parent and 
only secondarily with the child; it is 
often more valuable to deal with the 
child directly but to keep the family 
informed. With this approach patients 
are more willing to talk about their 
concerns, have a better understanding 
of the disease and are more willing 
to cooperate in the management of 
the disease. It is extremely important 
to reassure both child and parents that 
although inflammatory bowel disease 
is a chronic condition and may present 
major problems and although there is 
no specific cure, except perhaps sur­
gery for ulcerative colitis, there is a
great deal that we can do. A team ap­
proach involving the primary physi­
cian, gastroenterologist, nurse, sur­
geon, dietitian, pharmacist, psychia­
trist, stomal therapist and social 
worker gives the child the added con­
fidence that whenever a problem 
arises, there will always be someone 
available with whom to talk. Further­
more, patients may relate better to 
some members of the team than to 
others. There must, however, be one 
member of the team who is ultimately 
in charge; ideally this should be the 
primary physician.
Membership in the Ileitis/Colitis 
Foundation may be helpful to some 
patients. The literature distributed by 
this organization proves that the pa­
tients are not alone and that there are 
answers to questions they may have 
been reluctant to ask their physician.
For some, close association with 
another patient also proves valuable. 
Not all adolescents, however, benefit 
from this type of relationship and 
would rather forget about their dis­
ease until they need help.
Drugs are also valuable in the 
chronic phase of therapy. Sulfasala­
zine reduces the frequency and se­
verity of recurrences of ulcerative 
colitis.19 It is not as valuable as a 
prophylactic in Crohn’s disease. The 
National Cooperative Crohn’s Disease 
Study showed that neither prednisone 
nor sulfasalazine was helpful in pre­
venting recurrences.2 Long-term use of 
steroids should be avoided if possible 
because of their side-effects, such as 
the effect on growth. On the other 
hand, some evidence suggests that 
steroids, in adequate amount, may 
actually allow the patient to grow once 
the disease is suppressed by the medi­
cation.18’19 The price for this approach, 
however, is the side-effects that high 
doses of steroids may cause. Adoles­
cents do not like the round face, 
hirsutism and striae even though they 
know they may feel better with the 
medication.20 For those who need 
steroids continuously, alternate day 
doses as low as required to suppress 
disease activity should be the goal 
since the risk of side-effects is less.21
Other drugs used in the chronic 
phase have not been extensively eval­
uated. Metronidazole appears to be 
particularly useful in the management 
of perianal involvement in Crohn’s dis­
ease.22 Its beneficial action may be 
due to its effect on anaerobic bac­
teria. In one recent study, it was shown 
that levamisole, an immunologic sti­
mulant, was useful in Crohn’s disease 
by sustaining a remission that had 
been induced by other forms of thera-
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py.23 A recent study of disodium cro- 
moglycate suggested it may be useful 
in maintaining remission and in pa­
tients with mild ulcerative colitis.24 
Other studies25’26 have not confirmed 
its value but it may be useful in se­
lected cases. Various other forms of 
therapy have been attempted over the 
years but have either lost favour or 
have not been extensively studied or 
used.
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2. Nutritional Therapy
M icheline Ste-M arie, md, fr c p[c]*
Malnutrition contributes substantially 
to the severity and morbidity of 
inflammatory bowel disease in children. 
Causes of malnutrition include 
decreased oral intake, excessive 
nutrient losses, increased nutritional 
requirements and malabsorption. 
Nutritional therapy is used to correct 
specific deficiencies, delayed growth 
and puberty, and as primary therapy 
to achieve total bowel rest in patients
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with disease that is resistant to 
conventional medical treatment. Total 
parenteral nutrition has been used 
successfully in patients with 
nonfistulous Crohn’s disease and 
in those with retarded growth. Results 
are not as encouraging in patients who 
have Crohn's disease with fistula 
and in patients with ulcerative 
colitis. Continuous elemental enteral 
nutrition seems promising, but more 
controlled studies are needed to 
assess critically the value of this 
form of therapy.
La malnutrition contribue de facon 
marquee a la gravite et a la 
morbidity des maladies inflammatoires 
intestinales chez I’enfant. Les causes 
de malnutrition comprennent 
une reduction de I'apport oral, 
une perte nutritionnelle excessive, 
des besoins nutritionnels augmentes 
et la malabsorption. La therapie
nutritionnelle est utilisee pour 
corriger des carences specifiques, 
un delai de croissance ou le retard 
de la puberte, et comme traitement 
primaire pour mettre I'intestin 
au repos complet chez les patients 
dont la maladie est resistante 
au traitement medical traditionnel. 
L'alimentation parenterale totale 
a ete employee avec succes chez des 
patients ayant une maladie de Crohn 
non fistuleuse et chez ceux qui 
avaient un retard de croissance.
Les resultats ne sont pas aussi 
encourageants dans les cas de 
maladie de Crohn fistuleuse 
et chez les patients souffrant de 
colite ulcereuse. L'alimentation 
elementaire continue par voie 
intestinale semble prometteuse, 
mais d'autres etudes controlees 
sont requises pour evaluer de 
facon critique I'utilite de cette 
forme de traitement.
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Although it has long been known that 
malnourished individuals are less able 
to cope with disease, the impact of 
malnutrition on the onset, course and 
complications of inflammatory bowel 
disease was not recognized until a 
few years ago. Physicians always re­
commended a good diet to these pa­
tients, forgetting that many of them 
could not digest food and quite a few 
could not even eat. Malnutrition in 
children is even more serious because 
it influences growth and development.
This paper will briefly review the 
causes of malnutrition in inflammatory 
bowel disease in children, the indica­
tions for nutritional therapy and the 
techniques that can be used.
Causes of Malnutrition
Why do such patients suffer from 
malnutrition? Several reasons can be 
evoked; they may act singly or to­
gether to establish severe debilitation 
and morbidity.1
Decreased oral intake may be sec­
ondary to anorexia or abnormalities 
of taste in patients with active dis­
ease. Some patients voluntarily eat 
less because eating causes nausea, 
exacerbation of abdominal pain and 
diarrhea or because they have mouth 
ulcers. Sometimes, patients will limit 
their food intake to one or a few 
foods that they believe do not ex­
acerbate their symptoms.
Excessive nutrient loss is found 
mostly in patients with extensive 
Crohn's disease of the small bowel 
and in those with severe colitis. In 
the first category of patients malnu­
trition develops because of protein-IOs- 
ing enteropathy, steatorrhea and loss 
of electrolytes and minerals. Gastro­
intestinal bleeding in patients with 
colitis can aggravate the losses sec­
ondary to protein-losing enteropathy.
Crohn’s disease and ulcerative coli­
tis are high-energy illnesses and can 
rapidly deplete nutrient reserves. 
Active disease, fever, fistulas and in­
fection consume an enormous amount 
of energy; because nutrient reserves 
are low or absent and oral intake is 
decreased, malnutrition develops rap­
idly in such patients. Nitrogen require­
ments are increased during cortico­
steroid therapy because of increased 
excretion; finally, growth is an im­
portant protein-calorie consumer in 
children, particularly adolescents.
Absorptive defects are more pre­
valent in patients with Crohn’s dis­
ease than in those with ulcerative coli­
tis. Defects have been described at 
all stages of the digestive and absorp­
tive processes. Patients with jejunal
involvement are most susceptible to 
malabsorption. Severe ileal disease or 
ileal resection leads to loss of bile 
salts, contraction of the bile-salt pool 
and decreased secretion of bile salts 
leading to fat malabsorption.
Strictures, fistulas, enteroenterosto- 
mies or surgically produced blind 
pouches cause stasis of intestinal con­
tents and subsequent bacterial over­
growth; as a consequence, vitamin B12 
malabsorption and steatorrhea devel­
op. Diffuse granulomatous and in­
flammatory changes disrupt the in­
testinal mucosa’s absorptive functions, 
not only of fat but of most other 
nutrients. Extensive disease, fistulous 
bypass of several intestinal loops and 
multiple resections decrease the sur­
face area available for absorption.
Extensive lymphatic involvement in 
Crohn's disease adds to the impair­
ment of fat absorption caused by mu­
cosal disease and decreased secretion 
of bile salts. Finally, calcium, folate 
and fat-soluble vitamin malabsorp­
tion may be induced by the various 
drugs used for therapy.
Indications for Nutritional Therapy
Nutritional therapy in inflamma­
tory bowel disease is used to correct 
total protein-calorie malnutrition and 
specific deficiencies. Many children 
with Crohn’s disease have delayed 
growth and sexual maturation. No 
specific endocrine abnormality has 
been demonstrated in these patients;2 
since energy and protein deficiencies 
may he primarily responsible, nutri­
tional therapy is indicated.
In view of the relentless chronic 
course of these diseases and their dis­
couraging response to various medical 
and surgical treatments, nutritional 
therapy has been promoted as primary 
therapy, especially for Crohn’s dis­
ease. In these patients, nutritional the­
rapy may be indicated: (a) when short 
howel syndrome occurs resulting in a 
decreased absorptive area; (b) in pa­
tients with acute flare-up of the dis­
ease, when complete bowel rest is 
desirable to promote closure of fi­
stulas and reduced inflammation of 
the bowel wall and (c) in patients 
about to undergo operation whose nu­
tritional status must be improved.3
Some physicians even consider 
that bowel rest and nutritional therapy 
with the judicious use of anti-inflam­
matory drugs during the acute phase 
may be the treatment of choice to in­
duce long-term remission. Patients 
will benefit even more from this 
therapy if nutritional deficiencies are 
recognized early in the course of the
disease and corrected as soon as they 
are identified.
Nutritional deficiencies are more 
prevalent in patients with Crohn’s dis­
ease than in those with ulcerative 
colitis.1,1 Weight loss and protein defi­
ciency may be found in up to 80% 
of patients with Crohn’s disease and 
60% of patients with ulcerative coli­
tis. Anemia due to folate deficiency, 
iron or vitamin B,2 malabsorption is 
also common. Calcium, potassium and 
magnesium deficiencies resulting lar­
gely from diarrhea have been de­
scribed mostly in patients with Crohn’s 
disease (up to 30%). Deficiency of 
lipid-soluble vitamins, especially vita­
min D, are also common in Crohn’s 
disease (up to 75%). Metabolic bone 
disease may result from vitamin D 
deficiency, negative calcium balance 
and concomitant corticosteroid thera­
py. Zinc deficiency may be important 
in the pathogenesis of anorexia, ab­
normal taste sensation and possibly 
retarded growth and delayed sexual 
maturation.
Increased intestinal protein loss, as 
a result of protein-losing enteropathy, 
diffuse granulomatous involvement of 
the intestinal mucosa and gastrointes­
tinal bleeding is documented in up to 
70% of children with Crohn’s disease. 
Carbohydrate intolerance (particularly 
of lactose) secondary to bacterial over­
growth or mucosal dysfunction, or 
both, is present in about 20% of 
children with inflammatory bowel dis­
ease. Steatorrhea is found in about 
33% of the children. Low serum 
levels of folate, iron and calcium and 
an abnormal Schilling test result are 
also common. Therefore, it is ex­
tremely important to assess the nutri­
tional status of every child with in­
flammatory bowel disease so that nu­
tritional deficiencies can be corrected 
rapidly.
Methods of Nutritional Therapy
Of the various methods of nutri­
tional therapy, the simplest is an ade­
quate diet with or without oral sup­
plements. Continuous and intermit­
tent enteral alimentation, mostly 
nocturnal, is more invasive but com­
plications are few. Gastrostomy should 
be reserved for patients who cannot 
cope with a nasogastric tube. Needle 
catheter jejunostomy is a relatively 
new technique and needs to be eval­
uated in patients with inflammatory 
bowel disease. Parenteral nutrition 
through either peripheral vein or cen­
tral venous catheter has been used 
extensively, and enthusiastic reports in 
the literature have stimulated greater
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use of this method including total 
parenteral nutrition at home.
Restrictive diets are not indicated 
especially in children; no foodstuff 
has been shown to be harmful to the 
intestinal mucosa in inflammatory 
bowel disease with the possible ex­
ception of lactose in those patients 
who have proven lactase deficiency. 
Appetizing meals with preferred foods 
will increase caloric intake in an 
agreeable fashion. Vitamins, iron and 
calcium supplements can be added if 
necessary.
Oral supplements are indicated if 
patients cannot increase their caloric 
intake by diet alone. These formulas 
have high caloric value and may in­
duce early satiety thus making it im­
possible for children to reach their 
daily energy requirements, which may 
reach up to 4000 cal/d. The relatively 
high osmolarity of these formulas 
sometimes aggravates diarrhea.
Several studies have been published 
describing the benefits of total paren­
teral nutrition either in hospital or at 
home; most of the patients studied 
were adults although several studies 
included adolescents. A few dealt ex­
clusively with the pediatric population. 
If we analyse the data from some of 
these series (92 patients), some results 
are extremely encouraging, others not. 
When total parenteral nutrition was 
used as primary therapy in nonfi- 
stulous Crohn’s disease,514 improve­
ment of nutritional status was achieved 
in all. Temporary remission occurred 
in more than 80% of patients but 
long-term remission was less common 
(66%); this is probably a very opti­
mistic figure since in a few of these 
studies the follow-up did not exceed 
3 months. Patients with localized dis­
ease of recent onset responded better 
than other groups.
Results were not as encouraging in 
patients with ulcerative colitis.6’7,911,14’15 
In 38 patients nutritional repletion was 
accomplished in 34%. Temporary re­
mission was obtained in only 33%. 
It appears that total parenteral nutri­
tion in patients with ulcerative colitis 
is best used to prepare malnourished 
patients for operation and to supply 
postoperative nutritional support.
When total parenteral nutrition was 
used in patients with Crohn’s disease 
with fistulas (84 patients with 91 fi­
stulas),5'6,9,1,'14'1<i’17 spontaneous, defini­
tive closure of fistulas was rarely at­
tained in hospital and long-term heal­
ing without the use of corticosteroids 
was achieved in only 20% of patients. 
Nutritional repletion was accompli­
shed in 17%. Total parenteral nutri­
tion seems to provide temporary relief
of symptoms, decreases the discharge 
from the fistula and improves the 
nutritional status; the long-term bene­
fits are unproven.
The prevalence of growth retarda­
tion in children and adolescents with 
inflammatory bowel disease is about 
17%.18 In the 10 studies from which 
this figure comes, growth retardation 
was usually defined as height below 
the third percentile. Children with 
Crohn’s disease are more severely af­
fected (up to 58%) than those with 
ulcerative colitis (up to 22%). The 
pre-eminent causative factor is caloric 
insufficiency superimposed on pro­
tein, vitamin and mineral deficiencies. 
Nutritional therapy for growth retar­
dation is usually successful when con­
trol of the disease is effective. Hence, 
in children who have been medically 
or surgically treated and are asympto­
matic, growth often accelerates. This 
may be due to increased caloric intake 
brought about by the sense of well­
being.
When oral supplements cannot be 
used for nutritional rehabilitation, to­
tal parenteral nutrition can be tried. 
In four recent studies notable weight 
gain and linear growth were achieved 
in all patients.13,18‘20 This growth re­
sponse has been sustained up to 2 
years after initial therapy. The dura­
tion of total parenteral nutrition 
ranged from 2 weeks to several con­
secutive months. Patients in the study 
of Strobel and associates13 have been 
followed up for more than 2 years 
and still continue to show a positive 
growth response. These children were 
receiving total parenteral nutrition at 
home.
Total parenteral nutrition is not 
without complications and is an ex­
pensive form of treatment. Prepara­
tion of solutions and patient monitor­
ing can be time-consuming; quite a 
few children are reluctant to submit 
to repeated venipuncture. Recent­
ly, continuous enteral alimentation 
with an elemental diet has been shown 
to induce clinical remission and to 
achieve resumption of growth in chil­
dren with Crohn’s disease.
Morin and associates21 submitted 
four patients to continuous elemental 
enteral nutrition for 6 weeks. All pa­
tients achieved remission, their nutri­
tional status improved and they gained 
height and weight. One patient had 
to be operated upon 2 months after 
therapy. The other three had a flare- 
up of their disease 4(4 months after 
therapy and reverted to their abnor­
mal growth pattern. It is possible that 
repeated courses of enteral alimenta­
tion may sustain longer remission or
that nocturnal enteral alimentation, 
or both, may also be beneficial in 
these children when they are in re­
mission at the end of the continuous 
enteral alimentation period.
There are problems associated with 
the use of elemental diets.22 Problems 
secondary to diet composition include 
gastric retention and distension, diar­
rhea and fluid balance. Most of the 
formulas are unpalatable necessitating 
their long-term administration through 
a nasogastric tube. Azotemia, hepato- 
toxicity, gastrointestinal bleeding and 
skin rash have also been reported. 
Most of the available studies on en­
teral hyperalimentation in inflamma­
tory bowel disease are uncontrolled; 
furthermore, it has never been shown 
that such elemental diets are more 
beneficial to these patients than a 
normal diet prepared in a blender and 
fed by continuous gastric drip. There 
is an urgent need for carefully de­
signed and controlled studies to prove 
the efficacy of this form of therapy.
Summary
It is now well established that nu­
tritional therapy is of primary im­
portance in treating inflammatory 
bowel disease. The nutritional status 
of children with Crohn’s disease or 
ulcerative colitis should be investi­
gated early so that nutrition rehabili­
tation may be achieved before the 
devastating effects of malnutrition in­
crease the severity and the morbidity 
of these diseases.
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3. Surgical
Most patients with universal ulcerative 
colitis ultimately require a colectomy 
either to treat the inflammatory 
process or to prevent the subsequent 
development of a malignant tumour. 
Since the introduction of total 
proctocolectomy and ileostomy for 
the definitive surgical management 
of ulcerative colitis, this procedure 
has become the standard operative 
therapy for this disease. The 
description of the eversion technique of 
ileostomy in 1952 improved the 
life-style of patients with an ileostomy 
and made the total proctocolectomy 
a more attractive procedure. 
Nevertheless, many patients are 
emotionally disturbed by having an 
incontinent ileostomy and often 
will delay their surgery because of the 
associated psychologic trauma.
Because of this, the Kock pouch or 
continent ileostomy has been 
introduced and advocated during 
the past decade. This procedure has 
met with notable success but has
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found less application in the younger 
patient. However, even the continent 
ileostomy is associated with a certain 
amount of psychologic trauma because 
of the abdominal stoma. Therefore, 
the endorectal pull-through has 
recently been used for the management 
of ulcerative colitis. First introduced 
in 1948, this procedure allows total 
removal of the diseased bowel, 
maintains continence and eliminates 
the need for an ileostomy. During 
the last 3V2 years, the author has used 
the endorectal pull-through to treat 
24 patients with ulcerative colitis and 
1 with familial polyposis. The results 
are encouraging in that all patients 
are continent and the average daily 
stool frequency is 6 to 10. These 
results and those of others support 
the continued use of this new surgical 
approach to the management of 
ulcerative colitis.
La plupart des patients souffrant 
de colite ulcereuse disseminee 
necessitent eventuellement une 
colectomie, soit pour traiter le 
processus inflammatoire ou pour 
prevenir le developpement subsequent 
d'une tumeur maligne. Depuis 
I’avenement de la procto-colectomie 
totale et de I'ileostomie pour le 
traitement chirurgical definitif de la 
colite ulcereuse, cette intervention 
est devenue I’operation standard de 
cette maladie. La description en 
1952 de la technique d'ileostomie par 
eversion a amiSliore le style de vie 
des patients porteurs d'une ileostomie
18. K irschner BS. Voinchet O, Rosenberg IH : 
Growth retardation in inflammatory bowel 
disease. Gastroenterology 1978; 75: 504-11
19. L ayden T , Rosenberg F , N em chausky  G , 
E lson C, Rosenberg 1: Reversal of growth 
arrest in adolescents with Crohn’s disease 
after parenteral alim entation. Gastroenterol­
ogy 1976; 70: 1017-21
20. K elts D G . G rand R J, S hen  G , W atkin s 
JB, W erlin  SL. B o e h m e  C : N utritional 
basis of growth failure in children and 
adolescents with C rohn’s disease. Gastro­
enterology 1979; 76: 720-7
21. M o rin  CL, Ro u let  M , R oy CC, W eber A : 
Continuous elemental enteral alimentation 
in children with C rohn’s disease and growth 
failure. Gastroenterology 1980; 79: 1205-10
22. K oertz RL, M eyer JH : Elemental diets — 
facts and fantasies. Gastroenterology 1980; 
78: 393-410
et fait de la procto-colectomie totale, 
une intervention plus attrayante. 
Neanmoins, plusieurs patients 
eprouvent des difficultes emotionnelles 
a I'idee d'avoir une ileostomie 
incontinente et souvent vont retarder 
leur chirurgie a cause du traumatisme 
psychologique qui y est relie. Ceci 
a amene I’introduction, au cours 
de la derniere decennie, de la poche 
de Kock ou ileostomie continente; 
cette solution a ete largement 
preconisee. L'operation a eu un succes 
remarquable mais elle a trouve 
moins d'applications chez le sujet 
jeune. Toutefois, meme I'ileostomie 
continente cause un certain degre de 
traumatisme psychologique a cause 
du stoma abdominal. En consequence, 
I'anastomose transanale a recemment 
ete utilisee dans le traitement de 
la colite ulcereuse. Apparue en 1948, 
cette operation permet de resequer 
completement la partie de I'intestin 
malade, conserve la continence et 
elimine la necessity d'une ileostomie. 
Durant les derniers 31/2 ans, I'auteur 
a utilise I’anastomose transanale 
chez 24 patients souffrant de colite 
ulcereuse et chez 1 porteur d’une 
polypose familiale. Les resultats sont 
encourageants puisque tous les 
patients sont continents avec une 
frequence quotidienne moyenne 
de I'evacuation des selles de 6 a 10. 
Ces resultats et ceux d'autres 
auteurs militent en faveur de 
('utilisation de cette nouvelle approche 
chirurgicale dans le traitement de 
la colite ulcereuse.
Management of Ulcerative Colitis
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Ulcerative colitis was first described 
in 1859 by Sir Samuel Wilks, a path­
ologist and physician at Guy’s Hos­
pital in London. However, no attempt 
to treat the disease, in either its acute 
or chronic phases, was made until 
1902, when Weir performed a tube 
appendicostomy at Roosevelt Hospital 
in New York.1 In 1913 the first ileos­
tomy for ulcerative colitis was per­
formed in the United States.2 It be­
came the procedure of choice until 
1948 when Cattell3 recommended a 
three-stage operation consisting of an 
initial ileostomy, followed by a sub­
total colectomy with exteriorization of 
the sigmoid mucous fistula and a sub­
sequent abdominoperineal resection 
of the rectum. Shortly thereafter, the 
procedure was modified to two stages 
in which an initial ileostomy and sub­
total colectomy were followed by an 
abdominoperineal proctocolectomy. In 
1952, Goligher4 introduced a one- 
stage operation consisting of an end- 
ileostomy and a proctocolectomy. The 
eversion technique of ileostomy con­
struction by Brooke5 in 1952 notably 
improved ileostomy management and 
made the procedure of total procto­
colectomy and permanent ileostomy 
attractive to patients with ulcerative 
colitis.
Sphincter-saving operations in the 
definitive management of ulcerative 
colitis have been sought extensively 
during the past 25 years. In 1948, 
Ravitch6 proposed a technique in 
which the colon was resected, the 
rectal mucosa removed and an 
ileoanal anastomosis created. In 1966, 
Aylett7 reviewed his experience with 
300 patients who had undergone 
a subtotal colectomy and an ileoproc- 
tostomy for ulcerative colitis. Only 
5% of these patients subsequently re­
quired conversion to a permanent ileo­
stomy.
Indications for Operation
Americans who have inflammatory 
bowel disease number between 200- 
COO and 400 000. Fifteen thousand to 
30 000 new cases are diagnosed each 
year and 20% of the patients are 
less than 20 years old. Although a 
substantial number of patients with 
ulcerative colitis never require opera­
tion for their disease, many ultimately 
require a definitive operative proce­
dure. The medical management of ul­
cerative colitis is aimed at relieving 
symptoms. Although corticosteroids 
and sulfasalazine sometimes induce 
complete remission and even cure of 
ulcerative colitis, this happens relative­
ly infrequently.
Our indications for operation are: 
(a) persistent signs of disease after 2 
years of adequate medical therapy, 
including sulfasalazine and cortico­
steroids; (b) inability to wean the pa­
tient from high-dose corticosteroid 
therapy; (c) growth retardation or 
delay in the development of sec­
ondary sex characteristics, secondary 
either to the disease itself or to the 
corticosteroid therapy and (d) the risk 
of carcinoma of the colon in patients 
with long-standing ulcerative colitis. 
The incidence of carcinoma of the 
colon is about 3% during the first 
decade of the disease and, thereafter, 
increases at the rate of 20% per de­
cade.8,9 The carcinomas arising in ul­
cerative colitis tend to be multiple 
and much flatter than those of classic 
carcinoma of the colon, making their 
radiologic detection more difficult. 
Moreover, they tend to be mucin- 
secreting and anaplastic, carrying a 
much poorer prognosis than in classic 
carcinoma of the colon. For these 
reasons we recommend a total colec­
tomy for anybody who has had uni­
versal ulcerative colitis longer than 
10 years. Less common indications 
for surgery are unremitting hemor­
rhage and free perforation of the 
colon.
Types of Operation
Three operations are available for 
the definitive management of ulcera­
tive colitis in which the entire dis­
eased colon and rectum are removed. 
Lesser operations consisting of sub­
total colectomy and ileoproctostomy 
have been advocated for years and 
have been quite successful in the man­
agement of the basic disease process; 
however, they all leave diseased rec­
tum behind.7,10 The three definitive 
operations are total proctocolectomy 
with permanent end-ileostomy, total 
proctocolectomy with permanent end- 
ileostomy and a continent ileal re­
servoir (Kock pouch), and total colec­
tomy and endorectal removal of the 
rectal mucosa together with an ileo- 
anostomy. Total proctocolectomy with 
ileostomy is the commonest operation 
and has an excellent record of suc­
cess over the past 25 years. The con­
tinent ileostomy, initially described by 
Nils Kock, is an important contribu­
tion to the surgical treatment of ul­
cerative colitis and circumvents some 
of the psychosexual problems associ­
ated with conventional ileostomies.11,12 
The Kock pouch is less applicable to 
the child and young teenager and is 
more commonly used in adults. We 
have not used the Kock pouch.
Ileoanostomy following colectomy 
and excision of rectal mucosa, as orig­
inally described by Ravitch,6 has been 
used infrequently in ulcerative colitis, 
although this sphincter-saving opera­
tion has been used notably more often 
during the past 3 years. The endo­
rectal pull-through procedure for the 
treatment of Hirschsprung’s disease 
was initially popularized in 1964 by 
Soave13 and in 1968 by Boley and 
colleagues.14,15 In 1976, we16 described 
a modification of the endorectal pull- 
through for Hirschsprung’s disease 
that we have used successfully in 
over 60 infants and children. In 1969, 
Glotzer and PihF7 used this technique 
in two adults with ulcerative colitis; 
one subsequently required conversion 
to a permanent ileostomy, but the 
other had a good result. Because of 
our success with the modified endo­
rectal pull-through in the treatment of 
classic Hirschsprung’s disease, in 1974 
we began to use the same operative 
approach for the management of 
children with total colonic Hirsch­
sprung’s disease. Our experience with 
six children with total colonic and 
partial small intestinal aganglionosis 
who had undergone an endorectal 
pull-through procedure following a 
total colectomy has been excellent. All 
patients are totally continent and are 
having two or three formed bowel 
movements daily.18 One girl with 
aganglionosis extending to the distal 
jejunum, who underwent a total colec­
tomy and ileectomy followed by an 
endorectal pull-through and a jejuno- 
anostomy, is totally continent and has 
four to six soft stools daily, 7 years 
following operation. The encouraging 
results in this small group of children 
prompted us to consider this operative 
approach in 1977 for children and 
adults with ulcerative colitis. At that 
time, Martin and associates19 pub­
lished their experience with 17 pa­
tients who had chronic ulcerative col­
itis; 15 had satisfactory results. This 
important paper prompted several 
other surgeons to try this operation 
in both children and adults. In 1978, 
Parks and Nicholls20 described a mod­
ification of the endorectal pull- 
through. They added a reservoir to 
the procedure in order to decrease 
the stool frequency; however, a num­
ber of their patients were unable to 
defecate spontaneously and required 
a rectal tube for stool evacuation. 
Their more recent experience in a 
larger group of 35 patients has been 
better. The reservoir is still part of 
their operative approach, but the 
pouch is placed deeper in the rectal 
cuff than previously and this appears
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to have decreased the incidence of 
incomplete stool evacuation. In 1980, 
Fonkalsrud21 performed the operation 
initially described by Parks and 
Nicholls on five patients with ulcera­
tive colitis. Only one of these patients 
has had intestinal continuity restored; 
he has 4 to 12 stools daily and is 
totally continent. Peck22 described 29 
patients who underwent a rectal mu­
cosal replacement operation which in­
volved insertion of an ileal graft. This 
was done on 12 patients for familial 
polyposis and on 17 for ulcerative 
colitis. The operation is far more com­
plicated than the standard endorectal 
pull-through; however, in 25 patients 
who have had intestinal continuity re­
stored, the results have been quite 
satisfactory with complete fecal con­
tinence and an average stool fre­
quency of six per day.22 Telander and 
Perrault23 reported on 12 children and 
young adults with chronic ulcerative 
colitis who underwent a standard sub­
total colectomy with rectal mucosec­
tomy and ileoanal anastomosis. Fol­
low-up ranged from 7 to 27 months. 
All patients have rectal c.ontinence 
and satisfactory stool frequency.
In 1977, we began to use the en­
dorectal pull-through as the preferred 
operation for the definitive manage­
ment of ulcerative colitis in children 
and adults. The procedure has been 
used on 25 patients, 23 of whom have 
had their temporary ileostomy closed. 
The last two patients are awaiting 
closure of their ileostomy. The opera­
tion is performed either as a one-stage 
total colectomy, rectal mucosectomy 
and ileoanal anastomosis together with 
a loop ileostomy or as a two-stage 
procedure in which initially a sub­
total colectomy and ileostomy are per­
formed and a sigmoid to colon mu­
cous fistula is established, followed 
several months later by a rectal mu­
cosectomy and an ileoanal anasto­
mosis together with a temporary loop 
ileostomy. The two-stage procedure 
is usually carried out in the sicker 
patients receiving high-dose cortico­
steroids, in whom the risk of a colec­
tomy and an endorectal pull-through 
at one operation is too high. The 
temporary loop ileostomy is closed 
about 2 months after the pull-through 
procedure. Twenty-four of the 25 pa­
tients have ulcerative colitis and one 
adult has familial polyposis. The tech­
nical details of our operation18 are de­
scribed in a movie in the library of 
the American College of Surgeons. 
There have been no deaths from the 
operation and the complication rate 
has been quite low. The first patient 
to undergo this procedure had a small
cuff abscess that required drainage in 
the early postoperative period. Two 
other patients had intestinal obstruc­
tion due to adhesions following clo­
sure of the ileostomy. They were 
successfully treated with an entero- 
lvsis. All patients have excellent rectal 
continence and have an average of 6 
to 10 bowel movements of semi- 
formed stool daily. In some, the daily 
stool frequency is as low as 3 to 4, 
and in others it reaches 20. Most im­
portant. however, is that stool fre­
quency improves appreciably during 
the first postoperative year. The first 
patient in this series underwent an 
ileostomy at the time of drainage of 
her cuff abscess and has not asked to 
have the ileostomv closed although on 
physical examination her pull-through 
seems excellent. Recently a 16-year- 
old boy requested conversion to an 
end-ileostomy 18 months after his 
pull-through procedure because of 
stool frequency as high as 18 per day. 
He had never been incontinent and 
requested the conversion because of 
marked interference with his life­
style. The only other conversion to 
an ileostomy has been in a 27-year-old 
man who did well for 18 months 
after his pull-through procedure, with 
stool frequencies in the range of six 
to eight per dav. He then experienced 
increasing stool frequency associated 
with abdominal cramps that were not 
relieved by various medications. He 
found that these markedly interfered 
with his work and family life, so he 
requested an end-ileostomy, which 
was recently carried out.
Our results with this series of pa­
tients have encouraged us to continue 
to recommend this aproach to chil­
dren and adults with ulcerative col­
itis. If the patient or referring physi­
cian is not anxious to have the pull- 
through procedure done at the time 
of colectomy, we strongly recommend 
that a subtotal colectomy be per­
formed and a mucous fistula of the 
sigmoid colon be established, together 
with an end-ileostomy so that the 
pull-through procedure can be done 
at a later date if the patient desires. 
Obviously, if the entire rectum is re­
moved at the time of colectomy, a 
sphincter-saving operation cannot be 
performed later.
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4. Evolution of the Kock Continent 
Reservoir Ileostomy
Zane Cohen, md, frcs[c]
A continent reservoir ileostomy was 
constructed in 85 patients, 9 of whom 
were adolescents. Indications for 
the procedure included organic problems 
related to the ileostomy as well as 
psychologic and sexual difficulties 
related to an external appliance.
Fifty-eight patients had conversion 
from a conventional ileostomy. 
Twenty-five patients underwent total 
proctocolectomy and Kock ileostomy. 
An intussuscepted “nipple valve” 
was used in all cases.
Follow-up ranged from 4 to 10 months. 
There were no operative deaths. 
Eighty-two patients are completely 
continent with regard to both flatus 
and stool. Only two patients wear an 
external appliance. No one has 
requested a return to a conventional 
ileostomy. No reservoirs have been 
removed. Ten of the initial 17 patients 
(59%) required at least one additional 
surgical procedure for early or late 
complications, the most frequent of 
which were intestinal obstruction, 
sliding or prolapse of the nipple valve 
and fistula. Technical modifications 
have reduced this morbidity; they 
included using SGIA staples across 
the nipple valve and a fascial 
sling around the outlet. These modifica­
tions have been used in 28 additional 
patients and in 5 from the original 
series. Ten of these 33 patients 
(30%) have required intra-abdominal 
operation for revision, 5 because of 
sliding of the nipple valve. Further 
modifications using a Marlex mesh 
sling have been made in 40 additional 
patients and in 7 patients from 
the original series. Six of these 47 
patients (11%) have undergone or 
will undergo intra-abdominal operation
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for revision. Only one case of 
nipple valve sliding has occurred 
in this group. Marlex mesh has 
now been replaced by Prolene mesh.
The benefits of the continent 
ileostomy are substantial. The author's 
results have continued to improve 
with experience and with the technical 
modifications outlined.
Quatre-vingt-cinq patients, dont 
9 adolescents, ont regu une ileostomie 
continente a reservoir. Les 
indications operatoires incluent des 
problemes organiques relatifs a 
I'ileostomie ainsi que des difficultes 
psychologiques et sexuelles reliees a 
un appareil externe.
La conversion d'une ileostomie 
conventionnelle a ete pratiquee 
chez 58 patients. Vingt-cinq 
patients ont subi une 
procto-colectomie totale et une 
ileostomie de Kock. Une “valve 
a ecrou'' invaginee fut utilisee 
dans tous les cas.
La surveillance postoperatoire va 
de 4 a 10 mois. II n'y a eu aucun 
deces peroperatoire. Ouatre-vinqt-deux 
patients ont une continence complete 
pour les gaz et pour les feces. 
Seulement deux patients portent 
un appareil externe. Aucun n'a 
demande le retour a une 
ileostomie conventionnelle. Aucun 
reservoir n'a ete enleve. Dix des 17 
(59%) premiers patients ont 
necessite au moins une intervention 
chirurgicale additionnelle pour 
des complications precoces 
ou tardives, les plus frequentes 
etant (’obstruction intestinale, 
le glissement et le prolapsus de la 
valve a ecrou, ou une fistule.
Des modifications techniques 
ont reduit cette morbidite; 
ceci comprend I'emploi d'aqrafes 
SGIA en travers de la valve 
a ecrou et d'une bandelette 
aponevrotique autour de I'orifice.
Ces modifications ont ete appliquees 
a 28 patients additionnels et a 5 
de la premiere serie. Dix de ces 33 
patients (30%) ont necessite 
une operation intra-abdominale 
de revision dont 5 a cause du 
glissement de la valve. D’autres 
modifications faisant appel a une 
bandelette de tissu a mailles Marlex 
ont ete utilisees chez 40 patients
additionnels et chez 7 de la 
premiere serie. Six de ces 47 
patients (11% ) ont subi ou vont 
subir une operation de revision.
Un seul cas de glissement de la valve 
a ecrou est survenu dans ce groupe.
Le tissu a mailles Marlex a 
maintenant ete remplace par 
du tissu Prolene.
Les avantages de I’ileostomie 
continente a reservoir sont 
considerables. Les resultats 
continuent d'ameliorer avec 
('experience et les modifications 
decrites.
Children with ulcerative colitis still 
suffer from long-standing disability, 
severe growth retardation, delayed 
development of secondary sex char­
acteristics, interference with emotional 
maturation and occasionally malignant 
tumours of the colon.1 The reluctance 
of the physician, the patient and the 
patient’s family to accept the need for 
a permanent, continuously worn ap­
pliance, despite the very tolerable life 
it permits, is well known to all. In­
troduction of the continent reservoir 
by Nils Kock has helped to overcome 
much of the reluctance to elect opera­
tion. Moreover, the psychologic and 
sexual barriers associated with the 
conventional ileostomy have been 
mostly removed by the continent ileo­
stomy, which obviates the need for an 
external appliance. In this paper I dis­
cuss the indications and contraindica­
tions for the continent reservoir ileo­
stomy, its evolution, the results that 
can be achieved and the long-term 
biologic effects.
Indications and Contraindications
Indications for the continent ileo­
stomy include ulcerative colitis proven 
by tissue examination, ileostomy dys­
function and peristomal skin irritation 
and ulceration. In our series of pa­
tients, most of the conversions to a 
continent reservoir ileostomy were be­
cause of psychologic and sexual dif­
ficulties related to an external ap­
pliance. This is a valid indication for 
the procedure.
There are definite contraindications 
to the procedure. At the moment, we 
do not offer it to patients with Crohn’s 
disease or to those who are severely
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debilitated. Local or systemic sepsis 
and emergency surgery are also con­
traindications. Previous resection of a 
large segment of small bowel pre­
cludes using an additional 45 to 50 
cm of small bowel for construction 
of the reservoir ileostomy. We would 
not perform this procedure in children 
less than 12 years of age.
Preparation of the patient and the 
family is most important. In all 
cases, the nature of the disease is 
documented from previous medical 
records as well as from original mi-
1973
FIG. 1—Kock ileostomy: 1969 with 
antiperistaltic outlet, 1971 with isoperi­
staltic outlet and 1973 with intussus- 
cepted segment of ileum forming “nipple
valve”.
croscopic sections, if available. Ro­
entgenograms after a small bowel 
enema are made to rule out occult 
small bowel disease. A thorough ex­
planation of the benefits and possible 
complications of the procedure are 
outlined to both the patient and family. 
Literature is given to the patient and 
a movie is shown on the subject, if 
the patient wishes. Most importantly, 
however, each candidate is put in 
touch with patients who have already 
undergone the procedure so that per­
sonal contact can be made with 
further dissemination of information.
Evolution of the Procedure
The Kock ileostomy was first used 
in 19692 (Fig. 1). At that time an 
antiperistaltic outlet was used. This 
was changed to an isoperistaltic outlet 
in 1971 (Fig. 1). With both types of 
outlet incontinence developed in a 
high proportion of cases.3 So in 1973, 
Professor Kock developed the “nipple 
valve” which is an intussuscepted 
segment of distal ileum.4 With this 
modification the continence of the 
reservoir improved. However, be­
cause of “dessusception” of the nipple 
valve, many patients experienced dif­
ficulty in intubating the reservoir, and 
incontinence was still a problem. Pro­
fessor Kock further modified the pro­
cedure to reduce the complication of 
nipple valve sliding.4 This included 
separating the mesenteric masses, us­
ing a rotational suture, cauterizing the 
serosa of the nipple valve segment and 
stripping the peritoneum and fat on 
the mesentery to decrease the bulk of 
mesentery being intussuscepted.
Because of reported improved re­
sults with these modifications,4 we be­
came interested in the procedure and 
the following account is of our total 
experience during the past 4 years 
using various modifications of the 
technique.
Patients
A continent reservoir ileostomy has 
been constructed in 96 patients and I 
shall report the results in 85 patients 
who have been followed up for longer 
than 4 months. Nine of the 85 were 
adolescents between the ages of 15 
and 20 years whose standard ileostomy 
has been converted to a Kock ileo­
stomy. Few publications have outlined 
the results of the continent ileostomy 
in pediatric patients. Therefore, the 
following account will illustrate the 
overall results that can be achieved 
regardless of age.
Initial Technique
Between August 1977 and Novem­
ber 1978, using Kock’s technique4 and 
that described in our original publica­
tion,5 17 patients had a continent ileo­
stomy constructed. Eleven patients 
had conversion from a conventional 
ileostomy, 4 had a continent reservoir 
ileostomy constructed in association 
with a proctocolectomy, 1 had con­
version from a right colostomy and in 
1 a reservoir ileostomy, previously 
revised at another centre, was recon­
structed.
There were no deaths in this group. 
There were four cases (23%) of in­
testinal obstruction and two entero-
FIG. 2—Creation of 4- to 5-cm nipple valve by intussuscepting terminal ileal 
segment.
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cutaneous fistulas (12%) that required 
surgical intervention in the early post­
operative period. Also, there were 
late complications that required opera­
tion, including sliding of the nipple 
valve in three patients (18%) and com­
plete prolapse or eversion of the valve 
in one (6%). The revision rate for 
these initial 17 patients was 59%. 
More critical evaluation of the com­
plications shows that 4 of these 10 
patients required two additional opera­
tions and 2 of the 4 required four 
additional operations to correct the 
complications.
Despite the high operative revision 
rate, none of the patients requested 
a return to a conventional ileostomy
and all were extremely satisfied with 
the eventual result. Sixteen of these 
17 patients never wore an ileostomy 
appliance and 1 wore an external ap­
pliance only occasionally. (The prob­
lem that led the last patient to wear 
an appliance later resolved sponta­
neously and she ceased to wear the 
appliance.)
Modification of the Initial Technique
Because the functional results were 
excellent we continued to offer the con­
tinent ileostomy to selected patients 
and turned our attention to modifying 
the procedure to correct the problems 
of intestinal obstruction, fistula for­
mation, sliding of the nipple valve and
prolapse that had plagued us earlier. 
To correct these problems the reser­
voir was repositioned to prevent af­
ferent limb obstruction,5 SGIA staples 
(Auto Suture Company, Division of 
United States Surgical Corp., Nor­
walk, Conn.) were used across the 
valve to secure it in position and a 
strip of fascia taken from the anterior 
abdominal wall was sewn in place 
around the base of the outlet to pre­
vent prolapse.6
These modifications were used in 
28 additional patients and in 5 of the 
17 patients from the original series, 
between November 1978 and May 
1980. Eighteen of the 28 patients had 
a conventional ileostomy converted 
and 10 reservoir ileostomies were 
created in association with proctoco­
lectomy.
There were no deaths in this group. 
Major early complications requiring 
surgical intervention were perforation 
of the reservoir in one patient and 
pelvic abscess in another. Other early 
complications that occurred but for 
which surgery was not necessary were 
wound infection in two patients, ab­
scess and external fistula in one, fluid 
and electrolyte disturbances in two 
and inflammatory changes within the 
reservoir in two patients. Late com­
plications requiring further abdominal 
surgery continued to be appreciable. 
Sliding of the nipple valve occurred in 
five patients, fistulas formed in two 
and there was intestinal obstruction 
in one. The operative revision rate in 
this group of patients was 10 of 33 
(30%).
Although the rate had decreased 
from 59% to 30%, sliding of the 
nipple valve continued to be a major 
problem and led to further modifica­
tions in the surgical technique.
Further Modifications
The surgical technique used to June 
1981 is as follows. The construction 
of the reservoir itself is unaltered. Ap­
proximately 45 cm of distal ileum is 
used.6 Initially, the most distal 15 cm 
limbs are sutured together on their 
posterior aspect using absorbable su­
ture material. The limbs of the “U” 
are then opened along the antime- 
senteric border and the incision is 
carried 2 to 3 cm further on the 
afferent limb. The distal ileum is then 
intussuscepted over a 4- to 5-cm seg­
ment to create the nipple valve (Fig. 
2). The nipple valve is secured in 
position with three to four rows of 
staples using the SGIA stapler with­
out the blade (Fig. 3). The intestinal 
plate is folded over on itself to create 
the reservoir and the sides are com-
/
FIG. 3—Nipple valve is secured in position with three to four rows of staples 
using Auto Suture GIA stapler.
Karen
Youmj
FIG. 4— Strip of Marlex mesh is used as sling around base of outlet to secure 
nipple valve.
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plcted using two layers of absorbable 
suture material. Each corner of the 
reservoir is passed alongside the me­
sentery so that the reservoir will be 
positioned within the pelvis and the 
afferent limb will enter from the medial 
aspect. A strip of Marlex mesh is then 
passed through a previously created 
window in the mesentery at a posi­
tion approximating the base of the 
outlet (Fig. 4). The reservoir is 
sutured to the lower edge of the 
Marlex using absorbable suture and 
the corners of the Marlex are secured 
to the anterior rectus sheath using 
2-0 Prolene (Fig. 5). The medial aspect 
of the reservoir is then anchored to 
the medial aspect of the undersurface 
of the ileostomy opening. The excess 
outlet is trimmed away and the stoma 
is made flush with the skin (Fig. 6). A 
no. 30 French ileostomy catheter (A.B. 
Medena, Kungsbacka, Sweden) is 
placed within the reservoir and at­
tached to a straight drainage system.
This technique was used in 40 pa­
tients and in 7 of the 17 patients from 
the original series who required re­
operation. Of the 40 patients, 29 had 
conventional ileostomies converted to 
the continent reservoir type and 11 
procedures were done in association 
with proctocolectomy.
There were no deaths. Using these 
most recent modifications we had 
only one patient with sliding of the 
nipple valve. However, there were 
three with fistula that required further 
operation and one other with a fistula 
who is awaiting surgical inter­
vention. One patient with intestinal 
obstruction due to adhesions re­
quired two further operations. There 
were three peristomal infections, which 
healed spontaneously. Partial prolapse 
of the nipple valve occurred in four 
patients and required manual reduc­
tion and local peristomal revision to 
correct the problem. In this latest 
series, 6 of the 47 patients required 
abdominal revision operations. The 
reoperation rate has therefore been 
reduced to approximately 13%.
O verall F unc tiona l R esults
Of 85 patients, 1 committed suicide 
6 months after operation, so 84 pa­
tients were available for follow-up. 
Of these, 82 (97.5%) never wear an 
ileostomy appliance and 2 (2.5%) al­
ways wear an ileostomy appliance. 
Of these two, one is awaiting further 
surgical revision because of the de­
velopment of a fistula.
F u r th e r  Im provem ents
Although sliding of the nipple valve 
has almost been eliminated, the num­
ber of peristomal infections and entero- 
cutaneous fistulas has increased. This 
is most likely due to the introduction 
of Marlex mesh into the surgical tech­
nique. The other common complica­
tion in the latest series was partial 
prolapse of the nipple valve; this re­
quired local surgical revision. In an 
effort to reduce these complications, 
Prolene mesh has been substituted for 
the Marlex mesh. The Prolene mesh 
is more inert, more flexible and less 
likely to cause erosion and subse­
quent fistula. To reduce the incidence 
of nipple valve prolapse, the ileostomy 
opening is made considerably smaller. 
With these small modifications in 11 
additional patients operated on since 
lune 1981. no further cases of peri­
stomal infection, fistula or prolapse 
have been seen.
L ong-T erm  Effects
Bacteriology
Construction of a continent ileos-
FIG. 5— Corners of Marlex mesh are sutured to  anterior rectus sheath to secure 
mesenteric side of outlet and valve.
FIG . 6— Reservoir is anchored to abdominal wall and stoma is made flush with
skin.
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5. Surgical Treatment of Crohn’s Disease
A.L. Bensoussan, md,* J.N. L etourneau, md,* C.C. M orin, MDf and H. Blanchard , m d , frcs[c]*
Of 93 children with Crohn's disease 
treated at the Hdpital Sainte-Justine 
between 1967 and 1979, 39 were 
operated on. Ten had abscesses 
and anal fistulas drained and in 29 
the bowel was resected. The mean 
age of the children was 13 years. The 
average time between onset and 
diagnosis for both the medical and 
surgical groups was 13 months.
Medical treatment failed in 25 patients 
after an average time of 22 ±  17 
months. Fourteen patients had an 
initial laparotomy, with a false 
diagnosis of appendicitis in 8, 
abdominal tumour in 2 and Meckel's 
diverticulum in 1. Indications for 
operation were: intestinal obstruction, 
bowel fistula, intra-abdominal abscess, 
gastrointestinal hemorrhage, growth 
failure and toxic megacolon.
There were no deaths and only 
two postoperative infections. Crohn's 
disease seems to be becoming more 
frequent, more severe and starting 
earlier in life. Three to 6 weeks 
of preoperative preparation with 
enteral and parenteral nutrition allows 
operation to be performed under 
safer conditions. Although the 
recurrence rate after operation 
is still high, there is no doubt that 
the children enjoy a better quality 
of life, growth and a 50% chance 
of being disease-free 10 years later.
Ouatre-vingt treize enfants atteints de 
maladie de Crohn ont ete traites a 
I'Hopital Sainte-Justine entre 1967 et 
1979; 39 ont ete operes. Dix ont eu de 
multiples drainages d’abces et fistules 
anales et 29 ont eu une resection 
intestinale a un age moyen de 13 ans. 
Le temps moyen entre le debut 
des symptomes et le diagnostic a ete
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le meme chez les malades traites 
medicalement ou chirurgicalement 
(13 mois). Le traitement medical a ete 
essaye chez tous les patients mais 
chez 25 patients il a ete inefficace 
au bout d'un delai moyen de 
22 mois ± 1 7 . Quatorze patients 
ont eu une laparotomie d'emblee 
avec un faux diagnostic d ’appendicite 
chez 8, de tumeur chez 2 et de 
diverticule de Meckel chez 1.
Les indications operatoires ont ete: 
obstructions intestinales, fistules 
digestives, abces intra-abdominaux, 
hemorragies digestives, nanisme 
et megacolon toxique.
Aucune mortality n’est a deplorer. 
Les complications infectieuses 
postoperatoires sont au nombre de 
deux seulement. La maladie de Crohn 
semble plus frequente, plus severe 
et commence a un age plus jeune. 
Une bonne preparation de 3 a 6 
semaines avec une nutrition enterale et 
parenterale permet une chirurgie 
dans d'excellentes conditions. Bien 
que la recidive soit frequente, il n’y a 
pas de doute que les enfants operes 
jouissent d’une meilleure qualite 
de vie, d’une acceleration de la 
croissance et peuvent esperer ne pas 
avoir de recidive dans 50% des cas 
sur une periode de 10 ans.
The treatment of inflammatory bowel 
diseases still represents a major chal­
lenge. In recent years many meetings 
have been devoted to the subject and 
many large series have been reported 
in Canada and the United States.
Patients and Treatm ent
Between 1967 and 1979. 147 chil­
dren with inflammatory bowel disease 
were seen at Hopital Sainte-Justine in 
Montreal; 93 (52 boys, 41 girls) were 
treated for Crohn’s disease. The age 
at diagnosis ranged from 7 to 19 years 
(mean 13.4 years). A  family history 
of the disease was found in 12.9%. 
The average time from onset of symp­
toms to diagnosis was 13 months. 
This time was the same for those 
treated medically and surgically but 
differed according to the site of the 
disease: 9 months for the 24 children 
with ileal disease and 13 months for 
the 57 with ileocolic and the 3 with 
colonic involvement; it was longer, 31
months, for the 9 with diffuse dis­
ease.
Thirty-nine patients were operated 
on: 10 for perineal abscess and anal 
fistula; 29 (14 girls and 15 boys) un­
derwent bowel resection. The mean 
time from diagnosis to operation was 
22 ±  17 months. In 14 patients
operation was performed early (Table 
I) and the diagnosis was incorrect in 
12. Definitive operation was carried 
out in three. In four patients no addi­
tional procedure was performed when 
Crohn’s disease was found.
Among the 24 patients with ileal 
disease only 4 underwent ileal or ileo­
cecal resection (at a mean age o f 15.5 
years) because o f skin fistula after 
initial laparotomy, severe enteropathy, 
bowel obstruction and growth failure.
Among the 57 children with ileo­
colic involvement, 19 had a right 
ileocolectomy, at a mean age o f 14 
years. The reasons for operation were 
intestinal obstruction (eight children), 
skin fistula (three), growth failure 
(three), gastrointestinal hemorrhage 
(two) and right psoas abscess, pre­
vious bypass procedure and perfor­
ation of toxic megacolon (one each). 
Six additional procedures were done: 
drainage of abdominal abscess in five 
and partial sigmoid resection in one.
Total ileocolectomy was done in 
six patients, at a mean age o f 15 
years. Five children had colic resec­
tion for intestinal obstruction or in­
tractable disease after failure of med­
ical treatment, and one had an emer­
gency operation for toxic megacolon. 
Ileorecta! anastomosis was done once, 
but generally a temporary ileostomy 
and closure o f the rectal stump (Hart­
mann procedure) were performed.
Table I-Diagnosis before Initial
Operation in 14 Children
Diagnosis
No. of 
children
Acute appendicitis 8*
Lymphoma 1
Ovarian cyst 1
Recurrent anal fistula 1
Meckel's diverticulum It
Right psoas abcess It
Instestinal obstruction It
"Appendectomy was carried out in 5.
tDefinitive procedure done.
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Results
Among the 14 patients who had an 
early laparotomy, 4 had no additional 
procedure; 1 had no complications 
and is receiving medical treatment 
and the others had postoperative com­
plications (cutaneous fistula in 2, 
intra-abdominal abscess in 1) that 
were initially treated medically, with 
parenteral nutrition, but finally by 
definitive operation. Seven appendec­
tomies were done, five before referral 
to our hospital and two at our institu­
tion. None of these patients had a 
cutaneous fistula in the postoperative 
course even when the cecum was in­
volved. Four out of these seven pa­
tients underwent bowel resection 3 to 
6 years after failure of medical treat­
ment, one is under medical treatment 
and two are free of symptoms.
All four children who underwent 
ileal or ileocecal resection had a 
smooth postoperative course. One pa­
tient is free of disease after 9 years, 
two are asymptomatic without treat­
ment hut with radiologic changes 
that were noted 4 and 5 years re­
spectively after operation, and one 
had a true recurrence 6 months after 
the operation and is receiving med­
ical treatment.
No postoperative complications oc­
curred in 16 of the 19 children who 
had a right ileocolectomy. Three had 
to be reoperated on for intestinal 
adhesions (30 days postoperatively), 
bladder fistula (surgical closure 8 days 
postoperatively) and a postoperative 
flare-up with multiple perforations of 
the ileum. For the last child a prox­
imal ileostomy was created, which 
was closed 8 months later. This boy 
is now free of disease, 3 Vi years after 
closure of the proximal ileostomy. 
Four children were lost to follow-up. 
Twelve are free of disease at follow-up 
ranging from 6 months to 4 years. 
Three had a recurrence within 2 years 
and are being treated medically. None 
have been reoperated on. The mean 
weight gain of these children was 13 
kg, and the mean height gain was 
9 cm.
The postoperative course was 
smooth in four of six children who 
had a total colectomy. Aggressive an­
tibiotic treatment cured a supposed 
subphrenic abscess in one of them. 
The patient with toxic megacolon ex­
perienced a stenosis of the ileostomy 
and a wound abscess; 3 months later 
a new ileostomy was constructed and 
finally the rectum was removed 8 
months later by a perineal approach. 
The rectal disease did not improve 
in three patients and a secondary
proctectomy was done 6 to 21 months 
later. Two patients were free of dis­
ease for 3 and 4 years respectively 
and one has had occasional discharge 
from his perineal wound in the 3 
years since operation but no recur­
rence of the Crohn’s disease. Ueorec- 
tal anastomosis was done in three 
children, in one during the early lapa­
rotomy and in two after 1 year. Two 
of them had a recurrence of the rectal 
disease while under medical treatment, 
and one was operated on only 3 
months ago. However, these patients 
achieved a good increase in weight 
and height.
The cumulative recurrence rate in 
the medical group was 15% during 
the first year, 42% during the second, 
62% during the third and 92% at 6 
years. In the surgical group the cumu­
lative recurrence rate was 11% dur­
ing the first year, 26%, 41% and 
55% during the second, third and 
fourth years respectively.
Discussion
It is our impression that the fre­
quency of Crohn’s disease in children 
is increasing; for the last 2 years a 
new patient has been seen at our 
institution every 3 weeks.
Operation in Crohn’s disease is re­
served for the management of com­
plications; 70% to 90% of patients 
undergo operation during their life­
time and 30% to 60% will be oper­
ated on during childhood.
Three categories of patients are 
operated upon: those with chronic 
complications, those with acute com­
plications and those with a surgical 
abdominal emergency at the onset of 
the disease. The definition of intract­
ability varies, but we believe the dis­
ease is intractable once it interferes 
with the patient's life-style because of 
recurrent obstruction, pain, bleeding, 
draining fistula or inflammatory mass 
or when steroids are given, causing 
severe side-effects.
Careful preoperative care helps in 
preventing death and reducing mor­
bidity. Total parenteral nutrition fol­
lowed by continuous elemental en­
teral diet achieves complete bowel 
rest, treats malnutrition, brings elec­
trolytes into balance and provides 
perfect bowel cleansing. This routine 
preparation over a 3-week period was 
carried out in our institution for every 
elective operation. Plasma and blood 
were given when needed and steroids 
were started intravenously the day 
before operation. Antibiotics were 
given before and during the proce­
dure.
A midline abdominal incision pro­
vides the best exposure for explora­
tion and resection and greater free­
dom in choosing stoma sites. Resec­
tions must be limited to gross lesions 
and demarcation can be made by 
noting the creeping mesenteric fat and 
induration of the bowel wall. For this 
purpose frozen sections are helpful. 
End-to-end anastomosis is always the 
first choice. When internal fistula is 
found, only partial resection of the 
normal bowel is required. All ab­
scesses must be evacuated and cavities 
drained with a sump catheter.
The usual postoperative care is 
given. Steroids are administered intra­
venously for 4 days, then by mouth 
in decreasing doses to zero.
Acute complications such as pro­
fuse hemorrhage, toxic megacolon and 
perforation are clear indications for 
operation. Toxic megacolon can be 
associated with bleeding, perforation 
and septicemia. Physical examination 
is less reliable because of the effects 
of massive steroid therapy. Resuscita­
tion must be aggressive and include 
gastric aspiration, blood and plasma 
replacement and administration of an­
tibiotics. Frequent physical examina­
tions and repeated plain roentgeno­
grams will help to assess colonic dila­
tation. Timing of operation is based 
on the evolution of the disease. Oper­
ation is mandatory if there is no im­
provement after 1 or 2 days of in­
tensive therapy, if there is any dete­
rioration and if the diameter of the 
transverse colon reaches 7 to 10 cm 
on the plain roentgenogram.
Operation must be carefully done in 
order to avoid iatrogenic perforation. 
Peritoneal fluid samples are taken for 
culture. Generally, it is safer to per­
form a terminal ileostomy with clo­
sure of the rectal stump after remov­
ing the colon. Generous lavage helps 
to clean the abdominal cavity and 
frequently abdominal drainage is nec­
essary. In the case of profuse and 
persistent bleeding, one must make 
sure that it is not of rectal origin and 
then proceed with operation after re­
suscitation.
Perforation is uncommon in Crohn’s 
disease and is an indication for imme­
diate operation.
Patients with acute complications 
must be treated vigorously in the post­
operative period. They must be sup­
plied with parenteral followed by con­
tinuous enteral nutrition.
Some children present with an 
acute abdominal condition as the first 
manifestation of the disease. In these 
children a good history and a care­
ful physical examination do not al­
ways avoid a false diagnosis. Unnec-
T
8
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essary operation is performed most 
frequently when an incorrect diagnosis 
of acute appendicitis is made.
Three aspects of this disease are 
still subjects for debate: the recur­
rence rate, the rectal involvement and 
the growth failure.
According to the literature, the re­
currence rate seems to increase with 
the length of follow-up: 10% after 
1 year, 40% after 5 years, 50% 
after 10 years. The recurrence rate 
is not related to the age of the child 
at the first operation. However, the 
location and extent of the disease at 
the initial operation are of prognostic 
importance. Ileocolic involvement is 
associated with a greater rate of re­
currence requiring reoperation.
In our series no proctocolectomies 
were done at the first operation, but 
in four of six patients the ileostomy 
became permanent and the rectal 
pouch had to be removed. In the 
adolescent, preservation of the rec­
tum and the hope for a reanastomosis 
is an important psychological support. 
If resection of the rectal pouch 
becomes necessary later, it is more 
easily accepted. So, at the pri­
mary operation the level of rectal sec­
tion should be low enough to leave 
the rectum below the peritoneal re­
flection. It can be removed later, if 
needed, by a perineal aproach.
The growth failure is the result of 
limitation of food intake, malabsorp­
tion, protein loss and hypermetabol­
ism. Wesson and Shandling1 have 
shown that the growth response to 
operation varies with the age and the 
stage of puberty. In fact, growth fail­
ure is rarely the sole indication for 
operation, as pointed out by Gutt- 
man.2 According to Castile and asso­
ciates,3 patients requiring operation are 
shorter than those treated medically. 
Important increase in growth was 
noted immediately after operation,1’2’4 
but in adulthood both medically and 
surgically treated patients were the 
same height and appreciably shorter 
than normal. In the routine medical 
management of children with Crohn’s 
disease, caloric supplementation must 
begin at the time growth failure is 
first noted. A prospective study is 
presently being conducted in our insti­
tution, using a 3-week course of con­
tinuous elemental diet as the sole 
treatment in order to induce remis­
sion. Usually this treatment leads to 
a resumption of growth which lasts 
about 3 months. Repeated courses of 
elemental, enteral nutrition at home 
may be beneficial. If this attempt
fails, operation will be performed and 
may lead to some catch-up in growth.
Conclusions
Crohn’s disease in children seems 
to be occurring more frequently, to 
be more severe and to be starting 
earlier.
Good preoperative care with en­
teral or parenteral nutrition allows 
operation to be performed under safer 
conditions with very little morbidity 
and mortality.
Although the recurrence rate after 
operation is still high there is no 
doubt that patients enjoy a better 
quality of life, growth acceleration 
and a 50% chance of being free of 
disease 10 years later.
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6. Panel Discussion
Chairman: R. Postuma*
Panelists: A. B ensoussan, Z. Cohen, A. Coran, S. Moroz, M. Ste-Marie
Dr. Postuma: The frequency of in­
flammatory bowel disease in adoles­
cent patients appears to be increasing. 
We are seeing more patients with 
Crohn’s disease, usually with very ex­
tensive involvement of the small bowel
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and colon and with associated protein- 
calorie malnutrition.
There are presently a number of 
controversies in the management of 
these patients: Should malnutrition be 
managed with home parenteral nutri­
tion or is the continuous elemental 
diet preferable? Is growth retar­
dation and delay of sexual matura­
tion an indication for surgical inter­
vention in the absence of clearly iden­
tifiable obstruction? For how long 
should steroid therapy continue before 
surgical treatment is considered? In 
the surgical treatment of ulcerative 
colitis should one use the Kock pouch 
or the endorectal pull-through pro­
cedure?
These are some of the questions we 
should try to answer in this discussion. 
Question: In the October 1 979 sup­
plement of Gastroenterology, a fantas­
tic review of the treatment of Crohn’s 
disease was presented, and one of the 
main points made was the futility of 
using steroids to prevent exacerbation 
in patients who are in remission. Ob­
viously the use of steroids is of in­
terest in acute disease as we have been 
told. Why is it that so many patients, 
who come to us in an extreme state 
obviously requiring operation for 
Crohn’s disease that has been present 
for weeks or months, have had some­
times years of steroid therapy? Why 
do we see those patients still in 1981?
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Dr. Moroz: That is an excellent ques­
tion. Before the National Cooperative 
Crohn’s Disease Study was initiated, 
the management of this disease was 
really anybody’s guess. It was thought 
that the use of steroids on a long-term 
basis might be of some value, but 
the study findings do not support this. 
I don’t really know why people persist 
with steroids. I suppose they hope that 
the patient will ultimately go into 
remission so that surgery will be 
avoided, because in Crohn’s disease it 
is associated with numerous compli­
cations. We have been impressed, in 
the few such patients that we see, 
that those we have operated on have 
done much better following the opera­
tion than before, despite large doses 
of steroids that had been used in an 
attempt to keep the disease under 
control. Medical people have partly 
been influenced by the surgeons; sur­
geons have been reluctant to operate 
because the patients have been able 
to manage without operation. But as 
surgical techniques have improved 
(and you just heard that the expe­
rience with surgery seems to be bet­
ter), perhaps the patients about whom 
you have been talking won’t be ap­
pearing on your doorstop in future. 
They will have had shorter courses 
of steroids. I hope I have answered 
your question.
Question (Dr. Deschamps): In Mar­
tin’s article on endorectal pull-through, 
he states that extensive preparation 
should be done before operation in 
order to facilitate the procedure. How 
important is this and how do you 
carry this out?
Dr. Coran: Well, Martin, in his article 
and when speaking with him, men­
tioned that many of this patients were 
placed on parenteral nutrition for 
about a month, mainly with the idea 
of decreasing the amount of inflam­
mation in the rectum. We followed 
his advice in our first series of 
patients and found very little' change 
in the status of the rectum. Patients 
became better just as any patient with 
inflammatory bowel disease will when 
they have bowel rest and get good 
nutritional support such as total 
parenteral nutrition. On the other 
hand, if one diverts the fecal stream 
with an ileostomy, which we are 
doing now, we find the inflammatory 
process in the rectum markedly im­
proved and it is far easier to do the 
dissection. The dissection is quite dif­
ficult when there is a lot of inflamma­
tion. The difference in the volume of 
blood transfusion required in these two 
groups of patients has been quite im­
pressive.
Question (Dr. Filler, Toronto): Are
there any people with ulcerative colitis 
who have such severe disease that you 
cannot do the endorectal dissection? 
Dr. Coran: Yes, I think there are. In
our series, I had one patient about 35 
years old who had had disease for 25 
years, and had such severe inflam­
matory strictures and fibrosis in the 
rectum that we could not do the dis­
section. I think there will be such a 
group of patients, but mainly in the 
older age group. There are adults who 
have strictures of the rectum in which 
dissection is quite difficult, but in 
most the dissection can be done. 
Question: My question is for Drs. 
Coran and Cohen. In 1981 an ado­
lescent comes to us requiring a 
colectomy. The parents know about 
proctocolectomy and endorectal pull- 
through. Which procedure should we 
recommend at this stage? This may be 
an unfair question, but it’s realistic 
because those are the questions that 
well-informed patients ask.
Dr. Coran: Well, let me take two
aspects of that question. The expe­
rience now accumulated around the 
country with the endorectal pull- 
through for ulcerative colitis — name­
ly, Martin’s experience, our expe­
rience, that of the Mayo Clinic and 
that of the group at St. Mark’s Hos­
pital in London (Parks and Nicholls) 
— shows clearly that this operation 
works. Now, you may say you don’t 
want a patient to have 20 bowel move­
ments a day for 2 or 3 months, and 
that is a legitimate objection, but the 
fact is that many of the patients do 
quite well. On the other hand, if you 
proceed with the conventional 
standard approach for ulcerative 
colitis, you have burned all your 
bridges. If you do a proctocolectomy, 
you can never do the pull-through 
procedure. But, if you do the endo­
rectal pull-through and your patient 
happens to be dissatisfied with the 
frequency of bowel movements, you 
can always go back and do a proct­
ectomy and form a permanent ileo­
stomy. I have been asked this ques­
tion several times, principally by 
general surgeons around our state. 
Because they do not know how to do 
the endorectal pull-through and are 
faced with either taking care of their 
patients with ulcerative colitis in their 
hospital or referring them, I have sug­
gested that if they are not sure that 
this is a good operation, which I can 
understand because the data are not 
all in, they should just do a subtotal 
colectomy and an ileostomy. If you 
are going to do a subtotal colectomy 
for this disease, do not construct a
Hartmann pouch. It is almost im­
possible, and I have tried it already, 
to go back in and do an endorectal 
dissection when the rectal stump has 
been closed and dropped below the 
pelvic floor. You can’t do it, at least 
I can’t do it. So, if you are going to 
do a subtotal colectomy, you must 
leave the patient with a mucous fis­
tula of the rectum somewhere in the 
mid-sigmoid colon, and a permanent 
ileostomy, which I have done as part 
of a three-stage procedure. The ques­
tion that comes up after that is: 
“What happens if the patient con­
tinues to bleed from the rectum?” — 
that is very well managed with cort 
enemas.
Dr. Cohen: Surprisingly, I wouldn’t 
disagree with too much that Dr. Coran 
said. We are very interested in endo­
rectal pull-through, but I think it’s 
never going to be a technique that 
everyone is going to do. It’s a highly 
specialized technique. It’s also a tech­
nique that will be filled with compli­
cations when you first do it, the same 
as the continent ileostomy, although 
maybe less so than the continent ileo­
stomy. I would not disagree at all 
with maintaining someone’s rectum. I 
think you can staple it off and leave 
it within the peritoneal cavity, but I 
agree that it shouldn’t be done too 
low; recently, we had the experience 
of attempting to do an endorectal 
pull-through that was below the pelvic 
reflection and it was extremely diffi­
cult to do. I would like to make a 
couple of comments though about the 
results that are coming in regarding 
this procedure. Dr. Coran’s results are 
by far the best that I have ever heard. 
At a recent meeting of the American 
Society of Colon and Rectal Surgeons, 
some people from the Mayo Clinic 
were not at all pleased with their ileo­
anal surgery. In fact, their functional 
results were poor. They have now 
gone to balloon dilatation of the ileal 
segment above the ileoanal anasto­
mosis to create some type of reser­
voir function above the anastomosis; 
it is the feeling of the majority of the 
surgeons in that society that a straight 
ileoanal endorectal pull-through is 
not the operation of choice. A reser­
voir of some type, such as Parks’, 
which is similar to a Kock pouch with­
out the valve, or the Japanese folded 
J-type loop (they have actually three 
modifications of that) is necessary so 
that the frequency of bowel move­
ments will be reduced. So, although 
we are very interested in the proce­
dure, we would not recommend an 
ileoanal anastomosis in our adult 
patients. Parks has now done more
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than 50 operations and it is only his 
earlier patients who have had to in­
tubate their anus in order to empty 
the pouch; that is because he made 
the outlet a little too long when he 
was bringing it through the rectal cuff 
and anastomosing it to the anus. 
When he modified that technique 
recently, to make the outlet much 
shorter — in the 3- to 5-cm range — 
he had much better results with spon­
taneous evacuation and no inconti­
nence or anal soilage at night. In 
summary, we are very much in favour 
of endorectal pull-through. I think that 
it is a procedure that is going to be 
promoted and is here to stay, but it 
is a highly specialized technique and 
we would prefer to do it with some 
type of reservoir function.
Dr. Coran: Could I just say some­
thing about the reservoir and Parks’ 
experience. Parks spent a couple of 
days with us in Michigan. He has 
operated on 50 patients and the results 
are much better now; but one must 
realize that he is placing inside that 
endorectal pull-through — for those 
of you who have done this opera­
tion — a segment of bowel that has 
30 cm or so of suture line in the 
small bowel. Often we were worried 
about exactly what the blood supply 
was like at the very end of that bowel. 
I am concerned about the potential 
complications. I wonder how many 
of these reservoirs he’s had fall apart, 
if any, because I have not seen the 
latest report; but that to me is a very 
worrisome thing, just as I am con­
cerned about the length of the suture 
line in a Kock pouch. The J-loop that 
the Japanese have described and that 
Fonkalsrud is now using gives a fre­
quency of bowel movements no dif­
ferent from that in our experience 
with a straight endorectal pull- 
through; that is an average of six to 
eight bowel movements daily, and the 
incidence of incontinence is greater 
than ours; we’ve had none. So I am 
not sure that a reservoir is the answer. 
I think the point is that at the moment 
we don’t know how good any of these 
operations are, and it’s very impor­
tant that each institution looking at 
this problem and whose results are 
reasonable, continue to do the same 
operation and not jump from one to 
the other, as I have seen happen, so 
that in 10 years we can evaluate which 
is the best operation. Telander, who 
is the pediatric surgeon at the Mayo 
Clinic, is the one who introduced the 
endorectal pull-through there and has 
done it in over 30 teenagers and young 
adults. The results I described from 
the Mayo Clinic are solely his, and
his results with the straight endorectal 
pull-through are excellent. I think they 
are similar to our results in Michigan. 
Many of the other general surgeons 
at the Mayo Clinic have taken it up 
and their results have been variable. 
Dr. Postuma: In our experimental
work we noticed the pouch dilates 
tremendously, in one animal by a 
factor of 4, so that in the long-term 
the pouch might be a problem. 
Comment (John Patrick, Montreal): I 
have spent 5 years resuscitating 
severely malnourished children, in 
John Woodlow’s unit in the West 
Indies, and I want to make a com­
ment about your assessment of natu­
ral growth, and make a request that 
you distinguish between wasted and 
stunted individuals, because there is 
an important point at issue. I find that 
I can use the same techniques they 
used in malnourished children, in 
wasted children with Crohn’s disease 
and achieve weight gains of up to 1 kg 
a day in, say, a 30-kg teenager. For 
instance, the last child in my series 
put on 10 kg in 15 days; but it is 
very dangerous to push calories once 
expected weight and height have been 
reached. You can certainly kill chil­
dren with primary malnutrition by 
doing that, but it is a very worthwhile 
procedure whilst they are wasted.
Dr. Ste-Marie: I agree with that
completely. I think that the primary 
thing is really to be on the lookout 
for signs of malnutrition and then 
assess to what extent this malnutrition 
exists. Is it simply a marasmic type of 
malnutrition or is the growth stunted? 
Then you should start to rehabilitate 
these patients slowly. I agree with 
you.
I have a question for Dr. Coran. 
Has the physiology of your so-called 
distal ileum been studied, because the 
fact of so many bowel movements 
makes me think that there might be 
a disturbance of bile-salt reabsorption 
at this level, and I wonder if the bile- 
salt kinetics have been studied and, 
if so, if there is an increased bile- 
salt excretion, and would something 
like cholestyramine be helpful in these 
patients?
Dr. Coran: I don't know of any study
in which the physiology of the distal 
pull-through rectum has been looked 
at. We’ve looked at all these patients 
who have had a long enough follow-up 
in terms of the histology. One of my 
thoughts was that possibly the piece 
of ileum sitting in the rectal cuff might 
change its histologic pattern from that 
of small-bowel mucosa to colonic mu­
cosa and thereby enhance its ability 
to absorb water. We’ve biopsied all
these patients on a yearly basis, both 
to look at that problem and also to 
be sure that no other active disease 
was present, and have not seen any 
changes. It looks like normal, typical 
ileum such as is seen with an ileo­
stomy. A clinical observation that we 
have made is that during the 2-month 
period, when the patient has an ileo­
stomy in place after the pull-through 
has been done, the ileostomy drainage 
is typical. It’s relatively liquid in many 
of the patients, it’s not really firmed 
up. When you close the ileostomy and 
patients begin to have bowel move­
ments from below, for some reason 
the material becomes thicker, indicat­
ing at least to me that there is some 
increased water absorption by merely 
allowing the material to sit in this 
small rectal pouch, but we’ve never 
proven that with any kind of experi­
mental study.
Dr. Cohen: I think this is certainly
one of our concerns in construction 
of any kind of reservoir — the Kock 
pouch or the reservoir brought down 
to the anus — and I think that we 
have shown in studies that the bile- 
salt loss is increased, and whether 
this loss is detrimental or not. It is 
not excessive but is certainly in­
creased. In modifying the Kock pouch
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reservoir by making it into a triple 
loop with three 15-cm lengths, that 
extra 15 cm does make a difference. 
We have also done studies in patients 
who have had a 15-cm resection plus 
creation of a Kock pouch. Their bile- 
salt losses are excessive, and that is 
why we believe that previous bowel 
resection is a contraindication to the 
formation of a Kock pouch reservoir. 
So, I think there is a fairly fine line 
there as far as how much bowel 
function there is.
Question (Dr. Ciatworthy): I wanted
to ask you about severe perirectal dis­
ease in patients with granulomatous 
colitis. We have been troubled with 
this in three teenagers. Have you seen 
these patients recover? They don’t 
have excessive disease above the peri­
rectal area and their disease is lim­
ited. How would you handle these 
patients?
Dr. Ste-Marie: I can tackle that be­
cause, unfortunately, it seems to me 
that now quite a few younger patients 
present with severe rectal and sigmoid 
problems, and you really want to
spare them any kind of definitive 
surgery if you can. We have started, 
as I said in my paper, on a regimen 
of continuous elemental enteral nutri­
tion, and for the first 4 or 5 days 
we give them steroids intravenously 
and then we stop completely. We con­
tinue with 2 to 6 months of continu­
ous enteroalimentation. That is not as 
terrible as it sounds because there 
are feeding tubes available that are 
extremely soft and can stay in place 
for more than 2 months without 
being changed. The first patient 
we treated this way, 4 years ago, 
had extensive perianal involvement of 
the rectum, the sigmoid and the des­
cending colon; he became totally 
asymptomatic for 3 Vi years. Radiolo- 
gically the disease was still there, but 
he was asymptomatic and he grew 
and matured sexually. So this is 
the way that we are looking at the 
problem. In other words, we are trying 
our best to induce remission and we 
have been successful in four or five 
patients at least that I have followed 
in the past 5 years.
BOOK REVIEWS
AMBULATORY SURGERY AND THE 
BASICS OF EMERGENCY SUR­
GICAL CARE. Edited by Mark W. 
Wolcott. 699 pp. Illust. J.B. Lippincott 
Company, Philadelphia, 1981. Price 
not stated, paperbound. ISBN 0-397- 
50480-2.
This tightly edited textbook represents 
a significant revision of its predecessor, 
the fifth edition of “Ferguson’s Surgery 
of the Ambulatory Patient,” published in 
1974, the first edition of which appeared 
in 1942. This up-to-date publication con­
sists of 33 chapters prepared by 31 con­
tributors. The major addition to this 
text is the emphasis on the early and 
appropriate management of various 
forms of trauma, both major and minor. 
This book is particularly timely in view 
of the recent development of the field 
of emergency medicine.
The first chapter establishes the fact 
that this book is aimed at the surgeon 
or house officer for use in either the 
physician’s office, the hospital-based 
surgical clinic, the ambulatory surgery 
unit or the emergency room. The 
following chapter contains an index of 
all the procedures that can be carried 
out in an ambulatory surgical centre, 
such as the Surgi-Center in Phoenix, 
Arizona. I have always been impressed 
by how much more major surgery is
done on ambulatory patients in the 
United States than in Canada. There 
is an excellent description of the design 
and staffing of such an ambulatory 
surgery unit.
The book is well written and readable 
and there are many helpful illustrations. 
In addition, there are many cleverly 
drawn sketches; some of these we rec­
ognize from previous editions but most 
are new and complement the accom­
panying text. There is a bibliography at 
the end of each chapter. Many “how to 
do it” sections are included, such as 
placement of a subclavian or internal 
jugular catheter, emergency insertion of 
a chest tube, pericardiocentesis and 
the technique of producing local anes­
thesia for repair of inguinal hernias. 
There are many useful tables summariz­
ing such topics as the diagnosis of 
gastrointestinal bleeding, tetanus pro­
phylaxis, choice of antibiotics for or­
ganisms found in surgical infections and 
the Glasgow coma scale.
This book’s greatest use will likely be 
for those physicians or surgeons who 
first come in contact with the trauma 
patient. Chapter 4, the book’s longest, 
at 100 pages, deals with the initial 
evaluation and treatment of major 
trauma. It is followed by a new chapter, 
dealing with minor trauma — soft-tissue
Comment (Dr. Filler): Just one word 
about the Mayo Clinic experience, be­
cause Telander presented a paper co­
vering this problem last May. The 
problem was not different from what 
Dr. Coran described, that is, that with 
the endorectal pull-through, there were 
many bowel movements, certainly at 
the outset, which was distressing for 
many patients; in my small experience, 
the first month or so is really tough 
for these children. In an effort to elimi­
nate the difficulties of the first month, 
to make a reservoir at the bottom end, 
dilatation was used, first with a Foley 
balloon catheter and then with a spe­
cial balloon designed to fit the 
contour of the lower rectum. The 
results of those dilatations were 
quite good, although what it really 
did was cut down the frequency of 
the bowel movements. The other com­
plications were really not very im­
pressive, as Dr. Coran said.
Dr. Postuma: I want, on behalf of
the audience, to thank the panel again 
for an excellent presentation.
injuries and foreign bodies. Chapters on 
pain and coma have been added, and the 
section on snake and insect bites has 
been given its own chapter.
On the whole, this is a crisp, up-to- 
date volume that should be of value 
to those interested in this field. It may 
also be useful as a reference for teach­
ing nurses and other paramedical per­
sonnel. Certainly every emergency de­
partment should have this book as a 
ready reference guide. I predict that 
this book will have the same popularity 
as its predecessors.
E.D. M onaghan, md, frcs[c], facs
Department of surgery,
Royal Victoria Hospital,
McGill University,
Montreal, PQ
ATLAS OF COMPUTED BODY TO­
MOGRAPHY. Normal and Abnormal 
Anatomy. Lee C. Chiu and Rolf L. 
Shapiro. 199 pp. Illust. University 
Park Press, Baltimore, 1980. $19.95, 
paperbound. ISBN 0-8391-1532-6.
A collection of individual articles origin­
ally published in CT — The Journal of 
Computed Tomography, this atlas con­
tains a useful index and an excellent
continued on page 568
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The authors investigated the kinetics, 
in serum and tissues, of clindamycin, 
metronidazole, cefoxitin and 
moxalactam given during colon surgery 
in the dog. Colon, rectus muscle and 
subcutaneous fat samples were 
taken at times of maximal 
contamination during the initial 
operation and at a second operation,
9 days after the first, when septic 
complications were most likely to 
occur in the healing tissues. Bioassay 
was used to measure the amount of 
active antibiotics in serum and tissues.
Clindamycin achieved therapeutic 
levels in all tissues except those of 
the fresh wound, thus making it a 
better therapeutic than prophylactic 
agent. Metronidazole achieved 
therapeutic levels in both fresh and 
healing tissues. Cefoxitin and 
moxalactam did not achieve adequate 
levels in either fresh or healing 
tissues.
Les auteurs ont etudie la cinetique, 
dans le serum et les tissus, de 
clindamycine, metronidazole, cefoxitin 
et moxalactam, donne durant une 
chirurgie du colon chez le chien. Des 
echantillons de colon, de muscle 
grand droit et de la graisse sous- 
cutanee ont ete pris a des intervalles 
de contamination maximale durant
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I’operation initiate, et aussi apres 
9 jours, durant une operation 
secondaire au moment oil les 
complications septiques etaient les 
plus probables dans les tissus 
cicatrisants en phase postoperatoire. 
Les essais biologiques ont ete utilises 
pour mesurer le niveau d’antibiotique 
actif dans le serum et les tissus.
On a retrouve ces niveaux 
therapeutiques de clindamycine dans 
tous les tissus sauf les nouveiles 
plaies, done le rendant un meilleur 
agent therapeutique que prophylactique. 
On a retrouve le metronidazole a des 
niveaux therapeutiques dans les 
nouveiles plaies et les tissus 
cicatrisants. On n'a pas retrouve de 
niveaux satisfaisants de cefoxitin 
et moxalactam ni dans les nouveiles 
plaies, ni dans des tissus en voie 
de guerison.
An important concept in the prophy­
laxis of septic complications in colon 
surgery is the administration of anti­
biotics to obtain adequate tissue levels 
before contamination takes place. An­
tibiotics are virtually useless as pro­
phylactic agents if administered more 
than 3 hours after the period of bac­
terial contamination has ended.1 It is 
accepted that the rate of wound 
infection following bowel surgery 
without antibiotic prophylaxis ranges 
from 30% to 4 0 % Bernard and 
Cole,6 Polk and Lopez-Mayor7 and 
others3'5'6"10 have shown that preopera­
tive administration of antibiotics does 
decrease the rate of wound infection 
postoperatively. Although many dif­
ferent antibiotic regimens are used, 
many of them include an antibiotic 
that is effective against anaerobic or­
ganisms.3'6'9
We investigated four antibiotics 
(clindamycin, metronidazole, cefoxi­
tin and moxalactam) with good in- 
vitro activity against colonic flora and 
determined their serum levels; tissue 
levels were measured when infectious 
complications actually occurred. We 
measured the level of penetration into 
colonic tissues at the time of surgical 
manipulation and into the wound at 
the time of closure. We also deter­
mined the level of antibiotic penetra­
tion into healing tissues, such as the 
colon at the site of anastomosis and 
the 9-day-old abdominal wound, in 
which septic complications may have 
developed. The clinical implications 
in terms of prophylaxis and therapy 
are clear.
Characteristics of the Antibiotics
Clindamycin
This is a bacteriostatic agent; it acts 
on the 50 S subunit of the bacterial 
ribosome thereby inhibiting protein 
synthesis. It is effective against Sta­
phylococcus aureus, Peptococcus, 
Clostridium and Bacteroides spp, 
although resistant strains of the last 
three have been isolated.11'13 It is high­
ly bound to serum protein,14’15 having 
a serum half-life of about 3 hours.16 
Important side-effects of clindamycin 
include diarrhea and pseudomembran­
ous colitis. Tedesco and colleagues17 
reported an incidence of 21% diar­
rhea and 10% pseudomembranous 
colitis associated with clindamycin 
therapy. It is now agreed that pseudo­
membranous colitis is generally asso­
ciated with a toxin produced by over­
growth of Clostridium difficile 3* 
This toxin is found more frequently 
when symptoms are severe: from 15% 
to 20% in patients with mild uncom­
plicated diarrhea and up to 97% in 
patients with pseudomembranous col-
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itis.20 Gianella and colleagues21 found 
that clindamycin inhibits the transport 
of intestinal water, causing watery 
diarrhea without actual colitis.
In our laboratory, 2 of 97 clinical 
isolates of Bacteroides fragilis were 
resistant to clindamycin at a concen­
tration of 5 /zg/ml. The minimal in­
hibitory concentration of clindamycin 
for most anaerobes, particularly B. 
fragilis, is 1 /zg/ml.
Metronidazole
Metronidazole was first introduced 
as an antitrichomonal agent22 but is 
also effective against Entamoeba, 
Giardia and anaerobic bacteria.23 It 
is minimally bound to serum protein, 
and its half-life in man is 7 to 8 
hours.23,2,1 Reduction of its nitro group 
gives an intermediate compound that 
binds to critical sites in susceptible 
cells.23,25 Resistance to metronidazole 
is related to a decrease in the nitro­
reductase content of the organisms.25,26 
The rate of anaerobic wound infection 
following prophylactic use of an ade­
quate dosage of metronidazole in elec­
tive colon surgery is negligible.27'29 
Furthermore, when given intravenous­
ly, metronidazole levels in the bowel 
lumen are comparable to those 
achieved by oral administration. In­
terestingly, it is also effective in treat­
ing colitis due to C. difficile.30 It is 
mutagenic in the Ames bacterial test 
and in certain laboratory strains of 
mice. Retrospective surveys do not. 
however, demonstrate carcinogenicity 
in man.23 The minimal inhibitory con­
centration of metronidazole for many 
anaerobes is typically 0.1 /zg/ml.
Cefoxitin
Cefoxitin is a cephamvcin antibiotic 
that is resistant to hydrolysis by f}- 
lactamases.31 Its half-life is 40 to 60 
minutes and it is 70% to 75% pro­
tein-bound. It inhibits bacterial cell- 
wall synthesis, resulting in bacterial 
lysis and death. In vitro, it is effective 
against a large proportion of isolates 
of S. aureus. Streptococcus (except S. 
faecalis), Escherichia coli, B. fragilis 
and Clostridium spp. It lacks activity 
against Pseudomonas spp.32 The mini­
mal inhibitory concentration for anae­
robes given in the literature ranges 
from 4 to 8 pug/ml. In our laboratory, 
27 out of 97 isolates of B. fragilis 
tested at a concentration of 10 /zg/ml 
of cefoxitin were resistant to it.
Moxalactam
Moxalactam is a semisynthetic j3- 
lactam, third generation cephalo­
sporin. Its wide spectrum of effective­
ness includes Enterobacter spp. and a
large proportion of isolates of Pseu­
domonas aeruginosa and B. fragilis 
(which are generally resistant to the 
older cephalosporins).33 It is ineffec­
tive against enterococci.34 It also shows 
activity against S. aureus, with the 
exception of methicillin-resistant iso­
lates. but is less active than cefaman- 
dole34 in this respect.
It acts by interfering with the syn­
thesis of bacterial cell walls. It is 38% 
bound to serum protein35 and its elim­
ination half-life is 2V4 to 3 hours. The 
minimal inhibitory concentration for 
B. fragilis in the literature ranges from 
8 to 16 /zg/ml. In our laboratory, 97 
strains of B. fragilis were tested and. 
at a concentration of 10 /zg/ml, 52% 
were resistant to moxalactam.
Material and Methods
Operative Procedure
Conditioned mongrel dogs were 
subjected to 3 days of mechanical 
bowel preparation and liquid diet. Af­
ter anesthesia was induced with Nem­
butal, a single dose of the test anti­
biotic, equivalent to 10 mg/kg, was 
given intravenously. Blood samples 
were taken at 5-minute intervals after 
the initial dose, up to 30 minutes 
and then at each subsequent tissue 
sampling. The abdomen was en­
tered through a midline incision 
and the descending colon was 
mobilized. At 30 minutes after the 
antibiotic was given, a colotomy was 
performed using electrocautery, a fe­
cal sample was taken, if present in 
adequate amounts. At 60 minutes, 
the colotomy was extended. At 90 
minutes, the segment of colon was 
resected and a primary anastomosis 
was performed in two layers using 
3-0 chromic and 4-0 silk. Rectus mus­
cle and subcutaneous fat samples were 
taken from the abdominal incision at 
the time of closure after peritoneal 
irrigation with normal saline.
No other antibiotics were given 
until 9 days after the operation, when 
a second operation was performed. 
After induction of anesthesia, the
same dose of the same antibiotic was 
given. The abdomen was re-entered 
through the same midline incision. At 
60 minutes, the colon was resected 
at the site of anastomosis, and rectus 
muscle and subcutaneous fat samples 
were taken.
The mucosa and muscularis muco­
sae of the colon were separated im­
mediately upon resection. All tissue 
samples were wiped clean of gross 
blood and feces.
Microbiology
Each tissue sample was weighed 
and culture medium was added to 
give a dilution factor of approximately 
3 ml culture medium per gram wet 
weight of tissue. This was then ground 
at high speed using a Polvtron homo- 
genizer (Brinkmann Instruments, 
Westbury, NY). The tissue homogen­
ates and blood samples were then 
centrifuged. Standard, known concen­
trations of the test antibiotic were as­
sayed, using assay discs furnished by 
the individual pharmaceutical com­
panies and a standard, twofold tube 
dilution procedure in horse serum.
Assay discs were impregnated with 
0.1 ml of the standard concentrations 
of antibiotic, tissue supernatant or se­
rum. The discs were applied in tripli­
cate to blood agar previously plated 
with test organisms (Table I), and in­
cubated at 37°C for 18 hours. The 
diameter of the zones of growth inhi­
bition were then read to the nearest 
millimetre and the concentrations 
(/zg/ml) of unknown samples were 
derived from linear regression anal­
ysis. For tissue samples, the concen­
trations were then multiplied by the 
dilution factor (/zl/g) to obtain the 
final concentration (/zg/g).
Results and Discussion
Assay Method
One major advantage of the bioas­
say is that it measures the amount of 
active antibiotic available for anti­
microbial activity. It does not meas­
ure intermediate products of the drug
Table 1-Culture Media and Test Organisms Used for Each Antibiotic
Antibiotic Culture medium Test organism Incubation condition
Clindamycin Tryptic soy broth /(-hemolytic
Streptococcus pyogenes 
ATCC 14289
Aerobic, 37°C, 18 h
Metronidazole Thioglycolate Clostridium sporogenes 
M and B
Anaerobic, 37°C, 18 h
Cefoxitin Tryptic soy broth Escherichia coli 
ATCC 29891
Aerobic, 37"C, 18 h
Moxalactam Tryptic soy broth £  coli 
NCTC 10418
Aerobic, 37°C, 18 h
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that are not always active and can be 
detected by chromatography, spectro­
photometry, radioimmunoassay and 
other methods.
The antibiotics we studied vary 
greatly in their respective degrees of 
protein binding. It is generally agreed 
that the protein-bound portion of the 
drug has no antimicrobial activity.36 
The bioassay method measures only 
the active, unbound portion that dif­
fuses out to produce the zones of 
growth inhibition of the plated or­
ganism.
Choosing the medium is important, 
because preparation of standard 
curves in a medium different from 
that used for test samples may cause 
under- or overestimation of the anti­
biotic concentrations due to differen­
tial protein-binding and varying dif­
fusion rates.37 The appropriateness of 
our choice of diluent medium was 
verified with the most highly protein- 
bound antibiotic, clindamycin. Stand­
ard known concentrations of this an­
tibiotic were prepared in horse serum 
as well as in tryptic soy broth. The 
zones of growth inhibition for each 
concentration were essentially ident­
ical for both, yielding excellent posi­
tive correlations (r >  0.9).
Little is known experimentally 
about actual therapeutic levels of an 
antibiotic needed in tissues to cure an 
infectious complication. However, a 
clinically successful outcome is more 
likely to occur at serum concentra­
tions aimed at 10 times that of the
minimal inhibitory concentration, 
and this was the criterion we used.
Clindamycin
According to our data there was 
active mucosal uptake of clindamy­
cin, with active secretion into the lu­
minal contents (Table II). The muco­
sal levels were significantly higher 
than those of the corresponding se­
rum levels throughout the 30- to 90- 
minute period (P <  0.001, Student’s t- 
test, paired, two-tailed) (Fig. 1). The 
levels obtained in the mucosa and 
muscularis mucosae of the intact colon 
during this period were above the the­
rapeutic level of 10 /zg/ml. In the 
fresh wound, there were no detectable 
levels in the rectus muscle and sub­
cutaneous fat at the time the abdom­
inal incision was closed (mean 160 
minutes after the antibiotic was giv­
en), as well as at 45 minutes. Even 
though clindamycin does not pene­
trate the fresh wound at the time of 
closure, the fact that high levels are
(intact colon, first operation) (u.g/ml or 
ag /g ). Arrow indicates therapeutic level.
achieved in the mucosa and muscu­
laris, offering protection to an ob­
vious source of contamination, might 
make this drug a useful prophylactic 
agent. Hojer and Wetterfors,38 in a 
double-blind study with doxycycline, 
also found high levels in the bowel 
wall despite low levels in the subcu­
taneous fat; the incidence of wound 
infection in the treated group was 
low (3 of 39), compared with the 
placebo group (16 of 43).
Others have also found poor 
wound penetration by clindamycin 
given as a single dose. Alexander and 
colleagues,14 using a single intraven­
ously administered dose equivalent to 
15 mg/kg, found that it penetrated 
wound fluids slowly, reaching a peak 
concentration of 9 /zg/ml at about 
2'/i hours. However, Bagley and as­
sociates,39 using multiple intravenous 
doses of clindamycin before sampling 
(300 mg q6h for 36 hours) found a 
constant pool of clindamycin in the 
wound fluid collected from suction 
drainage following lymph-node dis­
section. The concentration in the 
wound fluids remained between 4 
and 5 /zg/ml throughout the 1- to 
6-hour interval following infusion of 
the last dose of clindamycin.
Comparison of the concentrations 
of antibiotic at the mucosa and mus­
cularis levels in the intact colon (first 
operation) with those at the anasto­
mosis (second operation) revealed no 
significant difference at either site. 
All tissue samples were taken at 60 
minutes after the antibiotic was giv­
en. Therapeutic levels were obtained 
in the intact colon as well as the site 
of anastomosis.
Clindamycin also penetrated the 
tissues of the healing wound; the 
levels obtained in these tissues were 
within the therapeutic range. Because 
the values obtained in the tissues ap­
proximated corresponding serum lev­
els, we initially thought that this was 
a reflection of the increased vascu­
larity of the healing wound. However, 
this may not be entirely true, since 
with other antibiotics studied the tis­
sue and serum levels in the healing 
wound were not similar. Perhaps with 
the increased permeability of the ves­
sels during the inflammatory process 
of healing, clindamycin, a highly pro­
tein-bound antibiotic, is drawn out 
of the intravascular space and binds 
to proteins in the interstitial compart­
ment, thus creating an equilibrium.
Metronidazole
This agent proved effective both 
prophylactically and therapeutically 
(Table III). Therapeutic levels were
Table II-C lin d a m y c in  Leve ls* ±  Standard Deviation
Sam ple, p g /g t
T im e (mean) Rectus muscle Subcutaneous fa t
Initial operation (fresh woound) 
(45 min)
N il detectable^ Nil detectable
Initial operation (fresh wound) 
(160 min)
N il detectable N il detectable
Secondary operation (healing wound) 
at closure (45 min)
7 .3  ±  2.5 11.3 ±  4 .5
'Lum inal contents, initial operation (30  min) =  
(M e a n  ±  standard deviation.
4  <  0.1 pglm l.
35.3 ±  14.1 pglg.
Table I I I - M etronidazole Levels*
Sam ple, pg/g
Tim e (mean) Rectus muscle Subcutaneous fa t
Initial operation (fresh wound) 
a t closure (130 min)
14.1 ±  3.2 3.7 ±  0 .2
Secondary operation (healing wound) 
at closure (60 min)
13.4 ±  3.0 9 .7  ±  1.5
'Lum inal contents, initial operation (30 min) =  3 .2  ±  0 .6  pglg.
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attained in the intact colon in 30 to 
90 minutes (Fig. 2), at the site of 
anastomosis, as well as in the tissues 
of fresh and healing wounds. The se­
rum kinetics of this antibiotic, with its 
prolonged duration of excretion, sug­
gests an enterohepatic circulation, as 
was found by Populaire and asso­
ciates22 in the rat, though not by 
Templeton40 in the mouse. Effective 
doses of metronidazole are secreted 
into the luminal contents, as Dion 
and colleagues10 have found.
C e f o x it in
Mucosal levels of cefoxitin began be­
low the corresponding serum levels, 
but equilibrated with serum levels by 
90 minutes (Fig. 3). Levels in the 
muscularis mucosae also started be­
low those in serum, but surpassed 
the serum levels by 90 minutes. How­
ever, because of the higher minimal 
inhibitory concentration, the thera­
peutic level should be at least 40 
/u,g/ml. Thus, even though the tissue 
levels were above the minimal inhi­
bitory concentration, therapeutic lev­
els were not attained (Table IV).
Although cefoxitin also penetrates 
the anastomotic site, as it does both 
the mucosa and muscularis of intact 
colon, therapeutic levels are not 
achieved. This antibiotic also does 
not penetrate the tissues of the fresh 
wound, nor does it attain therapeutic 
levels in the healing wound. Part of 
the reason for this may be the dose 
and frequency of administration. We 
gave a single dose intravenously, 
equivalent to 10 mg/kg before tissue
FIG. 2—Metronidazole concentrations 
(intact colon, first operation). Arrow 
indicates therapeutic level.
FIG. 3—Cefoxitin concentrations (in­
tact colon, first operation). Arrow indi­
cates therapeutic level.
and serum sampling. Other authors, 
using higher doses and for a longer 
time, obtained much higher serum and 
tissue levels41 with good clinical re­
sults.42-4'1
Moxalactam
When a single intravenous dose 
equivalent to 10 mg/kg was given, 
moxalactam did not maintain thera­
peutic levels in colonic tissues, nor in 
the tissues of the wound (Fig. 4, Table 
V). This suggests that either a larger 
initial dose or an additional intraoper­
ative dose is needed to maintain ade­
quate tissue levels, especially since 
the levels in intact colon decreased 
during the 30- to 90-minute period 
after administration of the antibiotic. 
Although there was no significant dif­
ference between the levels obtained at 
the anastomotic site and in the in­
tact colon, they were below therapeu- 
tice levels. Moxalactam levels ob­
tained in the healing tissues of the 
wound were also below therapeutic 
range, due to the higher range of its 
minimal inhibitory concentration.
Conclusions
Clindamycin maintains therapeutic 
levels in both the intact colon and 
the healing colonic tissue at the site 
of anastomosis. It has poor penetration 
into the luminal contents.
Metronidazole provides therapeutic 
levels in the colon, wound and the 
luminal contents, in both fresh and 
healing tissues of the colon and the 
wound.
The two cephalosporins, cefoxitin 
and moxalactam, do not attain thera­
peutic levels in fresh and healing tis­
sues of the colon and wound with the 
dosage and timing we used, nor do 
they achieve therapeutic levels in the 
luminal contents.
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SESAP III Critique
ITEM 38
Little is known about the metabolism of magnesium. However, in hypothyroidism, serum magnesium 
levels are usually elevated. They may be decreased in hypoparathyroidism, cirrhosis, pancreatitis, and 
short bowel syndrome.
The symptoms and signs of hypomagnesemia are primarily those of hyperactivity of the central 
nervous and neuromuscular systems. Coarse tremors, hyperreflexia, hyperirritability and personality 
changes, fasciculation of skeletal muscle, positive Chvostek’s and Trousseau’s signs, and convulsions 
have all been reported to be associated with magnesium deficiency. Magnesium is an essential 
component of virtually all enzymes and is necessary for the transfer of high-energy phosphate radicals 
from adenosine triphosphate (ATP). m
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CANADIAN CARDIOVASCULAR SOCIETY
Peripheral Arterial Transluminal Dilatation:
Early Results
K .W . Johnston, md, frcs[c], facs and R .F . Colapinto, md, frcp[c]
Over a 3-year period, 275 transluminal 
dilatations were performed for the 
treatment of peripheral arterial 
occlusive disease. The results have 
been evaluated prospectively using 
radiologic, clinical and noninvasive 
criteria. The cumulative success 
rates for all dilatations were 63 ±
4% (mean ±  1 standard error) at 
1 year and 53 ±  5% at 2 years, 
but varied depending upon the site 
of the dilatation and the extent of 
the arteriosclerosis. The results are 
best in patients who have short, 
localized stenoses or occlusions, 
especially in the iliac arteries.
Sur une periode de 3 ans, 275 
dilatations de la lumiere vasculaire ont 
ete pratiquees dans le traitement 
de (’occlusion des arteres periphe- 
riques. Les resultats ont ete evalues 
de maniere prospective a I'aide de 
criteres radiologiques, cliniques et 
d'epreuves de laboratoire non 
invasives. Les taux cumulatifs 
de succes pour toutes les dila­
tations ont ete 63% ±  4% 
(moyenne ±  I’ecart type) apres 1 an 
et de 53% ±  5% apres 2 ans; 
toutefois, ils variaient avec le site 
de la dilatation et I'etendue de 
I'arteriosclerose. Les meilleurs resultats 
sont obtenus chez les patients qui 
ont des occlusions ou des stenoses 
courtes et localisees, des arteres 
iliaques particulierement.
Percutaneous transluminal dilatation 
is a controversial procedure. Although 
it has been used successfully since
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19641 to treat selected patients with 
peripheral arterial occlusive disease 
and has been quite popular in Eu­
rope,2 only recently has the tech­
nique become popular in North 
America. The increased interest in 
this method can be traced to the in­
troduction o f a new balloon dilating 
catheter by Griintzig and H op ff in 
1974.3
The balloon catheters are made o f 
polyvinyl chloride or specially treated 
polyethylene and have a very low 
compliance. Consequently, as the in ­
flation pressure is increased, the 
balloon maintains its cylindrical shape 
and the diameter specified by the 
manufacturer even at high inflation 
pressures. I f  a correct balloon diame­
ter is chosen, there is little risk that 
the vessel will be overdistended and 
ruptured, even if a high inflation pres­
sure is necessary for dilatation.
Transluminal dilatation is success­
ful in certain patients, is associated 
with a low morbidity and mortality 
and a short hospital stay. The 
cost o f the procedure is low. In spite 
o f its advantages, it is often difficult 
to decide between transluminal dila­
tation and vascular reconstructive 
surgery because the long-term results 
o f dilatation are not yet known.
The purpose o f this paper is to de­
scribe the short- and long-term re­
sults o f transluminal dilatation in the 
treatment o f patients with peripheral 
arterial occlusive disease and to dis­
cuss the role o f this method.
Methods
A t the Toronto General Hospital, 
our experience with transluminal dila­
tation began in July 1978. Over the 
3 years to July 1, 1981, 275 peri­
pheral arterial dilatations were per­
formed for the treatment o f claudi­
cation, ischemic rest pain, night pain 
or gangrene. Selected for this proce­
dure instead o f vascular reconstruc­
tive surgery were patients whose ar­
terial stenosis was localized, less than 
10 cm long and accessible to dilata­
tion, and especially those who were 
poor surgical risks because o f under­
lying medical disease. A Griintzig- 
type, balloon, dilating catheter4 was 
used; the technique was standardized.5
The short- and long-term results 
were evaluated by radiologic, clinical 
and noninvasive vascular laboratory 
criteria. Dilatations were considered 
successful only if the following criteria 
were met: the pressure gradient meas­
ured prograde across the stenosis at 
the time o f arteriography was reduced 
to less than 10 mm Hg or decreased 
by at least 40 mm Hg; the patient's 
symptoms improved by at least one 
clinical grade; the ankle to brachial 
systolic pressure ratio increased by 
at least 0.10; the Doppler pulsatility 
index increased by more than 20% 
and the treadmill exercise distance 
doubled.
A  small microcomputer was used 
to store the essential patient data and 
to calculate the results by life-tab'e 
analysis. Information on new patients 
was added to the registry and updated 
after each patient follow-up visit.
Results
Overall
Fig. 1 shows the overall results for 
all dilatations; at 12 months the suc-
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FIG. 1— Overall results for all 275 
transluminal dilatations. Vertical bars 
indicate ±  1 standard error.
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cess rate was 63% and at 24 months 
53%.
Common Iliac Segment
In Fig. 2 the results for 97 com­
mon iliac artery dilatations show that 
the cumulative success rates were 
88% at 12 months and 83% at 24 
months. There was no significant dif­
ference between the results of dilata­
tion of common iliac artery stenoses 
and recanalization of completely oc­
cluded common iliac arteries.
External Iliac Segment
At 12 months the cumulative suc­
cess rate for 51 external iliac dilata­
tions was 71% and at 24 months 
48% (Fig. 3). Where both the com­
mon and external iliac arteries on the 
same side were dilated (20 instances'), 
the results were not very satisfactory 
(Fig. 4).
Femoropopliteal Segment
In the femoropopliteal segment 
there was a substantial difference be­
tween the results obtained for dilating 
stenoses and complete occlusions 
(Figs. 5 and 6). The success rate for 
dilatation of 50 femoropopliteal sten­
oses was 60% at 12 months and 52% 
at 24 months (Fig. 5). By comparison. 
33 occluded femoropopliteal stenoses 
were recanalized. The success rate at 
12 and 24 months was only 17% 
(Fig. 6).
Other Segments
Twenty-four peripheral arteries 
were dilated. Six of seven aortic dila­
tations were successful, but the re­
sults of common femoral, deep femo­
ral and tibial artery dilatations have 
not been very satisfactory.
Morbidity and Mortality
Our complication rate has been 
quite low. Although two patients died 
of myocardial infarction within 1 
week of the procedure, both had 
severe coronary artery disease. Their 
deaths were temporally related to the 
dilatation but no other relationship to 
the procedure could be established; 
this reflects the fact that dilatations 
were often carried out on patients 
for whom vascular operations carried 
a prohibitive risk. Small local hema­
tomas at the puncture site were com­
mon but usually resolved. Acute 
ischemia, presumably related to 
thrombosis at the site of the dilata­
tion, occurred in two cases. In both 
the ischemia was not severe and with 
heparinization the patients returned 
to predilatation status. Peripheral em­
bolism was not a frequent or clinically 
important complication. Perforation 
of the vessel, rupture of the balloon 
and other rare complications did not 
occur in this series.
Comment
As documented by our objective
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FIG. 2—Common iliac artery dilata­
tions, including stenoses and occlusions 
(n =  97).
FIG. 4— Common and external iliac 
artery dilatation on same side at same 
time (n =  20).
FIG. 3—External iliac dilatations (n 
=  51).
F’lG. 5—Results of dilatation in 33 
femoropopliteal stenoses.
data, transluminal dilatation is suc­
cessful in selected patients. When 
successful, the low morbidity and 
mortality of the procedure, the short 
hospital stay and the low cost are of 
great advantage. In our hands, it now 
has an important role in the manage­
ment of certain patients with peri­
pheral arterial occlusive disease.
This procedure may be of value in 
three situations. First, in multilevel 
disease, when the most important le­
sion is in the femoropopliteal or 
femorotibial artery segment, trans­
luminal dilatation is a useful adjunct 
to operation since it can be used to 
correct a minor localized lesion and 
improve the inflow before a distal 
vascular reconstruction is carried out. 
Second, transluminal dilatation may 
be valuable in treating certain post­
operative complications of saphenous 
vein grafting, such as valve cusp 
hyperplasia, intimal hyperplasia or 
atherosclerosis. Third, transluminal 
dilatation may be an alternative to 
vascular reconstructive surgery in 
some cases. The decision between 
transluminal dilatation and operation 
must be made by weighing several 
factors including the patient’s gen­
eral health and disability, and the 
site, extent, severity and accessibility 
of the arterial stenosis.
Our results show that the risks of 
transluminal dilatation are low; how­
ever, in experienced hands, the mor­
bidity and mortality of standard vas­
cular reconstructive procedures is also 
quite low. Except for localized lesions, 
in our experience, operation pro­
duces better hemodynamic results and 
is usually more durable than trans­
luminal dilatation. Nevertheless, the 
results of transluminal dilatation are 
acceptable and the procedure has the 
advantage that it can be repeated.
We acknowledge the financial support 
of the Toronto General Hospital Foun­
dation. the assistance of Mrs. Maureen 
Rae and Mrs. S. Ungaro, the collabora­
tion of the referring physicians and the 
secretarial help of Mrs. Denise Reynolds.
FIG. 6—Results of dilatation in 50 
femoropopliteal occlusions.
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Protection of ischemic Myocardium: 
the Roles of Nutrition and Myocardial Glycogen
C. W lTTNICH, DVM, R.C.J. CHIU, MD, PH D, FRCS[C], FACS AND A.H. McARDLE, PH D
The ischemic myocardium utilizes 
glycogen as metabolic substrate. The 
effects of oral nutrition on the levels 
of glycogen in the myocardium and of 
myocardial glycogen content on 
myocardial tolerance to ischemia were 
studied.
Rats were divided into groups and 
fed (a) rat chow, (b) rat chow plus 
5 %  dextrose, and elemental diets
(c) Flexical (Mead Johnson) or
(d) Vital (Ross Laboratories). Another 
group was starved. All fed groups 
gained weight normally while the 
starved rats lost 23%  of their body 
weight. Compared with the effect 
on rat chow, myocardial glycogen 
levels were elevated in the Flexical 
and starvation groups, while Vital 
depressed the level (P <  0.01). Thus, 
both caloric intake and diet affected 
myocardial glycogen content. Elevation 
of myocardial glycogen content after 
starvation contrasted with glycogen 
disappearance from the liver.
The level of myocardial glycogen 
and left ventricular function after global 
ischemia were correlated in dogs 
under cardiopulmonary bypass 
conditions. During 30 minutes of 
normothermic aortic cross-clamping, 
hearts with a preischemic myocardial 
glycogen content greater than 0.4 
g %  had less asystole or ventricular 
fibrillation. Their left ventricular 
function (stroke work index, myocardial
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contractility) upon reperfusion was 
substantially better than those with a 
myocardial glycogen level of less 
than 0.4 g% .
Dietary manipulation and the 
nutritional status can thus affect the 
myocardial glycogen content and may 
be useful in protecting the myocardium 
from ischemia.
Le glycogene est le substrat 
metabolique du myocarde ischemique. 
Les auteurs ont etudie les effets du 
contenu myocardique en glycogene 
sur la tolerance de cet organe a 
I'ischemie.
Les rats furent divises en groupes 
et nourris respectivement avec a) de 
la moulee pour rats, b) de la moulee 
pour rats avec glucose (5%), une 
de deux dietes elementaires, c) Flexical 
(Mead Johnson) ou d) Vital (Ross 
Laboratories). Un autre groupe fut 
soumis au jeune. Le gain ponderal 
fut normal dans tous les groupes 
dietetiques. Les rats malnourris 
perdirent 23%  de leur poids 
corporel. Compare aux rats nourris 
a la moulee, le contenu myocardique 
en glycogene etait augmente chez les 
rats soumis au jeune ou nourris au 
Flexical, tandis que le Vital diminuait 
le contenu myocardique en glycogene 
(P <  0.01). L'apport calorique ainsi 
que le contenu dietetique affectent 
done tous deux le niveau du glycogene 
myocardique. L'elevation du glycogene 
myocardique apres une periode de 
jeune contraste avec sa disparition du 
foie.
Nous avons constate une correlation 
entre le contenu myocardique en 
glycogene et la fonction ventriculaire 
gauche apres ischemie globale chez 
des chiens sous circulation extra- 
corporelle. L'incidence d’asystolie et 
de fibrillation ventriculaire durant une 
periode de 30 minutes de clampage 
aortique normothermique etait moindre 
pour les coeurs ayant un contenu 
myocardique en glycogene pre-
ischemique superieur a 0.4 g% . Leur 
fonction ventriculaire gauche (exprimee 
par I'indice d'ejection et la 
contractilite myocardique) etait aussi 
amelioree de fapon significative par 
rapport aux coeurs ayant un contenu 
myocardique en glycogene 
pre-ischemique inferieur a 0.4%.
Les manipulations dietetiques et 
I'etat nutritionnel peuvent done 
affecter le contenu myocardique en 
glycogene et pourraient etre employes 
pour proteger le myocarde envers 
I'ischemie.
The major energy reserve for the is­
chemic myocardium is glycogen, 
whose level can be correlated with 
the ability of the cardiac muscle to 
withstand anoxia and ischemia.1"9 The 
synthesis, degradation and amount of 
glycogen in the myocardium may be 
affected by the nutritional status of 
patients, and substrate utilization by 
the myocardium may be altered. In­
creasing myocardial tolerance to is­
chemia may protect the heart from 
global ischemia during cardiac surgery 
and reduce infarct size during coro­
nary occlusion. The effects of pre­
operative nutritional supplementation 
on myocardial glycogen levels and on 
cardiac function during and after an 
ischemic episode continue to be con­
troversial. We decided to investigate 
the effects of diet manipulation on 
myocardial glycogen content and to 
determine the extent to which existing 
glycogen levels in the normal heart 
may affect cardiac performance after 
global ischemia.
Materials and Methods
Experiment l —  Nutritional Studies
Male Sprague-Dawley rats, weigh­
ing 200 to 250 g, were randomly al­
located to four groups: those fed (a) 
rat chow (RMH 1000; Agway Manu­
facturers, Syracuse, NY) (26 rats), (b) 
rat chow plus 5% dextrose (21), (c)
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Flexical (Mead Johnson Canada, Ot­
tawa, Ont.) (21) and (d) Vital (Ross 
Laboratories, Montreal, PQ) (21). 
The composition of each diet is listed 
in Table I. The diets were fed ad 
libitum for 21 days. Another group 
of 26 rats was submitted to protein- 
calorie malnutrition by starving for 
7 days. Weight changes and the 
daily caloric intake were recorded 
for each group. The rats were individ­
ually housed in wire cages under iden­
tical conditions. After the feeding or 
starving, the rats were killed by stun­
ning and cervical dislocation. Samples 
of liver and heart were taken imme­
diately for biochemical analysis of 
tissue glycogen and DNA. The sam­
ples for glycogen were quick-frozen, 
weighed and processed according to 
the method of Good and associates.10 
The method of Schneider" determined 
DNA content. The data were analysed 
using the unpaired, two-tailed r-test.
Experiment 2 —
Myocardial Performance
The correlation between myocardial 
glycogen levels and cardiac perform­
ance after global ischemia was studied 
in 13 mongrel dogs of both sexes, 
fed standard dog chow without 
additional dietary manipulation. The 
dogs were anesthetized with sodium 
pentobarbital (30 mg/kg), intubated 
and ventilated mechanically. After a 
midline sternotomy and ligation of 
the azygous vein, normothermic car­
diopulmonary bypass was instituted, 
using snared cannulas in the superior 
and inferior venae cavae for venous 
drainage and a femoral artery cannula 
for oxygenated blood return.
Biopsy specimens of the right ven­
tricular myocardium were taken to
determine glycogen content before 
aortic cross-clamping and at the end 
of bypass. To study myocardial func­
tion, a Swan-Ganz catheter was in­
troduced through the right jugular 
vein and advanced to the pulmonary 
artery; pulmonary artery and wedge 
pressures were monitored. Cardiac 
output was determined with an Ed­
wards cardiac output computer and 
thermodilution techniques. A left ven­
tricular pressure line was attached to 
a transducer and Grass polygraph with 
an electronic differentiator to meas­
ure myocardial contractility (dp/dt). 
Electrocardiographic monitoring was 
done throughout. From these data, 
the stroke work index was derived 
using the formula: stroke work index 
=  stroke work -t- surface area (m 2), 
where stroke work =  systolic pres­
sure X cardiac output -r- heart rate. 
After 30 minutes of normothermic 
aortic cross-clamping, the myocar­
dium was reperfused for 30 minutes 
more and then the animal was taken 
off cardiopulmonary bypass. The ac­
tual indices of dp/dt, which reflect 
myocardial contractility, and stroke 
work index were recorded before and 
after cardiopulmonary bypass. These 
values were then expressed as per­
centage recovery.
Results
Experiment 1
The rats receiving the various diets 
gained weight normally (1 to 3 g/d). 
Table II shows the daily caloric in­
take for the four groups. The starved 
rats lost 23% of their original body 
weight and there was a significant 
(P <  0.01) increase in the DNA value
per gram wet weight of the myocar­
dium, indicating atrophy of the myo­
cytes.
The effects of various diets on tis­
sue stores of glycogen are shown in 
Figs. 1 and 2, where it can be seen 
that the liver responded to additional 
carbohydrate (dextrose) or fat (Flex­
ical) by significantly (P <  0.001) 
increasing its glycogen store. The 
group fed Vital maintained liver gly­
cogen levels comparable to those of 
the control, chow-fed group. Myocar­
dial glycogen did not demonstrate this 
pattern. Additional carbohydrate in 
the diet did not significantly influence 
the concentration of myocardial gly­
cogen as it did liver glycogen. The 
two elemental diets, Vital and Flexi­
cal, both altered myocardial glycogen 
levels from control values in opposing 
ways: Flexical raised the level 1.5 
times (P <  0.01) and Vital lowered 
it (P <  0.01).
The myocardial glycogen levels of 
the starved group were elevated to 
double the control values in contrast 
to the liver glycogen which was near­
ly totally depleted (Fig. 3).
Experiment 2
The correlation between myocardial 
glycogen content before the ischemic 
period and the myocardial perform-
FIG. 1—Liver glycogen content with 
different diets; n =  accepted standard 
value. Flexical elevated and Vital low­
ered glycogen level (P <  0.001).
FIG. 2— Myocardial glycogen con­
tent with different diets. Differences be­
tween Flexical and Vital are significant 
(P <  0.001).
Table I—Diet Composition, g% Dry Product
Protein or
Diet Fat Carbohydrate protein equivalent
Chow (RMH 1000) 6.30 57.40 14.50
Chow + dextrose (5%) 6.30 62.40 14.50
Flexical* 14.90 66.96 10.10
Vital* 4.11 70.25 15.80
'Flexical and Vital are elemental diets with protein in hydrolyzed form.
Table II--Range of Daily Dietary Intake*
Diet Cal/d Fat, g Carbohydrate, g Protein, g Total intake, g
Chow 59.1-87.2 1.1—1.6 9 .8 -14 .9 2.5—3.8 17.0-26.0
Chow + dextrose 68.3-97.2 1.1—1.6 12.5-17.9 2.5—3.8 19.7-29.0
Flexical 60.0 80.0 2.0-2.7 9 .0-12 .0 1.4-1 .9 12.0-16.0
Vital 7 9 .6 - 89.3 0.8-0 .9 14.8-16.6 3.3—3.7 18.8-21.2
*Rats require 6 0 - 90 Cal/d.
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ance during 30 minutes of normother- 
mic aortic cross-clamping in dogs was 
evident when the results were grouped 
according to the preischemic myo­
cardial glycogen levels, greater than 
or less than 0.4 g% (Figs. 4 and 5). 
Hearts having higher myocardial gly­
cogen levels before ischemia con­
tinued to beat during aortic cross­
clamping, with an electrocardiograph­
ic pattern near normal. Those with 
lower levels had a higher incidence 
of anoxic arrest or ventricular fibril­
lation during the 30-minute normo- 
thermic period of aortic clamping. Of 
the 13 dogs studied, 10 had reliable 
complete hemodynamic measure­
ments. Of these, hearts with the high­
er myocardial glycogen levels also 
had significantly (P <  0.05) better 
recovery of cardiac function after 
bypass, with a higher percentage re­
covery of both stroke work and myo­
cardial contractility. Thus, at least in 
normal hearts, those with higher gly­
cogen levels before ischemia were 
better able to tolerate the global 
ischemia.
Discussion
The myocardium utilizes 60% 
fatty acids, 28% glucose, 11% lac­
tate as well as ketones, if necessary, 
to produce energy under normal cir­
cumstances.12 This pattern of sub­
strate utilization has been questioned 
by a number of authors13"20 whose 
work clearly indicates that, even in 
normal hearts, substrate utilization by 
the myocardium depends on a variety 
of factors including substrate avail­
ability, hormones and intrinsic regu­
latory enzymes.
Anaerobic glycolysis occurs under 
conditions of myocardial ischemia, re­
sulting in near-total reliance on avail­
able glucose and glycogen stores to 
supply the energy demands of the 
heart.21'24 The rate of glycolysis cor­
relates well with the initial glycogen
FIG. 3—Myocardial glycogen was
significantly (P <  0.01) elevated and 
liver glycogen depleted in starved rats 
compared with those fed chow.
concentration. High levels of glycogen 
favour increased glycogenolysis dur­
ing anaerobic metabolism. It has been 
frequently reported1"9 that hearts with 
a higher myocardial glycogen content 
show better tolerance to ischemia and 
hypoxia. Thus, increasing the heart’s 
store of glycogen through nutritional 
manipulation would be useful in myo­
cardial protection.
Very little data exist on clinically 
feasible methods of dietary prepara­
tion of the heart other than by intra­
venous hyperalimentation or glucose- 
insulin-potassium administration and 
even less data are available on the 
effects of such measures on myocar­
dial glycogen content.25'30 If, indeed, 
myocardial glycogen acts as an energy 
reserve during ischemic and anoxic 
periods,1’2,4,6 a safe oral dietary regi­
men that increases myocardial stores 
of glycogen should increase the toler­
ance of the heart to both global and 
regional ischemia.
The results of this study indicate 
that dietary manipulation of myocar­
dial glycogen is possible. Nutritional 
management for 16 to 21 days was 
chosen because this interval had been 
reported31 to provide optimal nutri­
tional support leading to clinically sig­
nificant changes in body composition 
and cardiac function and appropriate 
metabolic responses to injury.
The rat studies utilized currently 
available hospital elemental diets. The 
two elemental diets tested, Flexical 
and Vital, provide equal calories per 
millilitre of oral intake. Only the 
source of these calories from carbo­
hydrate or fat differs; Flexical is high­
er in fat (free fatty acids, medium 
chain triglycerides) and Vital has less 
fat and more carbohydrate to provide 
the needed calories. The fat content 
of rat chow (RMH 1000) is mostly 
animal fat, which must be broken
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FIG. 4— Cardiac responses during 30 
minutes of normothermic aortic cross- 
clamping. Spontaneous contractions =  
synchronized mechanical contraction of 
left ventricle with corresponding QRS 
complex. Cardiac standstill and ventri­
cular fibrillation (V-fib) were confirmed 
by electrocardiogram.
down by the gastrointestinal tract be­
fore absorption. Once absorbed into 
the blood stream only relative con­
centrations matter. At present, pair 
feeding studies are being carried out 
to explore the significance of these 
observations.
It is known that starvation increases 
the myocardial levels of glycogen.32’33 
The increase we found in the starved 
rats cannot be accounted for by myo­
cardial atrophy alone, since the gly­
cogen to DNA ratio, which reflects 
glycogen content per cell, was also 
elevated in these animals. Starvation 
not only causes insulin resistance,34 
thereby decreasing glucose transport 
across cell membranes, but also elev­
ates free fatty acid and ketone con­
centrations in the blood.35-36 These are 
the principal substrates for the non­
ischemic myocardium. Lipolysis in the 
cardiac cell then inhibits glycolysis 
and glycogenolysis.37 The normally 
labile fraction of cardiac glycogen is 
then no longer used and the glycogen 
pool increases.38,39 Additional glucose 
available would be shunted to glyco- 
neogenesis. Lackey and colleagues40 
discussed the close relation between 
myocardial glycogen levels and the 
amount of ketone bodies present. 
Shipp and associates35 showed, by car­
bon-14 labelling, that glucose rather 
than fatty acids was the source of 
glycogen when both were given to a 
normal heart and that optimal glyco­
gen deposits were obtained when the 
myocardium was supplemented by 
both glucose and fatty acids together.35 
It appears therefore that through 
specific composition of diets, such as
FIG. 5— Cardiac function (stroke 
work index, myocardial contractility) 30 
minutes after cessation of cardiopulmo­
nary bypass (30 minutes normothermic 
aortic cross-clamping and 30 minutes 
reperfusion). Hearts with higher myo­
cardial glycogen (> 0 .4  g%, hatched
bars) had significantly (P <  0.001) bet­
ter functional recovery than those with 
< 0 .4  g% myocardial glycogen (white 
bars). Standard error of mean represents 
variations within each group.
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fat and carbohydrate together, which 
may play synergistic roles, one should 
be able to affect the glycogen con­
tent in the myocardium.
The data illustrate the different pat­
tern in the response of the heart ver­
sus the liver to nutrition, perhaps re­
flecting the homeostasis and protec­
tive action of the body towards con­
serving the heart. It also gives an 
indication of the strong drive for the 
heart’s reliance on free fatty acids, 
which are increased in starvation, as 
the fuel source, forcing glycogen to 
remain in storage.
Previous reports using isolated 
heart-muscle preparations have shown 
that higher glycogen stores resulted 
in improved hemodynamic function 
during ischemia and anoxia. We de­
cided to use the in-vivo normothermic 
cardiopulmonary and aortic cross- 
clamped heart as a model without 
the intervention of the protective ef­
fects of chemical cardioplegia and 
hypothermia. This was done to elim­
inate other factors and to maximize 
the metabolic consequences of myo­
cardial ischemia. The canine model 
was chosen to study myocardial per­
formance because this species could 
be subjected to cardiopulmonary by­
pass and global ischemia in the form 
of aortic cross-clamping, thus simulat­
ing conditions encountered in cardiac 
surgery.
Diet was not manipulated in the 
canine study and all dogs had normal 
hearts preoperatively. Significant (P 
<  0.001, y2 test) association could be 
established between a myocardial gly­
cogen level greater than 0.4 g% and 
better left ventricular function during 
aortic cross-clamping as well as the 
recovery of myocardial contractility 
and stroke work index after the ische­
mic period. There was no significant 
correlation between myocardial tissue 
lactate, blood lactate or glucose values 
and myocardial performance.
A nutritional preparation that 
would optimally raise myocardial gly­
cogen, shown now to improve cardiac 
tolerance to ischemia, is indeed feas­
ible. Such a preparation, if successful, 
could be a useful clinical adjunct in 
preparing patients for cardiac surgery, 
as well as for those suffering from 
unstable angina with risk of imminent 
myocardial infarction.
Conclusions
This study, although preliminary, 
revealed that: (a) caloric malnutrition 
in the form of starvation increased 
myocardial glycogen levels, (b) with 
adequate caloric intake the composi­
tion of the diet is important in af­
fecting the myocardial glycogen 
stores, (c) different dietary regimens 
alter both hepatic and cardiac glyco­
gen independently of one another, 
(d) hearts with higher myocardial gly­
cogen levels are better able to tolerate 
an episode of global ischemia, (e) the 
optimal composition of a dietary regi­
men that would maximally increase 
myocardial energy stores and also 
provide adequate total body nutrition 
is unknown and requires further in­
vestigation.
We are indebted to Mr. Roger Sam­
son, CP, Ms. Daniele Richer and Ms. 
Mimi Winsberg for technical assistance.
References
1. M errick A W : Cardiac glycogen following 
fulm inating anoxia. A m  J Physiol 1954; 
176: 83-5
2. Idem: Experim ental coronary occlusion in 
dogs and its effect upon the cardiac glyco­
gen fractions. Circ Res 1957; 5: 435-8
3. D aw es GS, M o t t  JC, Shelley  H J : The 
importance of cardiac glycogen for the 
maintenance of life in foetal lambs and 
new-born anim als during anoxia. J Physiol 
1959; 146: 516-38
4. Scheuer, J, Stezoski SW : Protective role 
of increased myocardial glycogen stores in 
cardiac anoxia in the rat. Circ Res 1970; 
27: 835-49
5. Lolley DM , H ew itt  RL: Protective effect 
of glycogen and glucose on the anoxic ar­
rested heart during cardiopulmonary bypass. 
Surg Forum  1972; 23: 145-7
6. H ewitt RL, Lolley DM, A drouny GA, 
D rapanas T : Protective effect of m yocar­
dial glycogen on cardiac function during 
anoxia. Surgery 1973; 73: 444-53
7. Iyengar SRK. C harrette EJP, Iyengar 
CKS, W asan S: M yocardial glycogen in 
prevention of perioperative ischemic injury 
o f the heart: a prelim inary report. Can J 
Surg 1976; 19: 246-51
8. L olley  DM , R ay JF  h i , M yers WO, S au t­
ter  RD, T e w k sbury  DA: Im portance of 
preoperative myocardial glycogen levels in 
human cardiac preservation. J Thorac Car- 
dioxasc Surg 1979; 78: 678-87
9. F euvray D, J ames F, de L eiris J :  E ffet
protecteur de la depletion des catechola­
mines endogenes sur l’ultrastructure du 
coeur isole de ra t au cours de perfusions 
hypoxiques de longue duree et apres r6- 
oxygenation. J Physiol (Paris) 1980: 76:
717-22
10. G ood CA, K ramer H. So m ogy i M: D eter­
mination o f glycogen. J Biol Chem 1933; 
100: 485-91
11. Sch n eid er  W C: Phosphorus compounds in 
anim al tissues; extraction and estimation of 
desoxypentose nucleic acid and of pentose 
nucleic acid. J B iol Chem  1945; 161: 293- 
303
12. Burton AC: Physiology and Biophysics o f  
Circulation, Y ear Bk Med, Chicago, 1965
13. G oodale W T, H ackel DB: Myocardial c a r­
bohydrate m etabolism  in norm al dogs, with 
effects of hyperglycemia and starvation. 
Circ Res 1953; 1: 509-17
14. Lukens F D : Influence of insulin on protein 
metabolism and cardiac glycogen in Hous- 
say animals. A m  J Physiol 1958; 192: 485- 
90
15. G oodale W T, O lson RE, H ackel DB: 
The effects of fasting and diabetes m ellitus 
on myocardial metabolism in man. A m  J 
M ed  1959: 27: 212-20
16. Scott  JC , F in k e l st e in  LJ, Spitzer J J :  
M yocardial removal of free fatty acids 
under norm al pathological conditions. A m  
J Physiol 1962: 203: 482-6
17. W illia m s  BJ, M ayer SE: Hormonal effects 
on glycogen metabolism in the rat heart 
in situ. M ol Pharmacol 1966; 2: 454-64
18. A d r o u n y  G A : D ifferential patterns o f gly­
cogen m etabolism  in cardiac and  skeletal 
muscles. A m  J Physiol 1969; 217: 686-93
19. N eely  JR , Rovetto  M J, O ram J F :  M yo­
cardial u tilization o f carbohydrates and  lip­
ids. Prog Cardiovasc D is 1972; 15: 289-329
20. D rake  A J, H a in es  JR , N oble  M I: P refer­
ential up take  of lactate by the norm al myo­
cardium  in dogs. Cardiovasc R es  1980; 14: 
65-72
21. H errm ann  G, Decherd G : C reatine  and 
glycogen content o f norm al and infarcted 
heart m uscle of the dog. Proc Soc E xp  Biol 
M ed  1935; 32: 1304-5
22. O p ie  L H : Effects of regional ischem ia on 
m etabolism  o f glucose and fatty acids. Rela­
tive ra tes  o f aerobic and anaerobic energy 
p roauction  during myocardial in farction  and 
com parison  with effects o f anoxia. Circ 
R es  1976; (5 suppl 1): 152-74
23. Serur  JR , U rschel  CW , So n n e n b l ic k  EH,
L a R aia P J : Experim ental m yocardial is­
chem ia. III. Protective effect o f glucose 
on m yocardial function. /  M ol Cell Cardiol 
1976; 8: 521-31
24. Di G e n n a r o  M, Bernabei R, V alle A, 
C o c c h i A, C arbo nin  PU : P rotection  by 
glucose in the anoxic and ischem ic myo­
cardium . Boll Soc Ital Cardiol 1977; 22: 
2086-9
25. R ebar B, O m a chi A, R ebar J j r : Effects 
of glucose infusion on dog m yocardial 
m etabolism . Circ Res 1959; 7: 977-81
26. M o f f it t  EA, R osevear JW , M o ln a r  GD, 
M cG o o n  D C : The effect of glucose-insulin- 
potassium  solution on ketosis following car­
diac surgery. Anesth Analg (C leve) 1971; 
50: 291-7
27. A bel RM, F ischer  JE , B uck ley  M J, 
A u s t e n  W G : Hyperalim entation in cardiac 
surgery. A review of sixty-four patien ts. J 
Thorac Cardiovasc Surg  1974; 67: 294-300
28. L o l ley  DM , H e w it t  RL, D rapanas T : Re- 
troperfusion  of the heart with a solution 
of glucose, insulin and potassium  during 
anoxic arrest. J Thorac Cardiovasc Surg 
1974; 67: 364-70
29. T e w k sb u r y  D, L olley  DM, M yers W O, 
R ay J F  i i i , Sautter R D : Clinical m ethods 
for elevating glycogen levels in the hum an 
heart. Surg Forum  1978; 29: 318-9
30. A n d o  T, K anazawa H, M atsu kaw a  T, 
E gu ch i S: An application of the  elem ental 
diets for the pre- and postoperative m an­
agem ent o f the infant cardiac surgical pa ­
tients. K yohu  Geka  1980; 33: 333-8
31. G ib b o n s  G W . Blackburn GL, H a r k en  DE, 
V aldes PJ, M oorehead D, B ist r ia n  BR: 
Pre- and  postoperative hyperalim entation  in 
the trea tm en t of cardiac cachexia. J Surg  
R es  1976; 20: 439-44
32. M acLeod J JR , P rendergast D G : G lycogen 
in the h ea rt and skeletal muscles in starved 
and well-fed animals. Proc Trans R  Soc 
Can  1921; 15: 37-40
33. E vans G : Glycogen content of ra t heart.
J P hysiol 1934; 82: 468-80
34. C u r f m a n  G D , O ’H ara DS, H o p k in s  BE, 
Sm it h  T W : Suppression o f m yocardial p ro ­
tein degradation  in the rat during fasting. 
E ffects o f insulin, glucose, and leucine. 
Circ R es  1980; 46: 581-9
35. Sh ip p  JC , O p ie  LH, C ha llon er  D : Fatty
acid and glucose m etabolism  in the  per­
fused h eart (C). N ature  (L ondon) 1961;
189: 1018-9
36. Y a f fe e  S, G old A, S a m pug na  J :  E ffects 
of prolonged starvation on p lasm a free 
fatty  acid  levels and fatty acid com position 
of m yocardial total lipids in the ra t. J 
N u tr  1980; 110: 2490-6
37. W it t e l s  B, B ressler R: Lipid m etabolism  
in the heart during fasting. Lah Invest 
1964; 13: 794-9
38. Russell JA , Bloom W L : E xtractab le  and 
residual glycogen in tissues of rat. A m  J 
Physiol 1955; 183: 345-55
39. D ratz A F, R ussell  JA , C ovey B M : U p ­
take o f labeled glucose by tissue glycogen 
in vivo. F ed  Proc 1956; 15: 52
40. L ackey RW, Bunde CA, H arris L C : The 
re la tionsh ip  o f cardiac glycogen deposition 
to blood ketone levels in experim ental 
ketosis. A m  J Physiol 1946; 145: 470-3
VOLUME 25, NO. 5, SEPTEMBER 1982 / THE CANADIAN JOURNAL OF SURGERY 537
Continuous Monitoring of Mixed Venous Oxygen 
Saturation in Cardiac Surgery
W.R.E. Ja m ie so n , m d , fa cs , frcs[c ], K .W . T u r n b u ll , m d , f r c p [c], A .J. L arrieu , m d , 
W.A. D odds, m d , f r c p [c ], J.C. A llison , m d , f r c p [c ] and G.F.O. T yers, m d , facs, frcs[c ]
Serial measurement of mixed venous 
oxygen saturation is useful in the care 
of critically ill patients. It is an 
index of cardiac output and overall 
tissue perfusion. Previously, lack of 
refinement of the technology for 
continuous monitoring of mixed 
venous oxygen saturation deterred 
its clinical application. The authors 
evaluated the Oximetrix Shaw™ 
catheter oximeter system between May 
1980 and April 1981 in 84 high-risk and 
moderately high-risk patients. Fifty-four 
had undergone only myocardial 
revascularization while 30 had 
undergone valvular or combined 
procedures. In 20 patients with 
compromised left ventricular function 
(mean ejection fraction of less than 
40°/o) continuous mixed venous oxygen 
saturation was compared to 
hemodynamic parameters in an 
intraoperative and early postoperative 
study. The results indicated that 
satisfactory mixed venous oxygen 
saturation (more than 65%) correlated 
with normal hemodynamic measure­
ments including cardiac output 
and cardiac index. In general, a fall 
in mixed venous oxygen saturation 
of more than 10% was noted before the 
mean blood pressure, heart rate or 
pulmonary capillary wedge pressure 
changed. Cardiac output, cardiac index, 
systemic vascular resistance and 
left ventricular stroke work index 
were found to change in association 
with a change in mixed venous oxygen 
saturation. A fall (mixed venous 
oxygen saturation less than 65%) 
can be related to: (a) abnormal 
hemodynamic status —  reduced cardiac 
output, hypotension, elevated 
systemic vascular resistance and
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arrhythmias, (b) abnormal oxygen 
demand —  shivering, suctioning, 
positioning and pyrexia and (c) 
abnormal oxygen supply —  anemia, 
airway obstruction and altered 
diffusion of oxygen at the alveolar 
capillary membrane. The Oximetrix 
system proved reliable. Mixed 
venous oxygen saturation is a 
nonspecific indicator of hemodynamic 
status. Continuous monitoring of 
the mixed venous oxygen saturation 
facilitates optimal patient manage­
ment by immediately alerting intensive 
care personnel to the development 
of inadequate tissue perfusion.
Les mesures seriees de la saturation 
en oxygene du sang veineux mele 
contribuent utilement aux soins donnes 
aux patients gravement malades.
Ceci constitue un index du debit 
cardiaque et de I'irrigation sanguine 
globale des tissus. Prealablement, 
le manque de raffinement de la 
technologie pour la surveillance 
continue de la saturation en oxygene 
du sang veineux mele differait de 
■'application en clinique. De mai 1980 
a avril 1981, les auteurs ont evalue 
I'oxymetre Oximetrix Shaw™ chez 
84 patients a risque eleve ou 
moderement eleve. Cinquante-quatre 
avaient subi une revascularisation 
myocardique uniquement, alors que les 
30 autres avaient eu une intervention 
valvulaire ou une operation mixte.
Chez 20 patients qui presentaient une 
fonction ventriculaire gauche alteree 
(avec une fraction d'ejection moyenne 
de moins de 40%), la mesure continue 
de la saturation en oxygene du sang 
veineux mele a ete comparee aux 
parametres hemodynamiques dans 
une etude couvrant la periode 
peroperatoire et postoperatoire 
precoce. Les resultats indiquent qu'une 
saturation en oxygene du sang veineux 
mele satisfaisante (de plus de 65%) 
montre une bonne correlation avec 
des mesures hemodynamiques 
normales, dont le debit cardiaque et 
I’index cardiaque. En general, une chute 
de la saturation en oxygene du sang 
veineux mele de plus de 10% a ete 
notee avant qu'il n'y ait de changement 
de la tension arterielle moyenne,
de la frequence cardiaque et de la 
pression capillaire pulmonaire. On 
a observe qu'il y avait changement 
dans le debit cardiaque, I'index 
cardiaque, la resistance vasculaire 
generate et I’index du travail 
ventriculaire gauche relie avec le 
changement de la saturation en 
oxygene du sang veineux mele. Une 
chute (une saturation en oxygene 
de moins de 65%) peut etre reliee a: 
a) un etat hemodynamique anormal —  
diminution du debit cardiaque, 
hypotension, augmentation de la 
resistance vasculaire generate et 
arythmie, b) une demande anormale 
en oxygene —  frissons, aspiration, 
mise en position ou pyrexie et c) 
un apport d'oxygene anormal —  
anemie, obstruction des voies 
respiratoires et alteration de la 
diffusion de I’oxygene au niveau de 
la membrane capillaire alveolaire.
Ce systeme d'oxymetrie s'est avere 
fiable. La saturation en oxygene 
du sang veineux mele est un 
indicateur non specifique de I’etat 
hemodynamique. Sa surveillance 
continue permet un traitement optimum 
du malade en informant le personnel 
des soins intensifs prestement 
du developpement d'une perfusion 
inadequate des tissus.
The usefulness o f  serial measurements 
o f  mixed venous oxygen saturation 
(Svo2) in the care o f  critically ill pa­
tients has been documented by many 
investigators.1'18 Between 1959 and 
1970, reports addressed the relation 
o f Svo2 to cardiac output.13,16'17'19,50 In 
1973 Martin and associates4 reported 
on the developm ent o f  a two-element 
fiberoptic catheter that measured 
Svo2, b u t ' measurements were 
often inaccurate because only two 
wavelengths o f  light were used. They 
showed that Svo2 was a useful corre­
late o f  cardiac output and overall tis­
sue perfusion. The development o f  a 
new fiberoptic catheter oximeter (O xi­
metrix Shaw™ catheter oximeter sys­
tem; Oximetrix, Inc., Mountain V iew . 
Calif.) has allowed accurate continu­
ous m onitoring o f  Svo2 in the pul­
monary artery o f  patients who un­
dergo cardiac surgery.
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Technique for Continuous 
Measurement of Svo2
The Shaw™ catheter oximeter sys­
tem consists of a signal processor, a 
coded optical module and a fiber­
optic catheter. The oximeter system 
is a spectrophotometric instrument 
that uses the standard technique for 
measurement of blood oxygen satura­
tion. The fiberoptic catheter we used 
was of 7.5-F diameter, containing two 
plastic fiberoptic light guides and was 
a balloon-tipped, flow-directed, ther­
modilution, pulmonary artery cath­
eter. It can be inserted percutaneous- 
ly in a peripheral vein. The optical 
module contains three light-emitting 
diodes, providing the source for three 
wavelengths of red and near-infrared 
light (range 600 to 1000 /xm). Each 
wavelength of light is pulsed in se­
quence at 244 cycles per second 
through a single optical fibre within 
the catheter to illuminate the blood 
flowing past the catheter tip. The light 
reflected by the blood is transmitted 
along the second optical fibre to a 
photodetector in the optical module. 
These light signals are then converted 
to electrical signals that are amplified 
and transmitted to the processor. The 
processor then samples these signals 
and from the intensities of the three 
wavelengths of reflected light, com­
putes and displays the average mixed 
venous oxygen saturation for the pre­
ceding 5 seconds. This average is up­
dated every second and is displayed 
in the digital readout on the processor 
display panel and recorded on a self- 
contained, two-speed strip chart re­
corder.
Audible and visible alarms are trig­
gered when oxygen saturation is out­
side either the low or high limits that 
can be selected by the operator. The 
system also has an “artefact condition” 
alarm that is triggered when the in­
tensity or character of the reflected 
light differs from that expected from 
flowing blood. This may occur during 
insertion or when the catheter tip 
impinges on a vessel wall or is par­
tially obstructed by debris.
Before insertion, calibration of the 
system requires correction of the fi- 
beroptics to the optical module and 
positioning of the tip against a refer­
ence surface within the tray. The sys­
tem is electronically calibrated within 
30 seconds. The system can also be 
calibrated in vivo by independently 
measuring the Svo2 from the pulmo­
nary artery blood sample and then 
correcting the reading on the micro­
processor.
Patients and Methods
Between May 1980 and April 1981. 
continuous measurement of Svo2 was 
carried out in 84 patients (69 men, 15 
women) ranging in age from 40 to 76 
years (mean 57.9 years). Fifty-four 
patients underwent only myocardial 
revascularization while 30 had valv­
ular or combined procedures. The 
surgical procedures included coronary 
artery bypass (54), coronary artery 
bypass with resection of a left ventri­
cular aneurysm (9), coronary artery 
bypass with valve replacement (7), 
single valve replacement (9), double 
valve replacement (3) and valve re­
placement with ascending aortic aneu­
rysmectomy (2). The average number 
of grafts placed per patient was 3.3. 
The patients selected for evaluation 
of the Svo2 had severe coronary ar­
tery disease with obstruction of the 
left main artery, congestive heart fail­
ure, inadequate contractility or un­
stable angina, or both, or severe insuf­
ficiency of the aortic and mitral valves 
or mitral stenosis with pulmonary hy­
pertension.
Repeated hemodynamic assess­
ments were performed in conjunction 
with Svo2 monitoring in 20 of the 84 
patients. The mean age of this sub­
group of patients was 59.7 years. 
The majority had atherosclerotic 
heart disease with compromised left 
ventricular function but normal cere­
bral and renal function. The mean 
preoperative ejection fraction was 
39.7 ±  0.2% (standard deviation) and 
the left ventricular end-diastolic pres­
sure was 21.2 ±  9.1 mm Hg. Most 
of these patients were taking nitrates 
and ^-blocking agents. The patients 
were premedicated with triazolam or 
diazepam and morphine, 10 mg intra­
muscularly 60 to 90 minutes before 
operation. The technique for anesthe­
sia consisted of induction with diaze­
pam (10 to 15 mg intravenously), thio­
pentone (50 to 150 mg intravenously), 
succinylcholine (100 mg) or pancuro­
nium bromide (0.1 mg/kg), oxygen 
and gentle intubation. Anesthesia was 
maintained with morphine (45 mg) in 
an intravenous drip, nitrous oxide- 
oxygen inhalation, pancuronium bro­
mide and intermittent administration 
of halothane. Fentanyl citrate in 
incremental doses (to a total of 10 
mg/kg) was added after cardiopul­
monary bypass was instituted. Ventila­
tion was controlled (Paco2 30 to 40 
mm Hg) and no muscle relaxant re­
versal was used at the end of the 
procedure.
Myocardial protection was provided 
by using systemic hypothermia (30°C), 
multidose hypothermic potassium (25
meq/1) crystalloid cardioplegia arid 
topical hypothermia with cold crystal­
loid solution. Myocardial temperature 
was maintained between 10° and 
20°C.
The study was designed to compare 
hemodynamic parameters with Svo2 
values at predetermined periods: (a) 
before induction of anesthesia, (b) 15 
minutes after induction of anesthesia, 
(c) after the sternotomy, (d) 15 min­
utes and (e) 30 minutes after cardio­
pulmonary bypass and (f) 15 minutes 
after admission to the recovery room 
or intensive care unit. Additional eva­
luations were made when important 
changes in Svo2 (more than 10%) 
were noted during the postoperative 
period. At each designated period. 
Svo2 arterial blood gases, blood pres­
sure, right atrial pressure, pulmonary 
capillary wedge pressure and tempera­
ture were recorded. Thermodilution 
cardiac outputs were measured and 
cardiac index, systemic vascular re­
sistance, pulmonary vascular resist­
ance and rate pressure product were 
calculated. Observations were made 
postoperatively to assess the effects of 
chest physiotherapy, positioning, en­
dotracheal tube suctioning and post­
operative shivering.
Statistical evaluations were made 
using shared variance, multiple corre­
lation, Student’s /-test and trend anal­
ysis.
Results
The mean cardiopulmonary bypass 
time for the 20 patients in the sub­
group who underwent comparative 
analysis was 151.3 ±  58.1 min­
utes. Tables I and II give the data 
obtained during the sample periods. 
Heart rate was increased (P <  0.05) 
after cardiopulmonary bypass. Mean 
blood pressure and pulmonary capil­
lary wedge pressure decreased after 
sternotomy (P <  0.05). Cardiac
index did not change significant­
ly throughout. Systemic vascular 
resistance and left ventricular stroke 
work index increased significantly (P 
<  0.05) after sternotomy but re­
turned to postinduction values after 
the end of bypass with the exception 
of left ventricular stroke work index 
which was increased in the recovery 
room (P <  0.05). The rate pressure 
products increased significantly (P <  
0.05) after sternotomy and after by­
pass.
Intraoperative and postoperative in­
terventions were required to maintain 
satisfactory tissue perfusion in many 
instances. The need for inotropic 
agents or vasopressors and vaso­
dilators was often first indicated
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by a decrease in Svo2. In the post­
sternotomy period, one patient re­
ceived inotropic agents and four re­
ceived vasodilators and at the 15- 
minute period after cardiopulmonary 
bypass five patients received inotropic 
agents and one received vasodilators. 
At the 30-minute period after cardio­
pulmonary bypass, 9 patients were 
receiving inotropic agents or vaso­
pressors and 1 was receiving vaso­
dilators, while in the recovery room 
11 and 13 were receiving these drugs 
respectively.
At the designated observation pe­
riods there was no significant dif­
ference in cardiac index or SvOi>. In­
terpretation of therapeutic needs based 
on mixed venous oxygen saturations 
correlated well with hemodynamic 
measurements including cardiac out­
put and cardiac index. There were 
high shared variances (R2 >  0.9) and 
even higher nonselective multiple cor­
relations (R >  0.95) between the mul­
tiple variables.
The hemodynamic profiles for the 
various observation periods are shown 
in Fig. 1. In the total group of 84 
patients, changes in Svo2 of more 
than 10% were often found to pre­
cede changes in hemodynamic status 
during the postoperative recovery pe­
riod. A fall in Svo2 was noted before
the mean blood pressure, heart rate 
or pulmonary capillary wedge pres­
sure changed. Cardiac output, sys­
temic vascular resistance, cardiac in­
dex and left ventricular stroke work 
index were found to have deteriorated 
after any persistent downward trend 
in Svo2. When the Svo2 was noted 
to be falling, evaluation of hemo­
dynamic parameters was neces­
sary to determine whether (a) preload 
(central venous pressure, pulmonary 
capillary wedge pressure and left 
atrial pressure) was inappropriate, (b) 
afterload (systemic and pulmonary 
vascular resistance) was elevated or (c) 
myocardial contractility (left ventri­
cular stroke work index) was altered. 
The Svo2 value was also helpful in 
delineating otherwise unsuspected car­
diac tamponade. Typically, cardiac 
tamponade was characterized by 
elevated filling pressures, reduced car­
diac output, elevated systemic vascular 
resistance and falling Svo2. However, 
distinct pressure abnormalities were 
lacking in three patients thought to 
have low cardiac output with elevated 
afterload. Vasodilators caused the 
Svo2 to plummet in these patients, in 
contrast to their beneficial effect in 
patients with reduced myocardial 
function without tamponade. Inotropic 
agents and volume were only of
modest benefit and typically, the Svo2 
continued to fall until the cardiac tam­
ponade was surgically relieved. In 
other cases where altered myocardial 
contractility or inappropriate preload 
were delineated as the cause of the
FIG. 1— Hemodynamic profiles for 
various observation periods. 1 =  prein­
duction (Svo2, 85.3 ±  3.1%), 2 =  post­
induction (Svo2, 74.0 ±  1.6%), 3 "  
poststernotomy (Svo2, 73.7 ± 1.7%),
4 =  15 minutes postbypass (Svo2, 74.0 
±  1.48%), 5 =  30 minutes postbypass 
(Svo2, 70.6 ±  1.41%), 6 =  recovery 
room (Svo2, 71.6 ±  1.1%).
T a b le  1--C a rd io va sc u la r R e sp o n se s and M ix e d  V e n o u s  O x y g e n  Saturations, M ean (SD)
P o stb yp a ss, m in
M e a su re m e nt P reinduction Postinduction P o s ts te m o to m y 15 30 R e c o v e ry  ro o m
H e a rt rate, beats/min 
M e a n  blood pressure ,
75.5 (16.0) 65.8 (14.9) 70.5 (15.7) 89.3 (19.7)* 85.7 (14.0)* 86.8 (18.5)*
m m  H g
P u lm o n a ry  capillary
86.3 (11.3)* 68.3 (11.0) 97.3 (20.7)* 84.3 (13.5)* 81.4 (12.2)* 100.0 (18.0)*
w e d g e  pressure, 
m m  H g 18.7 (5.9)* 12.7 (6.0) 18.3 (6.0)* 18.2 (5.9)* 18.6 (6.4)* 15.2 (5.1)
M ix e d  ve no us o x y g e n
saturation, % 85.3 (7.6)* 74.0 (7.1) 73.7 (7.8) 74.0 (6.6) 70.6 (6.3) 71.6 (5.1)
* P  <  0.05, S tudent's f-te st (com pared w it h  postinduction values).
Ta b le  I I - C ardiovascular Indices and M ix e d  V e n o u s S aturations, M ean (SD)
M e a su re m e nt P reinduction Postinduction P o s ts te rn o to m y
Posttaypass,
15
m in
30 R e c o v e ry  ro o m
C ardiac output, llm in 5.26 (0.56) 3.38 (1.13) 3.23 (0.91) 4.37 (1.59) 4.40 (1.66) 4.02 (0.87)
C ardiac index, 
l/min ■ m 2 2.73 (0.53) 1.77 (0.54) 1.67 (0.35) 2.32 (0.93) 2.32 (0.91) 2.13 (0.56)
S y s te m ic  vascular 
resistance, d y n e  
s e c  cm '5 1238 (108) 1617 (526) 2334 (598)* 1448 (561) 1399 (521) 1752 (459)
L e ft  ventricular s tro k e  
w o r k  index, 
g m -m lm 2 - beat 34.0 (10.9) 21.0 (10.9) 28.5 (12.2)* 23.5 (9.1) 23.8 (10.8) 30.2 (10.6)*
R a te  pressure product, 
m m  Hglbeat - m in 8568 (463) 6599 (155) 9443 (267)* 1 0367 (339)* 9607 (181)* 12 302 (392)*
M ix e d  ve no us o x y g e n  
saturation, % 85.3 (7.6)* 74.0 (7.1) 73.7 (7.8) 74.0 (6.6) 70.6 (6.3) 71.6 (5.1)
* P  <  0.05, S tudent's f-te st (com pared w it h  postinduction values).
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falling Svo2, appropriate management 
corrected the Svo2 (Figs. 2 and 3).
Continuous monitoring of the Svo2 
showed the effect of several nursing 
maneuvers, such as chest physiother­
apy (Fig. 4), endotracheal suctioning 
and turning the patient (Fig. 5). A 
profound decrease in Svo2 with shiv­
ering (extensive increase in metabolic
FIG. 2— Improvement in Svo2 value 
with institution of dopamine (arrow).
FIG. 3—Improvement in Svo, with 
infusion of plasma.
demands for oxygen) is illustrated in 
Fig. 6.
The hospital mortality for the 84 
patients was 4.8% (4 patients). Three 
died of low output syndrome, one of 
chronic renal failure following double 
valve replacement and aortocoronary 
bypass, the other died of systemic 
candidiasis following resection of a 
recurrent left ventricular false aneu­
rysm for endocarditis. In this group 
of high- and moderately high-risk pa­
tients the intra-aortic balloon pump 
was used in five patients with four 
survivors. The three patients who died 
of low output syndrome were not sup­
ported by the intra-aortic balloon 
pump because of peripheral vascular 
disease or surgeon’s preference.
The Oximetrix catheter was re­
liable and relatively easy to insert and 
to position. The development of 
serious arrhythmias during the place­
ment was usually not a problem.
Discussion
The role of serial measurements 
of mixed venous oxygen saturation 
(Svo2) has been extensively docu­
mented as an indicator of cardiac out­
put and tissue perfusion.1"18 The ade­
quacy of oxygen supply to the tissues
FIG. 5—Decreases in Svo2 with oral 
tracheal tube suctioning and positioning 
of patient (arrows).
is reflected by the tissue oxygen ten­
sion that is maintained.15 This can be 
closely monitored by measuring the 
mean venous oxygen tension of blood 
returning from the tissues; the tension 
varies greatly because of individual 
organ demands. The mean venous 
oxygen tension is reflected by the 
Svo2 of blood in the pulmonary artery 
following admixture in the right ven­
tricle.
The Fick formula for calculating 
cardiac output delineates the relation 
of cardiac output to mixed venous oxy­
gen saturation: cardiac output =
oxygen consumption -F arteriovenous 
oxygen difference. The arteriovenous 
oxygen difference indicates the extent 
to which cardiac output matches tis­
sue metabolism requirements. It is 
obtained by subtracting the venous 
oxygen content (hemoglobin level X 
venous saturation) from arterial oxy­
gen content (hemoglobin level X ar­
terial saturation). Thus cardiac out­
put =  oxygen concentration -f hemo­
globin X arterial saturation -  hemo­
globin x venous saturation. It be­
comes clear that the Svo2 varies direct­
ly with cardiac output when arterial 
oxygen content, hemoglobin and oxy­
gen consumption by the tissues re­
main constant. For example, if cardiac 
output falls, the ratio between oxygen 
consumption and cardiac output will 
rise and the Svo2 value will fall.
As indicated previously, this close 
and definite correlation between 
Svo2 and cardiac output has been 
clinically established by numerous in­
vestigators. From 1959 to 1970, five 
reports documented the preliminary 
investigation of Svo2 as a useful clin­
ical parameter.13-1617'19'20 Boyd and as­
sociates,13 in 1959, reported that the 
measurement of oxygen saturation in 
mixed venous blood from the pul­
monary artery was the single most 
helpful measurement in evaluating the 
status of the postcardiotomy patient. 
In their group of postoperative pa­
tients, an Svo2 value above 60% sep­
arated those with adequate from those 
with inadequate cardiac output. Mc­
Arthur and associates20 found similar 
results in their group of patients who 
underwent open-heart procedures and 
further categorized their observations: 
an Svo2 of 60% to 70% indicated 
circulatory competence, 50% to 60% 
reduced myocardial efficiency and 
40% to 50% circulatory failure. 
Scheinman and associates,16 and Muir 
and associates17 found similar results 
in groups of medical patients, with 
the lowest mean Svo2 found in pa­
tients with left ventricular failure and 
cardiogenic shock.
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The pioneering work of these in­
vestigators was widely recognized. 
However, the disadvantage of fre­
quent and intermittent determinations 
on single blood samples requiring ma­
terials and personnel precluded its 
widespread use in the critical care 
setting.
The availability of fiberoptics has 
permitted the development of cath­
eter oximeters based upon the prin­
ciples of spectrophotometry — as the 
oxygen content of the erythrocytes de­
creases, there is a progressive change 
in their colour from scarlet to purple. 
If light of different wavelengths illu­
minates the blood, the amount of 
reflected or backscattered light, at 
each wavelength, is dependent upon 
the colour and, therefore, the oxygen 
level of the blood. Since approximate­
ly 98% of the oxygen in the blood 
is chemically combined with hemo­
globin in erythrocytes, the absorption 
of red and infrared light is substan­
tially different for oxygenated and 
deoxygenated hemoglobin and varies 
for different wavelengths of light 
within this red/infrared spectrum. The 
relative amounts of oxygenated and 
deoxygenated hemoglobin can then be 
calculated by measuring the relative
absorption of light at selected wave­
lengths.
In 1973 Martin and associates4 de­
veloped a two-element fiberoptic cath­
eter. They reported a correlation co­
efficient of 0.985 between an in-vivo 
oximeter and a laboratory determined 
oxygen saturation. They indicated that 
a mean venous oxygen saturation of 
60% is probably within the acceptable 
range and they suggested treatment 
designed to improve cardiac output if 
the mean venous oxygen saturation 
falls to 40% or less. The development 
of the three-element fiberoptic cath­
eter (Oximetrix Shaw™ catheter oxi­
meter system) has facilitated the 
clinical application of Svo2 and elim­
inated the inaccurate measurements 
that often occurred with the two- 
element catheter.
Before 1980 the clinical application 
of the Svo2 value was primarily in 
infants.5’21'24 Parr and associates21 in 
1975 reported that mortality follow­
ing cardiac surgery in infants is more 
reliably predicted using cardiac index 
and Svo2 together than either meas­
urement alone. They stated that in­
terventions were necessary if the car­
diac index fell below 2.0 l/min«m2 or 
the Svo2 was below 30 mm Hg. In
1978 de la Rocha and associates,5 in 
assessing the status of 11 children fol­
lowing cardiac surgery, found that 
the Svo2 was a useful guide in estim­
ating cardiac index. They believed 
that if the metabolic rate, pulmonary 
gas exchange and hemoglobin level are 
unaltered, the Svo2 will vary directly 
with cardiac output. Wilkinson and 
associates23'24 reported in 1978 and
1979 that umbilical artery oximeter 
evaluation of oxygen saturation of 
85% to 95% indicated a stable state 
in the management of infants with 
respiratory distress syndrome and 
avoided frequent blood sampling for 
arterial blood gases.
Krauss and associates,9 in 1975, re­
ported in 19 adult patients a correla­
tion of 0.78 between the cardiac index 
and the continuous measurement of 
Svo2. They concluded that Svo2 was 
a reliable indicator of cardiac output 
and that its determination could re­
duce the frequency with which the 
cardiac output needs to be measured. 
A similar relationship between cardiac 
index and Svo, has been reported 
by others.1’5'12’25’20 Kazarian and Del 
Guercio,12 reporting in 1980 on 10 se­
riously injured patients, found that 
Svo2 is a function of cardiac output, 
intravascular volume and peripheral 
resistance, correlating oxygen deliv­
ered to the cell and oxygen con­
sumed by the cell. This report showed 
that an Svo2 of 70% represented pro­
vision of total tissue requirements.
In 1981 two reports indicated the 
reliability of the Oximetrix System 
used in our study.10,11 Beale and asso­
ciates10 reported that regression anal­
ysis of paired in vivo and in vitro 
Svo2 measurements revealed no loss 
of accuracy with time or changes in 
body temperature, hemoglobin level 
and cardiac output. They noted that 
a decline in Svo2 preceded deteriora­
tion in the clinical state of the patient. 
In the same year, Waller and asso­
ciates11 showed that if oxygen content 
and total body oxygen consumption 
were maintained, Svo2 reflected car­
diac output. A 5% change in Svo2 
correlated with a change in cardiac 
output as indicated by cardiac index 
and left ventricular stroke work index.
Mixed venous oxygen saturation is 
a nonspecific indicator of the ade­
quacy of cardiac output and tissue 
perfusion. Another nonspecific indi­
cator of adequate circulation, the peri­
pheral or “toe temperature,”2’27 is 
particularly reliable in infants and a 
temperature falling below 35°C repre­
sents inadequate cardiac output and 
tissue perfusion. The peripheral tem­
perature is inadequate for “beat-to-
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beat” assessment, while the Svo2 is an 
appropriate assessment of current cir­
culatory status. Hemodynamic track­
ing, as advocated by Barash,28 Ross 
and Braunwald29 and Lappas and as­
sociates,30 must be instituted when the 
Svo-> starts to fall so that the cause 
can be determined and appropriate 
management begun.
The normal range of Svo2 is 65% 
to 80%, which indicates normal he­
modynamic status and normal oxygen 
supply and demand. A falling Svo2 
of 55% to 65% may be related to 
(a) abnormal hemodynamics with re­
duced cardiac output, hypotension, 
elevated systemic vascular resistance 
and arrhythmias; (b) abnormal oxy­
gen demand associated with shivering, 
suctioning, pyrexia and positioning 
and (c) abnormal oxygen supply due 
to anemia, airway obstruction and re­
duced pulmonary venous oxygen sat­
uration. A rising Svo2 of 85% to 
95% may indicate abnormal hemo­
dynamics, such as elevated cardiac 
output or systemic vascular resistance, 
but it can indicate catheter wedging 
or migration.
Conclusions
The mixed venous oxygen satura­
tion has no fixed relation to any vari­
able of myocardial function. It rep­
resents the hemodynamic status of the 
patient and each hemodynamic vari­
able must be assessed if there are 
changes of more than 10% in the 
Svo2 value. Mixed venous oxygen sat­
uration facilitates optimal patient 
management by identifying early ma­
nifestations of inadequate tissue per­
fusion.
The statistical analyses of Dr. Todd 
Rogers and Mr. Ray Tomasiuk are grate­
fully acknowledged. Our appreciation is 
extended to Ms. Gayle Henderson for 
preparation of the manuscript.
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NOTICES
Surgical Symposium
The division of general surgery, 
University of Ottawa School of 
Medicine will hold its fourth annual 
November Surgical Symposium at the 
Hotel Plaza in Hull, Quebec, No­
vember 12 and 13, 1982. The program 
will deal with a wide variety of com­
mon surgical problems. In addition to 
local faculty, guests will include Dr. 
Lewis Flint, professor of surgery,
University of Louisville; Dr. Lloyd 
MacLean, professor of surgery, Mc­
Gill University; and Dr. Peter Cruse, 
professor of surgery, University of 
Calgary.
For additional information contact 
Dr. J.L. Wellington, Chairman, Pro­
gram committee, November Surgical 
Symposium, Department of surgery, 
Ottawa General Hospital, 501 Smyth 
Rd.. Ottawa, Ont. K1H 8L6.
American Association for 
Hand Surgery
The 12th annual meeting of the 
American Association for Hand Sur­
gery will be held at The Hyatt Regency 
Maui, Maui, Hawaii, October 7-10, 
1982. For further information contact 
Jean Kiefer, CPS, Central Office, 
2704 Marshall Ct., Madison, Wise. 
53705; phone (608) 238-3630.
continued on page 549
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VOLUNTARY CONTRIBUTIONS
Necrotizing Pancreatitis in Renal Transplant Patients
M. Burnstein , m d , D. Salter, m d , C. Cardella, m d , fr cp[c ] and H.S. H im a l , m d , facs, frcs[c]
Acute necrotizing pancreatitis 
developed in 5 of 405 patients who 
underwent renal transplantation.
All five patients were taking 
immunosuppressive medication 
(azathioprine and steroids). Three 
patients also received rabbit antithymus 
serum. Alcohol ingestion or 
cholelithiasis did not play any 
causative role in the pancreatitis, 
which began between 7 days and 
13 months after renal transplantation. 
The delay from the time of admission 
for pancreatitis to surgical exploration 
was a mean of 17 days. Operative 
findings included pancreatic necrosis, 
hemorrhage and abscess formation.
All five patients died of the 
complications of necrotizing 
pancreatitis — persistent sepsis, 
respiratory and renal failure, upper 
gastrointestinal bleeding and 
disseminated intravascular coagulation.
This review demonstrates that 
prolonged conservative therapy in 
renal transplant patients with 
necrotizing pancreatitis is associated 
with high mortality. The authors 
believe that earlier surgical intervention 
will lead to increased survival.
Une pancreatite necrosante aigue 
est apparue chez 5 de 405 patients 
qui avaient subi une greffe renale.
Les cinq malades recevaient des 
immunosuppresseurs (azathioprine et 
steroi'des). Trois patients recevaient 
aussi du serum de lapin a activite 
anti-thymique. L'ingestion d'alcool ou
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une cholelithiase n'ont joue aucun 
role etiologique dans I'apparition de 
la pancreatite qui est survenue 
de 7 jours a 13 mois apres la 
transplantation renale. Le delai moyen 
ecoule entre I'admission pour 
pancreatite et I'exploration chirurgicale 
a ete de 17 jours. A I'operation, les 
constatations comprenaient necrose 
pancreatique, hemorragie et formation 
d'abces. Les cinq patients sont 
morts des complications de la 
pancreatite necrosante — infection 
persistante, insuffisance renale et 
respiratoire, saignements des voies 
gastro-intestinales superieures et 
congulation intravasculaire disseminee.
Cette revue demontre qu'un 
traitement conservateur prolonge 
chez les greffes du rein atteints de 
pancreatite necrosante est accompagne 
d'une forte mortalite. Les auteurs 
croient qu'une intervention chirurgicale 
plus precoce pourrait ameliorer 
la survie.
Acute necrotizing pancreatitis is an 
uncommon complication of renal 
transplantation, occurring in less than 
2% of cases.1 The overall mortality 
is more than 70%. We have reviewed 
our experience at the Toronto West­
ern Hospital and report on five renal 
transplant patients who had acute 
necrotizing pancreatitis.
Patients
Between July 1967 and November 
1981. 405 patients underwent renal 
transplantation. Seven patients suf­
fered from pancreatitis postoperative- 
ly. In two the pancreatitis was mild 
with abdominal pain and elevated se­
rum amylase levels and resolved with­
in 3 days. The other five patients had 
acute necrotizing pancreatitis and the 
course of the disease in each case is 
described below.
Case 1
A 49-year-old man had chronic renal
failure due to focal glomerulonephritis. 
For 2 years he was maintained on hemo­dialysis. Then he underwent renal trans­plantation from a cadaver donor. Immu­nosuppression consisted of steroids, aza­thioprine and rabbit antithymus serum. Forty-eight hours later pyrexia and severe abdominal pain developed and the serum amylase level increased to more than 600 IU (normal 0 to 150 IU). The patient continued to deteriorate and hypotension and respiratory insufficiency developed. Seven days after transplantation he un­derwent exploratory laparotomy. Necro­tizing pancreatitis and gangrene of the distal ileum and right colon were found. The necrotic ileum and colon were re­sected, an ileostomy was created and the peripancreatic area was drained. The patient died 1 month after transplanta­tion, of persistent sepsis and multiple organ failure.
Case 2
A 33-year-old man had renal failure due to progressive membranous glome­rulonephritis. He was placed on hemo­dialysis and subsequently underwent re­nal transplantation. Immunosuppression consisted of steroids and azathioprine. Four months later he was admitted to hospital with abdominal pain and jaun­dice. The serum amylase level was great­er than 600 IU. Management consisted of intravenous therapy, nasogastric suc­tion and administration of antibiotics. The patient slowly improved, but 6 weeks later abdominal pain and jaundice returned; respiratory insufficiency and a temperature pattern of sepsis developed. When abdominal exploration was carried out. diffuse necrotizing pancreatitis was found. The peripancreatic space was drained and supportive therapy provided but the patient died.
Case 3
A 63-year-old man suffered from chronic renal failure due to polycystic kidney disease. He underwent bilateral nephrectomy and was maintained on hemodialysis until he received a cadaver kidney transplant. Immunosuppression consisted of steroids, azathioprine and rabbit antithymus serum. One year later, he was admitted with upper abdominal
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pain and fever. The serum amylase level 
was 400 1U. Computerized tomography 
showed that he had pancreatitis and a 
right nephric space abscess. Percutaneous 
drainage of the abscess was unsuccessful. 
The elevated serum amylase level and 
spiking fever persisted, respiratory 
insufficiency developed and 11 days 
after admission exploration was carried 
out. Necrotizing pancreatitis and a right 
nephric space abscess were found. The 
abscess was evacuated and the peripan- 
creatic space was extensively drained. 
Despite re-exploration for a perforated 
colon and vigorous systemic therapy, in­
cluding administration of Trasylol, the 
patient’s course was continuously down­
hill and he died 14 days after the initial 
laparotomy.
Case 4
A 54-year-old woman had renal fail­
ure due to chronic pyelonephritis. She 
was placed on hemodialysis until she 
received a cadaver renal transplant. Im­
munosuppression consisted of steroids 
and azathioprine. Six weeks after trans­
plantation, abdominal pain, jaundice, per­
sistent fever and elevated serum amylase 
level developed. This clinical picture 
persisted and 3 weeks after the initial 
episode of pancreatitis, laparotomy was 
performed. Diffuse necrotizing pancrea­
titis was found and extensive retroperi­
toneal drainage was carried out. Disse­
minated intravascular coagulation and 
acute respiratory distress syndrome de­
veloped and she died.
Case 5
In a 44-year-old man, chronic end- 
stage renal disease secondary to mem- 
branoproliferative glomerulonephritis de­
veloped. He was on hemodialysis for 
8 months and then received a kidney 
from his brother. Immunosuppression 
consisted of steroids, azathioprine and 
rabbit antithymus serum. An acute ab­
domen developed 14 weeks after trans­
plantation and his serum amylase level 
was 650 IU. Antibiotics and hyperali­
mentation were given. Three weeks later, 
exploration revealed extensive necro­
tizing pancreatitis, and, in spite of vigor­
ous supportive management, he died.
Discussion
Necrotizing pancreatitis is a serious 
complication in the patient who has 
received a renal transplant. In 1964, 
Starzl and associates2 reported five 
cases of pancreatitis; three died and 
in one case, necrotizing pancreatitis 
was the main cause of death. In 1966, 
Tilney and associates3 described two 
renal transplant patients who had 
hemorrhagic pancreatitis. One patient 
had pancreatitis 11 months after 
transplantation. Vigorous conservative 
therapy was instituted. When sudden 
deterioration 10 days later necessi­
tated laparotomy, acute hemorrhagic
pancreatitis was found. Progressive 
sepsis led to death. In the second pa­
tient pancreatitis developed 9 months 
after transplantation. The patient died 
1 week later. Autopsy revealed 
marked necrosis of the pancreas. In 
1968, Penn and colleagues4 reported 
one patient with pancreatic abscess 3 
months after transplantation. Re­
peated drainage led to eventual re­
covery.
In 1970, Johnson and Nabseth5 
reported a patient who had fatal nec­
rotizing pancreatitis months after 
renal transplantation. Review of the 
literature at that time revealed 23 
cases of acute pancreatitis; 12 of 
the 23 patients died. Since then, there 
have been many reports of pancreati­
tis associated with renal transplanta­
tion. Renning and associates6 reported 
5 patients, all of whom died, Penn 
and associates7 reported on 10 pa­
tients with only 1 survivor, Corrodi 
and associates8 reported 3 patients 
with 1 survivor, Fernandez and 
Rosenberg9 reported 2 patients, both 
of whom died, and Taft and asso­
ciates10 described 6 patients of whom 
4 died of severe necrotizing pancrea­
titis.
The etiology of pancreatitis in pa­
tients who receive a renal transplant 
remains obscure. Operation, renal 
failure, immunosuppressive medica­
tion, alcoholism, cholelithiasis and 
infective agents all play a role. Post­
operative pancreatitis is a well-recog­
nized entity. Although pancreatitis 
occurs most commonly after gastric 
resection or biliary tract explora­
tion,1113 it can also develop after sur­
gery distant from the pancreas (coro­
nary artery bypass, abdominoperineal 
resection, herniorrhaphy).14 In all these 
patients, pancreatitis usually develops 
within 10 days of operation and is 
almost always of the necrotizing hem­
orrhagic type with high mortality. The 
etiology of postoperative pancreatitis 
in patients who have had biliary tract 
or gastric surgery is related to mani­
pulation around the head of the pan­
creas leading to reflux of duodenal 
contents into the pancreatic duct.15 
Our case 1 falls into the category of 
postoperative pancreatitis.
Renal failure is also associated with 
pancreatitis. Robinson and col­
leagues16 reported four patients with 
chronic stable renal failure who had 
the clinical and biochemical features 
of pancreatitis. All four died. Hyper­
parathyroidism is commonly asso­
ciated with uremia and the hypercal­
cemia resulting from hyperparathy­
roidism probably led to pancreatitis 
in these four patients.
The intensive immunosuppressive 
regimen in renal transplant patients 
is the most likely explanation for pan­
creatitis in this group. It is well rec­
ognized that steroids may cause 
pancreatitis. In 1956, Stumpf and 
associates17 and Bencosme and Laza­
rus18 reported pancreatitis in rabbits 
given cortisone. In an autopsy review 
by Carone and Liebow19 of 54 patients 
treated with corticotropin or adrenal 
steroids, 16 had histologic evidence of 
acute pancreatitis. Following this re­
port, sporadic cases appeared attribut­
ing pancreatitis to steroid therapy.20'22 
In 1961 Nelp23 reviewed the literature 
and presented six cases of acute pan­
creatitis associated with the adminis­
tration of steroids. In most cases, the 
pancreatitis was severe with high 
mortality. The mechanism is probably 
related to alterations in pancreatic 
secretion in patients receiving ste­
roids.24
Azathioprine can also cause pan­
creatitis. Hume25 first documented the 
role of azathioprine in acute pancrea­
titis after renal transplantation. 
Nogueira and Freedman,26 Kawanishi 
and colleagues,27 Paloyan and asso­
ciates28 and Huizenga and associates29 
each presented patients with inflam­
matory bowel disease who were taking 
azathioprine. All had acute pancrea­
titis which resolved when the drug 
was withdrawn. The clinical picture 
recurred after challenge with azathio­
prine. Rapid improvement after cessa­
tion of azathioprine and abrupt recur­
rence after rechallenge with a single 
dose suggests a hypersensitivity reac­
tion. Infectious agents can also play a 
role in the pathogenesis of pancreati­
tis.30,31 Viral infections such as 
mumps, especially during septicemia, 
can cause pancreatitis. These cases 
are usually mild and resolve when the 
infection is controlled. Under condi­
tions of immunosuppression, the pan­
creas can become infected with vi­
ruses. Tilney and associates3 and Van 
Geertruyden and Toussaint32 cultured 
cytomegalic inclusion viruses from the 
pancreas of patients with pancreatitis. 
These inclusion bodies have also been 
found in pancreatic cells of patients 
without histologic evidence of pan­
creatitis.8
Alcoholism and cholelithiasis or 
choledocholithiasis are common 
causes of pancreatitis. In none of the 
five patients described in this report 
was there any evidence of any of 
these conditions.
The management of acute hemor­
rhagic necrotizing pancreatitis in the 
nontransplant atient is controversial. 
Most would accept that vigorous con-
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servative therapy should be the initial 
approach. The contentious aspect is 
the role of surgery. In the early part 
of the century, various authors sug­
gested early operation,33,34 but this 
concept fell into disrepute when sev­
eral reports were published indicating 
that the conservative rather than the 
surgical approach to acute pancreatitis 
resulted in decreased morbidity and 
mortality.35,36 In the late 1960s the 
pendulum began to swing towards ear­
lier operation specifically to prevent 
deterioration in critically ill pa­
tients.37,38
Many recent reports have com­
pared early operation and conserva­
tive management in patients with 
acute hemorrhagic pancreatitis. Jordan 
and Spjut14 discussed 37 patients with 
hemorrhagic pancreatitis. Sixteen pa­
tients who underwent medical therapy 
all died of the complications of pan­
creatitis. Of 21 patients who under­
went operation for pancreatitis, 9 
survived. Frey39 reported 68 patients 
with pancreatitis. Of 16 who under­
went operation, 6 survived while all 
52 patients who did not, died. Other 
reports have stressed the importance 
of early operation. Warshaw and as­
sociates40 described 38 patients with 
acute necrotizing pancreatitis who 
underwent early operation; 25 sur­
vived. White and Heimbach41 de­
scribed 30 patients with hemorrhagic 
pancreatitis who underwent early 
operation because medical therapy 
failed. Twenty-four of the 30 patients 
180%) survived.
The important concept that should 
be stressed in cases of necrotizing 
pancreatitis is that early operation in 
critically ill patients will lead to in­
creased survival. The difficulty here is 
to identify certain prognostic features 
that will select the high-risk patient 
who will benefit from early operation. 
Jacobs and associates42 in a retrospec­
tive study of 519 cases of acute pan­
creatitis found that sepsis, respiratory 
insufficiency and renal failure were 
poor prognostic signs and led to 
notable mortality.
In the five patients presented in 
this report the mean delay between 
admission for pancreatitis and sur­
gical exploration was 17 days. Con­
servative therapy was prolonged in 
spite of the fact that sepsis, decreased 
renal function and respiratory insuf­
ficiency were present in all five pa­
tients. Operation was considered too 
risky in these critically ill patients on 
maximum immunosuppression. This 
policy of prolonged conservative man­
agement was undoubtedly a major 
factor in the 100% mortality.
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Clinical Applications of Biomaterials
The 33rd Consensus Development 
Conference, on clinical applications of 
biomaterials, will be held at the Na­
tional Institutes of Health in Bethesda, 
Maryland, November 1-3, 1982.
This open forum will assess the 
value of currently used tests for com- 
patability and short- and long-term 
performance of biomaterials, consider 
the ways by which biomaterials are 
introduced into clinical care and de­
termine whether currently used bio­
materials fulfill the needs of the clini­
cian.
Consensus Conferences of the Na­
tional Institutes of H ealth  bring 
together biomedical investigators, prac­
tising physicians, consumers and re­
presentatives of public interest groups 
to provide a scientific assessment of 
drugs, device* a n d  procedures, and to 
evaluate their safety and effectiveness.
For registrjtion or further informa­
tion contact John W. Boretos, Building 
13, Rm. 3Wl3, National Institutes of 
Health, BethfMa, Md. 20205.
continued on page 563
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Because “biphasic infection” 
threatens to complicate surgery 
of the large bowel...
control sepsis with
an antibiotic to arrest primary 
gram-negative aerobic infection 
in combination with
Product Monograph available on request.
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Adenocarcinoma of the Appendix
B asil B aeta, m d , frcs[c],* W illiam  H . B arnes, m d , f r c s [c]* a n d  D J .  D esa , m d |
The experience in Hamilton, Ontario, 
with adenocarcinoma of the appendix, 
between 1974 and 1980, is re­
viewed and the findings are 
compared with those of a previous 
report from Hamilton. There were 
seven patients (five men and two 
women) in the current series. The 
average age was 55.6 years. The 
unusual presenting signs and symp­
toms of this tumour are noted; the 
diagnosis is rarely made preoperatively. 
This tumour often cannot be disting­
uished from cecal or ileal malignant 
tumours. Detailed histologic exa­
mination of all specimens is essential 
to identify epithelial types and to 
plan treatment. While appendectomy 
alone may suffice for tumours 
confined to the appendiceal mucosa, 
radical right hemicolectomy is still 
the standard therapy. The authors' 
study shows no improvement 
in preoperative diagnosis, or in 
prognosis, over the earlier report.
The authors recommend (a) 
that this condition be considered 
in the diagnosis of any appendiceal 
mass that is not obviously inflamma­
tory, and (b) the frequent use of 
frozen-section examination to confirm 
the diagnosis.
L'ensemble des cas d'adeno- 
carcinome de I’appendice 
traites a Hamilton, Ontario, 
entre 1974 et 1980 est passe 
en revue, et les constatations 
sont comparees a celles d'un rapport 
prealable emanant de Hamilton.
Sept patients (cinq hommes et 
deux femmes) constituent la presente 
serie. Leur age moyen etait 
de 55.6 ans. Les signes et 
symptomes inhabituels de cette 
tumeur apparaissant a la consultation 
sont notes; le diagnostic est 
rarement pose en preoperatoire.
Cette tumeur, souvent, ne peut etre 
distinguee des tumeurs malignes 
du caecum ou de I’ileon. Un examen 
histologique detaille de tous 
les prelevements est essentiel pour
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identifier les types epitheliaux et 
pour planifier le traitement.
Alors que I’appendicectomie 
seule peut etre suffisante dans 
les cas de tumeurs confinees a la 
muqueuse appendiculaire, 
I'hemicolectomie droite radicale 
demeure le traitement standard. 
Comparativement au rapport prealable, 
I'etude des auteurs ne revele 
aucune amelioration quant au 
diagnostic preoperatoire ou au 
pronostic. Les auteurs recommandent 
a) que cette affection soit 
envisagee dans le diagnostic 
de toute masse appendiculaire qui 
n'est pas manifestement 
inflammatoire et b) le recours 
frequent a I'examen des coupes 
en congelation pour confirmer 
le diagnostic.
While adenocarcinoma of the colon 
is a common tumour, primary adeno­
carcinoma of the appendix is unusual. 
Uihlein and McDonald1 reported 144 
tumours of the appendix at the Mayo 
Clinic from 1910 to 1943 of which 
88.2% were carcinoid, 8.3% malig­
nant mucocele and 3.5% adenocarci­
noma. Collins2 found 41 cases of ap­
pendiceal tumours in 50 000 specimens 
(0.08%).
An unusual presentation of this 
tumour prompted us to review the 
Hamilton experience and the Eng­
lish literature. Our study included all 
patients presenting with adenocarci­
noma of the appendix (exclusive of 
carcinoid) in the Hamilton area from 
Jan. 1, 1974 to Dec. 31, 1980. Qizil- 
bash3 documented the Hamilton ex­
perience up to 1974 and our study 
did not include any patients pre­
viously reported by him.
The seven cases of adenocarcinoma
FIG. 1— Cross-section of appendix, 
showing mucinous deposits.
of the appendix came from four of 
the six participating hospitals in 
Hamilton: Hamilton Cancer Clinic
four patients, and McMaster Univer­
sity Medical Centre, St. Joseph’s 
Hospital and Chedoke Hospital one 
patient each.
Five of the seven patients were men. 
The average age was 55.6 years.
The case histories of these seven 
patients are outlined briefly below:
Case Reports
Case 1
A 63-year-old man underwent modi­
fied right hemicolectomy for small bowel 
obstruction caused by a mass in the walls 
of the cecum and ileum. Dissection of 
the cecal mass showed a tubular appendix 
filled with glairy mucus with a grossly 
thickened, sclerotic wall, continuous with 
cecum (Figs. 1 and 2). The appendix 
was infiltrated by a well-differentiated 
adenocarcinoma with abundant mucin 
production and small colloid lakes of 
colonic type. There was invasion of the 
ileum. No primary cecal mucosal ab­
normality was noted.
This patient was alive and well 9 
months after operation.
Case 2
This 48-year-old man with acute ap­
pendicitis underwent appendectomy, then 
10 days later a right hemicolectomy. 
The appendix was found to contain prim­
ary mucoid adenocarcinoma. Ileocolic 
lymph nodes also contained tumour.
Three years later he suffered a pa­
thologic fracture of T10 for which he 
received radiotherapy. Otherwise he is 
well, at the time of writing.
Case 3
Roentgenography after a barium ene­
ma in a 51-year-old man showed a cecal 
mass, diagnosed as carcinoma of the 
cecum. He underwent a right hemi-
FIG. 2— Photomicrograph of appendix, 
showing well-differentiated adenocarcino­
ma (periodic acid-Schiff, reduced by 
67% from X30).
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colectomy. A moderately well-differen­
tiated adenocarcinoma of the appendix 
with pericolic abscess was found. The 
lymph nodes also contained tumour 
cells.
Twenty months after operation the 
tumour recurred, associated with bowel 
obstruction. The involved bowel was re­
sected. but 6 months later bowel ob­
struction recurred and he died shortly 
thereafter.
Case 4
An inflammatory mass in the right 
lower quadrant of a 58-year-old man 
was managed by incision and drainage. 
Two months later laparotomy was per­
formed. An unresectable mucin-secreting 
adenocarcinoma was found. The patient 
died 8 months after operation and no 
autopsy was performed.
Case 5
An 85-year-old man underwent ap­
pendectomy for acute appendicitis. A 
well-differentiated polypoid adenocarci­
noma was found that invaded the sub­
mucosa of the appendix. Seven months 
later carcinoma of the bladder was 
treated by radiotherapy. Lung metastases 
then developed for which radiotherapy 
also was given. The patient died 3 years 
after the appendectomy.
Case 6
Right ovarian cancer was diagnosed 
preoperatively in a 44-year-old woman. 
She underwent hysterectomy and bilateral 
salpingo-oophorectomy. One week later 
right hemicolectomy was performed. 
Widely disseminated adenocarcinoma of 
the appendix or cecum was found. She 
received radiotherapy to the pelvis but 
died of metastases 3 months after opera­
tion.
Case 7
This 41-year-old woman had a pre­
operative differential diagnosis of ap­
pendiceal abscess or torsion of the right 
ovary. Appendectomy, which included a 
cuff of cecum, was performed and 1 
month later she underwent right hemi­
colectomy. There was a moderately well- 
differentiated adenocarcinoma in a pre­
existing villous adenoma of the appendix, 
probably confined to the appendiceal 
wall since the lymph nodes contained no 
tumour cells. The patient was alive and 
well 4 years after the operation.
Discussion
Carcinoma of the vermiform ap­
pendix is usually diagnosed only after 
a thorough examination of the re­
sected specimen. It is rarely diag­
nosed preoperatively, because it is 
difficult to separate the signs and 
symptoms of an appendiceal tumour 
from those of the cecum or ileum.4’6 
There are, however, several detailed
reports on the variety of epithelial 
abnormalities of the appendix.1,3,7-11 
The appendix may be the site of hy­
perplastic epithelial lesions, villous 
adenomas and frank carcinomas. The 
carcinomas may be locally invasive, 
with infiltration of adjacent structures 
and may metastasize. Malignant 
change may occur in villous adenomas 
(as we believe happened in our case 
7) and. as in the colon, it is necessary 
to consider the possibility of malignant 
transformation in the other epithelial 
abnormalities.9,11 The problem of mu­
cinous cystadenoma and mucinous 
cystadenocarcinoma has been dis­
cussed by Gibbs11 who showed that 
the former is akin to the villous adeno­
ma, while the latter is a signet-ring, 
colloid carcinoma. Detailed histologic 
examination in all cases of “muco­
cele of appendix” and “pseudomyxo­
ma peritonei” is essential.
Wolff and Ahmed5,6 in 1976, found 
20% of patients with adenomatous 
lesions of the appendix who had an 
associated and quite separate primary 
adenocarcinoma of the colon. A tho­
rough search of the colorectum should 
therefore be carried out when benign 
appendiceal adenomas are found.
The classification of primary epi­
thelial tumours of the appendix set 
forth by Aranha and Reyes7 is useful.
The controversy surrounding the 
terms “mucocele” and “pseudomyxo­
ma peritonei” is well debated else­
where.12,13
The prognosis of adenocarcinoma of 
the appendix correlates with the histol­
ogic differentiation and the degree of 
invasion according to Dukes’ classifi­
cation.14 Didolkar and Fanous15 point­
ed out that perforation of the ap­
pendix in itself does not imply a poor 
prognosis, although perforation at the 
tumour site does adversely affect the 
outcome. The site of location of the 
tumour in the appendix does not af­
fect survival.
Since few centres have a large 
enough series, Andersson and associ­
ates,16 in 1976, collected 39 cases of 
colonic type primary adenocarcinoma 
of the appendix from the literature 
between 1956 and 1973 and added 12 
personal cases. Of the total of 51 
patients, 26 were treated by ap­
pendectomy alone; 12 (46%) sur­
vived 5 years. Right hemicolectomy 
was performed in 25 patients and 15 
(60%) survived 5 years.
It is now standard therapy to per­
form a radical right hemicolectomy 
for adenocarcinoma of the appendix. 
This is done at the first operation if 
the diagnosis is confirmed then or 2 
weeks later if the diagnosis is made
from permanent sections. Appendec­
tomy alone may suffice when the 
tumour is confined to the appendiceal 
mucosa, but each patient should be 
considered individually. The rationale 
for radical right hemicolectomy lies 
in the fact that the lymphatic and 
hematogenous drainage of the ap­
pendix are the same as those of the 
cecum.
The 2-week delay between appen­
dectomy and hemicolectomy is purely 
empirical.
We recommend that adenocarcino­
ma should be considered in the dif­
ferential diagnosis of any appendiceal 
mass that is not obviously inflamma­
tory and that frozen sections be ob­
tained to confirm the diagnosis. The 
question of the primary site of the 
tumour as cecal or appendiceal, is 
unimportant, since the treatment is the 
same. The surgeon must also be ready 
to reoperate should an initial appen­
dectomy reveal an unsuspected appen­
diceal carcinoma.
There has been no documented 
study of the value of adjuvant ther­
apy (chemo- or radiotherapy) in this 
disease.
The Hamilton experience appears 
similar to that of other centres. The 
rarity of this lesion and the need for 
adequate early treatment justifies con­
tinued vigilance.
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Should Prophylactic Antibiotics Be Given 
Perioperatively in Acute Appendicitis without Perforation?
M. Giacomantonio, md,* R. Bortolussi, md, F R C P [c ]f and D.A. Gillis, md, frcs[c]*
The authors question the need to give 
prophylactic antibiotics perioperatively 
in all cases of acute appendicitis 
without perforation to reduce the rate 
of wound infection. A retrospective 
study of 82 patients showed a wound 
infection rate of 4.8%; 3 of 53 patients 
who did not receive antibiotics had 
a wound infection compared with 
t of 29 patients who received 
antibiotics. A prospective double-blind 
clinical trial was performed comparing 
the results of perioperative adminis­
tration of cefamandole and placebo. 
One of 21 patients who received 
the placebo had a wound infection; 
none of the 21 patients given 
cefamandole had infection. Thus, the 
authors conclude that, although reports 
in the literature suggest that 
antibiotics given perioperatively 
decrease the rate of wound infection 
in acute appendicitis without 
perforation, the incidence of such 
infection is too low to warrant routine 
administration. They suggest that 
such antibiotic use be reserved for 
those suspected of having more 
serious disease.
Les auteurs mettent en question la 
necessity d’administrer des anti- 
biotiques en prophylaxie dans la 
periode peroperatoire dans tous les 
cas d’appendicite aigue non perforee 
dans le but de reduire la frequence 
des infections de plaie. Line etude
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retrospective portant sur 82 patients 
a revele un taux d’infection de 
plaie de 4.8%; 3 patients sur 53 qui 
n’avaient pas regu d’antibiotiques 
avaient developpe une infection de 
plaie comparativement a 1 patient 
sur 29 qui avaient repu des 
antibiotiques. Une etude clinique a 
double-insu a ete realisee comparant 
les resultats de ('administration 
peroperatoire de cefamandole au 
placebo. Un patient sur 21 au placebo 
a eu une infection de plaie; aucun 
des 21 patients qui ont recu du 
cefamandole n'a eu d'infection. En 
consequence, les auteurs concluent 
que malgre les publications suggerant 
que les antibiotiques administres dans 
la periode peroperatoire reduisent le 
taux des infections de plaie dans 
les cas d'appendicite aigue non 
perforee, I’incidence de ces infections 
est trop faible pour en justifier 
I'administration systematique. Ils 
suggerent que ces antibiotiques 
devraient etre reserves pour les cas 
oil Ton soupconne une atteinte plus 
serieuse.
Wound infection is an important per­
sisting complication of appendectomy. 
In gangrenous and perforated appen­dicitis wound infection causes serious 
morbidity and every effort is war­
ranted to eliminate this complica­
tion.1"3 Systemic antibiotics given pe­
rioperatively,4 delayed wound closure1 and antibiotics applied directly to the 
abdominal wound5 have all reduced 
the rate of wound infections in per­forated appendicitis.
The problem of wound infections 
in acute appendicitis without perfora­tion is not clearly defined. Some re­
ports6,7 suggest an appreciable infec­
tion rate while others1,8 suggest that
the infection rate is relatively low. As 
a result, some4,6'7 recommend giving 
antibiotics systemically preoperatively 
in all cases of appendicitis, whereas 
others suggest using antibiotics only 
in suspected perforation.1
In an attempt to solve this dilemma, 
we carried out a retrospective review 
of all cases of appendicitis over a 10- 
month period to determine the wound 
infection rate in acute appendicitis without perforation. Further, during 
the latter part of this period, a double­
blind, randomized, prospective trial 
was started to compare the use of 
cefamandole (Mandol) given perioper­
atively with a placebo to determine its 
efficacy in reducing the wound infec­
tion rate in acute appendicitis without 
perforation.
Patients and Methods
All patients in the study were in 
the pediatric age range. The usual 
surgical procedure for acute appendi­
citis without perforation performed at 
our institution is through a muscle­
splitting incision in the right lower 
quadrant, with inversion of the appen­
diceal stump and primary wound 
closure. Antibiotics are not given pre­
operatively unless perforation is sus­
pected.
Wound infection was defined as the 
presence of pus in the wound or 
wound pain, tenderness or erythema 
of sufficient magnitude to interfere 
with the patient’s well-being or to prolong hospital stay. Cases of read­
mission to hospital for wound infec­
tion were also included. This defini­
tion pertained to both the retrospec­
tive and prospective studies.
Patients who at operation had con­
ditions other than acute appendicitis
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without perforation were removed 
from the study.
Retrospective Study
The charts of all 109 patients oper­
ated on with either the pre- or post­
operative diagnosis of appendicitis 
over a 10-month period (February 
1980 to December 1980) were re­
viewed. We noted the pre- and post­
operative diagnosis, whether antibio­
tics were given, the pathologist’s re­
port, the method of wound closure, 
the postoperative course, the presence 
or absence of wound infection, the 
length of hospital stay and the results 
of culture of infected wounds.
Prospective Study
Forty-two patients admitted with 
the diagnosis of acute appendicitis 
without perforation were given one 
dose of either cefamandole (25 mg/kg) 
(21 patients) or a placebo (21 pa­
tients), intramuscularly or intrave­
nously, shortly before operation. If 
an acutely inflamed appendix with no 
perforation was found at operation, 
the same drug (cefamandole or place­
bo) was given immediately postopera- 
tively and again 6 hours later. The 
vials of drug or placebo were pre­
pared by the pharmacy and number- 
coded. The vials were distributed ran­
domly to consecutive patients. No one 
caring for the patients was aware 
which drug had been given. Permis­
sion for entry into the study was first 
obtained from the parent or guardian. 
No patient allergic to cephalosporins 
or penicillin was included in the trial.
Results
Retrospective Study
Of the 109 charts reviewed only 82 
patients had a postoperative diagnosis 
of acute appendicitis without perfora­
tion; 21 had a perforated appendix, 
5 had a normal appendix and 1 had 
primary peritonitis. Twenty-nine pa­
tients received antibiotics and 53 did 
not. No drains were used and all 
wounds were closed primarily.
There was one (3.4%) wound in­
fection in the group of patients given 
antibiotics and three (5.6%) in the 
nonantibiotic group. The overall 
wound infection rate was 4.8%.
The organisms grown from the 
wound infections were usually a mix­
ture of enteric organisms. No unusual 
pathogens were identified.
The length of hospital stay aver­
aged 4.3 days for patients who had 
no wound infection or other com­
plication and 11.3 days for patients 
with wound infection postoperatively.
There were two cases of pelvic ab­
scess postoperatively, but there was 
no death or other serious sequelae of 
infection.
Prospective Study
There were no wound infections in 
the 21 patients given cefamandole and 
only one infection in the group given 
placebo. The organisms grown were 
also a mixed enteric flora, primarily 
Escherichia coli. There were no im­
portant complications or untoward ef­
fects of either cefamandole or the 
placebo.
Discussion
The reported wound infection rate 
in acute appendicitis without perfora­
tion ranges from less than 3%5 to 
29%.4 These differences are difficult 
to explain. Nevertheless, depending 
upon individual experience with 
wound infection, the need for peri­
operative antibiotic prophylaxis will 
vary. It is possible that a reason for 
the discrepancy lies in the definition 
of wound infection. The rate of in­
fection will be less if only those cases 
with frank pus are included. We be­
lieve that the definition of infection 
should include only those wounds 
that did produce frank pus or inter­
fered with the patient’s well-being or 
time of discharge because of pain or 
tenderness.
Cefamandole was chosen as the 
study drug in our prospective trial 
because cephalosporins have already 
been shown to be effective in decreas­
ing wound infections in appendicitis;6,9 
cefamandole is effective against most 
gram-negative bacteria,10 has been 
used effectively in peritonitis11 and 
has been found safe for use in chil­
dren.12
The number of patients included in 
the prospective trial (42) is small and 
the results are not statistically signif­
icant. However, the rate of wound 
infection was very low (2%). The 
wound infection rate noted in our 
retrospective analysis was also rela­
tively low (4.8% overall and 5.6% in 
those not given antibiotics). These 
data, along with the results of other 
studies1’5’8 showing a low wound in­
fection rate in acute appendicitis with­
out perforation, suggested that con­
tinuing the prospective study would 
not be practical. Several hundred pa­
tients would be required if a statis­
tically significant decrease in wound 
infections with cefamandole was to be 
shown and, even if this proved to be 
the case, we believed that adminis­
tration of antibiotics to all patients
with suspected acute appendicitis 
without perforation would not be jus­
tified in view of the low infection 
rate without antibiotics. It is unrealis­
tic to assume the infection rate could 
be reduced to zero.
The diagnosis of perforated appen­
dicitis can be made in the majority 
of cases by careful clinical assessment 
and the leukocyte count.1,3 Although 
the wound infection rate in acute ap­
pendicitis without perforation may be 
lowered with perioperative adminis­
tration of antibiotics, the low infec­
tion rate associated with no antibiotics 
does not warrant their use in all pa­
tients. If the clinical impression at the 
time of diagnosis suggests more seri­
ous disease such as a gangrenous or 
perforated appendix, appropriate pre­
operative antibiotic coverage is war­
ranted.
We thank the surgical, house and 
nursing staffs of the Izaak Walton Killam 
Hospital for Children, Ms. S.K. Bell 
from the pharmacy. Dr. A.J. Wort and 
the department of diagnostic micro­
biology for their assistance. Apprecia­
tion is also expressed to Eli Lilly and 
Co. (Canada) Ltd. for their help with the 
prospective study.
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Cefamandole in Gastroduodenal Surgery: a Controlled, 
Prospective, Randomized, Double-Blind Study
R.T. Lewis, mb, frcs[c], facs,* 
B. Marien, md, frcs[c] , | M.
Acceptance of the value of antibiotic 
prophylaxis in gastroduodenal surgery 
is growing, but only one controlled, 
double-blind study justifying this is 
available. In this second, controlled, 
randomized, double-blind study 
60 patients underwent urgent and 
elective gastroduodenal operations. 
Among 32 patients receiving 
cefamandole perioperatively for 
prophylaxis, only 1 subsequently had 
a wound infection, but wound 
infections occurred in 8 of the 
28 patients who received a placebo 
(P <  0.01). Infection rates were 
higher in contaminated wounds and 
in urgent operations than in 
clean-contaminated wounds and 
elective surgery. The results confirm 
the value of antibiotic prophylaxis 
in this setting.
La valeur de ('utilisation prophylactique 
des antibiotiques en chirurgie 
gastro-duodenale est de plus en plus 
acceptee; toutefois il existe une 
seule etude controlee a double-insu 
en demontrant le bien fonde. Dans 
cette deuxieme etude controlee, 
randomisee, a double-insu, 60 patients 
ont subi des operations gastro- 
duodenales urgentes ou non urgente. 
Parmi les 32 patients qui ont repu 
en peroperatoire de la cefamandole 
en prophylaxie, 1 seul a par la suite 
developpe une infection de plaie 
alors que de telles infections sont 
survenues chez 8 des 28 patients 
qui ont requ du placebo (P <  0.01).
Les taux d'infection etaient plus
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eleves dans les cas de plaies 
contaminees et dans les operations 
d’urgence que dans les plaies non 
souillees et les interventions non 
urgentes. Ces resultats confirment 
I'utilite prophylactique des antibiotiques 
dans ce type d’operation.
Although several workers1'* have 
shown that antibiotics given prophy- 
lactically are of value in gastroduode­
nal surgery, there is still considerable 
doubt of their precise worth.5 This is 
probably because, until recently, most 
evaluations of antibiotic prophylaxis 
have shown serious defects in design. 
In a critical review of 131 articles, 
reporting clinical trials of systemic 
antibiotic prophylaxis from 1960 to 
1976, Chodak and Plaut6 found only 
6 that generated evaluable data, and 
could draw no conclusions on the 
value of antibiotic prophylaxis in gas­
troduodenal surgery. Up to Septem­
ber 1979, Hirschmann and Inui7 could 
find only one study that examined 
antibiotic prophylaxis in gastroduo­
denal operations in a prospective, con­
trolled, randomized, double-blind 
fashion, with explicit criteria for se­
lection of patients and outcomes and 
with statistical analysis of data. We 
therefore set up a rigid protocol at 
the Queen Elizabeth Hospital in 
Montreal, in September 1977, to de­
termine the value of the second-gen­
eration cephalosporin, cefamandole, in 
patients who were to undergo gastro­
duodenal operations.
Patients and Methods
All patients scheduled to undergo 
emergency or elective gastroduodenal 
surgery for peptic ulcer disease, tu­
mours or gastroduodenal bleeding 
were considered candidates for this 
study. Patients were excluded if in­
formed consent was refused, if they 
had received antibiotics in the preced­
ing 2 weeks or if they were allergic 
to penicillin. Those included were 
then randomly assigned to receive 
cefamandole intravenously in the peri­
operative period or an identically 
packaged placebo, 2 g 1 hour before 
operation, 2 g when called to the 
operating room and 2 g 5 hours after 
operation. The antibiotic and placebo
had previously been prepared, and 
randomized using standard statistical 
tables (Eli Lilly & Company [Canada] 
Ltd., Scarborough, Ont.). Upon com­
pletion of the study, the code retained 
by the hospital pharmacy was broken 
and the identity of the assignments 
was then revealed.
For each patient, the blood hemo­
globin level, leukocyte and differential 
counts and blood urea nitrogen and 
serum creatinine values were deter­
mined preoperatively, on the second 
postoperative day and thereafter as 
indicated. Serum bilirubin and alka­
line phosphatase levels were deter­
mined sporadically. At operation, the 
degree of wound contamination was 
noted8 and specimens were obtained 
for culture from the stomach contents 
and from the subcutaneous tissues of 
the wound before closure. The wound 
was routinely inspected by infection 
control personnel 5 and 7 days after 
operation. A wound infection was 
diagnosed when pus drained from the 
wound;9 a specimen of the pus 
was then obtained for culture. Red, 
tender or indurated wounds were fol­
lowed until these signs resolved spon­
taneously (uninfected) or the wound 
drained pus. A further follow-up re­
port on the wound was obtained from 
the patient’s surgeon 1 month after 
operation. Nonspecific postoperative 
pulmonary and urinary tract infec­
tions were diagnosed by clinical find­
ings with the aid of chest roentgeno­
grams, sputum culture or urine cul­
ture as indicated. For each patient, the 
age, sex, weight, height, duration of 
preoperative stay, operative diagnosis, 
operative procedure, assigned low- or 
high-risk category for postoperative 
infection10 and duration of operation 
were noted. A risk index of postoper­
ative infection was calculated as sug­
gested by Davidson and colleagues.11 
Ideal body weight for height was de­
termined from tables12 and the per­
centage actual body weight of the 
ideal was calculated. Statistical evalu­
ation was carried out where indicated 
by Student’s r-test and by x2 analysis.
Results
Sixty patients completed the proto­
col. When the code was broken, 32
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had received cefamandole and 28 the 
placebo. The groups were evenly 
matched for age, sex, weight, pre­
operative blood lymphocyte count and 
Davidson risk index (Table I); for 
operative diagnosis and risk of post­
operative infection according to in­
dications for operation (Table II) and 
for urgency of surgery, operative pro­
cedure and degree of wound conta­
mination (Table III).
Wound infections occurred in eight 
patients who received the placebo, but 
in only one patient in the cefamandole 
group (P < 0.01). The wound infec­
tion in the cefamandole group was 
due to Staphylococcus pyogenes, while 
the infections in the placebo group 
were caused by S. pyogenes in one 
patient, Staphylococcus epidermidis 
in another, coliform organisms in four 
patients, and streptococci in two. In 
six of the nine patients with wound 
infections, similar organisms had been 
grown from the stomach contents 
(Table IV). The development of sepsis 
postoperatively was related to the po­
tential degree of wound contamina­
tion and to the urgency of operation; 
no association was observed between 
postoperative infection and the weight 
of the patient, the preoperative blood 
lymphocyte count or Davidson risk 
index (Table V). Postoperative respi­
ratory infections occurred in three 
patients who received cefamandole 
and in seven who received the placebo 
(P >  0.1); urinary tract infections 
were found in only two patients in 
the cefamandole group, but in eight 
patients in the placebo group (P < 
0.02). No complications due to the 
use of cefamandole were recognized.
Discussion
Continuing doubts about the value 
of antibiotic prophylaxis in gastroduo­
denal surgery are justified by the fact 
that only in one study, by Polk and 
Lopez-Mayor,1 were stringent criteria 
for inclusion and critical evaluation 
followed.7 The present, controlled, 
double-blind study examines antibiotic 
prophylaxis in urgent as well as in 
elective gastroduodenal operations and 
confirms their worth. While the total 
numbers are small, the groups studied 
were well matched, exclusions were 
few and the results obtained are of 
statistical significance. The frequency 
of wound infection found in the pa­
tients who received the placebo is 
high, but approximates that previously 
reported.1-4
The dominant factor determining 
the risk of postoperative wound infec­
tion was the degree of contamination. 
In gastroduodenal operations, other 
investigators” have related this to the
extent of bacterial growth in the stom­
ach and to intragastric pH. We did 
not investigate this finding. But now 
that the histamine Hi receptor anta­
gonist, cimetidine, is used widely, it
is unusual to find a low intragastric 
pH even in patients who undergo 
operation for duodenal ulcer and pain 
resistant to medical treatment.14 Or­
ganisms grown from the stomach were
Table 1 - Com parison  o f Patient G roups
Cefam andole Placebo t
Factors (n =  32) (n =  28) value
Age, y r * 57.5 ±  2.5 61.4 +  3.6 0.92
Sex , maleffemale 18114 14114
W eight, actuallideal, % * 105.7 ±  4.5 05.9 +  4.3
Preoperative blood
lym phocytes, m m  3* 1785 ±  153 1504 +  129 1.39
R isk  index. % * 17.3 ±  1.6 17.1 ±  1.9 0.102
'M e a n  ±  standard  deviation.
Table 11 -Com parison  o f Patient G roups -  D ia gn o s is  and R isk  of Infection
D iagnosisJrisk
Cefam andole 
(n =  32)
Placebo 
(n =  28)
D iagnosis
Intractable duodenal ulcer 6 4
Gastric u lcer 4 2
Gastric tum our 9 13
Perforated duodenal ulcer 3 2
Gastric outlet obstruction 5 3
Bleeding peptic ulcer 5 4
R isk  based  on indications 
for surgery
High 24 22
Low 8 6
Table Il l-C o m p a r iso n  o f Patient Groups -  P rocedures and W o un d s
ProcedurefW ound
Cefam andole 
(n =  32)
Placebo 
(n =  28)
Procedure
Em ergency 7 5
Elective 25 23
Gastric resection 23 22
N o  gastric resection 9 6
W ound  classification
Contam inated 7 5
Clean-contam inated 25 23
W ound  infectionlno w oun d  infection 1/31 8/20*
* P  <  0.01.
Table IV - -Bacterio logy -  S tom ach  and Subcutaneous Fat
Bacteriology Cefam andole Placebo
Gastric content
Colrform s* 6 7
Gram -positive cocc it 10 10
B a c t e r o id e s  sp 2 0
C a n d id a  sp 5 4
N o  grow th 9 7
Subcutaneous fat
E s c h e r ic h ia  c o l i  * 1 1
Gram -positive cocc it 6 7
C a n d id a  sp 1 0
N o  grow th 19 16
N ot done 5 4
*  Coliform s =  E s c h e r ic h ia  c o l i  and P r o t e u s , E n te ro b a c t e r ,  K le b s ie l la  organism s, 
t  Gram -positive cocci =  Streptococci, S t a p h y lo c o c c u s  p y o g e n e s ,  S t a p h y lo c o c c u s  e p id e r m id is  and pep-
tostreptococci.
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similar to those responsible for pro­
ducing wound infections. In six pa­
tients, the stomach was clearly the 
source of contaminating organisms; 
one patient with postoperative contact 
dermatitis adjacent to the wound had 
an .S', epidermidis wound infection, 
probably from the skin flora. We 
have previously reported on the 
prevalence of coliform organisms as 
well as normal gram-positive flora of 
the stomach in these wound infec­
tions.4 The present study confirms 
these findings. Because of the small 
number of postoperative infections 
and incomplete data, the statistical 
significance of positive culture of the 
subcutaneous tissues could not be cal­
culated.
The reduced frequency of postoper­
ative urinary tract infections in pa­
tients receiving antibiotics prophylac- 
tically has been reported previously.15 
But since the present study did not 
examine the role of the indwelling 
Foley catheter in the urinary tract 
infections observed, the significance 
of our finding is uncertain.
The choice of cefamandole for pro­
phylaxis was predicated on its , in­
creased spectrum of activity against 
gram-negative organisms, when com­
pared with the activity of the first- 
generation cephalosporins. Since this 
broader spectrum is achieved at the 
expense of efficacy against staphylo­
cocci,16,17 it is of interest that the 
single failure of prophylaxis in the 
cefamandole group was in a patient 
with a staphylococcal infection. The 
first-generation cephalosporin, cefa- 
zolin. is effective against the gram­
negative bacilli that usually cause 
wound infections after gastroduodenal 
operations; it is also more effective 
than cefamandole against staphylococ­
ci and achieves higher serum concen­
trations and better tissue penetration 
than does cefamandole.18 Further, it 
now appears that a single dose of a 
suitable antibiotic may suffice for
prophylaxis.7 Whether a single dose 
of an antibiotic such as cefazolin is 
as effective as multiple doses in pre­
venting postoperative infections in 
elective gastroduodenal surgery re­
mains to be shown.
Conclusions
Patients who undergo elective or 
emergency gastroduodenal operations 
for peptic ulcer disease, tumour or 
gastroduodenal bleeding are at sub­
stantial risk of having postoperative 
wound infection.
The main source of these infections 
is operative contamination from the 
stomach contents.
Cefamandole given intravenously in 
the perioperative period reduces this 
risk of wound infection.
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NOTICES
continued from page 549
Sterling Bunnell Memorial 
Lectureship Program
The Sterling Bunnell Memorial Lec­
tureship was established in 1961 in 
honour of a surgeon who was world- 
renowned for his work in reconstruc­
tive surgery of the hand. Lecturers 
are selected on the basis of significant 
achievement in reconstructive surgery 
of the upper extremity.
On Nov. 4 and 5, 1982 the depart­
ment of orthopaedic surgery, Univer­
sity of California School of Medicine 
at San Francisco will commemorate 
the 100th anniversary of Sterling 
Bunnell’s birth by inviting previous 
guest lecturers to discuss the changes 
in the surgical treatment of the upper 
extremity that have taken place re­
cently. The faculty will include: J.H. 
Boyes, P.R. Lipscomb, L.W. Milford, 
R.G. Pulvertaft and D.C. Riordan.
Subjects to be discussed will in­
clude: soft tissue cover and transplan­
tation of tissue, rheumatoid arthritis, 
tendon ruptures and lacerations, crush 
fractures and dislocations, congenital 
anomalies, nerve lesions, and tendon 
transfers for the paralyzed upper ex­
tremity.
This program is sponsored by Ex­
tended Programs in Medical Educa­
tion, and will meet the criteria for 
ACCME/ AMA/CMA Category 1 
(formal) continuing education credit.
For further information, write: Ex­
tended Programs in Medical Educa­
tion, University of California School 
of Medicine, Rm. 569-U, Third and 
Parnassus, San Francisco, CA 94143, 
or call (415) 666-4251.
Table V - Risk Factors in Postoperative Sepsis
No wound P [t or y 2)
Factor Wound infection infection value
Risk index, % 21.8 ±  3.5 16.4 ±  2.3 0.05 (1.58)*
Weight, actualfideal, % 106 ±  8.2 105.8 +  3.3 NS
Low risklhigh risk9 2/7 12/39 NS
Emergencylelective 415 8/43 0.05 (3.95)*
Resectionlno resection 7/2 36/15 NS (0.19)
Preoperative blood lymphocytes,
mm 3 1694 ±  400 1648 ±  115 NS (0.102)
Contaminated/clean-contaminated 5/6 7/42 0.02 (5.45)*
Organisms in subcutaneous fat:
-  absentlpresent/not done 3/3/3 32/13/6 -
NS =  not significant.
*  =  statistically significant.
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NOW IN STROKE
The Advantages of ENTROPHEN*
To reduce the risk 
of stroke
Now, ENTROPHEN* is 
indicated for reducing the risk 
of recurrent transient ischemic 
attacks or stroke in men who 
have had transient ischemia 
of the brain due to fibrin 
platelet emboli. At present 
there is no evidence that 
ASA is effective in reducing 
transient ischemic attacks 
in women, or is of 
benefit in the treatment 
of completed strokes 
in men or women.
Inhibition of platelet 
cyclooxygenase activity 
by a single dose of 
ENTROPHEN*-10 
was comparable to 
that of plain ASA, 
although the effect was 
delayed, reflecting the 
delayed appearance of 
ASA in the plasma.1
cPlOMt
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USPl To reduce 
the risk of stroke 
with reduced risk 
of stomach upset
with reduced risk 
of stomach upset
When you prescribe 
ASA for long-term use, 
it is important not to create 
additional problems for 
your patients.
While they may benefit 
from the therapeutic 
effect of ASA, there is 
still a potential for 
gastric irritation and 
upset, particularly 
when the regimen calls 
for continuous daily 
dosage.
Clinical experience 
has shown that 
ENTROPHEN*, coated 
with POLYMER 37* 
reduces gastric distress 
in long-term treatment 
with high doses of ASA.
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TABLETS
entrophen*
(acetylsalicylic acid tablets, USP) 
Enteric-coated with POLYMER 37* 
Anti-inflammatory— Analgesic Agent 
Platelet Aggregation Inhibitor 
DESCRIPTION
ENTROPHEN* is an enteric-coated tablet contain­
ing acetylsalicylic acid coated with POLYM ER 37*. 
a partially esterified polyvinyl alcohol.
ACTION
Acetylsalicylic acid (ASA| has analgesic, anti­
pyretic and anti-inflammatory properties.
In rheumatic diseases, although the analgesic and 
antipyretic effects are useful, the major purpose 
for which ASA is used is to reduce the intensity of 
the inflammatory process. Inhibition of prosta­
glandin synthesis may be involved in the anti­
inflammatory action of ASA.
ASA also alters platelet aggregation and release 
reaction by inhibiting prostaglandin synthesis 
Thromboxane A2 is an essential step in platelet 
aggregation. ASA prevents Thromboxane A2 for­
mation by acetylation of platelet cyclooxygenase. 
This inhibition of prostaglandin synthesis is 
irreversible and affects platelet function for the 
life of the platelet.
The POLYMER 37* coating substantially resists 
disintegration in aqueous fluids having a pH lower 
than 3.5 for a period of at least 2 hours and is 
capable of disintegrating in aqueous fluids having 
a pH of at least 5.5 in from 10 to 30 minutes. Thus, 
POLYMER 37* coating effectively inhibits the 
release of ASA in the stomach, whilst allowing the 
tablet to dissolve in the upper portion of the small 
intestine for absorption from the duodenal area. 
Clinical experience has shown that POLYMER 37* 
coated acetylsalicylic acid diminishes or eliminates 
gastric distress during long-term treatment with 
high doses of ASA.
INDICATIONS
ENTROPHEN* is indicated whenever gastric 
intolerance to ASA is of concern.
ENTROPHEN* is indicated for the relief of signs 
and symptoms of the following:
Osteoarthritis 
Rheumatoid arthritis 
Spondylitis 
Bursitis
and other forms of rheumatism
Musculoskeletal disorders
Rheumatic fever, however, penicillin and other
appropriate therapy should be administered
concomitantly.
ASA is generally considered to be the primary 
therapy for most forms of arthritis.
ENTROPHEN* is also indicated for reducing the 
risk of recurrent transient ischemic attacks or 
stroke in men who have had transient ischemia of 
the brain due to fibrin platelet emboli. At present 
there is no evidence that ASA is effective in 
reducing transient ischemic attacks in women, or 
is of benefit in the treatment of completed strokes 
in men or women.
CONTRAINDICATIONS
Sensitivity to the ingredients 
Active peptic ulcer
Patients who had a bronchospastic reaction to 
ASA or non-steroidal anti-inflammatory drugs.
WARNINGS
ASA is one of the most frequent causes of 
accidental poisoning in toddlers and infants. 
ENTROPHEN* should, therefore, be kept well out 
of the reach of all children.
PRECAUTIONS
Salicylates should be administered with caution 
to patients with asthma and other allergic condi­
tions, with a history of gastrointestinal ulcerations, 
with bleeding tendencies, with significant anemia 
or with hypoprothrombinemia.
Salicylates can produce changes in thyroid 
function tests.
Acute hepatitis has been reported rarely in 
patients with systemic lupus erythematosus and 
juvenile rheumatoid arthritis with plasma sali­
cylate concentrations above 25 mg/100 mL
Patients have recovered upon cessation of 
therapy.
Use in Pregnancy
ASA does not appear to have any teratogenic 
effects. ASA has been found to delay parturition 
in rats This effect has also been described with 
non-steroidal anti-inflammatory agents which 
inhibit prostaglandin synthesis.
High doses (3 g daily) of ASA during pregnancy 
may lengthen the gestation and parturition time. 
Because of possible adverse effects on the 
neonate and the potential for increased maternal 
blood loss, ASA should be avoided during the last 
three months of pregnancy.
Drug Interactions
Caution is necessary when ENTROPHEN* 
and anticoagulants are prescribed concurrently, as 
ASA may potentiate the action of anticoagulants. 
Salicylates may potentiate sulfonylurea hypo­
glycemic agents. Large doses of salicylates may 
have a hypoglycemic action, and thus, affect the 
insulin requirements of diabetics.
Although salicylates in large doses are uricosuric 
agents, smaller amounts may depress uric acid 
clearance and thus decrease the uricosuric 
effects of probenecid, sulfinpyrazone and 
phenylbutazone.
Sodium excretion produced by spironolactone 
may be decreased in the presence of salicylates. 
Salicylates also retard the renal elimination of 
methotrexate.
ADVERSE REACTIONS
Gastrointestinal reactions: nausea, vomiting, 
diarrhea, gastrointestinal bleeding and/or ulcera­
tion. Ear reactions: tinnitus, vertigo, hearing loss. 
Hematologic reactions: leukopenia, thrombo­
cytopenia, purpura. Dermatologic and Hypersen­
sitivity reactions: urticaria, angioedema, pruritus, 
various skin eruptions, asthma and anaphylaxis. 
Miscellaneous reactions: acute reversible hepato- 
toxicity, mental confusion, drowsiness, sweating 
and thirst.
SYMPTOMS AND TREATMENT 
OF OVERDOSAGE 
Symptoms
In mild overdosage these may include rapid and 
deep breathing, nausea, vomiting (leading to 
alkalosis), hyperpnea, vertigo, tinnitus, flushing, 
sweating, thirst and tachycardia. (High blood 
levels of ASA lead to acidosis.) Severe cases may 
show fever, hemorrhage, excitement, confusion, 
convulsions or coma, and respiratory failure. 
Treatment
Treatment is essentially symptomatic and sup­
portive. Administer water, universal antidote and 
remove by gastric lavage or emesis. Force fluids 
(e.g., salty broth) to replace sodium loss. If the 
patient is unable to retain fluids orally, the alkalosis 
can be treated by hypertonic saline intravenously. 
If salicylism acidosis is present, sodium bicar­
bonate intravenously is preferred because it 
increases the renal excretion of salicylates. 
Vitamin K is indicated if there is evidence of 
hemorrhage. Hemodialysis has been used with 
success.
Respiratory depression may require artificial 
ventilation with oxygen. Convulsions may best be 
treated by the administration of succinylcholine 
and artificial ventilation with oxygen. Central 
nervous system depressant agents should not 
be used.
Hyperthermia and dehydration are immediate 
threats to life and initial therapy must be directed 
to their correction and to the maintenance of 
adequate renal function. External cooling with 
cool water or alcohol should be provided quickly 
to any child who has a rectal temperature over 
104°F.
DOSAGE AND ADMINISTRATION 
Analgesic; antipyretic
Up to 2.925 g daily as necessary. 
Anti-inflammatory
Because the suppression of inflammation in­
creases with the dose of salicylate even beyond 
the point of toxicity, the therapeutic objective is 
to employ as large a dose as possible short of 
toxicity. Most patients will tolerate blood salicylate 
levels in the range of 20 to 25 mg per cent. The 
most common reason for failing to obtain a 
therapeutic response to ASA is the administration 
of inadequate doses.
The generally accepted way to achieve effective 
anti-inflammatory salicylate blood levels of 20 to 
25 mg per cent is to titrate the dosage by starting 
with 2.6 to 3.9 g daily, according to the size, age 
and sex of the patient. If necessary, the dosage is 
then gradually adjusted by daily increments of 
0.65 g until symptoms of salicylism e.g., auditory 
symptoms, occur. Then, the dosage is decreased 
by 0.65 g daily until these symptoms disappear 
and maintained at that level as long as necessary. 
In adults the median dose at which tinnitus 
develops is 4.5 g per day, but the range extends 
from 2.6 to 6.0 g per day.
Intermittent administration is ineffective. Patients 
should be advised not to vary the dose from day 
to day depending on the level of pain because 
that often fluctuates independently of the intensity 
of the inflammation. A continuous regimen of 
0.65 g four times daily is considered to be 
minimum therapy for adults. ENTROPHEN* 
should be administered four times daily. For night­
time and early morning benefits, the last dose 
should be given at bedtime.
Once m aintenance dose is established, 
ENTROPHEN*-15 may be useful to encourage 
patient compliance.
Optimally, salicylate therapy should be monitored 
by periodic blood salicylate level determinations. 
If this is not practical, the appearance of auditory 
symptoms in the form of tinnitus or deafness are 
acceptable as an indication of the maximum 
tolerated salicylate dose.
There is an inverse relation between blood 
salicylate levels at which auditory symptoms 
appear and the age of the patient. In the young 
adult, this is usually in the range of 20 to 30 mg 
per cent. In children, however, the level may be 
much higher, or the effect apparently absent. 
Because salicylate toxicity may appear without 
such warning in children, the usual practice is to 
give ASA in a daily dose of 50 to 100 mg per 
kilogram of body weight and to follow blood levels 
aiming for a concentration of about 30 mg per cent. 
Rheumatic Fever
A total daily dosage of 100 mg per kilogram of 
body weight administered in divided doses to 
allay the pain, swelling and fever.
Cerebral ischemic attacks (men)
The recommended dosage is 1,300 mg per day 
(650 mg twice a day or 325 mg four times a day).
AVAILABILITY
No. 472— ENTROPHEN*-15 tablets containing 
975 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Oval, pale yellow, film-coated 
tablets with the FROSST name engraved on one 
face and 472 on the other and supplied in bottles 
of 100 and 500.
No. 470— ENTROPHEN*-10 tablets containing 
650 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Oval, orange, film-coated tablets, 
with the FROSST name engraved on one face 
and 470 on the other and supplied in bottles of 
100, 500 and 1,000.
No. 438— ENTROPHEN*-5 tablets containing 
325 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Round, brown, film-coated tablets, 
with the FROSST name engraved on one face 
and 438 on the other and supplied in bottles of 
100, 500 and 1,000
FULL PRODUCT MONOGRAPH AVAILABLE 
ON REQUEST.
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Urolithiasis in Children
S. O’R egan, mb, frcp[c], Y. Homsy, md, frcs[c] and J-G. Mongeau, md, frcp[c]
Between 1971 and 1980, 55 children with 
urolithiasis were assessed and 
treated. Pediatric urolithiasis accounted 
for 1:4090 hospital admissions. Forty 
percent of patients had no identifiable 
predisposition to urolithiasis. Eight 
patients presented with hematuria in 
the absence of renal colic suggesting 
that pediatric urolithiasis, although 
uncommon, is an important cause of 
painless hematuria.
Entre 1971 et 1980, 55 enfants 
souffrant d'urolithiase ont ete 
examines et traites. L'urolithiase 
pediatrique compte pour 1:4090 
hospitalisations. Quarante pourcent 
des malades n'offraient aucune 
predisposition identifiable a l'urolithiase. 
Huit patients ont ete regus alors 
qu’ils presentaient une hematurie 
en I'absence de colique renale, 
suggerant ainsi que bien que rare, 
l'urolithiase pediatrique est une cause 
importante d'hematurie indolore.
In the 19th century, urolithiasis in 
both adults and children was common 
in the West.1 The incidence decreased 
markedly in the early 20th century,2 
and the present low incidence of renal 
stones in children is illustrated by the 
relative paucity of reports in the litera­
ture during the past 30 years.3"12 In 
1951, Lattimer and Hubbard18 found 
no urinary calculi in children in 23 835 
admissions to Babies’ Hospital in New 
York. An incidence of urolithiasis 
ranging from 1 in 10003 pediatric ad­
missions in Britain15 to 1 in 7600 pe­
diatric admissions in the United States9 
has been described. However, a recent 
editorial19 has suggested that pediatric 
urolithiasis is either increasing in in­
cidence or is becoming increasingly 
recognized as a distinct entity. Be­
cause of the varying incidence of pe­
diatric urolithiasis in the US and the 
lack of similar data in Canada, there 
being only one analysis of pediatric
From the departments of pediatrics 
(nephrology division) and surgery 
(urology division), Centre de Recherche 
Pediatrique, Hopital Sainte-Justine, 
Montreal, PQ
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urolithiasis available,16 we have as­
sessed retrospectively the incidence of 
urolithiasis in children admitted to the 
Hopital Sainte-Justine in the decade 
1971 to 1980.
Patients and Methods
From Jan. 1, 1971 to Dec. 31, 1980, 
55 children with proven urinary stones 
were admitted to Hopital Sainte-Jus­
tine in Montreal. Clinical, laboratory 
and other data were analysed and re­
viewed, and the data compared with 
those of other recently published se­
ries.
Findings
The age of the 55 children at the 
time of admission ranged from 13 
months to 19 years (mean 10 years, 
8 months) with a male-to-female ratio 
of 1:1. In analysing the available data 
we classified all 55 cases of urolithias­
is on the basis of possible etiologic 
factors (Table I): nine children in 
group 1 had congenital abnormalities 
that might predispose to stasis, infec­
tion or other factors, which might 
in turn predispose to urolithiasis; 
group 2 consisted of seven patients 
with a metabolic abnormality, either 
congenital or acquired; in group 3
were 10 children with acquired uri­
nary abnormalities or other condi­
tions that would predispose to stone 
formation; group 4 consisted of 29 
children in whom there was no known 
etiologic factor.
The incidence of congenital, meta­
bolic and other identifiable etiologic 
factors was equal in the two sexes and 
accounted for over 47% of all cases 
of urolithiasis. Abdominal pain with 
hematuria, infection, dysuria and 
enuresis were the predominant symp­
toms associated with stone presenta­
tion (Table II). Painless macroscopic 
hematuria occurred in eight patients. 
As expected, the incidence of infection 
was high in all groups, particularly 
those in which there was an identi­
fiable etiologic factor: 7 children in 
group 1, 5 in group 2 and 7 in group
T a b le  I I -P r e s e n t in g  S y m p to m s and Signs
S ym p to m fs ig n
N o . o f 
children
M a c ro s c o p ic  h em aturia , 
pain less 8
A b d o m in a l pain  and  
h em atu ria 22
In fe c tio n 32
D y suria 1
Enuresis 1
T a b le  1 - C lass ification  o f  5 5  C h ildren  w ith  R enal S tones
Group Etio logy
N o . o f 
p a tien ts Boys G irls
1 C ongen ita l 9 5 4
M e g a u re te r 1 1 0
Ectop ic k idney 1 1 0
R e flu x 5 2 3
M e d u lla ry  sponge k idney 2 1 1
2 M e ta b o lic 7 4 3
C ystinuria 2 1 1
O xalosis 1 0 1
C rohn 's  d isease 1 1 0
Fanconi syndrom e  
H and-Schu ller-C hristian
1 0 1
disease
D u ch en n e  m uscular
1 1 0
d ystroph y 1 1 0
3 O th e r  recognizab le  causes  
N e u ro g e n ic  b ladder (due
10 5 5
to  parap legia) 
N e phrocalc inosis  (renal
5 2 3
tubu lar acidosis) 3 2 1
R e cu m b en c y 2 1 1
4 U n k n o w n 29 14 15
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3; 13 of 29 children in group 4 also 
had infection. The predominant organ­
ism was Escherichia coli (21), followed 
by Streptococcus faecalis (15) and Pro­
teus sp. (11 children). Neisseria, Pseudo­
monas and Klebsiella organisms were 
identified in two patients each. There 
was almost equal incidence of stones 
in the right and left kidneys (Table 
III). In four patients there were stones 
in both kidneys. There were six stones 
in the left ureter and three in the right. 
Several patients had recurrent stones. 
Operation was performed on 22 chil­
dren (Table IV). The two with bladder 
stones, one with a neurogenic bladder 
the other with a cystine calcium stone, 
required surgical removal of the stone.
The majority of stones were of the 
idiopathic type, that is without any 
apparent predisposing factor, apart 
from hypercalciuria noted in five 
cases. Many of the stones were small 
so major operative intervention was 
uncommon. It was required mainly 
for those who had large stones asso­
ciated usually with congenital anato­
mic abnormalities. A limited number 
of stones were available for chemical 
analysis, because most in the idiopa­
thic group were exceedingly small and 
many were passed spontaneously out­
side hospital. Of seven stones analysed, 
four contained calcium oxalate and 
two struvite.
Table Ill-Site of Calculi
Site No.
Kidney
Right 18
Left 16
Bilateral 4
Kidney + ureter,
right and left 4
Ureter
Right 3
Left 6
Bilateral 1
Ureter, left +
urethra (multiple) 1
Bladder 2
Table IV-Operative Procedures Performed
Operation No.
Pyelolithotomy 8
Nephrolithotomy 3
Pyelonephrolithotomy 1
Ureterolithotomy 3
Vesicolithotomy 4
Nephrectomy, nephroureterectomy,
heminephrectomy 3
Discussion
This retrospective survey demon­
strates a frequency of urolithiasis in 
children in Quebec of 1 in 4090 pe­
diatric hospital admissions. There was 
no identifiable cause for the condition 
in 53% of the 55 children. The in­
cidence of pediatric urolithiasis in 
previously reported series has ranged 
from 1 in 100015 to none in more than 
21 000 hospital admissions.18 A recent 
survey16 indicated an incidence of 1 in 
1380 hospital admissions in New­
foundland.
In our series, eight patients pre­
sented with macroscopic painless 
hematuria. Iitaka and West20 described 
four patients with this presenting 
symptom, supporting the finding that 
urolithiasis in children may present 
with hematuria in the absence of renal 
colic. However, in these cases, radio- 
logic investigation can usually dif­
ferentiate urolithiasis from other 
causes of painless hematuria such as 
glomerulonephritis or malignant tu­
mour.
Of interest was the high rate of 
infection especially in those with pre­
disposing metabolic factors. More­
over. in children with no definitive 
cause, 45% had associated infection, 
a rate much higher than that pre­
viously reported.5’16 When the stones 
were passed the infection resolved and 
did not recur. The predominant or­
ganism in patients with infection was 
E. coli followed by S. faecalis and 
Proteus sp., which was noted especially 
in patients with associated neurologic 
deficits such as neurogenic bladder. 
In these patients, stones were recur­
rent in spite of efforts to maintain 
urine sterility by prophylactic admi­
nistration of antibiotics.
The incidence of urinary tract ab­
normalities associated with pediatric 
urolithiasis in previously reported se­
ries has ranged from 9% to 
70%.5'6’8-10’12-15 In Newfoundland 18% 
of patients had anatomic abnormali­
ties of the genitourinary tract.16 In our 
series, 14 (25%) had predisposing 
anatomic abnormalities, including con­
genital and acquired ones. In contrast 
to the findings of the Newfoundland 
study, five of our patients had meta­
bolic disorders (cystinuria, oxalosis 
and renal tubular acidosis). The inci­
dence of metabolic disorders asso­
ciated with urolithiasis has ranged 
from 0% to 38% in other series.6’10 
In only 5 of 14 in whom 24-hour uri­
nary calcium was measured was there 
hypercalciuria (i.e., daily excretion of 
calcium greater than 4 mg/kg). None 
of these patients had evidence of hy­
perparathyroidism, in contrast to the
observations of Wenzl and colleagues12 
who noted hyperparathyroidism or 
hyperadrenocorticism in four of five 
hypercalciuric patients. A family his­
tory of urolithiasis was elicited in the 
case of 10 (34%) of the 29 patients 
with idiopathic urolithiasis, a rate 
lower than that noted in other series 
(36% to 44%).10’16
The major concerns in the manage­
ment of urolithiasis in children are 
immediate treatment and prevention of 
recurrence. Obviously stones causing 
obstructive uropathy, or those too 
large to pass spontaneously require 
surgical removal. However, a high 
percentage of stones may be passed 
spontaneously. The major problem is 
preventing recurrence. The recurrence 
rate in children appears lower than in 
adults; it is reported to be between 
16% and 44% :3/1 In patients with 
cystinuric stones, a high fluid intake 
with urinary alkalinization and, if ne­
cessary, penicillamine are required. 
Elimination of stasis, if possible, with 
prophylactic antibiotic therapy may 
aid in preventing recurrence of stones 
in patients with infection-associated 
calculi. Thiazide diuretics may be of 
value in patients with renal-leak hyper­
calciuria. The decision to prescribe 
lifelong thiazide therapy in children 
with documented renal hypercalciuria 
with stone formation is, in the ab­
sence of recurrent stone formation, a 
difficult one because of the side-effects 
of thiazide therapy such as hyper­
uricemia and hyperglycemia. However, 
recently it has been noted that in chil­
dren with hypercalciuria who have 
macroscopic hematuria and are at risk 
of developing stones, the hematuria 
rapidly resolves when they are treated 
with thiazides.21 Despite this observa­
tion the place of thiazide therapy for 
these children is still uncertain.
In summary, urolithiasis in children, 
though not a common phenomenon, 
is extremely variable in its presenta­
tion and thus must be included in the 
differential diagnosis of conditions 
such as acute abdominal pain and 
painless hematuria. Investigations 
should include radiologic study of 
the urinary tract by intravenous 
pyelography and voiding cystogram, 
investigation of possible metabolic 
causes by determination of serum cal­
cium, phosphate, uric acid, electro­
lytes and creatinine levels in addition 
to the 24-hour urine level of calcium, 
uric acid, oxalate and creatinine ex­
cretion for determination of calcium- 
to-creatinine excretion ratio.22 A pro­
file of urinary aminoacid excretion in 
addition to urinalysis will detect cy­
stinuria.
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continued from page 520
bibliography, which has been conve­
niently divided into sections on the basis 
of systems but considers separately the 
neck, the spine and contents, and the 
skeletal system.
Truly an atlas, most pages contain up 
to six illustrations. The figures are not 
quite up to the standard found in jour­
nals of radiology but nevertheless have 
reproduced well on the good quality 
paper. They are clearly labelled with 
letters and small arrows and can be fol­
lowed easily with the text. There is 
minimal use of long lines to the peri­
phery of figures which is so irritating 
in many other atlases. Clear line draw­
ing assist the reader.
There are 14 chapters separated into 
“normal” and “abnormal” for each area; 
only the chapter on the upper extremities 
has no “abnormal” section. However, the 
type of bony and soft tissue abnormal­
ities encountered in the upper limb are 
illustrated in the section on abnormal 
lower extremities. The trunk is treated 
in orderly manner by proceeding caudal- 
ly from neck to pelvis with additional 
chapters on the retroperitoneal compart­
ments and fasciae.
Most of the scans were made on the 
body of a 48-year-old man using an EMI 
5005 machine (320 x  320 matrix). In 
many areas either positive contrast me­
dium or air was injected into tubular 
structures such as arteries, veins and 
biliary system, but one must be careful 
to read the explanation at the beginning 
of each chapter because the contrast 
material used is not uniform.
Films of frozen sections made at the 
same level as the scans appear alongside 
them. Because the development of new 
generations of computerized tomography 
(CT) scanners has been so rapid over 
the past few years the tomograms do
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not show the structures as clearly as is 
now possible although in general they 
are of reasonably good quality.
The abnormal scans demonstrate the 
usefulness of CT and the authors’ com­
ments concerning their own experience 
are an added bonus. An important as­
pect of body CT is the correct manipu­
lation of the window setting to obtain 
both good pictures and diagnosis. This 
is well illustrated by the authors with 
respect to liver metastases and should 
always be considered by anyone review­
ing CT scans. Two pitfalls for the un­
wary, namely pseudodilatation of the 
pancreatic duct caused by a fat plane 
and an unusual configuration of the 
spleen mimicking a tumour of the pan­
creatic tail, are further valuable points. 
An interesting demonstration of the 
intra- and extraperitoneal spaces follow­
ing perforation of the colon with extra­
vasation of barium is afforded by both 
conventional roentgenograms and CT 
scans. Some illustrations of cadaver 
studies showing air in the retroperitoneal 
tissues are also included. One important 
omission is that of normal lung studies. 
The machine settings demonstrate the 
mediastinal anatomy well but a further 
series showing the lung vasculature 
would be helpful.
Rarely is one able to comment posi­
tively on the cost of a good book. For 
US $19.95 in paperback, this atlas is 
extremely good value and will be most 
useful to anyone who uses CT, either 
to the imager as an aid to anatomy and 
pathology or to the clinician as an in­
dication of the potential of the modality.
D.J. M a r t in , m d
Head of ultrasound.
Department of radiology.
The Hospital for Sick Children,
Toronto, Ont.
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stops nausea, helps keep
the patient calm and alert
Indications: nausea and vomiting of various 
etiologies: gastrointestinal disorders, drug 
intolerance, motion and radiation sickness, 
post-operative conditions, pregnancy, vertigo and 
migraines.
Dosage: Adults, oral route -  Usual effective 
dosage is 5 to 10 mg, 3 or 4 times daily; in very 
mild cases, a single dose of 5 to 10 mg is often 
adequate. This dosage may be increased as 
required by increments of 10 mg every 2 or 3 days 
until symptoms are controlled. For maintenance 
therapy the dosage should be reduced to the 
minimum effective dose. Rectal route -  The 
suggested adult dose is 20 to 50 mg daily. 
Children: oral and rectal routes -  up to 10 mg 
per day in divided doses according to body weight. 
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while on therapy. Tardive dyskinesia may occur in 
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encountered. Other side effects due to 
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for complete list, see product monograph. 
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antiemetic may be all it takes 
nausea in the ward
□Anaesthesia □ Surgery 
□ Chemotherapy □ Radiation therapy
Stemetil rapidly controls nausea in 
most hospitalized patients
A single dose of Stemetil usually stops 
nausea in just 30-45 minutes,1 and keeps 
working for up to four hours.
Stemetil helps keep surgical 
patients comfortable and alert
Stemetil does not cause excessive sedation,2 
so vital signs can be taken without delay. The 
mild anxiolytic effect helps keep patients 
calm and co-operative.2 Stemetil is well 
tolerated, and remarkably free from toxic 
side effects.3 4
A  dosage form for every need
Ampoules 2 mL/10 mg (i.m./i.v. inf.) 
Tablets 5 and 10 mg 
Suppositories 5 and 10 mg 
Liquid 5 mg/5 mL
STEMETIL prochlorperazine
stops nausea, helps keep the patient 
calm and alert
RHONEPOULENC PHARMA Inc. 
8580 Esplanade 
Montreal, Quebec 
®authorized user
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Effects of Magnesium Infusions on Magnesium 
and Nitrogen Balance during Parenteral Nutrition
Joel  B. F r e e m a n , m d , frcs[c ], facs, M arion  F. W ittin e , b sc, L ew is D. Stegin k , ph d and
E dward  D. M ason , m d , facs
The effects of magnesium infusions on 
urinary and fecal magnesium excretion, 
serum magnesium and nitrogen balance 
were examined in seven well-nourished 
and three nutritionally depleted 
adult surgical patients receiving total 
parenteral nutrition. They were 
maintained on constant nitrogen and 
caloric intake for 14 ±  2 days. 
Magnesium doses ranged from 0 to 
664 mg/d and were given in varying 
crossover patterns. In both groups, 
urinary magnesium excretion increased 
as the amount of magnesium infused 
increased but, at comparable 
magnesium infusions, depleted patients 
excreted significantly less magnesium. 
Renal conservation was most 
pronounced in well-nourished patients 
on magnesium-free intake and in 
depleted patients given 70 mg 
magnesium daily. Urinary magnesium 
losses were 40 ±  5 mg/d and 
33 ±  8 mg/d, respectively, in these 
two groups. Endogenous fecal 
magnesium excretion was minimal 
and ranged from 2 to 38 mg/d.
At each level of magnesium intake, 
serum levels of well-nourished patients 
were normal. With infusions of less 
than 200 mg/d, serum magnesium 
concentrations in depleted subjects 
averaged 1.6 mg/dl. Reduced urinary 
magnesium excretion as well as 
borderline serum levels measured in 
depleted adults suggest that the 
magnesium dosage should be higher 
than that usually recommended during 
total parenteral nutrition. In both 
groups a positive correlation between 
magnesium and nitrogen balance 
was noted.
Les effets des perfusions de 
magnesium sur l'excretion urinaire et 
fecale du magnesium, la concentration 
serique du magnesium et le bilan 
azote ont ete etudies chez sept
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patients chirurgicaux adultes 
bien nourris et chez trois patients 
souffrant d'une carence nutritionnelle 
et recevant une alimentation 
parenterale totale. Tous ont repu 
un apport calorique et azote 
constant pendant 14 ±  2 jours.
Les doses de magnesium ont varie 
de 0 a 664 mg/j et ont ete 
administrees selon diverses 
sequences de chasse-croise.
Dans les deux groupes, I’excretion 
urinaire de magnesium a augmente avec 
les quantites de magnesium perfusees 
mais, pour des perfusions 
comparables de magnesium, 
les patients carences excretaient 
significativement moins de magnesium. 
La conservation par le rein etait 
la plus marquee chez les patients 
bien nourris qui ne recevaient pas 
de magnesium et chez les patients 
carences recevant 70 mg/j de 
magnesium. La perte urinaire 
de magnesium etait de 40 ±  5 mg/j 
et de 33 ±  8 mg/j respectivement 
pour les deux groupes. L'excretion 
fecale endogene du magnesium 
etait minime et variait de 2 a 38 mg/j. 
A chaque niveau d'apport de 
magnesium, les niveaux seriques 
chez les patients bien nourris 
etaient normaux. Avec des 
perfusions de moins de 200 mg/j, les 
concentrations seriques de 
magnesium chez les sujets 
carences etaient de 1.6 mg/j 
en moyenne. L'excretion urinaire 
reduite du magnesium ainsi que 
les taux seriques limites mesures 
chez les adultes carences indiquent 
que la dose de magnesium devrait 
etre plus eleve que celle qui est 
habituellement recommandee 
durant I’alimentation parenterale 
totale. Chez les deux groupes, 
une correlation positive a ete 
observee entre le magnesium 
et le bilan azote.
Magnesium, the major intracellular 
divalent cation, is a vital cofactor in 
numerous enzymatic reactions and is 
required for protein synthesis, neuro­
muscular function and cellular integ­
rity. The healthy adult human body 
contains 20 to 30 g o f this metal, of 
which only 15% is rapidly exchange­
able and therefore available to supply 
deficient tissues.1'2 Magnesium defi­
ciency is manifested by various clin­
ical and biochemical symptoms, in­
cluding nausea, dizziness, depression, 
muscular weakness and convulsions.1,4 
Low serum levels o f magnesium, cal­
cium and potassium, low magnesium 
concentrations in muscle, bone and 
red cells, reduced urinary excretion 
o f magnesium and calcium, and ex­
cessive potassium losses in the urine 
have all been found in cases of mag­
nesium deficiency. Because of its bio­
logic importance, a daily magnesium 
intake of 300 to 350 mg is recom­
mended for adults on oral diets.5 Of 
this ingested amount, 30% to 50% 
is absorbed and utilizable.2,8'7
During parenteral nutrition the 
amount o f magnesium that should be 
infused is not known with certainty. 
Manifestations o f magnesium deple­
tion have become evident after pro­
longed intravenous feeding with mag­
nesium-free fluids and during gastro­
intestinal suctioning.1'8 As a result, the 
suggested parenteral magnesium re­
placement ranges from 48 to 600 mg 
(4 to 50 meq) daily.0 Our purpose was 
to determine the optimal level o f 
magnesium for infusion during total 
parenteral nutrition in nourished and 
nutritionally depleted surgical pa­
tients. We measured the effects of 
varying doses o f magnesium (0 to 664 
m g/d) on excretion, serum concentra­
tion and nitrogen balance.
Patients and Methods
Ten patients were studied post- 
operatively for 14 ±  2 days. Based 
on nutritional and medical histories, 
they were assigned to two groups: 
morbidly obese well-nourished pa­
tients (n =  7) having a mean pre­
operative weight o f 130.1 ±  9.6 kg 
and nutritionally depleted patients 
(n =  3) who had an average weight 
o f 41.2 ±  6.3 kg. Table I summar­
izes the clinical data for each group.
Total parenteral nutrition was 
started at 08:00 hours on the morning 
following operation. The solutions 
consisted o f 25%  dextrose with the 
nitrogen being derived from either 
4.25% crystalline amino acids (Fre-
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amine II [8.5%]; McGaw Labora­
tories, Glendale, Calif.) in six patients 
or 5% protein hydrolysate (Arnigen; 
Baxter Travenol Laboratories of Can­
ada Ltd., Malton, Ont.) in four pa­
tients. The average nitrogen intake 
was 17.7 g/d. The source of added 
magnesium was magnesium sulfate 
heptahydrate (Eli Lilly & Co., Indi­
anapolis, Ind.) (2 ml of 50% solution 
contains approximately 100 mg or 8 
meq of magnesium). Individuals on 
protein hydrolysate received 24 mg of 
magnesium per litre of protein solution. 
This was considered in all calculations. 
Analysis of crystalline amino acid and
glucose solutions revealed no detec­
table amounts of magnesium. Five 
patients received two or more levels 
of magnesium intravenously in a va­
riety of crossover patterns.
Depleted patients received not less 
than 6 meq of magnesium daily. Oral 
intake was restricted to distilled water. 
All nutrients, including electrolytes, 
minerals and vitamins were given 
through the subclavian vein with a 
constant infusion pump at a rate of 
125 ml/h. Nitrogen, calcium, phos­
phorus and caloric intakes were main­
tained constant throughout each study 
period. Each patient received 10 ml
Table 1 -Clinical Data
Clinical feature
Group
Nourished Depleted
Sex distribution,
femalelmale 611 2/1
Age, yr* 36 +  4 50 ±  6
Preoperative weight, kg* 130.1 ±  9.6 41.2 ±  6.3
Procedure
Gastric bypass 7
Sphincteroplasty 1
Multiple small bowel 
resections leading to
malabsorption 2
'Mean ±  standard error of mean.
Table 11-Effect of Infused Magnesium on Urinary and Serum 
Magnesium* Levels in Seven Nourished Patients!
Magnesium Urinary loss of Magnesium Serum level of
infused, mg/d magnesium, mgld balance, mg/d magnesium, mg/dl
0 40 ±  5 40 ±  5 1.8
73 ±  0 139 ±  16 -66 ±  16 1.8
97 +  0 75 ±  6 +22 ±  6 2.0
196 ±  1 184 ±  15 +12 ±  14 2.1
369 ±  0 332 +  23 +37 ±  23 2.3
390 ±  4 230 ±  14 + 160 ±  10 2.5
664 ±  0 608 +  47 +56 ±  47 2.2
*Values expressed as mean ±  SEM.
tEach patient was studied for 14 +  2 days at the infusion rate shown in the left-hand column. During 
the study period magnesium infusion rates were doubled for several 48-hour periods in three of the 
seven patients and then returned to normal infusion levels, to confirm the results.
Table Ill-Effect of Infused Magnesium on Urinary 
and Serum Magnesium Levels* in Three Nutritionally Depleted Patientsf
Magnesium 
infused, mg/d
Urinary loss of 
magnesium, mg/d
Magnesium 
balance, mg/d
Serum level of 
magnesium, mg/dl
70 ±  3 33 ±  8 +37 ±  10 1.5
172 ±  1 76 ±  27 + 96 ±  26 1.6
263 ±  5 184 ±  12 +79 +  10 1.9
369 ±  0 253 ±  38 + 116 ±  38 2.3
'Values expressed as mean ±  SEM.
tEach patient was studied for 12 to 28 days. The magnesium infusion rates (left-hand column) were 
doubled for 48-hour periods and returned to normal to confirm the results. Rates required to attain 
positive magnesium balance were lower than in well-nourished subjects (see Table II). The magnesium 
infusion of 369 mg is a mean of the crossover studies from three patients. The high positive 
magnesium balance indicates that further increments of magnesium infusion should not be given.
of fat and water-soluble vitamins 
daily.
Spectrophotometric analyses for 
magnesium were performed daily on 
24-hour urine aliquots and also on 
serum every 3 days.10’" Urinary crea­
tinine concentration was measured 
daily to assure complete collections. 
Stools were analysed for magnesium 
by atomic absorption flame photo­
metry.12 Nitrogen in urine, feces and 
nasogastric fluid, as well as the nitro­
gen content of the amino acid and 
protein hydrolysate solutions, was de­
termined by the microKjeldahl meth­
od. Nitrogen balance was calculated 
on the basis of total nitrogen infused 
minus the sum of urinary, fecal and 
nasogastric nitrogen losses.
Results
Very little intravenously adminis­
tered magnesium is lost through 
feces.1,6 Hence, stools collected over 
any 24-hour period were selected at 
random for analysis. Our results in­
dicated a range of 2 to 38 mg of 
magnesium for each period. This con­
firmed previous data and pointed to 
urinary losses as the principal factor 
in determining magnesium balance.13 
Since fecal and dermal losses were 
negligible, magnesium balance was 
taken to be the difference between 
infused magnesium and total daily 
urinary magnesium loss.
In nourished subjects a dose of 0 
to 72 mg of magnesium daily resulted 
in a negative balance (Table II). When 
the dosage was raised to 96 mg, a 
positive balance of 22 ±  6 mg/d was 
noted. At all daily intakes greater 
than 97 mg, magnesium balance was 
positive. The highest positive balance, 
160 ±  10 mg/d, was attained when 
390 mg of magnesium was infused. 
Increasing the dose to 664 mg/d 
raised urinary magnesium output and 
yielded a lower, but still positive bal­
ance. In contrast to the nourished pa­
tients, depleted subjects receiving 70 
mg of magnesium daily were in posi­
tive balance (Table III). Urinary losses 
at this intake were minimal (33 ±  
8 mg/d). As magnesium input was 
increased, there was a greater output 
in the urine. A dosage of 369 mg/d 
resulted in the optimal positive bal­
ance of 116 ±  38 mg/d. At this in­
take, serum levels rose to 2.3 mg/dl. 
In depleted subjects receiving 70 or 
172 mg of magnesium daily, serum 
levels were borderline low. When 
magnesium-free total parenteral nu­
trition or 73 mg/d of magnesium was 
administered to nourished patients, 
the average serum levels were 1.8
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mg/dl. At higher infusions, serum 
levels rose to normal ranges. A dose 
of 664 mg/d did not raise serum mag­
nesium concentrations above the nor­
mal range.
With the exception of anorexia, 
clinical signs and symptoms of mag­
nesium deficiency were not apparent 
in any of the patients studied. The 
amount of magnesium given intra­
venously not only affected serum 
levels and urinary output of this 
macro-metal, but also exerted a con­
siderable influence on urinary nitro­
gen. Crossover studies involving both 
the nourished and the depleted sub­
jects demonstrated a direct positive 
correlation between magnesium and 
nitrogen balance (Table IV). Plotting 
magnesium and nitrogen balances 
gave a straight line graph with a cor­
relation coefficient of 0.982 for the 
nutritionally depleted patients.
Discussion
In nourished and depleted patients, 
urinary magnesium excretion was pro­
portional to the amount infused. How­
ever, at comparable intakes, the uri­
nary magnesium output of depleted 
subjects was consistently lower than 
that of nourished subjects. This con­
firms Shils’ data which showed that 
the simplest measurement of magne­
sium deficiency was a decrease in 
urinary excretion.4
Infusion of 72 mg of magnesium 
or less, in nourished patients, resulted 
in a negative balance. Approximately 
100 mg of magnesium daily was re­
quired to maintain a positive balance 
and normal serum values. However, 
at intakes of 70 to 172 mg/d in de­
pleted subjects, not only was renal 
conservation prominent but serum 
magnesium levels were borderline low. 
Only when the dose was increased to 
369 mg/d were values equivalent for 
both depleted and nourished subjects. 
At a daily infusion of 390 mg of mag­
nesium, optimal positive balance was 
attained in the nourished subjects. 
Further increases did not improve 
balance, but resulted in greater uri­
nary magnesium losses. An intake of 
369 mg/d yielded a high positive 
magnesium balance and favourable 
serum levels in depleted subjects.
The finding of low urinary magne­
sium excretion in depleted patients 
was not unexpected. Most macro- and 
trace-metal deficiency syndromes 
share this characteristic. Of note, 
however, was the observation that 
urinary excretion levels rose and were 
apparently dose-responsive to paren­
teral magnesium administration. This
suggested that in depleted or well- 
nourished patients, the urinary excre­
tion mechanism is quick to adjust it­
self to parenteral loading or, alter­
natively, that cellular utilization mech­
anisms are easily overloaded and re­
spond by allowing excessive macro­
metals to be excreted in the urine 
even though body stores may not be 
completely replete. Clearly, the best 
reflection of magnesium deficiency is 
a decrease in urinary magnesium ex­
cretion. On the other hand, even 
though body stores are probably still 
being replaced during parenteral in­
fusion, the excess magnesium is lost 
in the urine and represents adminis­
tration that exceeds the body’s util­
ization capabilities.
Assuming that kidney function in 
our patients was normal, we can infer 
from our results that a daily dose of 
approximately 390 mg of magnesium 
during total parenteral nutrition 
would be salutary for both depleted 
and well-nourished subjects postoper- 
atively. This amount would also cover 
losses via feces and sweat, which are 
estimated to be 15 mg/d.14 The ad­
ministration of 8 ml of 50% magne­
sium sulfate supplies this amount 
since a 2-ml vial of 50% magnesium 
sulfate contains 100 mg or 8 meq of 
magnesium. In the rare instance that 
protein hydrolysates are used, the in­
herent content of 24 mg magnesium 
per litre of hydrolysate must be taken 
into account. Most catabolic patients 
are magnesium deficient even though 
this deficiency may not be reflected by 
serum levels. Severe deficiency will 
also be more common in infants, who 
have reduced body stores, in alco­
holics and in parenterally fed patients 
receiving magnesium-free solutions 
particularly when there are on-going 
gastrointestinal losses.
Clinically, magnesium deficiency
may present with nausea, anorexia, 
dizziness or weakness. All of these are 
common in parenterally fed patients 
and may in themselves prevent conver­
sion from parenteral to enteral feeding. 
In addition, magnesium deficiency may 
also be confused with hypocalcemia 
and may be associated with a posi­
tive Trousseau or Chvostek’s sign, 
tremors or, rarely, convulsions.
Most magnesium deficient patients 
have low serum magnesium levels. 
However, a low urinary magnesium 
excretion represents a more accurate 
reflection of total body magnesium 
depletion.3 Urinary magnesium will be 
less than 3 meq/d (36 mg) after 5 
to 7 days of a magnesium-free diet. 
However, monitoring serum magne­
sium is still important during magne­
sium repletion. While such serum 
levels may not accurately reflect body 
magnesium stores, they are none the 
less vital in order to prevent magne­
sium intoxication. This may occur 
with excessive magnesium infusion, 
renal failure or after repeated enemas 
with magnesium salts.
We chose morbidly obese patients 
undergoing elective gastric bypass to 
represent a normal, well-nourished 
study group having similar degrees of 
operative trauma. Magnesium is not 
stored in adipose tissue to any great 
extent. These obese patients essen­
tially had magnesium balances similar 
to those reported by Macbeth and 
Mabbott15 who measured magnesium 
balance postoperatively in lean pa­
tients.
The positive correlation of magne­
sium balance with nitrogen balance 
observed in this study is noteworthy. 
It suggests that as magnesium balance 
accrued, more magnesium was avail­
able for cytoplasmic synthesis, al­
though this needs to be confirmed by 
more complicated labelling methods.
Table IV—Effect of Increased Magnesium Infusions on Magnesium 
and Nitrogen Balance* -  Crossover Studies!
Magnesium 
infused, mgld
Magnesium 
balance, mgld
Nitrogen 
balance, gld
0 -41 ±  5 -5.1 ±  1.2
97 ±  0 +28 ±  17 + 3.4 ±  0.3
0 -47 ±  23 +2.4 ±  0.2
386 ±  8 + 171 ±  52 + 3.3 ±  0.8
195 ±  2 +27 ±  24 -4.5 ±  1.1
394 ±  0 + 150 ±  72 + 1.4 ±  0.4
270 ±  0 + 62 ±  10 +0.3 ±  0.3
369 ±  0 + 116 ±  38 + 1.0 ±  0.6
'Values expressed as mean ±  SEM.
tCarried out for 48 hours on four of the seven well-nourished patients.
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the touchstone of surgery
T he  touchstone. . .  a hard black 
stone used through the ages to meas­
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the Surgical Education and Self- 
Assessment Program (SESAP IV) 
represents a modern-day touchstone.
A way to confirm your knowledge of 
current clinical advances in surgery.
To identify and correct areas of 
personal educational need. To compare 
your achievement with that of your 
peers. To chart an efficient continuing 
education plan for the future.
If you were to select only one con­
tinuing medical education program in 
which to participate this year, it seems 
unlikely that any other choice could 
offer as much. SESAP IV not only 
can let you discover where you stand, 
but can help you do something about 
possible knowledge deficiencies.
The product of more than a decade of refinement
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the American College of Surgeons has 
made available a new Surgical Educa­
tion and Self-Assessment Program. 
Each SESAP is carefully designed to 
present much material that should be 
understood by all practicing surgeons 
regardless of their special competence.
Successive SESAP programs have 
been refined in response to partici­
pants’ suggestions to meet your 
expressed needs and interests. SESAP 
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reflects the efforts of seven College 
committees composed of 49 nationally 
recognized surgical authorities.
Pinpoint and satisfy your own needs-to-know
SESAP IV is more than simply an 
exercise in self-assessment. It starts 
with a carefully selected series of 400 
multiple-choice items covering 16 
important areas of surgical interest, 
and with seven challenging Patient 
Management Problems (PMP). The 
multiple-choice items require approxi­
mately ten hours to complete; the 
PMPs approximately four hours. The
program continues with confidential 
computerized individual scoring and 
feedback (optional), and with two 
comprehensive syllabi with response 
critiques and references for further 
study. Lastly, Norm Tables will allow 
you to compare efforts with those of 
your peers.
There’s much more to SESAP IV. 
But, a significant point is that the 
experience will not only help you 
identify knowledge deficiencies, but 
help you plan more precisely how to 
meet your personal CME needs.
The challenge and satisfaction of knowing where you stand
SESAP IV is designed to help you 
attain that level of knowledge which is 
expected of a surgeon conscientiously 
continuing his or her education in the 
interest of good, competent patient 
care. It offers up to 75 hours of 
Category 1 CME credit. More impor­
tantly, it offers you a unique oppor­
tunity to assess your knowledge of the
principles as well as the clinically 
accepted advances in surgery of the 
last decade.
SESAP IV may be especially valu­
able if you are a candidate for certifi­
cation or recertification; the American 
Board of Surgery bases the greater 
part of its examination for recertifica­
tion on material contained in SESAP.
Participants in past SESAP pro­
grams have found them most helpful. 
A survey of more than 4,200 
participants in SESAP III indicated 
that 90% felt the experience was 
valuable or extremely valuable. In 
addition, nearly 80% felt that 
participation helped them take better 
care of their patients.
Whether you are among the more 
than 50,000 surgeons in all specialties 
who have participated in previous 
SESAP programs or are new to the 
concept, SESAP IV merits becoming 
an integral part of your personal plan 
for continuing education. Send for 
more information today.
Enrollment now open for the most comprehensive, authoritative, flexible, and individualized home-study continuing education program in surgery.
SESAPAmerican College of Surgeons
55 East Erie Street 
Chicago, Illinois 60611
Yes, I wish to learn more about SESAP IV. Please send me, 
without cost or obligation, a Prospectus explaining in detail the 
fourth Surgical Education and Self-Assessment Program of the American College of Surgeons.
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Magnesium is required as an activator 
or cofactor for many oxidative and 
enzymatic systems essentia] to inter­
mediary metabolism, and also for nu­
cleic acid synthesis. Hence, its salutary 
effect on nitrogen balance was not 
unexpected. Two patients (Table IV) 
had unrealistic improvements in nitro­
gen balance in response to magnesium 
positivity. However, two variables 
were present: the administration of 
more magnesium and the reversal of 
a negative nitrogen balance in mark­
edly depleted patients. Such depleted 
patients require only small amounts of 
nitrogen to produce marked positive 
changes in nitrogen balance. When 
all crossover data comparing magne­
sium balance were compared by cor­
relation coefficient, a straight line 
curve (r =  0.83> was obtained. This 
correlates well with recent studies 
which have shown that muscle magne­
sium contents are decreased in pro­
tein-calorie malnutrition.16
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ATLAS OF PELVIC SURGERY. Clif­
ford R. Wheeless, Jr. 399 pp. Must.
Lea & Febiger, Philadelphia, 1981.
$81. ISBN 0-8121-0727-6.
This book comes from one of the best 
known and most respected centres of 
gynecologic surgery in North America. 
It continues the surgical tradition stem­
ming from TeLinde and reflects a back­
ground of training from a wide range of 
master gynecologists. One can expect 
from Dr. Wheeless a high standard of 
surgical expertise and those expectations 
are fully realized.
Dr. Wheeless systematically covers a 
wide range of gynecologic surgical tech­
niques and has not hesitated to include 
some procedures that might be dismissed 
as of purely historical interest. The spec­
trum covered is comprehensive and in­
cludes a number of current technical 
procedures that are not in the main­
stream of surgery — for example, laser 
surgery or cryosurgery of the cervix. Few 
procedures have been excluded, although 
it is noteworthy that the section on tubal 
surgery is limited and makes no refer­
ence to microsurgical techniques. The 
text is strongest in those sections that 
deal with standard procedures and lapa­
roscopy. To some extent the coverage is 
too comprehensive and unselective and 
some rather minor, even trivial, surgical 
procedures receive specific mention, such 
as the division of adhesions by laparo­
scopy.
The text is well written in simple, 
easily understood language. Procedures 
are outlined with admirable clarity. How­
ever, the illustrations are of more vari­
able quality and are not always easy 
to follow. Some could have been omitted 
or replaced by photographs — for ex­
ample, the presentation of views obtained 
at the time of diagnostic laparoscopy.
This book can be safely recommended 
to all practising clinicians who will find 
it invaluable as a reference for unfami­
liar and infrequently performed opera­
tions, or even to review one’s standard 
practice of regular surgical procedures. 
The book is essentially a technical ma­
nual and does not deal with indications 
for surgery nor with pre- and postopera­
tive management. To this extent its value 
for residents is limited and they may 
prefer other standard textbooks that take 
a wider approach.
This book has formidable competition. 
Other texts of operative gynecology are 
more comprehensive in their approach 
and are better illustrated. For some 
purposes, it will be necessary to refer to 
a more specialized text, for example, to 
understand radical pelvic surgery for 
malignant diseases or in reconstructive 
tubal surgery or for a helpful approach 
to a new technical procedure. The ac­
count of some newer techniques is in-
continued on page 589
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CASE 4
Extensive Neurofibromatosis of the 
Abdominal Wall, Penis and Scrotum
Walter J. Peters, ph d, md, frcs[c] and E. Steven Samuel, md, frcs[c]
The authors describe a rare case of 
neurofibromatosis involving the 
abdominal wall, scrotum and penis. 
Penile and scrotal involvement 
precluded any form of sexual activity. 
Neurosarcomatous degeneration in 
the region of the abdominal wall was 
successfully treated by radical 
excision and skin grafting. Secondary 
reconstruction of the penis and 
scrotum allowed relatively normal 
sexual activity.
Les auteurs decrivent un rare cas 
de neurofibromatose avec atteinte de 
la paroi abdominale, du scrotum 
et du penis. Les atteintes du penis 
et du scrotum empechaient toute 
forme d'activite sexuelle. On a traite 
avec succes la degeneration 
neurosarcomateuse de la region de 
la paroi abdominale par excision 
radicale et greffe cutanee. La 
reconstruction secondaire du penis 
et du scrotum a permis une activite 
sexuelle relativement normale.
Neurofibromatosis (von Recklinghau­
sen’s disease) is a hereditary (mende- 
lian dominant) hamartomatous dis­
order, characterized by the develop­
ment of numerous soft tissue tumours 
in the form of multiple neurofibro­
mas. It was first described by von 
Recklinghausen1 in 1882, who showed 
that the tumours arose along cutane­
ous nerves. It was subsequently shown 
that they developed from the nerve 
sheath and that the main cell type 
was the Schwann cell.2,3 Although 
these tumours most commonly involve 
the skin, they may involve any organ 
or tissue from skin to viscera and 
may be associated with cranial, peri­
pheral or visceral nerves.2,3
The cutaneous lesions of neuro­
fibromatosis are frequently only one 
manifestation of a generalized consti­
tutional disorder. There may be mul­
tiple cafe-au-lait spots,2 also skeletal 
developmental anomalies, pulmonary 
changes, mental retardation, involve-
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ment of other systems and association 
with various syndromes.3,4 The trade 
mark of von Recklinghausen’s disease 
is the neurofibroma, which may be of 
two types. Patients with plexiform 
neurofibromatosis are considered to 
have von Recklinghausen’s disease, 
even if this lesion is the sole mani­
festation of the disease.2,5 Nonplexi- 
form neurofibromas may or may not 
be associated with neurofibromatosis.2 
Patients in the latter group must show 
cafe-au-lait pigmentation before a de­
finitive diagnosis of neurofibromatosis 
can be made.2
Visceral involvement with neuro­
fibromatosis is relatively uncommon;6 
most frequently involved is the digest­
ive tract.2-3 Neurofibromatosis in­
volving the urinary tract is rare.7 The 
present paper describes an apparently 
unique case of extensive neurofibro­
matosis of the abdominal wall, penis 
and scrotum.
Case Report
A 22-year-old man requested penile 
reconstruction because of lack of penile 
length (Fig. 1). His penis was only about 
1.5 cm long whether flaccid or erect. He 
had not had sexual intercourse. He re­
ported only one ejaculation —  during 
his sleep. There were no complaints or 
symptoms related to the urinary tract.
A massive pigmented lesion involving
FIG. 1—Appearance of abdominal
wall, scrotum and penis.
his abdominal wall, penis and scrotum 
was present at birth and had enlarged 
in proportion to his body size. He also 
had multiple, discrete, small cafe-au-lait 
spots (Fig. 1). There was slight gyneco­
mastia. The abdominal wall revealed a 
firm, tender, erythematous, round mass 
in the right lower quadrant which the 
patient had noted 2 months previously. 
The findings on karyotyping and endo­
crine investigation were normal.
Under general anesthesia, an excision- 
al biopsy of the new abdominal lesion 
was carried out. Quick section revealed 
malignant degeneration to neurosarcoma, 
so extensive excision of the abnormal 
tissue from the abdominal wall and 
suprapubic areas was done. Skin was 
grafted over exposed deep fascia. Penile 
reconstruction was deferred. Subsequent 
histologic sections showed cells that ap­
peared to arise from nerve sheaths. 
There was obvious malignant degenera­
tion with marked pleomorphism of nu­
clei and nucleoli.
The patient remained free of further 
malignant degeneration for 2 years. His 
initial problem of lack of penile length, 
which persisted, was aggravated by sub­
sequent scrotal swelling and resulting 
suprapubic scar hypertrophy (Fig. 2).
His penis and scrotum were explored 
and then reconstructed. The penis and 
testicles were found to be bound 
down within the black, fleshy, 
spongy neurofibromatous tissue filling 
the scrotum. When the bulk of this 
tissue was removed, relatively normal
FIG. 2—Following first excision.
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H G . 3—Penis and testes after removal of bulk of neuro- 
fibromatous tissue.
appearing penile and testicular structures 
were found (Fig. 3). A simulated erection 
with a tourniquet (Fig. 4) showed a 
penile length of 15 cm.
The bulk of the neurofibromatous 
tissue and about 80% of the scrotum 
were removed. The skin on the glans 
and distal penile shaft were preserved 
and the remaining shaft was resurfaced 
with a split-thickness skin graft. The 
scrotum was reconstructed using ad­
vancement flaps from the remaining 
posterior and inferior scrotal tissue (Fig. 
5).
FIG. 6—Appearance 6 months after 
operation.
About 2 months after operation, fol­
lowing genetic counselling, the patient 
began to experience normal sexual ac­
tivity. During the subsequent 2 months, 
he had sexual relations with three mem­
bers of the opposite sex. Six months 
after operation (Fig. 6) he developed an 
apparently lasting, regular, mutually- 
rewarding relationship with a single 
partner.
Discussion
The findings and progression of von 
Recklinghausen’s disease are extreme­
ly variable and unpredictable.4 Most 
frequently, it is relatively quiescent. 
Many cases are mild or with only a 
single lesion (formes frustes2) and 
probably go unrecognized. It may be 
a chronic progressive disease with ini­
tial manifestations in infancy or child­
hood.7 Isolated cases make up about 
half those reported in the literature 
and it is impossible to distinguish 
them clinically from familial cases.4
Involvement of the urinary tract is 
rare: only about 35 cases have been 
reported.5 8’9 The bladder has been the 
commonest site,7 but isolated cases 
have been reported with involvement 
of prostate, urethra, spermatic cord, 
penis and tunica albuginea.10 Our pa­
tient is unique because of his extens­
ive involvement, which masked a 
relatively normal reproductive system.
Malignant degeneration in von 
Recklinghausen’s disease was first re­
ported by Hosoi11 in 1931 who noted 
an incidence of 13%. Subsequently, 
numerous reports have documented 
malignant degeneration, the incidence 
ranging from 3% to 29% A12-14 Most 
commonly, malignant degeneration 
occurs in neurofibromas of large 
nerve trunks.15 It is rare in cutaneous 
neurofibromas and was seen in only 
2 of 678 patients in one study.16 His­
tologically, most malignant tumours 
in neurofibromatosis have the appear­
ance of anaplastic fibrosarcomas and 
give no indication of their origin from
a neurofibroma.15,16 In our patient, 
the pattern of neurofibroma was still 
present, with an increase in the num­
ber and pleomorphism of nuclei. This 
finding is suggestive of an early ma­
lignant lesion.12
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Solitary Diverticulitis of the Right Colon
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Inflammation of a solitary diverticulum 
of the right colon is uncommon; 
approximately 500 cases have been 
reported.
A 72-year-old woman underwent 
laparotomy for possible appendicitis. 
Unexpectedly, a mass was found 
in the ascending colon close to the 
ileocecal junction. Carcinoma was 
suspected and right hemicolectomy 
was done. The pathological diagnosis 
was acute suppurative solitary 
diverticulitis with perforation and 
pericolic abscess.
From his case and a review of the 
literature the author concludes that 
inflammation in a solitary diverticulum 
of the cecum is a distinct entity.
Its etiology is uncertain, but a 
congenital origin is widely accepted. 
Clinically it mimics appendicitis; 
at operation it is often indistinguishable 
from carcinoma. Roentgenogram after 
a barium enema is diagnostic. The 
condition is treated by diverticulectomy, 
wedge resection or colectomy. 
Abscesses are drained.
L'inflammation d'un diverticule solitaire 
du colon droit est peu frequent; 
environ 500 cas ont ete signales.
Une femme de 72 ans a subi 
une laparotomie pour une appendicite 
soupconnee. Contrairement a ce qui 
etait attendu, une masse a ete 
decouverte dans le colon ascendant 
pres de la jonction ileo-coecale.
Un cancer etant soupconne, une 
hemicolectomie droite fut pratiquee.
Le diagnostic du pathologiste fut une 
diverticulite solitaire aigue suppuree 
avec perforation et abces pericolique.
A partir de ce cas et d'une revue 
de la litterature, I'auteur conclut que 
l'inflammation d’un diverticule 
solitaire du coecum est une entite 
distincte. Son etiologie est incertaine 
bien qu'une origine congenitale 
soit largement acceptee. Cette 
affection ressemble cliniquement a 
une appendicite; a I'operation elle 
est souvent indiscernable d'un cancer. 
Le diagnostic peut etre etabli a la 
radiographie apres lavement baryte.
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Le traitement est soit par diverticuiec- 
tomie, resection cuneiforme ou 
colectomie. Les abces sont draines.
The general uncertainty of the nature 
of solitary diverticulitis of the right 
colon close to the ileocecal valve is 
reflected in the number of names by 
which it has been described: non­
specific ulcer, solitary cecal ulcer, 
acute cecitis, phlegmonous cecitis, 
acute cecal diverticulitis.1 Although 
12% of cases occur in the ascending 
colon,2 it is commonly called cecal 
diverticulitis.
The disease is uncommon. Potier3 
described the first case in 1912. The 
latest review4 states that approximate­
ly 460 cases have been recorded in 
the English literature. With the addi­
tion of another 40 cases since then,5'10 
the total now stands at approximately 
500 cases. The lesion is probably 
commoner than the figures sug­
gest;1’11'12 some cases are unreported 
or unrecognized, but some can be 
found buried in reports on appendi­
citis; for example, in a series of 1000 
laparotomies for appendicitis,13 two 
patients had perforated cecal diverti­
culitis, one had nonperforated diverti­
culitis and two had cecitis of un­
known cause.
The diagnosis is rarely made pre- 
operatively and is usually encountered 
unexpectedly at operation for appen­
dicitis. Greaney and Snyder14 reported 
an incidence of 1 in every 500 celi­
otomies for acute abdominal com­
plaints. Treatment is also difficult be­
cause frequently the lesion resembles 
a neoplasm and a radical resection 
is carried out under adverse condi­
tions. Any surgeon operating on a 
patient with an acute abdomen should 
be aware of this lesion.
Case Report
A 72-year-old woman was admitted 
with a 48-hour history of abdominal 
pain aggravated by movement. Initially 
the pain was in the upper abdomen, but 
shifted to the right lower quadrant on 
the day of admission. She had no nausea 
or vomiting but was anorexic. She had 
a normal bowel movement on each day 
of her illness.
The patient was well nourished and 
in no distress. Her temperature was 
37.5°C. She had moderate tenderness in 
the right lower quadrant with some 
guarding and rebound tenderness.
Her hemoglobin level was 13.4 g/dl. 
the leukocyte count 12.5 x  10V1 with 
79% neutrophils. Urinalysis gave nega­
tive results and abdominal roentgeno­
grams showed no abnormality.
A provisional diagnosis of appendicitis 
was made. Preoperatively she was given 
2 g of cefoxitin intravenously. At opera­
tion the appendix appeared normal. Ex­
ploration revealed a mass measuring 
5 x  8 cm in the posteromedial wall of 
the ascending colon close to the ileocecal 
junction. As a carcinoma could not be 
ruled out, right hemicolectomy was 
done. The wound was closed by the 
delayed primary suture technique. Cefox­
itin was continued every 6 hours post- 
operatively for 4 days.
The patient’s recovery was smooth. 
Roentgenography after barium enema 2 
months later did not reveal any other 
diverticula. She has remained well.
Examination of the resected specimen 
showed a solitary diverticulum of the 
ascending colon, which had perforated 
and formed a pericolic abscess. The 
ostium was 3 cm from the ileocecal 
valve. It contained fecal material. Micro­
scopic examination showed acute sup­
purative diverticulitis.
Discussion
Solitary diverticula should not be 
confused with multiple diverticulosis 
of the colon. In a study of normal 
subjects in Oxford, England, the in­
cidence of diverticulosis was found 
to be 7.6% in those under the age 
of 60 years and 35% in those older 
than 60.15 The disease is rare in de­
veloping countries.16 It invariably in­
volves the sigmoid colon and in ex­
tensive diverticulosis, the proximal 
bowel is affected in continuity.17 The 
cecum is thus involved in 4% of cases 
and diverticulosis is found on roent­
genography after barium enema.18
In contrast, certain characteristics 
of right-sided diverticula make them 
a distinct entity. They are uncommon. 
In Williams’ series18 they constituted 
only 1% of cases. Nearly 80% occur 
in the area from 1 cm proximal to 
2 cm distal to the ileocecal valve.11 
They are usually solitary. When left­
sided disease is also present it appears 
in older patients. Hughes17 suggested 
that the combination may be coinci­
dental and unrelated.
Etiology
The etiology of solitary diverticula 
remains uncertain, although a conge-
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nital origin is widely accepted.2’5-"-12-19
The theory of congenital origin is 
based on embryologic studies done in 
the early part of this century.20 An 
outgrowth of the cecum develops in 
the sixth week and atrophies by about 
the seventh week. If this “transient 
appendix” fails to disappear, a diverti­
culum or a duplication of the appen­
dix results.21'03
To support their thesis, proponents 
of a developmental antecedent quote 
the age at which the disease occurs. 
It has been reported in a 3-year-old 
girl.24 In a review of 318 cases,2 the 
average age of patients was 41.4 years 
which is about 10 years less than for 
left colon diverticulosis. The incidence 
does not increase with age.17
Solitary diverticula are also thought 
to be of the congenital or true variety 
because of the presence of muscle in 
the wall. Schnug25 believe that they 
were similar in origin to a Meckel’s 
diverticulum and contained all layers 
of the intestinal coat. Because he was 
unable to find any muscle apart from 
the muscularis mucosae, Hughes17 has 
questioned this concept. He cited Ed­
wards20 who pointed out that so-called 
congenital jejunal diverticula have hy­
pertrophy of the muscularis mucosae.
Unfortunately, in many cases, the 
wall tissue cannot be identified with 
certainty because it has been de­
stroyed by inflammation.
Pathologic Features
Solitary diverticula may measure 
up to 15 mm in diameter at the os­
tium.17 Characteristically, they have a 
shorter and wider neck than the mul­
tiple variety. They contain fecaliths 
or fecal material that may initiate 
the inflammatory process by obstruct­
ing the lumen.2 Once started, the le­
sion may progress to gangrene and 
perforation. Anteriorly situated diver­
ticula are likely to lead to generalized 
peritonitis; if posteriorly placed they 
tend to be localized and produce an 
inflammatory mass resembling can­
cer.27
Diagnosis
Clinically, the disease mimics acute 
appendicitis. In the first review of the 
world literature, Anderson28 collected 
99 cases. The correct diagnosis was 
made in only 6% — patients whose 
appendix had already been removed; 
in 84% appendicitis was suspected. 
Diverticulitis and carcinoma are the 
next most frequent diagnoses, made in 
an almost equal number of cases.
Most patients have pain in the right 
lower quadrant of the abdomen. The
duration of pain may be 24 to 72 
hours, but some may have recurrent 
attacks over many weeks or months. 
Nausea and vomiting are not com­
mon. A few have melena.
On physical examination there is 
tenderness in the right lower quadrant 
and a mass may be palpable. Most 
authors report moderate elevation of 
temperature but, apart from leuko­
cytosis, laboratory findings are usual­
ly normal.
The similarity to acute appendicitis 
prompted Laimon and Cohn29 to state 
that, even in retrospect, it was im­
possible to select notable variants in 
the clinical findings to differentiate 
the two conditions. Others have com­
mented that the longer duration of 
illness,30 the absence of nausea and 
vomiting" and the lesser toxicity27 
are helpful clues. Roentgenography 
after barium enema has been diagnos­
tic in practically all cases in which 
it has been done.31 However, no pa­
tient suspected of having appendicitis 
will be subjected to this investigation.
Intraoperative diagnosis is also dif­
ficult. Wagner and Zollinger2 found 
that the correct diagnosis was made 
at operation in 61.8%; in 31.4% 
cancer was diagnosed. Greaney and 
Snyder" classified the operative find­
ings into two types: the “usual” and 
the “hidden”. The first type is the 
easily recognized inflamed diverticu­
lum; the second is characterized by 
an inflammatory mass.
To distinguish an inflammatory 
from a malignant lesion, a number of 
authors recommend palpating the os­
tium through the normal bowel 
wall.2532 xhis maneuver was done in 
our case, but the lesion appeared to 
have a central depression with heaped 
up edges characteristic of a malignant 
ulcer.
Others advise cecotomy with biop­
sy and frozen section,33 or biopsy only 
and treatment with antibiotics fol­
lowed by reoperation if a malignant 
lesion is found in the biopsy speci­
men.1 Garner and colleagues4 advised 
against this approach to intraoperative 
diagnosis for a number of reasons: 
contamination from unprepared bow­
el, spread of malignant cells, the un­
reliability of biopsy (many carcinomas 
have an inflammatory reaction at the 
periphery). Blind resection was con­
sidered safer.
Treatment
■ To aid in selecting the proper 
operation. Wagner and Zollinger2 
proposed a classification based on the 
gross pathologic features, the opera­
tion depending on the extent of in­
volvement of the bowel wall: if in­
flammation is confined to the diverti­
culum, simple diverticulectomy is 
done: a wedge resection is necessary 
when the surrounding bowel wall is 
indurated; ileocecal encroachment re­
quires ileocecal resection; and a mass 
that cannot be distinguished from a 
carcinoma is treated by colectomy. 
Abscesses are drained and any per­
foration is closed.
When a diverticulum only is re­
moved, appendectomy should be done 
if it can be performed easily. For the 
diverticulum found incidentally at 
laparotomy for another condition, 
some authors advise excision or in­
version. Most prefer not to treat an 
asymptomatic patient when a diverti­
culum is found on routine roentgeno­
grams after barium enema.
Conclusions
Solitary diverticulitis of the right 
colon is an uncommon condition that 
is difficult to diagnose and treat. It 
should be considered in the differen­
tial diagnosis of a mass found unex­
pectedly at operation for suspected 
appendicitis.
References
t. Bahabozorgui S, DeM uth W E jr , Blake- 
more W S: Diverticulitis o f the ascending 
colon. A m  J Surg  1968: 115: 295-300 
2. W agner DE, Zollinger RW: Diverticulitis 
of the cecum and ascending colon. Arch  
Surg (Chicago) 1961: 83: 436-43 
'3. P otier F: Diverticulite et appendicite. Bull 
M em  Soc Anat (Paris) 1912: 87: 29-31
4 . G arner OP jr , Bolin JA , LeSage MA. 
N elson NC: Acute solitary cecal diverti­
culitis. A m  Surg 1973: 39: 700-5
5. M agness LJ, Sanfelippo PM , van H eerden 
JA . J udd ES: D iverticular disease o f the 
right colon. Surg Gynecol Obstet 1975; 140: 
30-2
6. Rao DD: Solitary perforated diverticulum 
of ascending colon (C). Br M ed J 1977: 
2: 192
7. N orfray JF . G ivens JD , Sparberg MS. 
D wyer RM: Cecal diverticulitis in young 
patients. Gastrointest Radiol 1980: 5: 379- 
82
8. M ittal VK, Cortez JA, Olson AM: 
Solitary perforated diverticulum of the 
ascending colon: report of two cases. Dis 
Colon Rectum  1981: 24: 47-9
9. Kovalcik PJ, Sustarsic DL: Cecal diver­
ticulitis. A m  Surg 1981: 47: 72-3
10. Cutajar CL: Solitary cecal diverticula.
Dis Colon Rectum  1978: 21: 627-9
11. Lauridsen J. Ross FP : Acute diverticulitis 
of cecum; report of 4 cases and review 
of 153 surgical cases. A M  A Arch Surg 
1952; 64: 320-30
12. Inglis FG , H ampson LG: Solitary diverti­
culitis of the caecum and ascending colon. 
Can J Surg 1959; 2: 166-75
13. Lewis FR, Holcroft JW, Boey J, Dunphy 
JE: Appendicitis: a critical review of diag­
nosis and treatm ent in 1000 cases. Arch  
Surg  1975: 110: 677-84
14. G reaney EM, Snyder W H : Acute diverti­
culitis of the cecum encountered a t emer­
gency surgery. A m  J Surg 1957; 94: 270-9
15. M anousos ON, T ruelove SC, Lumsden K: 
Prevalence of colonic diverticulosis in gen­
eral population of Oxford area. Br M ed J 
1967: 3: 762-3
580 VOLUME 25, NO. 5, SEPTEMBER 1982 / THE CANADIAN JOURNAL OF SURGERY
16. P a in ter  NS, Burkett DP: Diverticular dis­ease of the colon: a deficiency disease of western civilization. Br M ed J 1971- 2* 450-4
17. H ugh es  LE: Postmortem survey of diverti­cular disease of the colon. I: Diverticulosis and diverticulitis. Gut 1969; 10: 336-44
18. W illia m s  K L: Acute solitary ulcers and acute diverticulitis of the caecum and ascending colon. Br J Surg 1960 ; 47: 351-8
19. Solitary diverticulum of the caecum (E). Br M ed J 1968; 4: 659-60
20. K elly  HA, H urdon  E: The Vermiform
Appendix and Its Diseases, Saunders, Phila­delphia, 1905
21. G ladsto ne  RJ, W akeley  CPG: The rela­tive frequency of the various positions of the vermiform appendix; as ascertained by
an analysis of 3000 cases: with an account of its development. Br J Surg 1923-24; 11: 503-20
22. C ave AJE: Appendix vermiformis duplex. J A not 1936; 70: 283-9223. W augh TR: Appendix vermiformis duplex. Arch Surg 1941; 42: 311-2024. O dqvist B. P etren  T : Ein Fall von ange- borener Divertikelbildung des Blinddarms. Virchows Arch [Pathol Anal] 1931; 280: 581-6
25. Sc h n u g  E: Acute diverticulitis of the cecum. Surgery 1943; 13: 282-9
26. E dwards H C : Intestinal diverticulosis and diverticulitis. Ann R Coll Surg Engl 1954; 14: 371-88
27. A n sco m be  AR, K eddie NC, Sch o field  PF: Solitary ulcers and diverticulitis of the caecum. Br J Surg 1967; 54: 553-7
28. A n d er so n  L: Acute diverticulitis of cecum; study of 99 surgical cases. Surgery 1947; 22- 479-88
29. L a im o n  H, C o h n  P: Diverticulitis of the cecum. A report of eight cases. Am  J Surg 1962; 103: 146-9
30. R igler  RG, C herry  JW: Diverticulitis ofthe cecum: preoperative diagnosis. AmSurg 1960; 26: 405-8
31. Schapira  A . L e ic h t l in g  J J ,  W o l f  BS. 
M arshak  RH, J a n o w it z  HD: Diverticulitis of the cecum and right colon: clinical and radiographic features; report of 18 cases. Am J Dig Dis 1958; 3: 351-8332. L e ic h t l in g  JJ: Acute cecal diverticulitis. Gastroenterology 1955 ; 29: 453-60
33. N icholas  EE, F ry m ark  W B , Ra f f e n s - 
perger JR: Acute cecal diverticulitis. JAMA  1962; 182: 157-60
The Estrogen Receptor Test: a Prognostic Tool 
in Primary Breast Cancer
L aurie  A. L ogan , M. C h r is t in e  C r ip p s , m d , f r c p [c ], W olfg a n g  E . H ir t e , m d , f r c p [c ], fa c p  and
E dna F . R a p p , m d , f r c p [c ]
To evaluate the usefulness of the 
estrogen receptor test as a prognostic 
indicator, a retrospective study 
of 134 patients with primary breast 
cancer was carried out at the 
Ottawa Civic Hospital. The estrogen 
receptor values, measured in a 
single laboratory, were correlated with 
the recurrence rate and the survival 
time after recurrence.
Other well-established prognostic 
data, such as stage of cancer, 
lymph-node involvement and meno­
pausal state, have been similarly 
examined to ensure that information 
obtained from the estrogen receptor 
test offers more than a duplication of 
information from these traditional 
methods. It was found that this test 
is a useful prognostic tool when 
used on premenopausal women. The 
results of the study show that 
(a) breast cancer patients having 
positive estrogen receptor values 
have recurrences less frequently,
Cb) among estrogen receptor-negative
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patients there is more than a 50% 
chance of early recurrence in 
premenopausal women compared 
with less than a 20% chance in 
postmenopausal women, (c) conven­
tional adjuvant chemotherapy in 
estrogen receptor-negative premeno­
pausal patients does not prevent 
early recurrence, hence, this group 
requires more aggressive adjuvant 
treatment and (d) the method 
described by Heuson and colleagues 
for estrogen receptor determination 
follows the trends of better-established 
tests.
Dans le but d'evaluer I'utilite 
du test des recepteurs 
du pronostic, une etude 
retrospective de 134 patientes 
atteintes d'un cancer primaire du 
sein a ete menee a I'Hopital Civique 
d’Ottawa. Une correlation a ete 
recherchee entre les mesures des 
recepteurs oestrogeniques 
qui furent realisees dans un seul 
laboratoire et le taux de recidive 
ainsi que la periode de survie 
apres une recidive.
D’autres elements pronostiques 
reconnus tels que le stade clinique 
du cancer, I’atteinte des ganglions 
lymphatiques et I'etat menopausique 
ont ete examines de fagon similaire 
de fagon a s'assurer que I'information 
tiree du test des recepteurs 
oestrogeniques n'etait pas qu'une 
repetition de celle qui est obtenue 
par ces methodes traditionnelles. On
a decouvert que ce test est un 
outil utile pour apprecier le pronostic 
chez la femme premenopausique.
Les resultats de cette etude 
montrent que a) les patientes 
souffrant de cancer du sein, qui 
ont un test des recepteurs 
oestrogeniques positif, ont moins 
souvent de recidives, b) parmi 
les patientes qui ont un test 
negatif, les risques d'un recidive 
precoce sont de plus de 50% chez 
les femmes premenopausiques 
alors qu'ils sont de moins de 20% 
apres la menopause, c) chez les 
patientes premenopausiques dont 
le test est negatif, la chimiotherapie 
adjuvante conventionnelle ne previent 
pas les recidives precoces et ce 
groupe necessite done un traitement 
adjuvant plus agressif, et d) la 
methode decrite par Heuson et 
collaborateurs pour la determination 
des recepteurs oestrogeniques 
suit les tendances des tests 
mieux etablis
The determ ination of estrogen recep­
tor status in women with breast can ­
cer was initiated by M cG uire and 
associates' in 1975. A m inim um  of 
500 mg of m alignant tissue was re ­
quired and receptor levels were m eas­
ured in fem tom oles per milligram of 
tissue protein. A  value less than 3 
fm ol/m g  was considered to be a nega­
tive result; anything greater was posi­
tive. Patients with estrogen receptor­
positive tum ours responded favour-
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ably to endocrine therapy while the 
converse was true of receptor-negative 
tumours. Receptor positivity was then 
subdivided on the basis of the per­
centage of response. A level between 
3 and 10 fmol/mg produced a 50% 
response rate. This increased to 66% 
in tumours with a value greater than 
10 fmol/mg.
Since 1975 the test procedure has 
become more sensitive, necessitating a 
change in these boundary values. 
Lippman2 in 1979 set out the follow­
ing values: 7 fmol/mg or less rep­
resents estrogen receptor negativity, 
more than 7 but less than 40 fmol/mg 
represents moderate positivity and 
more than 40 fmol/mg represents 
high positivity.
McGuire and associates1 have as­
sociated the presence of highly posi­
tive estrogen receptor values with a 
lower frequency of recurrences. If 
metastases do appear, women with 
estrogen receptor-positive primary tu­
mours survive longer than those with 
receptor-negative primary tumours 
regardless of menopausal stage. Post­
menopausal patients 'tend to have 
higher estrogen receptor values than 
premenopausal women, a possible 
reason being the lack of endogenous 
estrogens which bind to and render un­
available some of the estrogen recep­
tor sites.3
Patients and Methods
We carried out a retrospective 
study of 134 patients with histologic­
ally proven primary breast cancer 
and known estrogen receptor values, 
seen at the Ottawa Civic Hospital be­
tween 1977 and 1979. The estrogen 
receptor values were estimated by the 
method of Heuson and colleagues4 
using the classification of Lippmann.2
The following data were obtained: 
menopausal status, stage of cancer, 
estrogen receptor status, date of mas­
tectomy, adjuvant therapy used, date 
of recurrence if any and time from 
recurrence to death or to survival at 
the time of writing. In 1977, 1978 
and 1979, the estrogen receptor test 
was done on 28, 57 and 49 patients 
respectively. For the purpose of our 
study, the following definitions were 
used:
•  Menopausal status: Women
younger than 45 years were classified 
as premenopausal, while those older 
than 52 years were considered post­
menopausal and those between 45 and 
52 years were perimenopausal.
•  Stage: Postsurgical staging, done 
at the time of mastectomy, was used 
to determine the number of axillary 
nodes, if any, that were involved with
cancer. Women having stage II or 
stage III disease were subdivided into 
three categories according to the de­
gree of lymph-node involvement: 1, 
no involvement; 2, one to three nodes 
involved and 3, four or more nodes 
involved. Women with stage IV or in­
operable disease were not included in 
this study, which dealt with primary 
breast cancer patients who were free 
of measurable disease after resection.
•  Adjuvant therapy: Evaluation of 
the response to adjuvant therapy of 
patients with varying stages of cancer, 
menopausal status and estrogen re­
ceptor values would have required a 
larger sample size and has not been 
attempted. As a matter of interest, 
however, adjuvant therapy was cate­
gorized into three groups: 1, chemo­
therapy alone: 2, chemotherapy and 
radiotherapy and 3, radiotherapy 
alone. The percentages of each of 
these treatment modalities used on 
the three groups of estrogen receptor 
values has been recorded to demon­
strate the current trend in treatment 
at the Ottawa Civic Hospital.
In this study the recurrence rate 
and survival time after a recurrence 
were recorded for women in each of 
the receptor and menopausal cate­
gories, and in each stage of disease. 
Since treatment methods have not 
changed during the last 3 years the 
results of all years were recorded to­
gether. Statistical analysis was done 
using the •/* test where indicated.
Results
Recurrence Rales
The recurrence rate of the estrogen 
receptor-negative tumours was signif­
icantly higher (0.05 >  P >  0.02) than 
that of the receptor-positive tumours 
(Fig. 1).
For stage I cancer the recurrence 
rate was significantly lower (0.01 >
P >  0.001) than for other stages (Fig. 
2), but the rate for each of the other
ESTROGEN-RECEPTOR VALUE, 
fm o l/m g  p r o t e i n
stages did not differ significantly 
(0.1 >  P >  0.05). The recurrence 
rate for patients with stage II, 
TjNnMo, appeared to be substantially 
lower than for patients with stage II. 
T2N+, cancers.
A significantly higher recurrence 
rate (0.01 >  P >  0.001) was ob­
served among women less than 45 
years of age. The recurrence rate of 
peri- and postmenopausal women did 
not differ significantly (Fig. 3).
Thus, women with stage I or II 
disease, no lymph-node involvement 
and positive receptor values had the 
lowest recurrence rates.
Survival Time after Recurrence
Irrespective of age, women of re­
ceptor-negative status who died from 
their cancer did so within a year of 
their first recurrence. There was a dif­
ference in the percentage of deaths 
between the two age groups such 
that approximately 50% (7 of 15) of 
the premenopausal women died as op­
posed to 25% (6 of 22) of the post­
menopausal women.
None of the patients who had no 
lymph-node involvement but had re­
current tumour have died while 50% 
of those with four or more lymph 
nodes involved died within a year of 
recurrence. The follow-up of both 
groups of patients was comparable.
Twenty-two of the 134 women in 
the study have had recurrent disease.
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FIG . 3— Recurrence rate and meno­
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Tables I and II compare the stage of 
the cancer, age of the patient and 
estrogen receptor value with the re­
sponse after recurrence (survival v. 
death). Women with stages I, II and 
III cancers, with less than four nodes 
involved, demonstrated a relatively 
equal distribution of receptor values. 
The majority (15 of 26) of patients 
with stage II cancers having four or 
more nodes involved, however, had 
a receptor value less than 7 fmol/mg 
while only 1 woman in this group had 
a high receptor value. Of patients 
having negative receptor values and 
stage II cancer with four or more 
nodes involved, 47% (7 of 15) had re­
current disease and 4 of the 7 died 
well within a year of the recurrence.
In Table II there appears to be no 
relation between menopausal state, 
estrogen receptor value and response 
after recurrence in the 45 to 52-year 
and over 52-year age groups. In the 
premenopausal group, however, it is 
interesting that the majority (15 of 
22) had receptor-negative tumours
and of these 53% (8 of 15) had re­
current disease. Of the eight recur­
rences, three were stage I or II cancer 
(zero to three nodes involved). The 
recurrence rate for receptor-negative 
tumours reflects their aggressive na­
ture irrespective of stage. Eleven of 
the 15 premenopausal women had re­
ceived some form of adjuvant chemo­
therapy.
None of the seven women who 
were estrogen receptor-positive have 
had recurrent tumour. Six presented 
initially with stage I or II disease and 
four of them were treated with ad­
juvant chemotherapy.
Table III shows the present trends 
in adjuvant therapy for breast cancer 
at the Ottawa Civic Hospital. Radio­
therapy is used to treat approximately 
one third of all patients regardless of 
receptor status. A combination of ra­
diation and chemotherapy is not often 
used. Most patients are entered into 
phase 3 of the Eastern Cooperative 
Oncology Group (ECOG) study or 
National Surgical Adjuvant Breast
Project (NSABP), trials that are 
studying the effects of various chemo­
therapy or hormonal adjuvant regi­
mens, or both, on women with tu­
mours of different receptor status. 
Chemotherapy has been found to in­
crease the disease-free interval.
Discussion
The method for measuring the es­
trogen receptor value, described by 
Heuson and colleagues,4 was not 
standardized but was performed in a 
consistent manner in one laboratory, 
but since the results of this study cor­
respond with those of trials using a 
standardized test, the method we used 
is reasonable.
As a prognostic tool the estrogen 
receptor test does not appear to be 
useful for the majority of patients 
with primary breast cancer who are 
postmenopausal and have stage I or 
II cancer. These women tend to have 
a good prognosis and low incidence 
of recurrence. The receptor status of 
their tumours seems to be unrelated 
to their stage and does not change 
their initial prognosis determined 
through clinical and surgical inves­
tigation.
In this review there is a sim' . 
lack of correlation between the ^eri- 
menopausal group and estrogen re­
ceptor values; the latter is of no use 
in anticipating recurrences.
The estrogen receptor test is of 
value, however, in premenopausal 
women who present initially with 
stage I or II cancer. In general, 
women with tumour in these early 
stages have recurrences less frequent­
ly than do women with more locally 
advanced disease. In the past such 
women did not receive adjuvant ther­
apy. This approach should be disre­
garded in premenopausal women who 
have early stage, estrogen receptor­
negative cancer. Fifteen of 22 pre­
menopausal patients in this study were 
receptor-negative and 8 of them had 
stage I or II disease. More aggressive 
adjuvant therapy in these women may 
decrease the number of recurrences or 
increase overall survival, or both — 
a goal especially desirable for women 
in the prime of life.
A prospective ECOG trial was be­
gun in 1978 to compare the response 
of premenopausal women with stage 
II cancer to three treatment regimens: 
cyclophosphamide, methotrexate and 
5-fluorouracil (CMF), cyclophospha­
mide, methotrexate, 5-FU and predni­
sone (CMFP), and cyclophosphamide, 
methotrexate, 5-FU, prednisone and 
tamoxifen (CMFPT). Estrogen recep­
tor values were among the staging
Table 1-Correlation of Estrogen Receptor Value and Stage of Cancer
Estrogen _________________________________ ^ta^e________________________________
receptor I II II III III
value, ____________ K 4  nodes) (5*4 nodes) « 4  nodes) (>4 nodes)
fmollmg Total S D Total S D Total S D Total S D Total S D
>40 17 1 0 20 1 0 1 0 0 2 0 0 1 0 1
7-40 6 0 0 19 3 1 10 0 0 4 0 0 1 0 0
<7 12 2 0 18 5 0 15 3 4 3 1 0 3 0 1
Total = total no. of patients in each category, S = no. of patients with recurrence who are still alive, 
D = no. of patients with recurrence who died.
Table II—Correlation of Estrogen Receptor Value 
with Menopausal Status
Estrogen ___________  ___________________ Age, yr
receptor
value,
fmollmg
<45 45-52 >52
Total S D Total S D Total S D
>40 3 0 0 11 2 0 28 1 1
7 40 4 0 0 17 1 1 19 2 0
<7 15 5 3 14 2 0 23 2 2
Total = total no. of patients in each category, S = no. of patients with recurrence who are alive, D = 
no. of patients with recurrence who died.
Table III--Percentage of Patients Who Received 
Adjuvant Treatment
—
Treatment >40
Estrogen receptor value, 
fmollmg protein
7-40 <7
No adjuvant 
therapy
Radiotherapy 36 33 29 24
Radiotherapy + 
chemotherapy 0 3 6 7
Chemotherapy 10 28 27 6
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criteria required. It is a well-known 
fact5 that although adjuvant chemo­
therapy in these women has not as 
yet increased their overall survival it 
has increased the disease-free interval. 
Increasing the quality of life is suf­
ficient reason to search for the opti­
mal combination of chemotherapeutic 
and hormonal agents.
In our review, four of the seven 
premenopausal women with receptor­
positive, stage I or II disease were 
treated with various agents; none has 
had recurrent disease. This good re­
sponse may in part be due to their 
receptor-positive status.
Twelve of the receptor-negative 
women were also given adjuvant 
chemotherapy, yet 8 have had recur­
rence. This suggests that premeno­
pausal women with negative estrogen 
receptor values should be treated with 
more aggressive regimens. The ECOG
and NSABP trials, assessing several 
treatment regimens, may yield valuable 
results. For this reason we recommend 
that the estrogen receptor test be done 
on all women with breast cancer.
Although not dealt with in this 
study, there is another important rea­
son for using the estrogen receptor 
test. McGuire and associates1 and 
others have found that estrogen re­
ceptor values are useful in indicating 
which women (receptor-negative) will 
not benefit from secondary treatment, 
such as surgical castration with its 
inherent risks. By avoiding unpleasant, 
useless treatments we can increase 
the quality of life of many such 
women.
From this study we conclude that 
the estrogen receptor test done by the 
method of Heuson and colleagues is 
a useful prognostic tool in premeno­
pausal women and should continue
to be used so that this relatively new 
test can be studied further.
We thank Dr. W.J. Poznanski for 
technical assistance, Dr. C. Danjoux for 
advice and Mrs. P. Mair for secretarial 
help.
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L’hyperalimentation a domicile par voie digestive
Eric Poulin, md, frcp[c]* et Helene Langevin, dt pf
II n’existe que tres peu de rapports 
dans la litterature concernant I’usage 
de I'hyperalimentation a domicile 
par voie digestive chez les grands 
handicapes intestinaux.
Les auteurs presentent cinq malades 
qui ont ete traites a domicile durant 
un total de 78 mois par I'infusion 
continue d’une diete elementaire 
via une intubation nasogastrique. La 
plupart de ces malades avaient subi 
des resections massives de I'intestin.
A cause des differences de facilite 
d'utilisation, de morbidite, de couts 
et de complications psychologiques 
par rapport aux methodes d’hyperali- 
mentation intraveineuses a domicile, 
on suggere de reserver ces dernieres 
techniques pour les malades qui ont 
d'abord subi un echec a la therapie 
par voie digestive.
*Du service de chirurgie gene rale et 
+service de dietetique, Hopital du 
Saint-Sacrement, Quebec, PQ
Accepte pour publication le 4 fevrier, 
1982
Les demandes de tires d part doivent 
etre adressees an: Dr Eric Poulin, 
Service de chirurgie generale, Hopital 
du Saint-Sacrement, 1050, Chemin 
Ste-Foy, Quebec, PQ C IS  4L8
There are few reports in the 
contemporary literature on the use 
of home hyperalimentation by the 
enteral route, especially for intestinaliy 
crippled patients.
The authors describe five patients 
who had a total of 78 months of 
therapy by continuous nasogastric 
infusion of an elemental diet at home. 
The majority of the patients had 
undergone massive bowel resection.
Home intravenous hyperalimentation 
techniques are compared with respect 
to feasibility, morbidity, cost and 
psychologic impact for the patient. 
Because of the differences, the authors 
suggest that home intravenous 
hyperalimentation should be reserved 
for patients who have failed a trial 
of enteral therapy.
Pour corriger et meme prevenir les 
effets negatifs de la malnutrition, on 
a vu se developper rapidement, de­
pths les travaux originaux de Dudrick 
et collaborateurs,1 plusieurs techni­
ques d’alimentation intraveineuse tant 
centrale que peripherique. De fa?on 
parallele, on a obtenu des effets sem- 
blables par la voie digestive lorsque 
celle-ci etait utilisable.2"1
Depuis, certains malades ne sont 
hospitalises que pour des raisons d’in- 
tervention nutritionnelle, et quelques 
uns necessitent ces traitements a vie 
comme seul moyen de survie. Afin de 
rationaliser les couts de ces hospitali­
sations prolongees, on a assiste ces 
dernieres annees au developpement 
des techniques d’alimentation intra­
veineuse a domicile.49 Nous avons 
voulu evaluer la possibility d’utiliser 
la voie digestive, meme apres resec­
tion intestinale massive, comme mode 
de traitement a domicile pour des 
periodes plus ou moins etendues, et 
si possible, etablir les differences dans 
la facilite d’utilisation, la morbidite, 
les couts et les complications psycho­
logiques par rapport aux techniques 
intraveineuses.
Patients et methodes
Nous presentons cinq malades qui 
ont ete traites a I’Hopital du Saint- 
Sacrement de Quebec depuis 1978. 
Presque tous ces malades ont subi une 
diminution importante de leur surface 
d’absorption intestinale, soit par at- 
teinte radique, soit par resection chi- 
rurgicale pour maladie de Crohn ou
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volvulus du grele necrose. Aucun de 
ces malades n’etait capable de sub- 
venir a ses besoins nutritionnels en 
ingerant une diete normale, a cause 
de sa symptomatologie, de l’insuffi- 
sance des surfaces d’absorption, ou 
des deux a la fois.
Presentation des cas
Cas 1.—Une femme de 51 ans por- 
teuse d’une maladie de Crohn particu- 
lierement agressive depuis 1955, a subi
depuis, 17 hospitalisations pour diverses 
complications de sa maladie. Cinq chi- 
rurgies de resection lui ont laisse 120 
cm de jejunum (mesure peroperatoire, 
du cote mesenterique) sans ileon, colon, 
ou rectum. Elle a une jejunostomie ter- 
minale (fig. 1).
Cas 2.—Une femme de 57 ans a subi 
en 1953 une hysterectomie suivie de 
curietherapie pour une neoplasie du col 
uterin. En octobre 1978, elle a re?u 
6000 rad pour un epithelioma transi- 
tionnel de la vessie, grade II/III. Elle
FIG. 1—Cas 1. Representation graphique et radiologique de I'intestin restant 
chez cette malade operee a multiples reprises pour maladie de Crohn (120 cm de 
jejunum).
FIG. 2—Cas 2. Representation graphique et radiologique de I’atteinte radique. 
A noter la stagnation, les stenoses et dilatations du grele observees 48 heures apres 
le transit du grele.
developpa une enterite radique lui lais- 
sant des douleurs abdominales crampi- 
formes et de 10 a 12 selles par jour 
(fig. 2).
Cas 3.—Un homme de 28 ans a subi 
en juin 1976 une laparotomie pour clas­
sifier une maladie de Hodgkin (IIB). En 
fevrier 1979, il s’est presente a la salle 
d’urgence et il a du subir une resection 
massive de I’intestin grele pour un vol­
vulus necrose (fig. 3). Il lui est reste 
60 cm de jejunum et 10 cm d’ileon. Un 
mois apres l’operation, la quantite de 
selles se limita a 5 ou 6 par jour pour 
un volume variant entre 500 et 900 ml.
Cas 4 .—Une femme de 60 ans est
porteuse d’une maladie de Crohn depuis 
1958. Six resections intestinales pour des 
complications de la maladie lui ont laisse 
82 cm de grele (mesure sur le rebord 
mesenterique) et le colon gauche (fig. 4).
Cas 5 .—Un homme de 20 ans est
porteur d’une maladie de Crohn de
l’ileon depuis 1972. Peu tapageuse pen­
dant les premieres annees, sa maladie 
necessita en 1978 une hemicolectomie 
droite (10 cm d’ileon) et la resection d’un 
segment de jejunum (28 cm). Une 
deuxieme resection de 10 cm en 1979 
permit de traiter une hemorragie severe. 
A l’ete 1980, une nouvelle recidive de- 
vint tellement symptomatique que toute 
alimentation substantielle lui apportait 
des crampes abdominales et des diar- 
rhees tres importantes. Une remission
spontanee suivit 3 mois de traitement 
continu a la diete elementaire a domicile 
comnie seul apport nutritif.
FIG. 3—Cas 3. Representation gra­
phique de I’intestin restant apres resec­
tion massive pour volvulus necrose.
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Chez trois de ces cinq malades, le 
debut des traitements par diete ele- 
mentaire a ete precede d'une correc­
tion de la phase hydro-electrolytique 
du syndrome de l’intestin court et 
d’une periode d’hyperalimentatiori 
intra-veineuse centrale.
Les criteres de selection des mala­
des pour 1’hyperalimentation a domi­
cile par infusion continue d’une diete 
elementaire sont presentes au tableau 
I. Le protocole suivi a ete virtuelle- 
ment le meme dans tous les cas: Apres 
le traitement approprie, en milieu hos- 
pitalier, de la phase aigue de la mala- 
die, des renseignements pertinents sur 
la technique d’hyperalimentation par 
voie digestive et une bonne prepara­
tion psychologique sont fournis aux 
malades. Apres avoir accepte In te r ­
vention, les patients regoivent d’une 
infirmiere specialisee un enseignement 
pratique sur 1’insertion d’un tube de 
gavage. Deux types de tubes ont ete 
utilises soit les “infant feeding tubes” 
no 8 French de Argyle (Sherwood 
Medical Industries, Inc., St. Louis, 
Mo.) pour usage hospitalier et les nou- 
veaux tubes lestes en silicone Keo- 
feed (Hedeco, Mountainview, Calif.) 
lorsque Ton prevoyait une periode de 
traitement superieure a 2 mois. Ces 
derniers coutent cependant plus cher 
(0.75 vs $10.00 Can.). On enseigne 
aux malades les techniques de veri­
fication de la localisation du tube par 
aspiration de liquide gastrique a la 
seringue ou par la production d’un 
bruit epigastrique lors de 1’injection 
d air par le tube. Tous les malades 
deviennent remarquablement habiles 
et peuvent changer leur tube de ga­
vage a leur gre, de fagon tres securi- 
taire.
Une dietetiste specialisee en soins 
nutritionnels intensifs apprend ensuite 
aux malades a traiter les complica­
tions reliees au changement de debit 
de la solution (crampes, diarrhees) et 
leur enseigne la technique de prepa­
ration “propre mais non sterile” des 
dietes elementaires a domicile.
La plupart des malades ont d’abord 
subi une perfusion d’eau seulement 
dans leur “intestin court”, puis une 
perfusion de solute glucose a 5% 
pour evaluer la tolerance intestinale. 
Un programme initial de dilution des 
di&tes elementaires pour ce type de 
malade est presente au tableau II.
La duree de chacune des etapes est 
proportionnelle a la tolerance du ma­
lade et celui-ci n’est pas renvoye a 
domicile tant qu’il n'atteint pas un 
bilan azote positif et que 1’ensemble 
de son ingestion ne correspond pas a 
ses besoins nutritionnels.
A la maison, les solutions sont gar-
dees au refrigerateur et on conseille 
au malade de ne pas mettre plus que 
600 ml dans chaque sac pour ainsi 
diminuer la proliferation bacterienne 
qui se produit dans les solutions gar- 
dees trop longtemps a la temperature 
de la piece.10 Cette precaution permet 
aussi d’eviter les consequences en- 
nuyeuses d’une administration subite 
d’une tres grande quantite de solution 
hyperosmolaire, s’il y avait malfonc- 
tionnement de la valve d’administra- 
tion durant la nuit par exemple. On
Fig. 4b
FIG . 4— Cas 4. (a) Representation
graphique du greie et du colon restants 
chez cette malade ayant subi six resec­
tions intestinales pour maladie de 
C rohn, (b) Recidive de 20 cm dans le 
quadrant inferieur gauche avec fistule 
cutanee a bas debit non visible sur le 
cliche.
conseille de plus au malade d’elever 
la tete de son lit de 30° pour l’admi- 
nistration nocturne, afin d’eviter la 
possibility d’aspiration bronchique. On 
procede au lavage des sacs et tubu- 
lures a l’eau et au savon. comme s’il 
s’agissait de vaisselle ordinaire, et on 
les etend a secher apres les avoir 
rinces a 1’eau du robinet.
Le malade, en plus de revoir son 
medecin traitant, revoit aussi periodi- 
quement la dietetiste en soins nutri­
tionnels intensifs pour la correction 
des problemes techniques, s’il y en a. 
les evaluations nutritionnelles appro- 
priees et pour des conseils dans la 
progression vers l’alimentation nor- 
male. selon sa tolerance.
R esultats
Cette experience represente 78 mois 
d’hyperalimentation a domicile, soit 
pres de 7 annees-patients d’utilisation 
a domicile de dietes elementaires en 
infusion continue pour maintenir 
l’etat nutritionnel chez cinq grands 
handicapes intestinaux.
II n’y a eu aucune mortality et 
aucun des malades n’a subi de com-
Tableau I-Criteres de selection des malades 
et contre-indications relatives de I'hyperalimen 
tation elementaire a domicile par voie digestive
Criteres de selection
Echec de ('utilisation des aliments "nor- 
maux” pour se nourrir adequatement (bi­
lan azote negatif)
Succes de I'alimentation enterale par infu­
sion continue de diete elementaire lors 
d’un sejour hospitalier 
Comprehension et acceptation de la thera- 
pie par le malade et sa famille 
Motivation a reussir le traitement 
Autonomie de la personne 
Acces facile a la consultation a I'hopital si 
necessaire
Contre-indications relatives 
Difficulty a avaler 
Hocquet
Fistule digestive haute 
Diarrhee importante 
Vomissements
Diminution de I'etat de conscience 
Debilite mentale
Tableau 11-Administration 
progressive de la diete 
elementaire
Apport
Jour Cal ml
1 750 1500
2 1200 1500
3 1500 1500
4 et
suivants +300/j +300/j
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plications techniques ou septiques re- 
liees a la methode. Au plus, quelques 
episodes de diarrhees et de crampes 
abdominales nous ont ete signales par 
les malades lors d’erreurs de regula­
rity dans le debit des solutions. Au- 
cun malade n’a souffert de pneumonie 
d’aspiration et aucun incident hemor- 
ragique du a l’insertion ou au main- 
tien prolonge des tubes de gavage 
n’a ete observe.
Du cote metabolique, nous avons 
verifie des episodes d’hypoglycemie, 
de 3 a 4 heures apres l’arret de l’in- 
fusion, chez la malade (cas 1) a qui 
il ne reste que 120 cm de jejunum et 
une jejunostomie. Cette malade a un 
calendrier d’infusion de 18 heures par 
jour et au lieu de recommencer son 
infusion de diete elementaire tot en 
apres-midi, lors de l’apparition de 
symptomes, elle consomme des liqui- 
des contenant des sucres simples afin 
de pouvoir continuer ses activites a 
l’exterieur.
Nous avons ete agreablement sur-
pris par la facilite ?.vec laquelle les 
malades utilisent les tubes nasogas- 
triques. Quoique la plupart des ma­
lades preferent enlever leur tube de 
gavage pour effectuer des sorties, une 
malade (cas 1) le porte durant des 
periodes prolongees, ne l’enlevant que 
pour des nettoyages periodiques. Elle 
ne le considere “pas plus ennuyeux et 
visible qu’un appareil auditif’’.
II est aussi a noter que depuis le 
debut de notre experience, aucun de 
ces malades n’a du etre rehospitalise 
en raison de complications dues a la 
methode; au fait, les seules rehospi­
talisations sont survenues chez un ma­
lade (cas 3) qui a du subir une chole- 
cystectomie, et chez une malade (cas 
4) qui a presente une recidive de la 
maladie de Crohn affectant 20 des 
82 cm d’intestin grele qu'il lui reste.
Du cote nutritionnel, les malades 
ont pu augmenter leur poids durant 
la duree du traitement (tableau III) 
malgre la severite de l’atteinte intes- 
tinale. La plupart se sont rapproches
Tableau 111- Profii ponderal
Longueur du grele, Poids, kg
Cas no cm Habituel Initial Actuel
1 120 50 37.5 51
2 Normal mais irradie 54 42 47.5
3 70 63 47 65
4 82 51 37.5 42
5
_ ____
>2 m 55 50 47
Tableau IV-Resume d'ingestion
Autres ingestion durant Temps
Cas no
Depense energetique 
basale, Calfj*
Calories infusees 
a domicile, Ij
le traitement, Cal d'infusion
Debut Fin h/j
1 1300 1800 0 500 18
2 1200 1500 700 1800 16
3 1600 1200 500 2000 12
4 1000 1200 500 800 12
5 1500 3000 200 2000 24
"Formule de calcui de la depense energetique basal; hommes = 66 + (13.7 x poids/kg) + (5 x 
taillefcm) - 6.8 age, femmes = 655 + (9.6 x poidslkg) + (1.7 x tailielcm) - 4.7 age.
Tableau V-Caracteristiques des malades
Cas no Diagnostic
Debut du 
traitement
Duree du 
traitement a 
ce jour, mo Pronostic
1 Crohn mars 1978 36 Traitement a vie
2 Entente radique octobre 1979 4 Traitement cesse
3 Volvulus et necrose 
du grele mars 1979 23 Traitement cesse
4 Crohn fevrier 1980 12 Traitement a vie
5 Crohn aout 1980 3 Traitement cesse
en de?a de 10% de leur poids habi- 
tuel et, jusqu'a ce jour, on maintenu 
ce poids.
II faut aussi realiser la flexibility du 
traitement par infusion de diete ele­
mentaire a domicile. Plus l’atteinte in- 
testinale etait severe, plus l’ingestion 
d’aliments autres que la diete elemen­
taire en infusion a ete limitee. Cepen- 
dant, a mesure que l’adaptation intes- 
tinale s’est faite ou que la maladie 
est entree en remission, l’ingestion 
d’aliments “normaux” par le malade 
a augmente. Les malades eux-memes 
se livrent frequemment a des expe­
riences et viennent a connaitre leurs 
limites en alimentation normale.
De plus, pour avoir enseigne aux 
malades la redaction d’un journal die- 
tetique periodique, la dietetiste est 
parvenue a evaluer (tableau IV) la 
quantite de calories ingerees par les 
malades. Ainsi, elle a pu regler le 
temps et le volume des infusions de 
farjon a satisfaire les besoins nutri- 
tionnels.
Pour certains malades, la progres­
sion qualitative et quantitative de l’in~ 
gestion orale d’une diete normale, 
sans provoquer de nouvelle sympto- 
matologie intestinale, s’est soldee par 
1’arret de la therapie (tableau V). Ce- 
pendant, deux malades necessiteront 
probablement cette therapie durant 
toute leur vie.
De tops les malades que nous avons 
decrits, la plupart ont presente, a un 
moment ou I'autre de leur maladie 
chronique. des problemes psycholo- 
giques importants (tableau VI).
Cependant, a part un refus initial 
de traitement exprime sous le coup 
du decouragement par la plupart des 
malades, et les quelques problemes 
crees par les malades ayant des ante­
cedents psychiatriques, l'acceptation 
de la therapie a ete uniforme. Les 
malades comprennent facilement les 
principes de base de l’administration 
des dietes elementaires et ne sont pas 
effrayes par les aspects techniques 
qu’ils maitrisent facilement. 11s ont de 
plus la sensation d’avoir la possibility 
de controler le traitement. Ils expri- 
ment egalement leur satisfaction du 
fait que la therapie peut etre inter- 
rompue et reprise de fa^on abrupte, 
sans probleme metabolique, s’il sur- 
vient une circonstance imprevue ne- 
cessitant un deplacement hors de la 
maison.
Discussion
Quoique la litterature recente pre­
sente plusieurs series de malades trai- 
tes a domicile par alimentation intra- 
veineuse centrale,4’6'9 elle est avare de 
rapports sur les traitements a domicile
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par infusion continue de dietes ele- 
mentaires11,12 et elle est pratiquement 
inexistante quant aux cas de resection 
intestinale massive. Pourtant des 
1976, Shaffer et collaborateurs13 rap- 
portaient le cas d’un malade souffrant 
d’un syndrome de Gardner ayant subi 
1 amputation massive de la majeure 
partie de l'intestin grele pour envahis- 
sement mesenterique d’une tumeur 
desmoide. Ce malade, a qui il ne 
restait que quelques centimetres d’in- 
testin grele, est, jusqu’a ce jour, main- 
tenu a domicile avec 1’infusion noc­
turne d’une diete elementaire par un 
tube de gastrostomie (Brown RA: 
Communication personnelle, 1981). T1 
mene une vie active et travaille re- 
gulierement comme representant en 
valeurs immobilieres.
Nous croyons done, avec la serie 
de malades que nous presentons, que 
le syndrome du soit-disant “intestin 
court” ne devrait pas constituer, en 
soi, un critere d’exclusion absolu a 
cette forme de traitement a domicile.
II est toujours surprenant de cons- 
tater que lorsqu’un systeme continu 
de perfusion goutte a goutte est uti­
lise, comme dans la methode decrite. 
une quantite importante de substrat 
peut etre fournie au malade et ab- 
sorbee par une surface minimale d’in- 
testin grele. Par exemple, a un debit 
de 100 m l/h en infusion de 24 beures, 
on peut fournir 2400 Cal au malade 
en une journee et il ne faut pas une 
tres grande surface intestinale pour 
absorber en une heure 100 ml d’une 
solution predigeree d’elements nutri- 
tifs reduits a leur plus simple expres­
sion, tels sucres simples, acides ami­
nes et electrolytes mono ou bivalents. 
L’absorption se fait alors a un rythme 
de 1.6 ml/min.
Nous croyons aussi qu’une tech­
nique qui fait appel a la modification 
d’une fonction familiere au malade 
est plus facile a comprendre par celui- 
ci. Elle ne necessite pas une periode 
d’entrainement prolongee et une in­
frastructure medicale et para-medicale 
onereuse comme celle decrite pour 
l’alimentation intraveineuse a domi­
cile. Nous croyons meme que la tech­
nique d’hyperalimentation a domicile
par voie digestive est a la portee de 
la plupart des milieux hospitaliers.
Si Ton se refere aux publications 
qui decrivent les experiences d’hyper­
alimentation intraveineuse a domi­
cile,4,69 on est a meme de constater 
une morbidity non negligeable et une 
mortality occasionnelle par septicemie 
avec ce mode de traitement. De plus, 
le malade doit etre rehospitalise pour 
toutes sortes de complications reliees 
soit au catheter sous-clavier, a une 
infection ou a une panoplie de pro­
blemes metaboliques associes a l’ali­
mentation intraveineuse prolongee.
Au chapitre des couts, les dietes 
enterales coutent de quatre a cinq fois 
moins que les solutions pour alimen­
tation intraveineuse (tableau VII). Si 
on ajoute a cela les couts de refrige­
ration, de fabrication et de transport 
des solutions, les fournitures diverses 
pour les changements de pansement 
sous-clavier et le temps du personnel 
qui doit controler periodiquement la 
qualite des soins, la note augmente 
encore. A ceci s’additionnent les couts 
de traitement des diverses complica­
tions de la technique qui peuvent ne- 
cessiter certaines periodes de rehospi­
talisation.
Le cout total d’une annee de the- 
rapie intraveineuse a domicile peut 
varier de $30 000 a $50 000 et peut 
vraisemblablement etre de 8 a 10 
fois plus important que celui de la 
therapie par voie digestive.
Que la therapie nutritionnelle soit 
donnee par voie intraveineuse ou di­
gestive, ces malades qui requierent 
une intervention nutritionnelle suscep­
tible de se prolonger toute leur vie, 
presentent des problemes psychologi- 
ques particuliers, surtout lorsqu’ils 
sont atteints d'une affection chronique 
et recidivante telle la maladie de 
Crohn (tableau VIII).
Cependant, les malades qui sont a 
1’alimentation intraveineuse a domi­
cile doivent en plus acquerir une ex­
pertise speciale qui leur apporte des 
problemes particuliers. Ils deviennent 
responsables des solutions intravei- 
neuses, ils doivent surveiller un sys­
teme pompe-catheter et eviter toute 
infection du systeme. Ils developpent
une dependance envers la technique 
et 1’equipe traitante qui provoque des 
reactions depressives et une peur se- 
rieuse des complications possibles. 
D’ailleurs on rapporte que la plupart 
de ces malades ont des incidents se- 
rieux a raconter tels hemorragies, 
thromboses du catheter et arret de la 
pompe d’infusion.14,15
Malgre tous les problemes psycho- 
logiques particuliers a ces malades. 
nous n’avons pas remarque de telles 
reactions de dependance. de frustra­
tion et de peur avec l’alimentation 
par voie digestive a domicile. Il faut 
dire que certaines activites tels le bain 
et la douche sont limitees avec la 
technique intraveineuse a cause de la 
possibility de contamination du ca­
theter sous-clavier; elles sont possibles, 
sans restriction, avec la technique par 
voie digestive. De plus, comme il n’y 
a pas de problemes de transport ou 
de preparation, les voyages a I’exte- 
rieur sont plus faciles. En effet, la 
diete elementaire est presentee sous 
forme de sachets en poudre faciles a 
emporter et a preparer comparative- 
ment aux sacs ou bouteilles refrigeres 
de l’hyperalimentation intraveineuse.
De par son aspect “plus naturel”. 
sa technologie plus facile a compren­
dre et a appliquer et sa versatility, 
l'alimentation a domicile par voie di­
gestive permet d’exercer avec plus de 
facility un plus grand nombre d’ac- 
tivites. Les malades traites par voie 
digestive n’ont pas 1’impression que 
l’equipe traitante gere leur vie quoti- 
dienne.
Conclusions
Lorsqu’un malade necessite une 
technique d’alimentation intensive a
Tableau Vll-Couts par 2000 Cai/j pour 1 an
Cout, $
Diete Total Par jour
Non elementaire 
Elementaire standard
1 789.00 4.90
(20 g N/l)
Elementaire surplus
4 380.00 13.00
proteique (40 g N/l) 
Hyperalimentation
8 760.00 24.00
intraveineuse 20 075.00 55.00
Tableau VIII-Problemes psychologiques 
des grands handicapes intestinaux
Negation de la maladie 
Desespoir, depression, anxiete 
Perte de fonction de l’alimentation (deuil) 
Alteration de la fonction sexuelle 
Alteration de I’image corporelle 
Hypomanie, reactions paranoides
Tableau VI-Problemes psychologiques*
Cas no Antecedents
Refus
initial
Reaction
depressive
Reaction
psychotique
Cooperation 
au traitement
1 - +  +  + - - + + +
2 - +  + + - + + +
3 + - - + + + +
4 +  + + +  + + - +
5 - - - + + +
* -  =  absent, +  =  faible, + +  =  modere, + +  +  =  important.
-s
■ X 
-X
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domicile, nous croyons que tous les 
efforts devraient etre faits pour utili- 
ser des dietes elementaires en infusion 
continue avant de songer a l’hyper- 
alimentation intraveineuse a domicile.
•  La technique est possible malgre 
des resections intestinales impor- 
tantes.
•  Les couts en comparaison avec 
rhyperalimentation intraveineuse a 
domicile sont nettement inferieurs.
•  La morbidite est negligeable.
•  Les aspects techniques et physio- 
logiques de l’administration enterale 
sont plus facilement compris du ma- 
lade et necessitent beaucoup moins de 
support professionnel.
•  Le traitement est bien accepte 
par Ie malade. II n’y a pas de pro- 
blerne psychologique majeur tel un 
sentiment d’alienation a la technologie 
du traitement ou de dependance a 
l’egard de 1'equipe traitante.
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continued from page 574
evitably limited in this type of general 
text and a specific monograph is needed 
to achieve an understanding of such 
developments.
Despite these limitations, it is a re­
liable account of gynecologic surgery, 
clearly based on excellent technique 
and extensive clinical experience. It will 
provide useful reading for the general 
gynecologist or general surgeon who has 
to cope with pelvic problems.
M e l v i l l e  G .  K f.r r , m b . c h  b . f r c o g . 
f r c s ( e d i n ) ,  f r c s [c ]
Professor and head,
Obstetrics and gynecology,
Foothills Hospital,
Calgary, Alta.
CLINICAL SCIENCE FOR SUR­
GEONS. Edited by William Burnett. 
849 pp. Illust. Butterworth & Co. 
(Canada) Ltd., Scarborough, Ont., 
1981. $99.95. ISBN 0-407-00181-6.
Produced by a group of specialists, some 
who are members of the Board of 
Examiners of the Royal Australasian 
College of Surgeons and many others 
such as W. Burnett. H. Dudley, J.E. 
Dunphy, G.B. Ong and Sir E. Hughes 
who are world renowned, this book fills 
a void for the surgeon in training in 
the field of clinical sciences — that of 
basic sciences. The contents are estab­
lished facts as of 1981 — not contro­
versies.
The text comprises three sections: the
basis of clinical science, major systems 
of the body and the principles of surgi­
cal practice.
The basis of clinical science encom­
passes the physiology of the normal cell, 
changes in growth and aging, a con­
sideration of cell injury and adaptation, 
basic concepts of neoplasia, inflammation 
and immunology. There are presenta­
tions on system control, body water and 
electrolytes and fundamentals of meta­
bolism and nutrition.
The second section, major systems of 
the body, considers the nervous, cardio­
vascular, respiratory, alimentary, urinary, 
endocrine and musculoskeletal systems 
and places emphasis on areas such as 
the breast.
The principles of surgical practice con­
tains a number of most important chap­
ters necessary for the practice of surgery, 
but which we do not often find together 
in one text; for example, relevant pre­
operative, operative and postoperative 
assessment of the patient, physics 
and principles of radiation. laser, 
ultrasonics, kinetics of drug therapy, 
mechanics of pain, hazards in the operat­
ing room and the science of ergonomics. 
Research principles such as clinical trials 
and statistics and the value of the com­
puter are discussed.
The format of the volume is excellent 
and the book is easy to read. Each chap­
ter has its own table of contents.
Between the covers of one book the 
principles of physiology, biochemistry, 
pathology, pharmacology and physics are 
brought together in a concerted, organ­
ized, coordinated manner pointing out 
their relevance and application to the
theory and practice of all fields of sur­
gery.
This is an extremely detailed, compre­
hensive text and is most desirable for 
all surgeons in training and for the 
qualified surgeon to help them keep 
abreast of the advances, now that re­
certification is imminent.
A l f r e d  J. S t e d m a n . m d , f r c s [c ],
FACS
Department of surgery.
Grace General Hospital,
Ottawa. Ont.
SYNOPSIS OF CRITICAL CARE. 
Practical Management of the Acutely 
III. Edited by William J. Sibbald. 269 
pp. Illust. Critical Care/Trauma Unit, 
Victoria Hospital, London, Ont., 1980. 
$13.95 (Can.), paperbound.
If this book has a real place, it is in 
the medium- to smaller-sized hospitals. 
It contains a wealth of information that 
is easy to find and retrieve in a hurry 
and covers almost the entire field of 
acute critical care medicine in a re­
markably concise manner.
In a treatise of this type it is always 
extremely difficult to know at what level 
to pitch one’s information. Each of the 
various sections in this book contains 
some elementary remarks on physiology 
and pathophysiology that may seem 
too basic to be of use to anyone 
treating the. problems and conditions 
dealt with in the text. However, in 
emergency situations, a brief review of 
the basics would indeed be a help to
continued on next page
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the generalist or individual called upon 
to administer urgent care or treatment. 
For this reason the book is valuable to 
those treating emergencies without the 
full back-up and potential of institutions 
that have larger critical care units and 
readily available specialist care.
If there is any defect in this work 
it is the recommendations and proposals 
put forward for situations where there 
is full specialist back-up. These may 
not be applicable where such help is 
not available, in which case, clearly 
spelled out alternative courses of ac­
tion in less than optimal situations 
would have helped, with perhaps some 
tips on transportation of the patient. 
An example of the problem is given in 
airway emergencies in children. This 
chapter deals with diagnosis and symp­
toms well. It states that “tracheostomy 
is considered radical at present” and 
outlines the care as being optimum if a 
nasal endotracheal tube is used by an 
otolaryngologist inserted under general 
anesthesia administered by an anesthetist. 
While one agrees that this is the ideal, 
some reference to what should be done 
in less than ideal situations would be 
helpful indeed. There are other exam­
ples of a similar nature in the book.
I found that the most helpful sections 
were those on cardiac emergencies, acute 
disturbances of consciousness, shock, 
trauma and acute poisonings.
In summary, this book is readable. It 
is concise with little wasted paper or 
words, well illustrated and beautifully 
presented. Information can be found
quickly. It is one of the most up-to-date 
works available for the smaller- or me­
dium-sized hospital or intensive care
unit, where it should be on hand and 
ready for use at any time.
J o h n  Ross, m d , f c f p
Family practice unit,
Health Science Centre,
Memorial University of Newfoundland, 
St. John’s, Nfld.
TECHNIQUES IN SKIN SURGERY.
Ervin Epstein and Ervin Epstein, Jr.
203 pp. Illust. Lea & Febiger, Phila­
delphia; The Macmillan Company of
Canada Limited, Toronto, 1979.
$22.50. ISBN 0-8121-0677-6.
This concise text on dermatologic 
surgery outlines the various surgical pro­
cedures with little discussion of alter­
native methods of treatment. Basic sur­
gical principles are clearly outlined as are 
the sections on scalpel and scissors sur­
gery, shave surgery and skin biopsy tech­
niques. A series of short chapters covers 
endothermy and cautery excision, elec­
trodesiccation, electrocoagulation, cryo­
surgery, cosmetic and superficial chemo­
therapy, Moh’s technique, hair trans­
plantation, nail surgery, dermabrasion 
and the various office procedures for 
skin cancer, acne and xanthelasma, 
hidradenitis, superficial cysts and rhino- 
phyma. Each one details the indications, 
contraindications, equipment required,
preoperative preparation, procedure and 
postoperative care, the advantages and 
disadvantages and then evaluates the 
various procedures. The authors have 
included an excellent chapter on cardio­
pulmonary resuscitation and there is also 
a discussion on local anesthetics listing 
in table form the approximate maxi­
mum dose for an average adult.
Preoperative, intraoperative and post­
operative illustrations would have been 
of great assistance in almost every 
chapter, but the authors have obviously 
tried to save space. In the chapter on 
cosmetic chemotherapy, the statement 
“this procedure can be utilized to era­
dicate wrinkles” might be misleading 
since the operation will only improve, 
not eliminate, this problem. The section 
on hair transplantation should have in­
cluded some statistics on patient satisfac­
tion and the overall appearance of the 
scalp postoperatively. Many surgeons 
would disagree with the use of dermabra­
sion for treating labial leukoplakia, 
Bowen’s disease and superficial basal cell 
epitheliomas. The chapter on Moh’s tech­
nique is well written. The chapter on skin 
cancer discusses alternative methods of 
treatment including excision, electro­
desiccation. radiotherapy and chemo- 
surgery. The final chapter on rhino- 
phyma, which is well outlined, might have 
included the combination of shaving 
and dermabrasion for this condition.
In summary, this textbook on derma­
tologic surgery should be of value to 
the medical student and resident and, as 
a quick reference, to the more experi­
enced clinicians who perform these pro­
cedures.
H. B r u c e  W i l l i a m s , m d , f r c s [c ] 
Director,
Plastic and reconstructive surgery,
The Montreal General Hospital, 
Montreal, PQ
TRANSACTIONS OF THE AMER­
ICAN ASSOCIATION OF GENITO­
URINARY SURGEONS. Volume 
LXXI. 1979. American Association of 
Genito-Urinary Surgeons. 164 pp. 
Illust. The Williams & Wilkins Com­
pany, Baltimore; The Macmillan 
Company of Canada Limited, To­
ronto, $37.95, paperbound.
This book is basically a compilation of 
papers presented during the 1979 an­
nual meeting of the American Associa­
tion of Genito-Urinary Surgeons. The 
authors are leading urologists and the 
work presented is, generally, original 
and stimulating. Furthermore, the book 
contains discussion of the papers by 
knowledgeable people in the field. The 
reader will find these discussions most 
interesting and they will help to place 
the work in its proper perspective.
The subjects discussed in this book 
cover a broad spectrum and, as in 
previous editions, are topical and 
thought-provoking. The main advan­
tage of having access to these transac­
tions is to become familiar with current 
investigative work taking place in lead-
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ing centres in the western hemisphere. 
Unfortunately, much of this advantage 
is lost because of the time lag between 
presentation and publication of the book. 
During this time, most of the work will 
have been presented at other meetings 
and published in other scientific journals, 
so the urologist will find little new 
in this publication. Nevertheless, I be­
lieve the book should be acquired by 
every medical school library to be avail­
able as a reference for residents and 
staff.
Said A. A wad , m d , fr c s | c]
Member,
Editorial Board.
Professor and head,
Department of urology,
Dalhousie University,
Halifax, NS
TRAUMA CARE. Edited by William 
Odling-Smee and Alan Crockard. 657 
pp. Illust. Grime & Stratton, Inc., 
New York; Academic Press Canada, 
Don Mills, Ont. 1981. $58.50. ISBN 
0-8089-1271-2.
With contributions by 19 authors, this 
book is presented as a complete manual 
on trauma care. The material has been 
chiefly based on the experience of the
group from the Royal Victoria Hospital 
in Belfast, but the principles outlined 
apply to any hospital in any country.
The first 11 chapters are devoted to 
general principles and include such topics 
as the metabolic response to trauma, 
tissue repair and renal failure after 
trauma. These are set out in a straight­
forward manner. Especially well pre­
sented are the last 19 chapters, which 
cover in a systematic fashion the recog­
nition and treatment of specific injuries. 
Each chapter is preceded by an action 
list, which alerts the readers and pre­
pares them for what is to follow. In all 
sections principles are set out in a log­
ical sequence. There is an abundance of 
line diagrams.
This is an outstanding work. It moves 
well from one chapter to the next and 
reads well. It is, I believe, a complete 
working manual for emergency room 
physicians. It should be required study 
material for surgical residents. It is a 
good reference book for nurses working 
in emergency rooms. The principles of 
trauma would be excellent reading for 
medical students in their final year.
C.M. C o u v e s . M D . f r c s ( f.d i n ) ,
FRCS[C]
Kelowna General Hospital,
Kelowna, BC
CLASSIFIED ADVERTISING 
As a further service to its readers 
the Canadian Journal of Surgery is 
pleased to accept suitable classified 
advertisements. The deadline is 1 
month before the issue date. Copy 
should be mailed to: Canadian
Journal of Surgery, PO Box 8650, 
Ottawa, Ont. K1G 0G8. Rates are 
available on request.
COLON AND RECTAL SURGEON —  tra ined in 
endoscopy, wanted for association w ith  general 
surgeon and proctologist. Established com m u­
nity  practices w ith in  a 80 km radius of New York, 
on the northeastern seaboard. Associated w ith  
teaching hospitals, university a ffilia ted . Salary 
and fringe benefits, leading to fu ll partnership. 
Send curriculum  vitae to : Robert E. Sax, MD, 
782 C lin ton Ave., Bridgeport, Connecticut 06604, 
USA. — S82-018
ORTHOPEDIC SURGEON: PQ —  M cG ill U niver­
s ity  and Royal V ictoria Hospital —  geographic 
fu ll-tim e  orthopedic surgeon to jo in  academic 
s ta ff o f M cGill Faculty o f M edicine as associate 
professor w ith  equivalent sta ff appointm ent at 
the Royal Victoria Hospital. Applicant must have 
extensive experience in undergraduate and post­
graduate teaching as w e ll as research tra in ing  in 
immunology w ith  special sk ills  in ce ll cu ltu re . 
Appointment w ill be made in accordance w ith  
Canadian Immigration requirem ents. Please con­
tact: Dean Richard L. Cruess, Faculty of M edicine, 
M cG ill University, 3655 Drummond St., M ontrea l, 
PQ H3G 1Y6. — S82-017
Plastic Surgeon
•Required for an Active Staff appointment in a University affiliated hospital in Toronto.
Qualifications
•  Fellowship in Plastic Surgery by the Royal 
College of Physicians and Surgeons of 
Canada.
•  A minimum of one year training in microsurgery.
•  Training in basic science or clinical research.
Duties
•  Active clinical general plastic surgery 
hospital staff appointment.
•  Supervision of microvascular Resident 
Training laboratory.
•  Clinical and basic science microvascular research.
•  Regular clinical and academic postgraduate 
teaching of Junior Rotating Interns and 
Plastic Surgery Residents.
Remuneration
•  Fee for service.
•  Possible supplementary stipend 
for Research activities.
Date of Appointment
•  January 1st, 1983
Apply to
Dr. A. Freiberg
Head, Service of Plastic Surgery 
Director of Medical Education 
St. Joseph’s Health Centre 
30 The Queensway 
Toronto, Ontario 
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Claforan
■ (cefotaxime sodium)
IM / IV
i
ANTIBIOTIC
ACTION
In  v itro  studies indicate tha t the bacterial action o f CLAFORAN (cefotaxime sod ium l a 
sem isynthetic  cephalosporin antib iotic, results from  inh ib ition  of cell wall synthesis,
INDICATIONS AND CLINICAL USES
CLAFORAN (cefotaxime sodium ) may be indicated fo r the trea tm ent o f infections 
beVow- suscePt'ble strains o f the designated m icro-organism s in the diseases listed
Lower respiratory tract infections: pneumonia and lung abscess caused by 
Streptococcus pneum oniae  (form erly Dip/ococcus pneum oniae), o ther Streptococci 
(excluding \ Enterococci, e.g.,S. faecalis), Staphylococcus aureus (penicillinase and 
non-pen ic illinase producing), Escherichia coli. Hem ophilus in fluenzae, (including 
am p ic illin -res is tant strains), and unspecified Klebsiella  species.
Urinary tract infections: caused by Escherichia coli, unspecified Klebsiella species 
(inc lud ing K. pneum oniae), Proteus m irabilis, indole-positive Proteus, Serratia 
m arcescens  and Staphylococcus epidermidis. Also, uncom plicated gonorrhea caused 
by/v. gonorrhoeae  including penicillin-resistant strains.
Bacteremia/Septicemia: caused by Escherichia coli, unspecified Klebsiella strains and 
Serratia marcescens.
Skin infections: caused by Staphylococcus aureus  (penicillinase and non-penicillinase 
producing), S. epidermidis, Group A Streptococci, Escherichia coli, Proteus m irab ilis  
and indo le -positive  Proteus.
Intra-abdominal infections: caused by Escherichia coli, and unspecified Klebsiella 
species.
Gynecological infections: inc luding pelvic in flam m atory disease, endom etritis and 
pelv ic ce llu lit is  caused by E. coli, Group A  Streptococci and Staphylococcus 
ep iderm id is , anaerobic bacteria including unspecified Peptococcus and 
Peptostreptococcus  strains and some strains o f Bacteroides fragilis. In several cases 
a lthough c lin ica l cures were achieved, bacteriological fo llow -up  was not available. 
C lin ica l experience with CLAFORAN in anaerobic in fections is lim ited. CLAFORAN has 
been used w ith  some success in wound and in tra-abdom inal in fections against some 
stra ins o f un identified Bacteroides and anaerobic cocci.
CLAFORAN has been shown to be active against som e strains o f Pseudomonas.
In the  trea tm en t o f  infections encountered in im m unosuppressed and granulocytopenic 
patients, results o f therapy w ith  cefotaxim e have not been impressive.
CLAFORAN shou ld  not be considered in the trea tm ent o f enterococcal in fections i e 
Strep, faecalis. ' ‘
Specim ens fo r  bacteriologic culture should be obtained p rio r to  therapy in order to 
n i A c ^ o  a MldT u tify  the causat.ive organisms and to determ ine the ir susceptib ilities to 
CLAFORAN. Therapy may be instituted before results o f susceptib ility  studies are 
know n; an tib io tic  treatment should be re-evaluated once these results become 
available.
CONTRAINDICATIONS
CLAFORAN is contraindicated in patients who have shown hypersensitiv ity to 
ce fo tax im e sod ium , the cephalosporin, or the pen ic illin  groups o f antib iotics.
WARNINGS
Before therapy w ith  CLAFORAN is instituted, it m ust be determ ined whether the patient 
nas had p rev ious hypersensitivity reactions to cefotaxim e, cephalosporins, pen icillins 
o r o the r drugs. CLAFORAN should be given w ith  caution to patients w ith  Type 1 
hype rsens itiv ity  reactions to  penicillin. Antib iotics, including CLAFORAN should be 
adm in is tered w ith  caution to  patients w ho have dem onstrated som e form  of allergy 
particu la rly  to  drugs. If an a llergic reaction to  CLAFORAN occurs, the drug should be 
d iscontinued and the patient treated w ith  the usual agents (e.g. epinephrine, 
an tih is tam ine , pressor amines or corticosteroids).
PRECAUTIONS
Pregnancy: The safety o f CLAFORAN (cefotaxime sodium ) in pregnancy has not been 
'ed' Consequentty, use o f the drug in pregnant wom en requires that the likely 
benefit from  the  drug  be weighed against the possible risk to  the m other and fetus.
NKUrS! % M o th e rs : CLAFORAN is excreted in human m ilk in low  concentrations. Caution 
snou ld be exercised when the drug is administered to nursing mothers.
Pediatric Use: The safety and effectiveness o f CLAFORAN in in fants and children have 
ys t been establ ished. It has, however, been used in ch ildren a t a dosaqe range o f  
100-150 m g /k g /d a y  in  2-4 d iv ided  doses.
Kidney : A lth ough  CLAFORAN rare ly produces alterations in kidney function, evaluation 
o t renal status is recom mended, especially in severely ill patients receiving high doses. 
Patients w ith  m arked ly impaired renal function should be placed on the special dosage 
schedule recom m ended under DOSAGE AND ADMINISTRATION, because normal 
m eta bo lite s86 indivicJua*s are to produce excessive serum concentration o f the
Prolonged use o f CLAFORAN m ay result in the overgrow th o f nonsusceptible 
organism s. Constant observation o f the patient's cond ition is essential. If superinfection 
occurs, the rapy shou ld be discontinued and appropriate measures taken.
Positive d irect C oom b 's test is known to develop in ind iv idua ls du ring  treatm ent w ith  
the  cepha losporin  group of antib iotics, including cefotaxim e sodium .
In labora to ry tests a false positive reaction to glucose m ay occur w ith  reducing 
substances bu t no t w ith  the use o f specific glucose oxydase methods.
ADVERSE REACTIONS
The m ost freq uen t adverse reactions encountered are:
Local (5%) -  in jec tion  site in flam m ation w ith  intravenous adm in istration. Pain, 
in dura tion  and tenderness after in tram uscular injection.
Hypersensitivity (1.8%) -  Rash, pruritus, fever.
Gastrointestinal (1.7%) -  Colitis (not pseudomembranous), diarrhea, nausea, and 
vom iting . A  few  cases o f pseudomembranous colitis  have been reported.
Hemic and Lymphatic System -  M ild reversible leukopenia, granulocytopenia and 
th ro m bo cytope n ia  have been reported. Some patients developed positive direct 
C oom b 's test du rin g  treatment w ith  CLAFORAN (cefotaxime sodium ).
Genitourinary System -  Moniliasis, vaginitis.
Central Nervous System (0.2%) -  Headache.
Liver -  T ransient elevations in SGOT, SGPT, serum LDH, and serum  alkaline 
phosphatase levels have been reported.
Kidney -  Increased serum  creatinine and BUN have occasionally been observed.
SYMPTOMS AND TREATMENT OF OVERDOSAGE
Since no case o f overdosage has been reported to date w ith  CLAFORAN, no specific 
in fo rm a tion  on sym ptom s or trea tm ent is available. Treatment o f overdosage should be 
sym ptom atic .
DOSAGE AND ADMINISTRATION
CLAFORAN (cefo tax im e sodium) m ay be administered in travenously or 
in tram uscu la rly  a fte r reconstitution (see table w ith  recom mended m ode of 
reconstitu tion  accord ing to route o f adm inistration). Dosage and route o f adm inistration 
shou ld be dete rm ined  by susceptibility o f the causative organism s, severity o f the 
in fection and con d itio n  o f the patient.
(grams) Frequency and Roirta
1 1 gram IM (single dose)
2 1 gram every 12 hours 
IM or IV
3-4 1 gram every 6-8 hours 
IMor IV
4-6 1 gram every 4-6 hours 
IMor IV
6-8 2 grams every 6-8 hours IV
up to 12 2 grams every 4 hours IV
AMOUNT OF APPROXIMATE APPROXIMATE
DILUENT TO WITHDRAWABLE AVERAGE
BE ADDED VOLUME CONCENTRATION
(ml)# (ml) (mg/ml)
2 2.2 230
3 3.4 300
5 6.0 330
10 10.2 50
10 10.4 95
10 11.0 180
USUAL ADULT DOSAGE OF CLAFORAN (CEFOTAXIME SODIUM)
n.iiw itou
Type of Infection
Uncomplicated Gonorrhea
Uncomplicated infections 
such as pneumococcal 
pneumonia or acute urinary 
tract infection
Moderately severe 
infections
Severe infections
Infections commonly 
needing antibiotics in 
higher dosage 
(e.g., septicemia)
Life-threatening infections
THE M AXIM UM  DAILY DOSAGE SHOULD NOT EXCEED 12 GRAMS.
Adm in istra tion  o f CLAFORAN should be continued fo r a m in im um  o f 48 to 72 hours 
after the pafentdefervesces o r after evidence of bacterial eradication has been 
obtained; a m in im um  o f 10 days o f trea tm ent is recommended fo r infections caused by 
Uroup A  beta-hem olytic Streptococci in order to guard against the risk o f rheumatic 
Tever o r g lom erulonephritis ; frequent bacteriologic and clinical appraisal is necessary 
during therapy o f chronic urina ry tract infections and may be required fo r several 
m onths after therapy has been com pleted; persistent infections may require prolonaed 
treatm ent. Doses less than those recom m ended shou ld  no t be employed.
DOSAGE FOR PATIENTS WITH IMPAIRED RENAL FUNCTION
Aet ^ o ^ h estir" atad creatin ine clearance o f less than 20 m l/m in /1 .7 3 m 2 the dose 
° ^  i ^ i ^ ^ ^ n?iUSt k0 ]^a*ved (see PRECAUTIONS). If serum creatinine values alone are 
available, the fo llow ing  fo rm ula  (based on sex, we ight and age o f the patient) m av be 
used to convert these values in to  creatinine clearance.
Males: Weight (kg) x (140 -  age)
72 x serum creatinine
Females: 0.85 x above value
RECONSTITUTION
The fo llow ing  table is provided as a guide fo r reconstituting CLAFORAN (cefotaxime 
sodium ) fo r both in tram uscular and intravenous adm inistration.
STRENGTH
Intramuscular
500 mg vial
1 g vial
2 g vial
Intravenous
500 mg vial
1 g vial
2 g vial
‘ Shake to dissolve.
Parenteral drug products should be inspected visually fo r particulate m atter and 
d iscoloration p rio r to adm in istration. Solutions o f CLAFORAN range from  ligh t ye llow  
to  amber, depending on concentration and diluent used. The dry powder as we ll as 
solutions tend to  darken, depending on storage conditions.
For intramuscular use: CLAFORAN should be reconstituted on ly  w ith  Sterile Water fo r 
in jection in accordance w ith  the volum es recommended in the preceding table.
For intravenous bolus use- 500 mg, 1 gram  and 2 gram vials should be reconstituted
CTAm e3St 10 m any ° * the so*u tions recommended under COMPATIBILITY/ o I A d ILI t y .
For intravenous infusion use: 1 o r 2 gram s o f CLAFORAN may be reconstituted
w ith  50 or 100 m l o f any o f the so lu tions recommended under COMPATIBILITY/STABILITY.
ADMINISTRATION
Intramuscular: CLAFORAN (cefotaxim e sodium ) should be in jected we ll w ith in  the body 
ot a relative ly large muscle such as the upper outer quadrant o f the buttock (i.e , gluteus 
m axim us); aspiration is necessary to  avoid inadvertent in jection in to a blood vessel. 
Intravenous: The intravenous route is preferable fo r patients w ith  bacteremia, bacterial 
septicemia, or other severe or life-threatening infections, or fo r patients who may be 
poor risks because o f lowered resistance resulting from  such deb ilita ting conditions as 
m alnutrition , traum a, surgery, diabetes, heart failure, or malignancy, particularly if 
shock is present o r im pending.
For bolus adm in istration a so lution conta in ing 1 gram or 2 grams o f CLAFORAN can be 
in jected over a period o f three to five m inutes. Using an infusion system, it may also be 
given over a longer period o f tim e through the tubing system by which the patient may 
be receiving other in travenous solutions. Butterfly® or scalp vein type needles are
* ° r .th,s tYP® of in fusion. However, during infusion o f the solution containing 
CLAFORAN, it is advisable to  discontinue tem porarily  the adm inistration o f other 
solutions at the same site.
COMPATIBILITY AND STABILITY
CLAFORAN (cefotaxime sodium ) m ay be reconstituted w ith  any o f the fo llow inq  and 
should be used fresh ly prepared:
Sterile Water fo r Injection 
Sodium  Chloride Injection B.P.
5% Dextrose Injection B.P.
Dextrose and Sodium  Chloride Injection 
Compound Sodium  Lactate Injection B.P.
If a solution m ust be stored, on ly  the so lution prepared w ith  Sterile Water fo r Injection 
m ay be kept under refrigera tion (below  5°C) fo r not longer than 24 hours. Any unused 
solutions should be discarded.
CLAFORAN is com patible w ith  1 % lignocaine. O nly freshly prepared solutions should 
be used. CLAFORAN solutions exh ib it m axim um  stability in the pH 5-7 range.
A solution o f 1 gram o f CLAFORAN in 14 m l o f Sterile Water fo r Injection is isotonic. 
Solutions o f CLAFORAN m ust not be adm ixed w ith  am inoglycoside solutions. If 
CLAFORAN and am inoglycosides are to be administered to the same patient, they must 
be administered separately and not as a m ixed injection.
DOSAGE FORMS
CLAFORAN (cefotaxime sodium ) is supplied as a sterile, white to  pale ye llow  powder in 
vials containing 500 mg, 1.0 gram  and 2.0 gram s of cefotaxime sodium (expressed as 
acid on a dry basis).
CLAFORAN in the dry state should be stored at room temperature (below 30°C) 
protected from  ligh t and heat. So lutions o f CLAFORAN range from  light ye llow  to 
amber, depending on concentration and the diluent used. The solutions tend to darken 
depending on storage cond itions and should be protected from  elevated temperatures 
and excessive light.
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